[
  {
    "bcr_patient_uuid": "30a1fe5e-5b12-472c-aa86-c2db8167ab23",
    "patient_ID": "TCGA.02.0001",
    "bcr_drug_barcode": "TCGA-02-0001-D22170",
    "bcr_drug_uuid": "2a1a1dd1-cc4a-4bf3-82b6-731e4ec7fcdd",
    "form_completion_date": "2009-4-3",
    "pharmaceutical_therapy_drug_name": "CELEBREX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 278,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "30a1fe5e-5b12-472c-aa86-c2db8167ab23",
    "patient_ID": "TCGA.02.0001",
    "bcr_drug_barcode": "TCGA-02-0001-D22171",
    "bcr_drug_uuid": "d3b26cd2-fb66-4ec7-8314-698391885e0e",
    "form_completion_date": "2009-4-3",
    "pharmaceutical_therapy_drug_name": "CRA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 278,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "30a1fe5e-5b12-472c-aa86-c2db8167ab23",
    "patient_ID": "TCGA.02.0001",
    "bcr_drug_barcode": "TCGA-02-0001-D22173",
    "bcr_drug_uuid": "5a058cdd-9bef-421b-a0a9-c8e7f3cd6d7e",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "CELEBREX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "30a1fe5e-5b12-472c-aa86-c2db8167ab23",
    "patient_ID": "TCGA.02.0001",
    "bcr_drug_barcode": "TCGA-02-0001-D22172",
    "bcr_drug_uuid": "a1cf26d0-3ef0-4a24-a5e9-4ff9b547b359",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "CIS RETINOIC ACID",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "df3c1d61-79c1-43e9-971a-8029497ffeab",
    "patient_ID": "TCGA.02.0003",
    "bcr_drug_barcode": "TCGA-02-0003-D22177",
    "bcr_drug_uuid": "002b8484-0175-4f88-bef8-302dcc58cbec",
    "form_completion_date": "2009-4-2",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 80
  },
  {
    "bcr_patient_uuid": "3ac8f759-2df0-4ef5-913f-ce05b8dd8937",
    "patient_ID": "TCGA.02.0004",
    "bcr_drug_barcode": "TCGA-02-0004-D22181",
    "bcr_drug_uuid": "e339b977-4671-400c-b0b3-a782471c671a",
    "form_completion_date": "2009-4-7",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "3ac8f759-2df0-4ef5-913f-ce05b8dd8937",
    "patient_ID": "TCGA.02.0004",
    "bcr_drug_barcode": "TCGA-02-0004-D22182",
    "bcr_drug_uuid": "2e973179-037d-49cc-a384-de00ea937af0",
    "form_completion_date": "2009-4-7",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "98714d95-b62e-4f34-9cd1-91542da463eb",
    "patient_ID": "TCGA.02.0006",
    "bcr_drug_barcode": "TCGA-02-0006-D22186",
    "bcr_drug_uuid": "320ce724-3c10-45fb-88c3-371db663e082",
    "form_completion_date": "2009-3-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "days_to_drug_end": 148,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "98714d95-b62e-4f34-9cd1-91542da463eb",
    "patient_ID": "TCGA.02.0006",
    "bcr_drug_barcode": "TCGA-02-0006-D22188",
    "bcr_drug_uuid": "92099a94-6caa-4884-816f-3debbd48ffea",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "98714d95-b62e-4f34-9cd1-91542da463eb",
    "patient_ID": "TCGA.02.0006",
    "bcr_drug_barcode": "TCGA-02-0006-D22187",
    "bcr_drug_uuid": "d60942f5-44e9-4ed9-b1b6-c5ddcc322fe2",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "CIS RETINOIC ACID",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "fb75eb9d-05be-4e6b-a515-f39efb15e66c",
    "patient_ID": "TCGA.02.0007",
    "bcr_drug_barcode": "TCGA-02-0007-D22193",
    "bcr_drug_uuid": "1381035b-2efb-4798-9d74-df273767cc70",
    "form_completion_date": "2009-4-2",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 338,
    "drug_cycles": 5,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "fb75eb9d-05be-4e6b-a515-f39efb15e66c",
    "patient_ID": "TCGA.02.0007",
    "bcr_drug_barcode": "TCGA-02-0007-D22192",
    "bcr_drug_uuid": "bea568d6-0832-4265-8059-36333799bf64",
    "form_completion_date": "2009-4-2",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 338,
    "drug_cycles": 5,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "45a58ede-e7a4-424d-851e-e6a4062e46e4",
    "patient_ID": "TCGA.02.0010",
    "bcr_drug_barcode": "TCGA-02-0010-D22199",
    "bcr_drug_uuid": "905a344f-2c01-4d7e-8827-0e95ee366cc6",
    "form_completion_date": "2009-3-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 509,
    "days_to_drug_end": 569,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "45a58ede-e7a4-424d-851e-e6a4062e46e4",
    "patient_ID": "TCGA.02.0010",
    "bcr_drug_barcode": "TCGA-02-0010-D22201",
    "bcr_drug_uuid": "5f34c085-4d08-4a72-965c-0b86567bcad9",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "THALIDOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "45a58ede-e7a4-424d-851e-e6a4062e46e4",
    "patient_ID": "TCGA.02.0010",
    "bcr_drug_barcode": "TCGA-02-0010-D22200",
    "bcr_drug_uuid": "2efba21c-1f13-4b86-9f24-048e1a28bb39",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "CPT 11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "33ae5566-3c72-4cae-b516-1708db090e32",
    "patient_ID": "TCGA.02.0011",
    "bcr_drug_barcode": "TCGA-02-0011-D22205",
    "bcr_drug_uuid": "6b9428b1-a33e-420e-b8de-81a7ada75fbc",
    "form_completion_date": "2009-4-2",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "33ae5566-3c72-4cae-b516-1708db090e32",
    "patient_ID": "TCGA.02.0011",
    "bcr_drug_barcode": "TCGA-02-0011-D22206",
    "bcr_drug_uuid": "0335931c-c730-41a7-bd44-6d0e7341b15c",
    "form_completion_date": "2009-4-2",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "CONCURRENT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "33ae5566-3c72-4cae-b516-1708db090e32",
    "patient_ID": "TCGA.02.0011",
    "bcr_drug_barcode": "TCGA-02-0011-D22207",
    "bcr_drug_uuid": "10bbdac1-8c83-465e-9627-b7a593e0412f",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "33ae5566-3c72-4cae-b516-1708db090e32",
    "patient_ID": "TCGA.02.0011",
    "bcr_drug_barcode": "TCGA-02-0011-D22208",
    "bcr_drug_uuid": "7096b979-87b4-421f-99e6-805c14dbcf71",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "IRESSA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "83264f30-94be-4573-b519-fb0b0fce36c3",
    "patient_ID": "TCGA.02.0014",
    "bcr_drug_barcode": "TCGA-02-0014-D22212",
    "bcr_drug_uuid": "77649890-b648-4970-869d-030d256135f8",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "ANTI NECPLATENS",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2349,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "83264f30-94be-4573-b519-fb0b0fce36c3",
    "patient_ID": "TCGA.02.0014",
    "bcr_drug_barcode": "TCGA-02-0014-D22213",
    "bcr_drug_uuid": "63cc60e9-7eec-4e8b-af9c-f4af6bb71f9f",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "697afd24-9632-4244-a455-f95b1fa4f0bf",
    "patient_ID": "TCGA.02.0015",
    "bcr_drug_barcode": "TCGA-02-0015-D22217",
    "bcr_drug_uuid": "6ae29bf7-1eea-4c1c-8fc4-b119b171d775",
    "form_completion_date": "2009-4-7",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFER",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "697afd24-9632-4244-a455-f95b1fa4f0bf",
    "patient_ID": "TCGA.02.0015",
    "bcr_drug_barcode": "TCGA-02-0015-D22218",
    "bcr_drug_uuid": "465b317b-ab2d-46d9-96b0-ad9c128e8c70",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "AE 788",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "adc0c9c3-002a-4fab-b148-e162020ad051",
    "patient_ID": "TCGA.02.0016",
    "bcr_drug_barcode": "TCGA-02-0016-D22222",
    "bcr_drug_uuid": "02b3ae53-67db-4d28-9fd3-a8cd06d06924",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1041,
    "drug_cycles": 30,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "d85fa9be-f7fb-407b-af46-31f495b210d6",
    "patient_ID": "TCGA.02.0021",
    "bcr_drug_barcode": "TCGA-02-0021-D22226",
    "bcr_drug_uuid": "d5499e0c-1439-4d9e-bd58-2d15a4171cd1",
    "form_completion_date": "2009-4-3",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 191,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "d85fa9be-f7fb-407b-af46-31f495b210d6",
    "patient_ID": "TCGA.02.0021",
    "bcr_drug_barcode": "TCGA-02-0021-D22227",
    "bcr_drug_uuid": "c3982d30-95ec-4ec4-b5f7-891f938fe23f",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "6 THIGUANINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "d85fa9be-f7fb-407b-af46-31f495b210d6",
    "patient_ID": "TCGA.02.0021",
    "bcr_drug_barcode": "TCGA-02-0021-D22228",
    "bcr_drug_uuid": "1af1c421-aad6-4864-a78c-e772e4f534c4",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "d85fa9be-f7fb-407b-af46-31f495b210d6",
    "patient_ID": "TCGA.02.0021",
    "bcr_drug_barcode": "TCGA-02-0021-D22229",
    "bcr_drug_uuid": "e2763140-683c-40fe-997b-1fa4b9a5f771",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "d85fa9be-f7fb-407b-af46-31f495b210d6",
    "patient_ID": "TCGA.02.0021",
    "bcr_drug_barcode": "TCGA-02-0021-D22230",
    "bcr_drug_uuid": "f1f3243d-83f2-48a5-9c99-5db40834e83c",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "CELEBREX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "c45e9e8b-35ab-4477-acdc-b18be0b3497d",
    "patient_ID": "TCGA.02.0023",
    "bcr_drug_barcode": "TCGA-02-0023-D22234",
    "bcr_drug_uuid": "381a9de3-54d9-46eb-98f1-e1d7a4b6c703",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": -9,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 34,
    "drug_cycles": 1,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "c45e9e8b-35ab-4477-acdc-b18be0b3497d",
    "patient_ID": "TCGA.02.0023",
    "bcr_drug_barcode": "TCGA-02-0023-D22235",
    "bcr_drug_uuid": "8519da40-12d5-436f-a778-c1332d5fa008",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "0553e60e-3510-417d-af8a-75947ebe8ab6",
    "patient_ID": "TCGA.02.0024",
    "bcr_drug_barcode": "TCGA-02-0024-D22239",
    "bcr_drug_uuid": "8d287c5f-fd9f-4917-9da8-613ebca66e18",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 152,
    "days_to_drug_end": 701,
    "drug_cycles": 18,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "6630e547-2596-4fb7-a657-c19497ff13b2",
    "patient_ID": "TCGA.02.0025",
    "bcr_drug_barcode": "TCGA-02-0025-D22243",
    "bcr_drug_uuid": "abf7ad8f-866f-4841-b560-a3d5f55b161d",
    "form_completion_date": "2009-4-7",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 656,
    "drug_cycles": 18,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "6630e547-2596-4fb7-a657-c19497ff13b2",
    "patient_ID": "TCGA.02.0025",
    "bcr_drug_barcode": "TCGA-02-0025-D22244",
    "bcr_drug_uuid": "7726c40b-c129-406c-9934-3045d33bef13",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "SARASAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "6630e547-2596-4fb7-a657-c19497ff13b2",
    "patient_ID": "TCGA.02.0025",
    "bcr_drug_barcode": "TCGA-02-0025-D22245",
    "bcr_drug_uuid": "817d99bb-c990-4362-98a0-9c2370b9de66",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "43d89926-2378-4498-bfba-6d6624d951b4",
    "patient_ID": "TCGA.02.0026",
    "bcr_drug_barcode": "TCGA-02-0026-D22249",
    "bcr_drug_uuid": "b0a8bcf7-62bc-4c7d-9f66-e5867bfa6d22",
    "form_completion_date": "2009-4-2",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 418,
    "drug_cycles": 11,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "43d89926-2378-4498-bfba-6d6624d951b4",
    "patient_ID": "TCGA.02.0026",
    "bcr_drug_barcode": "TCGA-02-0026-D22250",
    "bcr_drug_uuid": "a681c716-74f4-47db-a8d3-3779eb9efe16",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "GLEEVEC",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "43d89926-2378-4498-bfba-6d6624d951b4",
    "patient_ID": "TCGA.02.0026",
    "bcr_drug_barcode": "TCGA-02-0026-D22251",
    "bcr_drug_uuid": "89f039df-00db-4c1b-9783-b44ff5c92b40",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "HYDROXYUREA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "a1eca6d7-09ba-418a-a787-77be67e672dd",
    "patient_ID": "TCGA.02.0027",
    "bcr_drug_barcode": "TCGA-02-0027-D22255",
    "bcr_drug_uuid": "9df04f6d-09fb-40f9-acf0-f32ff126ca0b",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "days_to_drug_end": 256,
    "drug_cycles": 6,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1200
  },
  {
    "bcr_patient_uuid": "a1eca6d7-09ba-418a-a787-77be67e672dd",
    "patient_ID": "TCGA.02.0027",
    "bcr_drug_barcode": "TCGA-02-0027-D22257",
    "bcr_drug_uuid": "d7f5f3f3-8e59-4b35-94c3-02355e51025d",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "a1eca6d7-09ba-418a-a787-77be67e672dd",
    "patient_ID": "TCGA.02.0027",
    "bcr_drug_barcode": "TCGA-02-0027-D22259",
    "bcr_drug_uuid": "8a2601d6-1b2f-45d7-9bea-16481300dc74",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "CELEBREX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "a1eca6d7-09ba-418a-a787-77be67e672dd",
    "patient_ID": "TCGA.02.0027",
    "bcr_drug_barcode": "TCGA-02-0027-D22258",
    "bcr_drug_uuid": "030333c0-03b7-4284-900d-ac4ba551a88b",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "a1eca6d7-09ba-418a-a787-77be67e672dd",
    "patient_ID": "TCGA.02.0027",
    "bcr_drug_barcode": "TCGA-02-0027-D22256",
    "bcr_drug_uuid": "6280c8cf-29b4-4d74-b665-8af6ba6811f1",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "6 THIGUANINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "7ef0564e-d95d-4df5-969b-b204c207daea",
    "patient_ID": "TCGA.02.0028",
    "bcr_drug_barcode": "TCGA-02-0028-D22263",
    "bcr_drug_uuid": "1a26b01c-d85a-4b21-b938-11e16569d33b",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1939,
    "days_to_drug_end": 2304,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "7ef0564e-d95d-4df5-969b-b204c207daea",
    "patient_ID": "TCGA.02.0028",
    "bcr_drug_barcode": "TCGA-02-0028-D22266",
    "bcr_drug_uuid": "f7885e62-8263-4af0-9b44-e157a399e22a",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "7ef0564e-d95d-4df5-969b-b204c207daea",
    "patient_ID": "TCGA.02.0028",
    "bcr_drug_barcode": "TCGA-02-0028-D22264",
    "bcr_drug_uuid": "d9dcdba1-75c3-4b39-9ce8-567b0edde452",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "CELEBREX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "7ef0564e-d95d-4df5-969b-b204c207daea",
    "patient_ID": "TCGA.02.0028",
    "bcr_drug_barcode": "TCGA-02-0028-D22265",
    "bcr_drug_uuid": "b56285ab-465d-42e0-83bd-dbbee7c7f914",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "69205453-c504-4684-8d32-57c82efc679d",
    "patient_ID": "TCGA.02.0034",
    "bcr_drug_barcode": "TCGA-02-0034-D22272",
    "bcr_drug_uuid": "48589866-d698-42b7-9097-bc9ed8082b64",
    "form_completion_date": "2009-4-6",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 159,
    "drug_cycles": 2,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "fcce7f31-a392-4177-8dca-cfbe6e73fc2e",
    "patient_ID": "TCGA.02.0038",
    "bcr_drug_barcode": "TCGA-02-0038-D22278",
    "bcr_drug_uuid": "6ea926e4-df08-42ec-ade3-7652d154e9d7",
    "form_completion_date": "2009-4-6",
    "pharmaceutical_therapy_drug_name": "TANCEVA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 113,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 174,
    "drug_cycles": 2,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "de0cb811-bae0-407e-b8b3-97d1512bfa80",
    "patient_ID": "TCGA.02.0043",
    "bcr_drug_barcode": "TCGA-02-0043-D22284",
    "bcr_drug_uuid": "66509a77-13aa-4d5b-ab08-c57b60e5ae89",
    "form_completion_date": "2009-4-3",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 297,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 359,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "de0cb811-bae0-407e-b8b3-97d1512bfa80",
    "patient_ID": "TCGA.02.0043",
    "bcr_drug_barcode": "TCGA-02-0043-D22285",
    "bcr_drug_uuid": "9c1ea4cd-db68-48d9-ba9a-d9a5b654bffd",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "6 THIGUANINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "de0cb811-bae0-407e-b8b3-97d1512bfa80",
    "patient_ID": "TCGA.02.0043",
    "bcr_drug_barcode": "TCGA-02-0043-D22287",
    "bcr_drug_uuid": "f211d513-fa21-4154-916c-f25a36f97278",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "de0cb811-bae0-407e-b8b3-97d1512bfa80",
    "patient_ID": "TCGA.02.0043",
    "bcr_drug_barcode": "TCGA-02-0043-D22286",
    "bcr_drug_uuid": "7c4b6e2a-da96-45c9-90d1-74b0f4ab910e",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "de0cb811-bae0-407e-b8b3-97d1512bfa80",
    "patient_ID": "TCGA.02.0043",
    "bcr_drug_barcode": "TCGA-02-0043-D22288",
    "bcr_drug_uuid": "82d24b56-9ac3-43ae-8d2d-df2a7204a925",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "CELEBREX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "5a448bf3-8e87-4791-91f2-908307a32ed1",
    "patient_ID": "TCGA.02.0052",
    "bcr_drug_barcode": "TCGA-02-0052-D22300",
    "bcr_drug_uuid": "a6ff91bc-199f-4e27-ba88-8de1445c2128",
    "form_completion_date": "2009-4-6",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 204,
    "drug_cycles": 5,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "4df7d5e4-f762-4e80-b9d1-96ec21fb43ca",
    "patient_ID": "TCGA.02.0054",
    "bcr_drug_barcode": "TCGA-02-0054-D22304",
    "bcr_drug_uuid": "a0bdd31d-089a-4b13-8305-1569b7547024",
    "form_completion_date": "2009-4-2",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 73,
    "drug_cycles": 1,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "4df7d5e4-f762-4e80-b9d1-96ec21fb43ca",
    "patient_ID": "TCGA.02.0054",
    "bcr_drug_barcode": "TCGA-02-0054-D22307",
    "bcr_drug_uuid": "c0dc35a0-30a4-49a7-a186-77add0e2545d",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "4df7d5e4-f762-4e80-b9d1-96ec21fb43ca",
    "patient_ID": "TCGA.02.0054",
    "bcr_drug_barcode": "TCGA-02-0054-D22305",
    "bcr_drug_uuid": "a9985add-cc7a-494e-8c11-5dacb11645a4",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "6 THIGUANINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "4df7d5e4-f762-4e80-b9d1-96ec21fb43ca",
    "patient_ID": "TCGA.02.0054",
    "bcr_drug_barcode": "TCGA-02-0054-D22306",
    "bcr_drug_uuid": "8a13d934-4131-43f6-be8a-10e5f8f2d02b",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "4df7d5e4-f762-4e80-b9d1-96ec21fb43ca",
    "patient_ID": "TCGA.02.0054",
    "bcr_drug_barcode": "TCGA-02-0054-D22308",
    "bcr_drug_uuid": "f6d318a3-f616-4a92-ae44-3b884e19697c",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "CELEBREX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "da5f6940-e8ee-4fd1-a8da-4cd68e02e59c",
    "patient_ID": "TCGA.02.0055",
    "bcr_drug_barcode": "TCGA-02-0055-D22312",
    "bcr_drug_uuid": "5d44f37b-8705-452d-89a6-84e6213d425c",
    "form_completion_date": "2009-4-2",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": -112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 0,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "da5f6940-e8ee-4fd1-a8da-4cd68e02e59c",
    "patient_ID": "TCGA.02.0055",
    "bcr_drug_barcode": "TCGA-02-0055-D22313",
    "bcr_drug_uuid": "488d0b21-86b6-468f-bb9e-e982ee2ade6c",
    "form_completion_date": "2009-4-2",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": -112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 0,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "7ee03602-bfec-413d-a05b-609cf60c6481",
    "patient_ID": "TCGA.02.0057",
    "bcr_drug_barcode": "TCGA-02-0057-D22317",
    "bcr_drug_uuid": "e8923938-fe8f-452f-b16a-3dcb080bd1b2",
    "form_completion_date": "2009-4-3",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFER",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "7ee03602-bfec-413d-a05b-609cf60c6481",
    "patient_ID": "TCGA.02.0057",
    "bcr_drug_barcode": "TCGA-02-0057-D22318",
    "bcr_drug_uuid": "6cfc4787-75d0-4636-8070-28f88fd51a84",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "9734478b-05a2-4b5c-b8aa-9e6b0b0db02d",
    "patient_ID": "TCGA.02.0058",
    "bcr_drug_barcode": "TCGA-02-0058-D22322",
    "bcr_drug_uuid": "ed10899c-ef8d-46a2-ac37-405109f6d899",
    "form_completion_date": "2009-4-2",
    "pharmaceutical_therapy_drug_name": "TEMOZOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "drug_cycles": 2,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "686ac6b5-fdb2-417e-9e32-cbad7214e677",
    "patient_ID": "TCGA.02.0060",
    "bcr_drug_barcode": "TCGA-02-0060-D22328",
    "bcr_drug_uuid": "123720bd-30bc-45bd-a9d7-2676c2a7d56e",
    "form_completion_date": "2009-4-2",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "686ac6b5-fdb2-417e-9e32-cbad7214e677",
    "patient_ID": "TCGA.02.0060",
    "bcr_drug_barcode": "TCGA-02-0060-D22329",
    "bcr_drug_uuid": "ab324f3a-3f83-49d7-a42d-9012e081b67b",
    "form_completion_date": "2009-4-2",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 3,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "CONCURRENT",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "d0fe540c-8e4b-4d97-8966-5899dea8555e",
    "patient_ID": "TCGA.02.0064",
    "bcr_drug_barcode": "TCGA-02-0064-D22333",
    "bcr_drug_uuid": "f666732d-a31c-47c5-b37e-e9067348783e",
    "form_completion_date": "2009-4-6",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 358,
    "drug_cycles": 12,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "d0fe540c-8e4b-4d97-8966-5899dea8555e",
    "patient_ID": "TCGA.02.0064",
    "bcr_drug_barcode": "TCGA-02-0064-D22335",
    "bcr_drug_uuid": "d255a807-f73a-4875-9bed-acaaccf3b263",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "d0fe540c-8e4b-4d97-8966-5899dea8555e",
    "patient_ID": "TCGA.02.0064",
    "bcr_drug_barcode": "TCGA-02-0064-D22334",
    "bcr_drug_uuid": "4766dfa3-d9b1-4d6d-92ab-549b524bf532",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "CPT 11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "38771a9a-f8b1-4867-b540-56c7d9f5820a",
    "patient_ID": "TCGA.02.0068",
    "bcr_drug_barcode": "TCGA-02-0068-D22340",
    "bcr_drug_uuid": "233ae38d-fa55-4001-9c8c-8bfec436f961",
    "form_completion_date": "2009-4-2",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "drug_cycles": 3,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "38771a9a-f8b1-4867-b540-56c7d9f5820a",
    "patient_ID": "TCGA.02.0068",
    "bcr_drug_barcode": "TCGA-02-0068-D22339",
    "bcr_drug_uuid": "327833c2-eada-4472-a549-47e0aaf24a89",
    "form_completion_date": "2009-4-2",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "38771a9a-f8b1-4867-b540-56c7d9f5820a",
    "patient_ID": "TCGA.02.0068",
    "bcr_drug_barcode": "TCGA-02-0068-D22342",
    "bcr_drug_uuid": "154c9621-ed23-4ff5-bdfb-a072e5d1d9d2",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "38771a9a-f8b1-4867-b540-56c7d9f5820a",
    "patient_ID": "TCGA.02.0068",
    "bcr_drug_barcode": "TCGA-02-0068-D22341",
    "bcr_drug_uuid": "9c071a67-d256-4f59-8e18-026d5c078f30",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "CPT 11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "73b1136f-c4b6-472a-b21d-2c789bd53d26",
    "patient_ID": "TCGA.02.0069",
    "bcr_drug_barcode": "TCGA-02-0069-D22346",
    "bcr_drug_uuid": "6ff13c26-9e16-4a6f-b6d1-6e9a5da977dd",
    "form_completion_date": "2009-4-3",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 945,
    "drug_cycles": 24,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "73b1136f-c4b6-472a-b21d-2c789bd53d26",
    "patient_ID": "TCGA.02.0069",
    "bcr_drug_barcode": "TCGA-02-0069-D22347",
    "bcr_drug_uuid": "82e93428-1cad-47ee-aee2-47cf7ae9b9b3",
    "form_completion_date": "2009-4-3",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 945,
    "drug_cycles": 24,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "CONCURRENT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "863c285c-5b87-42b9-b8b3-1ae832a6ded3",
    "patient_ID": "TCGA.02.0070",
    "bcr_drug_barcode": "TCGA-02-0070-D22351",
    "bcr_drug_uuid": "e2ca146d-2379-4643-9f88-5d7c37b077e9",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 57,
    "drug_cycles": 1,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "281e1a57-9a8c-4fa0-ac5e-e5e1df7ef8e2",
    "patient_ID": "TCGA.02.0074",
    "bcr_drug_barcode": "TCGA-02-0074-D22358",
    "bcr_drug_uuid": "aeabf7d7-93f9-4e3e-96de-89cbb9d9c0c3",
    "form_completion_date": "2009-4-2",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 3,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "CONCURRENT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "281e1a57-9a8c-4fa0-ac5e-e5e1df7ef8e2",
    "patient_ID": "TCGA.02.0074",
    "bcr_drug_barcode": "TCGA-02-0074-D22357",
    "bcr_drug_uuid": "4a0cb621-9779-4919-94ff-84e3f54f5b60",
    "form_completion_date": "2009-4-2",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 3,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "b196f82b-ef3f-4e05-99f7-da5df65e691e",
    "patient_ID": "TCGA.02.0075",
    "bcr_drug_barcode": "TCGA-02-0075-D22362",
    "bcr_drug_uuid": "bd6a5572-393e-4f6b-a49d-281ad0a57957",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 36,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "5da36fd2-0cea-41b8-90dc-b94c3c28cbd9",
    "patient_ID": "TCGA.02.0080",
    "bcr_drug_barcode": "TCGA-02-0080-D22368",
    "bcr_drug_uuid": "5ee34649-1c83-49ef-b922-065a0f155cbd",
    "form_completion_date": "2009-4-6",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 352,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 443,
    "drug_cycles": 4,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "5da36fd2-0cea-41b8-90dc-b94c3c28cbd9",
    "patient_ID": "TCGA.02.0080",
    "bcr_drug_barcode": "TCGA-02-0080-D22369",
    "bcr_drug_uuid": "0ef5ac75-6090-4b0d-bb21-2fe3bc5aacbe",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "CIS RETINOIC ACID",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "b72fab50-aed2-48e7-b6ad-2a5bc7157cfd",
    "patient_ID": "TCGA.02.0083",
    "bcr_drug_barcode": "TCGA-02-0083-D22373",
    "bcr_drug_uuid": "7d85d8f8-72b4-4df5-a4b2-5c11a91aeb35",
    "form_completion_date": "2009-3-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "days_to_drug_end": 404,
    "drug_cycles": 11,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "2deec528-4550-47b2-9a0d-cac7eeb24f3e",
    "patient_ID": "TCGA.02.0085",
    "bcr_drug_barcode": "TCGA-02-0085-D22379",
    "bcr_drug_uuid": "ed242d21-f512-4d71-b84a-d984ab74d85a",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 740,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 786,
    "drug_cycles": 1,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "8e3fbea7-d22e-40fc-8031-58fe6fe091bb",
    "patient_ID": "TCGA.02.0086",
    "bcr_drug_barcode": "TCGA-02-0086-D22383",
    "bcr_drug_uuid": "76bee23b-29eb-45a4-97b8-071b3128ed10",
    "form_completion_date": "2009-3-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "days_to_drug_end": 85,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "8e3fbea7-d22e-40fc-8031-58fe6fe091bb",
    "patient_ID": "TCGA.02.0086",
    "bcr_drug_barcode": "TCGA-02-0086-D22386",
    "bcr_drug_uuid": "10da5014-8aa5-4d41-973f-9fe43fe804d3",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8e3fbea7-d22e-40fc-8031-58fe6fe091bb",
    "patient_ID": "TCGA.02.0086",
    "bcr_drug_barcode": "TCGA-02-0086-D22385",
    "bcr_drug_uuid": "1d2d1b52-3d71-4c73-9a43-42b721cf8ad3",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8e3fbea7-d22e-40fc-8031-58fe6fe091bb",
    "patient_ID": "TCGA.02.0086",
    "bcr_drug_barcode": "TCGA-02-0086-D22384",
    "bcr_drug_uuid": "9aeaaf2c-b830-4af5-ace4-7f7d80dc2b49",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "6 THIGUANINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8e3fbea7-d22e-40fc-8031-58fe6fe091bb",
    "patient_ID": "TCGA.02.0086",
    "bcr_drug_barcode": "TCGA-02-0086-D22387",
    "bcr_drug_uuid": "436a7dc4-a65d-4f49-879f-6aad1651f850",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "CELEBREX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "dfaae397-52c3-4d29-b665-971969e23432",
    "patient_ID": "TCGA.02.0089",
    "bcr_drug_barcode": "TCGA-02-0089-D22393",
    "bcr_drug_uuid": "3b085f46-3808-4f78-9c76-3ca8b5c429ea",
    "form_completion_date": "2009-4-3",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 282,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1400
  },
  {
    "bcr_patient_uuid": "883dc176-925a-44f7-9ec8-e0cce33c2a54",
    "patient_ID": "TCGA.02.0099",
    "bcr_drug_barcode": "TCGA-02-0099-D22397",
    "bcr_drug_uuid": "e2a47f17-36bc-4cba-a6fa-47c158296e09",
    "form_completion_date": "2009-4-6",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": -260,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": -124,
    "drug_cycles": 3,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "883dc176-925a-44f7-9ec8-e0cce33c2a54",
    "patient_ID": "TCGA.02.0099",
    "bcr_drug_barcode": "TCGA-02-0099-D22398",
    "bcr_drug_uuid": "c2d328e7-b288-4776-9bbf-04b11d4f7d59",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "f3e57166-c428-4a44-9396-679e3a2b16a2",
    "patient_ID": "TCGA.02.0102",
    "bcr_drug_barcode": "TCGA-02-0102-D22402",
    "bcr_drug_uuid": "f05609fb-b7bf-4808-ab41-c11964b611a2",
    "form_completion_date": "2009-4-3",
    "pharmaceutical_therapy_drug_name": "PROCARBIZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 158,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 402,
    "drug_cycles": 5,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "f3e57166-c428-4a44-9396-679e3a2b16a2",
    "patient_ID": "TCGA.02.0102",
    "bcr_drug_barcode": "TCGA-02-0102-D22404",
    "bcr_drug_uuid": "3c73d8fc-2b92-4c36-bf08-24950b1a0b67",
    "form_completion_date": "2009-4-3",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 158,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 402,
    "drug_cycles": 5,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1.4
  },
  {
    "bcr_patient_uuid": "f3e57166-c428-4a44-9396-679e3a2b16a2",
    "patient_ID": "TCGA.02.0102",
    "bcr_drug_barcode": "TCGA-02-0102-D22403",
    "bcr_drug_uuid": "acf036aa-2cb4-4117-afc5-507b3656dea9",
    "form_completion_date": "2009-4-3",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 158,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 402,
    "drug_cycles": 5,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "db38e6b7-102f-4670-875f-b327790c70e4",
    "patient_ID": "TCGA.02.0104",
    "bcr_drug_barcode": "TCGA-02-0104-D22409",
    "bcr_drug_uuid": "219dee18-a9b8-4cdc-a463-88879617d73c",
    "form_completion_date": "2009-4-7",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1536,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1786,
    "drug_cycles": 9,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "db38e6b7-102f-4670-875f-b327790c70e4",
    "patient_ID": "TCGA.02.0104",
    "bcr_drug_barcode": "TCGA-02-0104-D22408",
    "bcr_drug_uuid": "34d27c68-08bc-44aa-89c8-4555fb49057f",
    "form_completion_date": "2009-4-7",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1536,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1786,
    "drug_cycles": 9,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "d0b7d446-5488-41a2-a22a-c1e00a009482",
    "patient_ID": "TCGA.02.0106",
    "bcr_drug_barcode": "TCGA-02-0106-D22413",
    "bcr_drug_uuid": "0ec06cf1-d0ed-47c5-8646-3bbe5b3eb030",
    "form_completion_date": "2009-4-2",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "drug_cycles": 5,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "d0b7d446-5488-41a2-a22a-c1e00a009482",
    "patient_ID": "TCGA.02.0106",
    "bcr_drug_barcode": "TCGA-02-0106-D22414",
    "bcr_drug_uuid": "f6d0c953-dc0b-4d9f-83ec-4cc1624cbdb8",
    "form_completion_date": "2009-4-2",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "drug_cycles": 5,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 500
  },
  {
    "bcr_patient_uuid": "d0b7d446-5488-41a2-a22a-c1e00a009482",
    "patient_ID": "TCGA.02.0106",
    "bcr_drug_barcode": "TCGA-02-0106-D22415",
    "bcr_drug_uuid": "4c7d5f84-ebce-4c62-b160-6fbfd6c10432",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "IL 13",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "372a4cc6-8fc9-4157-9cdc-fe020b176249",
    "patient_ID": "TCGA.02.0107",
    "bcr_drug_barcode": "TCGA-02-0107-D22419",
    "bcr_drug_uuid": "9332ab3e-d1f2-49cd-9c2e-cb27c9b962ff",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 100,
    "days_to_drug_end": 130,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "09ddf661-25fd-4baa-a1e8-bf90b2bb1d31",
    "patient_ID": "TCGA.02.0111",
    "bcr_drug_barcode": "TCGA-02-0111-D22423",
    "bcr_drug_uuid": "f0537f98-6c41-4965-984e-4f548827b55b",
    "form_completion_date": "2009-5-21",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 74,
    "drug_cycles": 1,
    "drug_units": "UG/M2",
    "drug_tota_dose_units": "UG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "b363b624-a5b0-46e4-b671-8813cc12eaf4",
    "patient_ID": "TCGA.02.0113",
    "bcr_drug_barcode": "TCGA-02-0113-D22427",
    "bcr_drug_uuid": "c73c0ef0-22b3-4917-94df-d02087332304",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1930,
    "days_to_drug_end": 2628,
    "drug_cycles": 24,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4800
  },
  {
    "bcr_patient_uuid": "658c8e31-2c60-40f0-ab25-d0d0168647db",
    "patient_ID": "TCGA.02.0114",
    "bcr_drug_barcode": "TCGA-02-0114-D22433",
    "bcr_drug_uuid": "37a224b5-8bb9-438b-91cf-83174264c136",
    "form_completion_date": "2009-4-3",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 197,
    "drug_cycles": 4,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1.4
  },
  {
    "bcr_patient_uuid": "658c8e31-2c60-40f0-ab25-d0d0168647db",
    "patient_ID": "TCGA.02.0114",
    "bcr_drug_barcode": "TCGA-02-0114-D22431",
    "bcr_drug_uuid": "1f2ad536-aa3a-4db1-88f4-3451364bfa13",
    "form_completion_date": "2009-4-3",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 197,
    "drug_cycles": 4,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "658c8e31-2c60-40f0-ab25-d0d0168647db",
    "patient_ID": "TCGA.02.0114",
    "bcr_drug_barcode": "TCGA-02-0114-D22432",
    "bcr_drug_uuid": "8683efcd-7496-4354-8e28-7f3ec63b2641",
    "form_completion_date": "2009-4-3",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 197,
    "drug_cycles": 4,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "658c8e31-2c60-40f0-ab25-d0d0168647db",
    "patient_ID": "TCGA.02.0114",
    "bcr_drug_barcode": "TCGA-02-0114-D22434",
    "bcr_drug_uuid": "67f47f28-a7dd-4942-b2b3-6020d81f8765",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "658c8e31-2c60-40f0-ab25-d0d0168647db",
    "patient_ID": "TCGA.02.0114",
    "bcr_drug_barcode": "TCGA-02-0114-D22435",
    "bcr_drug_uuid": "43da4650-5357-4f9a-91e7-cb34251f506b",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "c9b25b65-ef41-4ffb-8b1c-a9e3a3c5cd8c",
    "patient_ID": "TCGA.02.0115",
    "bcr_drug_barcode": "TCGA-02-0115-D22439",
    "bcr_drug_uuid": "bc1308f0-4580-4cfe-a65d-a1414063fc3e",
    "form_completion_date": "2009-4-3",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c9b25b65-ef41-4ffb-8b1c-a9e3a3c5cd8c",
    "patient_ID": "TCGA.02.0115",
    "bcr_drug_barcode": "TCGA-02-0115-D22440",
    "bcr_drug_uuid": "e7518de3-9dde-4b08-8737-0ed473c88314",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "e117fe84-f003-40a4-96b5-8e26d0513151",
    "patient_ID": "TCGA.02.0116",
    "bcr_drug_barcode": "TCGA-02-0116-D22444",
    "bcr_drug_uuid": "ba2e9f4d-4ffb-4af0-b77b-5b95795ecac5",
    "form_completion_date": "2009-4-2",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 388,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 900
  },
  {
    "bcr_patient_uuid": "e117fe84-f003-40a4-96b5-8e26d0513151",
    "patient_ID": "TCGA.02.0116",
    "bcr_drug_barcode": "TCGA-02-0116-D22445",
    "bcr_drug_uuid": "c8c94551-3b0f-456f-9e2d-fca13581fdd0",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "GLEEVEC",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "e117fe84-f003-40a4-96b5-8e26d0513151",
    "patient_ID": "TCGA.02.0116",
    "bcr_drug_barcode": "TCGA-02-0116-D22446",
    "bcr_drug_uuid": "de987cca-547e-43b8-9480-2ce3805760bc",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "HYDOXYUREA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "96fa386d-f930-45da-96ba-e7ca3f9de5b2",
    "patient_ID": "TCGA.02.0289",
    "bcr_drug_barcode": "TCGA-02-0289-D22464",
    "bcr_drug_uuid": "c4cfa885-fa73-4e9e-b8a8-5ccc78cf2d76",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "96fa386d-f930-45da-96ba-e7ca3f9de5b2",
    "patient_ID": "TCGA.02.0289",
    "bcr_drug_barcode": "TCGA-02-0289-D22465",
    "bcr_drug_uuid": "12bef7f0-c881-4493-90d0-cc69ab55f33b",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "96fa386d-f930-45da-96ba-e7ca3f9de5b2",
    "patient_ID": "TCGA.02.0289",
    "bcr_drug_barcode": "TCGA-02-0289-D22466",
    "bcr_drug_uuid": "21ee9961-fca0-4eb2-a3d9-592399d70254",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 2,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1.4
  },
  {
    "bcr_patient_uuid": "74a70685-d95e-45a5-b8a9-80106c8b1bd7",
    "patient_ID": "TCGA.02.0290",
    "bcr_drug_barcode": "TCGA-02-0290-D22471",
    "bcr_drug_uuid": "b3816dc9-5c68-4b1a-9911-3a24e466c1d5",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "74a70685-d95e-45a5-b8a9-80106c8b1bd7",
    "patient_ID": "TCGA.02.0290",
    "bcr_drug_barcode": "TCGA-02-0290-D22470",
    "bcr_drug_uuid": "02f26633-30d0-49d2-8a21-a68c1ff86140",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "74a70685-d95e-45a5-b8a9-80106c8b1bd7",
    "patient_ID": "TCGA.02.0290",
    "bcr_drug_barcode": "TCGA-02-0290-D22472",
    "bcr_drug_uuid": "46b8272d-8180-4cf2-a019-5c3d2d4ef9f0",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1.4
  },
  {
    "bcr_patient_uuid": "6879e9da-dacf-48b3-8e95-760796f96a1b",
    "patient_ID": "TCGA.02.0317",
    "bcr_drug_barcode": "TCGA-02-0317-D22476",
    "bcr_drug_uuid": "91d4a74b-253a-403c-a8b0-d11fe903c32b",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "ANTI NEOPASTONS",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "days_to_drug_end": 176,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f49b3e5a-6d40-4018-86ae-8396455d8878",
    "patient_ID": "TCGA.02.0325",
    "bcr_drug_barcode": "TCGA-02-0325-D22484",
    "bcr_drug_uuid": "703967d3-9a15-4d3c-8d94-c5e0fcc3ca72",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "days_to_drug_end": 115,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "f49b3e5a-6d40-4018-86ae-8396455d8878",
    "patient_ID": "TCGA.02.0325",
    "bcr_drug_barcode": "TCGA-02-0325-D22485",
    "bcr_drug_uuid": "6727dd81-6557-46ae-8e31-88e03580df5b",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "days_to_drug_end": 115,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "f49b3e5a-6d40-4018-86ae-8396455d8878",
    "patient_ID": "TCGA.02.0325",
    "bcr_drug_barcode": "TCGA-02-0325-D22486",
    "bcr_drug_uuid": "43404af4-1315-44ad-b278-38539c39ab3a",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "days_to_drug_end": 115,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1.4
  },
  {
    "bcr_patient_uuid": "f49b3e5a-6d40-4018-86ae-8396455d8878",
    "patient_ID": "TCGA.02.0325",
    "bcr_drug_barcode": "TCGA-02-0325-D22487",
    "bcr_drug_uuid": "fa3bc8e6-6871-4d45-8216-b08c462cd221",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "CIS RETINOIC ACID",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "799bfae2-b189-43bc-a3bc-d425cd4fe556",
    "patient_ID": "TCGA.02.0330",
    "bcr_drug_barcode": "TCGA-02-0330-D22494",
    "bcr_drug_uuid": "f3701df0-3721-45d6-a038-3c24661f7f16",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 107,
    "days_to_drug_end": 137,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "799bfae2-b189-43bc-a3bc-d425cd4fe556",
    "patient_ID": "TCGA.02.0330",
    "bcr_drug_barcode": "TCGA-02-0330-D22493",
    "bcr_drug_uuid": "4e0aebfc-df13-42fc-a793-d5d4dc99cf23",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 107,
    "days_to_drug_end": 137,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "799bfae2-b189-43bc-a3bc-d425cd4fe556",
    "patient_ID": "TCGA.02.0330",
    "bcr_drug_barcode": "TCGA-02-0330-D22495",
    "bcr_drug_uuid": "bae1d58e-c5b0-41af-a5f5-49bad9bdc115",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 107,
    "days_to_drug_end": 137,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1.4
  },
  {
    "bcr_patient_uuid": "799bfae2-b189-43bc-a3bc-d425cd4fe556",
    "patient_ID": "TCGA.02.0330",
    "bcr_drug_barcode": "TCGA-02-0330-D22496",
    "bcr_drug_uuid": "9c66da29-90f0-4d32-807d-2e26102af9ab",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "799bfae2-b189-43bc-a3bc-d425cd4fe556",
    "patient_ID": "TCGA.02.0330",
    "bcr_drug_barcode": "TCGA-02-0330-D22497",
    "bcr_drug_uuid": "27d1c399-192b-4a14-b7bf-92b2c5736d9b",
    "form_completion_date": "2010-1-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "54b4c27e-aaa6-4a79-b289-0ba251a5460e",
    "patient_ID": "TCGA.02.0332",
    "bcr_drug_barcode": "TCGA-02-0332-D22503",
    "bcr_drug_uuid": "932cf03a-0537-48ff-b690-b3731334f7ed",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 99,
    "days_to_drug_end": 230,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1.4
  },
  {
    "bcr_patient_uuid": "54b4c27e-aaa6-4a79-b289-0ba251a5460e",
    "patient_ID": "TCGA.02.0332",
    "bcr_drug_barcode": "TCGA-02-0332-D22501",
    "bcr_drug_uuid": "12cba36b-aeac-4513-8da8-b6a26ca5dc63",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 99,
    "days_to_drug_end": 230,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "54b4c27e-aaa6-4a79-b289-0ba251a5460e",
    "patient_ID": "TCGA.02.0332",
    "bcr_drug_barcode": "TCGA-02-0332-D22502",
    "bcr_drug_uuid": "3210e4e5-05bd-439c-bfce-71eb25c4eb6a",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 99,
    "days_to_drug_end": 230,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "19146c75-8f41-44f3-8423-7db4d0d0efe1",
    "patient_ID": "TCGA.02.0337",
    "bcr_drug_barcode": "TCGA-02-0337-D22509",
    "bcr_drug_uuid": "e042cb9c-02d7-4209-8668-bdd60e2d46fc",
    "form_completion_date": "2009-4-2",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 185,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 428,
    "drug_cycles": 5,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "19146c75-8f41-44f3-8423-7db4d0d0efe1",
    "patient_ID": "TCGA.02.0337",
    "bcr_drug_barcode": "TCGA-02-0337-D22510",
    "bcr_drug_uuid": "3015f1ab-862e-42e0-a887-01e34aa9e664",
    "form_completion_date": "2009-4-2",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 185,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 434,
    "drug_cycles": 5,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "19146c75-8f41-44f3-8423-7db4d0d0efe1",
    "patient_ID": "TCGA.02.0337",
    "bcr_drug_barcode": "TCGA-02-0337-D22511",
    "bcr_drug_uuid": "7caf9972-ebaa-4d55-83e5-fd60607c4d9e",
    "form_completion_date": "2009-4-2",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 185,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 428,
    "drug_cycles": 5,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1.4
  },
  {
    "bcr_patient_uuid": "1e63e985-fbb7-4e43-93a5-e718d0b4ad09",
    "patient_ID": "TCGA.02.0432",
    "bcr_drug_barcode": "TCGA-02-0432-D22523",
    "bcr_drug_uuid": "4b421965-8a83-48c3-821e-6abb9028825b",
    "form_completion_date": "2009-4-2",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 329,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "502f47db-7d3d-4081-ab15-1c38e7e78652",
    "patient_ID": "TCGA.02.0440",
    "bcr_drug_barcode": "TCGA-02-0440-D22529",
    "bcr_drug_uuid": "39e50ea9-ae50-44b3-a6ee-6a828ccaace4",
    "form_completion_date": "2009-5-21",
    "pharmaceutical_therapy_drug_name": "CIS-RETINOIC ACID",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 269,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 288,
    "drug_cycles": 1,
    "drug_units": "UG/M2",
    "drug_tota_dose_units": "UG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "c4171de5-8dac-44bd-a6eb-174f9451dbb7",
    "patient_ID": "TCGA.02.2466",
    "bcr_drug_barcode": "TCGA-02-2466-D22539",
    "bcr_drug_uuid": "9e4408c4-80d4-4f61-89b8-aeb1d4019c89",
    "form_completion_date": "2010-4-9",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 71,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c4171de5-8dac-44bd-a6eb-174f9451dbb7",
    "patient_ID": "TCGA.02.2466",
    "bcr_drug_barcode": "TCGA-02-2466-D22540",
    "bcr_drug_uuid": "e22d9741-01d5-4cb1-85f4-5c799debe439",
    "form_completion_date": "2010-4-9",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 102,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e948d951-9299-4dec-9772-60b4ac3569cb",
    "patient_ID": "TCGA.02.2470",
    "bcr_drug_barcode": "TCGA-02-2470-D22545",
    "bcr_drug_uuid": "ca19a225-58be-46c6-87bf-451aa203a916",
    "form_completion_date": "2010-4-9",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 100,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 183,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e948d951-9299-4dec-9772-60b4ac3569cb",
    "patient_ID": "TCGA.02.2470",
    "bcr_drug_barcode": "TCGA-02-2470-D22544",
    "bcr_drug_uuid": "0f1a9c38-5268-4002-9ca5-fb58a32560c5",
    "form_completion_date": "2010-4-9",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 99,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a2ac9937-f351-4d78-9261-264bf6c21e0c",
    "patient_ID": "TCGA.02.2483",
    "bcr_drug_barcode": "TCGA-02-2483-D22549",
    "bcr_drug_uuid": "1dfce847-d041-4c1c-adfd-1334273f24b4",
    "form_completion_date": "2010-4-9",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a2ac9937-f351-4d78-9261-264bf6c21e0c",
    "patient_ID": "TCGA.02.2483",
    "bcr_drug_barcode": "TCGA-02-2483-D22550",
    "bcr_drug_uuid": "162e3959-b282-44ef-af11-884de20d51af",
    "form_completion_date": "2010-4-9",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 466,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "521ea765-1bd1-423d-a75d-091243df37a9",
    "patient_ID": "TCGA.02.2485",
    "bcr_drug_barcode": "TCGA-02-2485-D22554",
    "bcr_drug_uuid": "a18761a0-c227-4d0c-b4c7-9270e3d86830",
    "form_completion_date": "2010-4-9",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "521ea765-1bd1-423d-a75d-091243df37a9",
    "patient_ID": "TCGA.02.2485",
    "bcr_drug_barcode": "TCGA-02-2485-D22555",
    "bcr_drug_uuid": "b8b49c28-df16-4cd8-bf0f-5de4714280c3",
    "form_completion_date": "2010-4-9",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 186,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "79a68b32-29a3-47bf-9b2b-643ec7323d73",
    "patient_ID": "TCGA.02.2486",
    "bcr_drug_barcode": "TCGA-02-2486-D22560",
    "bcr_drug_uuid": "e72519ec-4208-49ba-b7c5-4a57556468e1",
    "form_completion_date": "2010-4-9",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 440,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "79a68b32-29a3-47bf-9b2b-643ec7323d73",
    "patient_ID": "TCGA.02.2486",
    "bcr_drug_barcode": "TCGA-02-2486-D22559",
    "bcr_drug_uuid": "cc49574c-adf2-4c38-850d-82c34a75c392",
    "form_completion_date": "2010-4-9",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 66,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "79a68b32-29a3-47bf-9b2b-643ec7323d73",
    "patient_ID": "TCGA.02.2486",
    "bcr_drug_barcode": "TCGA-02-2486-D22561",
    "bcr_drug_uuid": "14647534-0503-45c7-a4fd-c663698cc041",
    "form_completion_date": "2010-4-9",
    "pharmaceutical_therapy_drug_name": "ACCUTANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 130,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 230,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 40,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "2cb9975f-2d1e-4c74-867f-8b151c22b246",
    "patient_ID": "TCGA.06.0119",
    "bcr_drug_barcode": "TCGA-06-0119-D40091",
    "bcr_drug_uuid": "692851A9-BEB3-4552-BF4B-84D8D2CDF7AA",
    "form_completion_date": "2013-2-12",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 58
  },
  {
    "bcr_patient_uuid": "c2651206-36c5-4f3c-a0d6-3ffc07b27a93",
    "patient_ID": "TCGA.06.0124",
    "bcr_drug_barcode": "TCGA-06-0124-D22567",
    "bcr_drug_uuid": "7e3259cc-0c25-4f11-9cf4-0750346e1bab",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8da3103e-3e6c-4176-a583-d5fe5e60601e",
    "patient_ID": "TCGA.06.0125",
    "bcr_drug_barcode": "TCGA-06-0125-D22571",
    "bcr_drug_uuid": "38d50ec6-4a60-4851-8a76-a99e2c52457d",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "CPT 11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 880,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 941,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 566
  },
  {
    "bcr_patient_uuid": "8da3103e-3e6c-4176-a583-d5fe5e60601e",
    "patient_ID": "TCGA.06.0125",
    "bcr_drug_barcode": "TCGA-06-0125-D22572",
    "bcr_drug_uuid": "0254badb-e288-40cf-b1c2-451ff481f440",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "THALIDOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1032,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1352,
    "drug_cycles": 11,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "8da3103e-3e6c-4176-a583-d5fe5e60601e",
    "patient_ID": "TCGA.06.0125",
    "bcr_drug_barcode": "TCGA-06-0125-D22570",
    "bcr_drug_uuid": "44e0e55b-fa57-44e8-a62f-a2faebf89093",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 452,
    "drug_cycles": 14,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "f66d92ff-85ad-4c83-b127-ce34c8488040",
    "patient_ID": "TCGA.06.0127",
    "bcr_drug_barcode": "TCGA-06-0127-D22579",
    "bcr_drug_uuid": "b1c20d80-9871-47e2-b6ee-f09d529ffc0e",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 64,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "31e6e6c8-9197-4927-bfe4-8f6836f963da",
    "patient_ID": "TCGA.06.0128",
    "bcr_drug_barcode": "TCGA-06-0128-D22584",
    "bcr_drug_uuid": "5cfe1775-d0a9-4064-b778-b5d1c9e6bd35",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "MGI 114",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 207,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 391,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 11
  },
  {
    "bcr_patient_uuid": "31e6e6c8-9197-4927-bfe4-8f6836f963da",
    "patient_ID": "TCGA.06.0128",
    "bcr_drug_barcode": "TCGA-06-0128-D22583",
    "bcr_drug_uuid": "91e8bca9-8278-42fe-96bb-f15a06621726",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "SURAMIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "drug_cycles": 13,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "31e6e6c8-9197-4927-bfe4-8f6836f963da",
    "patient_ID": "TCGA.06.0128",
    "bcr_drug_barcode": "TCGA-06-0128-D22585",
    "bcr_drug_uuid": "1d3b6e46-d5b9-4f0c-9622-11856df3ecd5",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 422,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 450,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 285
  },
  {
    "bcr_patient_uuid": "31e6e6c8-9197-4927-bfe4-8f6836f963da",
    "patient_ID": "TCGA.06.0128",
    "bcr_drug_barcode": "TCGA-06-0128-D22586",
    "bcr_drug_uuid": "9b3053be-86f1-4f2a-a739-56327e3bb658",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "BCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 481,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 511,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 382
  },
  {
    "bcr_patient_uuid": "31e6e6c8-9197-4927-bfe4-8f6836f963da",
    "patient_ID": "TCGA.06.0128",
    "bcr_drug_barcode": "TCGA-06-0128-D22587",
    "bcr_drug_uuid": "6743c37a-57a0-40b7-a349-c6233b4ed7d2",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 601,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 649,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 18
  },
  {
    "bcr_patient_uuid": "bde84ea9-55c9-4d6d-be86-58fd9222c1d6",
    "patient_ID": "TCGA.06.0129",
    "bcr_drug_barcode": "TCGA-06-0129-D22593",
    "bcr_drug_uuid": "abf937a1-94a5-4183-b184-6c50ca8f3de7",
    "form_completion_date": "2009-5-26",
    "pharmaceutical_therapy_drug_name": "IL-13PE",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 183,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 238,
    "drug_units": "ML",
    "drug_tota_dose_units": "ML",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "ADJUVANT AND PROGRESSION",
    "drug_total_dose": 19.5
  },
  {
    "bcr_patient_uuid": "bde84ea9-55c9-4d6d-be86-58fd9222c1d6",
    "patient_ID": "TCGA.06.0129",
    "bcr_drug_barcode": "TCGA-06-0129-D22592",
    "bcr_drug_uuid": "10974b31-2686-4ac4-8a3d-991e76adfe45",
    "form_completion_date": "2009-5-26",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 120,
    "drug_cycles": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "ADJUVANT AND PROGRESSION"
  },
  {
    "bcr_patient_uuid": "7cada85b-00b1-41e5-9924-e09eb077ad56",
    "patient_ID": "TCGA.06.0130",
    "bcr_drug_barcode": "TCGA-06-0130-D22597",
    "bcr_drug_uuid": "6c2a4e65-a69c-4d2a-be46-949d100ecee9",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 280,
    "drug_cycles": 8,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "0133e584-111e-450a-b451-77a2799ef529",
    "patient_ID": "TCGA.06.0133",
    "bcr_drug_barcode": "TCGA-06-0133-D22605",
    "bcr_drug_uuid": "604a09e9-831d-4186-ad3b-3f22fdf2624c",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "CPT 11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 430,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 263
  },
  {
    "bcr_patient_uuid": "0133e584-111e-450a-b451-77a2799ef529",
    "patient_ID": "TCGA.06.0133",
    "bcr_drug_barcode": "TCGA-06-0133-D22603",
    "bcr_drug_uuid": "60a5d5e3-1991-4dc4-b19d-ac60256ea546",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 53,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "0133e584-111e-450a-b451-77a2799ef529",
    "patient_ID": "TCGA.06.0133",
    "bcr_drug_barcode": "TCGA-06-0133-D22606",
    "bcr_drug_uuid": "7e1d547f-f584-40de-ab7a-bf94c47a812d",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 430,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 927
  },
  {
    "bcr_patient_uuid": "0133e584-111e-450a-b451-77a2799ef529",
    "patient_ID": "TCGA.06.0133",
    "bcr_drug_barcode": "TCGA-06-0133-D22604",
    "bcr_drug_uuid": "cc3a0dee-a602-4643-af4d-b6acc3e91057",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "EMD",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 53,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "d0de6676-6ba1-4d79-a9b0-ec3f1e8a8775",
    "patient_ID": "TCGA.06.0137",
    "bcr_drug_barcode": "TCGA-06-0137-D22610",
    "bcr_drug_uuid": "c284553d-f34c-4cfa-acb5-836087b0ffc9",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFER",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 637,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 637,
    "drug_cycles": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "5bbeb8a7-3ac2-4ef1-bd48-6f83bc994a75",
    "patient_ID": "TCGA.06.0139",
    "bcr_drug_barcode": "TCGA-06-0139-D22616",
    "bcr_drug_uuid": "ff6710e6-b842-40e5-842a-f27dfd162d4a",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 203,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 278,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 910
  },
  {
    "bcr_patient_uuid": "5bbeb8a7-3ac2-4ef1-bd48-6f83bc994a75",
    "patient_ID": "TCGA.06.0139",
    "bcr_drug_barcode": "TCGA-06-0139-D22615",
    "bcr_drug_uuid": "50a0fd98-cd01-4d3f-a09b-b7ffbb15e201",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "CPT11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 203,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 278,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 265
  },
  {
    "bcr_patient_uuid": "4b43da9d-60ee-4269-b44d-d92c034b844c",
    "patient_ID": "TCGA.06.0141",
    "bcr_drug_barcode": "TCGA-06-0141-D22621",
    "bcr_drug_uuid": "0103ae04-6325-44a5-a6a8-046799ba81da",
    "form_completion_date": "2012-1-25",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 235,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 270,
    "drug_cycles": 2,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 170,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 170
  },
  {
    "bcr_patient_uuid": "4b43da9d-60ee-4269-b44d-d92c034b844c",
    "patient_ID": "TCGA.06.0141",
    "bcr_drug_barcode": "TCGA-06-0141-D22619",
    "bcr_drug_uuid": "886aa7a5-5ed0-4363-8c6f-46cde591cd3e",
    "form_completion_date": "2012-1-25",
    "pharmaceutical_therapy_drug_name": "CAI NABIT 9712",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 250,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 250
  },
  {
    "bcr_patient_uuid": "4b43da9d-60ee-4269-b44d-d92c034b844c",
    "patient_ID": "TCGA.06.0141",
    "bcr_drug_barcode": "TCGA-06-0141-D22620",
    "bcr_drug_uuid": "05585355-2853-43cb-9ccb-5eab30b24a1b",
    "form_completion_date": "2012-1-25",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 155,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 217,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "3258cb3b-f63b-463c-b2e4-d638149157c5",
    "patient_ID": "TCGA.06.0145",
    "bcr_drug_barcode": "TCGA-06-0145-D22627",
    "bcr_drug_uuid": "59c565d1-b731-4e6a-8b0b-d07c51187028",
    "form_completion_date": "2011-11-28",
    "pharmaceutical_therapy_drug_name": "PYRAZINAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 50,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 871,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1524
  },
  {
    "bcr_patient_uuid": "3003cbfa-98d5-464d-90a5-b1bef32bcef1",
    "patient_ID": "TCGA.06.0146",
    "bcr_drug_barcode": "TCGA-06-0146-D22630",
    "bcr_drug_uuid": "570ef6f6-5f74-4479-95d7-429acbe78eb4",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE (BCNU)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 315,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 480
  },
  {
    "bcr_patient_uuid": "3003cbfa-98d5-464d-90a5-b1bef32bcef1",
    "patient_ID": "TCGA.06.0146",
    "bcr_drug_barcode": "TCGA-06-0146-D22631",
    "bcr_drug_uuid": "0566690b-972e-4bcd-a141-e770fb8cf03d",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 315,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "562d2831-ea9e-4ee1-bcee-77138e0a7d9d",
    "patient_ID": "TCGA.06.0147",
    "bcr_drug_barcode": "TCGA-06-0147-D22638",
    "bcr_drug_uuid": "7feff97f-2e17-40a0-849a-3e180fd4f6f5",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 156,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 399,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "562d2831-ea9e-4ee1-bcee-77138e0a7d9d",
    "patient_ID": "TCGA.06.0147",
    "bcr_drug_barcode": "TCGA-06-0147-D22636",
    "bcr_drug_uuid": "8c1c6e53-1d86-4d32-8b09-2e52f16be47a",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE (BCNU)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 64,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "562d2831-ea9e-4ee1-bcee-77138e0a7d9d",
    "patient_ID": "TCGA.06.0147",
    "bcr_drug_barcode": "TCGA-06-0147-D22637",
    "bcr_drug_uuid": "2f7858e7-ab26-42ea-91c0-a714dfffc125",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "drug_cycles": 2,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 10,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "562d2831-ea9e-4ee1-bcee-77138e0a7d9d",
    "patient_ID": "TCGA.06.0147",
    "bcr_drug_barcode": "TCGA-06-0147-D22635",
    "bcr_drug_uuid": "6496d9ca-5bf0-4bda-9529-1fb107bcb6a1",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFER",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 0,
    "drug_cycles": 1,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_dose": 4,
    "drug_route": "INTRATUMORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4
  },
  {
    "bcr_patient_uuid": "f2cef0e2-fece-4499-9f99-c5719aff8b5a",
    "patient_ID": "TCGA.06.0150",
    "bcr_drug_barcode": "TCGA-06-0150-D40099",
    "bcr_drug_uuid": "D3590881-5B0B-47A0-AFC0-CCB49F8E5E1D",
    "form_completion_date": "2013-2-12",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false
  },
  {
    "bcr_patient_uuid": "f2cef0e2-fece-4499-9f99-c5719aff8b5a",
    "patient_ID": "TCGA.06.0150",
    "bcr_drug_barcode": "TCGA-06-0150-D40100",
    "bcr_drug_uuid": "01A5865D-4395-4BDD-9BD2-941879FAB640",
    "form_completion_date": "2013-2-12",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 335,
    "pharmaceutical_tx_ongoing_indicator": false
  },
  {
    "bcr_patient_uuid": "f2cef0e2-fece-4499-9f99-c5719aff8b5a",
    "patient_ID": "TCGA.06.0150",
    "bcr_drug_barcode": "TCGA-06-0150-D40102",
    "bcr_drug_uuid": "BC761489-0EA6-4B2F-BBC9-A363E881AC5F",
    "form_completion_date": "2013-2-12",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 495,
    "pharmaceutical_tx_ongoing_indicator": false
  },
  {
    "bcr_patient_uuid": "c57d6674-08d1-4eda-9ec1-ae439923d7cf",
    "patient_ID": "TCGA.06.0151",
    "bcr_drug_barcode": "TCGA-06-0151-D40181",
    "bcr_drug_uuid": "B85E2544-B0C2-4E36-9A9E-67DF3A18B9E5",
    "form_completion_date": "2013-2-13",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134
  },
  {
    "bcr_patient_uuid": "c57d6674-08d1-4eda-9ec1-ae439923d7cf",
    "patient_ID": "TCGA.06.0151",
    "bcr_drug_barcode": "TCGA-06-0151-D40182",
    "bcr_drug_uuid": "CB62D25B-80D8-4115-8D85-AE584278C41C",
    "form_completion_date": "2013-2-13",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFERS",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 179,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179
  },
  {
    "bcr_patient_uuid": "c57d6674-08d1-4eda-9ec1-ae439923d7cf",
    "patient_ID": "TCGA.06.0151",
    "bcr_drug_barcode": "TCGA-06-0151-D40183",
    "bcr_drug_uuid": "348FF8BA-F450-4DCC-9FF4-9953CE7275FE",
    "form_completion_date": "2013-2-13",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1330,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1381
  },
  {
    "bcr_patient_uuid": "f5bc5d97-e054-4e53-992d-71b896bd97d5",
    "patient_ID": "TCGA.06.0152",
    "bcr_drug_barcode": "TCGA-06-0152-D22649",
    "bcr_drug_uuid": "afeb0618-1975-4d78-a889-c3bd92b36eb7",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 263,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 293,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 80,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "f5bc5d97-e054-4e53-992d-71b896bd97d5",
    "patient_ID": "TCGA.06.0152",
    "bcr_drug_barcode": "TCGA-06-0152-D22648",
    "bcr_drug_uuid": "9a226e9f-9727-4c5f-8b0e-1e61618d6e33",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 2,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f5bc5d97-e054-4e53-992d-71b896bd97d5",
    "patient_ID": "TCGA.06.0152",
    "bcr_drug_barcode": "TCGA-06-0152-D22650",
    "bcr_drug_uuid": "3d1353a8-5085-4a0d-88b6-fdd4b5f28569",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 293,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 293,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "f5bc5d97-e054-4e53-992d-71b896bd97d5",
    "patient_ID": "TCGA.06.0152",
    "bcr_drug_barcode": "TCGA-06-0152-D22651",
    "bcr_drug_uuid": "a5649f70-0afd-4ce0-9377-9a2c55dcecfc",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 293,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 293,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "24ae6f30-eec8-49a7-abde-246b3873679e",
    "patient_ID": "TCGA.06.0154",
    "bcr_drug_barcode": "TCGA-06-0154-D22655",
    "bcr_drug_uuid": "7ab3f8d8-87db-49d6-bdf2-8b713609ae93",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "CI 980",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 89,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "24ae6f30-eec8-49a7-abde-246b3873679e",
    "patient_ID": "TCGA.06.0154",
    "bcr_drug_barcode": "TCGA-06-0154-D22658",
    "bcr_drug_uuid": "2c557135-cdb8-47d5-91de-a196c8fa77d3",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 373,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "24ae6f30-eec8-49a7-abde-246b3873679e",
    "patient_ID": "TCGA.06.0154",
    "bcr_drug_barcode": "TCGA-06-0154-D22657",
    "bcr_drug_uuid": "dbcdec89-79b1-48e7-83b6-ff51dc7bb3a7",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFER",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 235,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 235,
    "drug_cycles": 1,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_dose": 8,
    "drug_route": "INTRATUMORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 8
  },
  {
    "bcr_patient_uuid": "24ae6f30-eec8-49a7-abde-246b3873679e",
    "patient_ID": "TCGA.06.0154",
    "bcr_drug_barcode": "TCGA-06-0154-D22656",
    "bcr_drug_uuid": "fd6f69ec-53bd-4df7-b878-ffb8c8357eaa",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 160,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 191,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "fa1f1cfc-9da0-488b-93fe-60aaff99c171",
    "patient_ID": "TCGA.06.0155",
    "bcr_drug_barcode": "TCGA-06-0155-D22666",
    "bcr_drug_uuid": "12a9f37f-e7e1-47e5-84f8-6e25d7f19061",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "CI980",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 9,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 52,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "fa1f1cfc-9da0-488b-93fe-60aaff99c171",
    "patient_ID": "TCGA.06.0155",
    "bcr_drug_barcode": "TCGA-06-0155-D22664",
    "bcr_drug_uuid": "cfb4a806-be88-4509-84a0-1ff9aa164266",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFER",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 257,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 257,
    "drug_cycles": 1,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_route": "OTHER",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 8
  },
  {
    "bcr_patient_uuid": "fa1f1cfc-9da0-488b-93fe-60aaff99c171",
    "patient_ID": "TCGA.06.0155",
    "bcr_drug_barcode": "TCGA-06-0155-D22663",
    "bcr_drug_uuid": "afd3dda1-105f-49dc-938b-ed20c47f7d0e",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "BCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 144,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 236,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 80
  },
  {
    "bcr_patient_uuid": "fa1f1cfc-9da0-488b-93fe-60aaff99c171",
    "patient_ID": "TCGA.06.0155",
    "bcr_drug_barcode": "TCGA-06-0155-D22665",
    "bcr_drug_uuid": "b17c22ef-2efa-439d-9236-25db55221c3b",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 175,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 205,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 80,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "15e058e8-2f33-4fb4-92af-3d9dea1fa906",
    "patient_ID": "TCGA.06.0156",
    "bcr_drug_barcode": "TCGA-06-0156-D22670",
    "bcr_drug_uuid": "dbb7ebf3-eee9-45fd-8064-afbbb30c75ab",
    "form_completion_date": "2011-11-28",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 2,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bc316a17-9d73-4ef3-97e9-c4ac5516b75a",
    "patient_ID": "TCGA.06.0158",
    "bcr_drug_barcode": "TCGA-06-0158-D22677",
    "bcr_drug_uuid": "ddceed7c-1346-497b-87f2-f3c1b72f517a",
    "form_completion_date": "2011-11-28",
    "pharmaceutical_therapy_drug_name": "CARMUSTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 99,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "5f8f66a0-4068-4e9d-82fc-4fe1fc3f63aa",
    "patient_ID": "TCGA.06.0159",
    "bcr_drug_barcode": "TCGA-06-0159-D40188",
    "bcr_drug_uuid": "E5A986AD-E2E2-4B1B-9CAB-D712EC054E3E",
    "form_completion_date": "2013-2-13",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162
  },
  {
    "bcr_patient_uuid": "a9b5ef55-9987-4842-b4f3-d029265ef17f",
    "patient_ID": "TCGA.06.0160",
    "bcr_drug_barcode": "TCGA-06-0160-D40192",
    "bcr_drug_uuid": "EF52F1C9-7619-4826-9EDA-6D6F6EF359C5",
    "form_completion_date": "2013-2-13",
    "pharmaceutical_therapy_drug_name": "CI-980",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 63
  },
  {
    "bcr_patient_uuid": "a9b5ef55-9987-4842-b4f3-d029265ef17f",
    "patient_ID": "TCGA.06.0160",
    "bcr_drug_barcode": "TCGA-06-0160-D40193",
    "bcr_drug_uuid": "2001B8EF-EF02-4982-BEE7-8C785CBF04B9",
    "form_completion_date": "2013-2-13",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 190,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 242
  },
  {
    "bcr_patient_uuid": "a9b5ef55-9987-4842-b4f3-d029265ef17f",
    "patient_ID": "TCGA.06.0160",
    "bcr_drug_barcode": "TCGA-06-0160-D40194",
    "bcr_drug_uuid": "8AECA090-CCAD-4810-909A-C357E3576567",
    "form_completion_date": "2013-2-13",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 277,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 277
  },
  {
    "bcr_patient_uuid": "da89dcc7-7453-44a7-b43d-5b3478c5d9a7",
    "patient_ID": "TCGA.06.0162",
    "bcr_drug_barcode": "TCGA-06-0162-D22681",
    "bcr_drug_uuid": "ed06b80b-df64-483d-8228-5e747bccc285",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "CAI (NABTT 9712)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 74,
    "drug_cycles": 2,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "88fcfd59-294a-4166-b703-e698a72b1a53",
    "patient_ID": "TCGA.06.0165",
    "bcr_drug_barcode": "TCGA-06-0165-D40197",
    "bcr_drug_uuid": "2E4F263F-280C-4694-A7A3-BFA52E4E8556",
    "form_completion_date": "2013-2-13",
    "pharmaceutical_therapy_drug_name": "OXALIPLATIN",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 31
  },
  {
    "bcr_patient_uuid": "88fcfd59-294a-4166-b703-e698a72b1a53",
    "patient_ID": "TCGA.06.0165",
    "bcr_drug_barcode": "TCGA-06-0165-D40199",
    "bcr_drug_uuid": "00A80670-919B-4311-A8B0-553DA259B21E",
    "form_completion_date": "2013-2-13",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 122,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153
  },
  {
    "bcr_patient_uuid": "88fcfd59-294a-4166-b703-e698a72b1a53",
    "patient_ID": "TCGA.06.0165",
    "bcr_drug_barcode": "TCGA-06-0165-D40200",
    "bcr_drug_uuid": "4BDED05E-0D16-44BA-A8CF-A2A15A51C6CA",
    "form_completion_date": "2013-2-13",
    "pharmaceutical_therapy_drug_name": "ACCUTANE",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 122,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153
  },
  {
    "bcr_patient_uuid": "88fcfd59-294a-4166-b703-e698a72b1a53",
    "patient_ID": "TCGA.06.0165",
    "bcr_drug_barcode": "TCGA-06-0165-D40203",
    "bcr_drug_uuid": "E313C951-871F-415B-A38A-AB56206EF85B",
    "form_completion_date": "2013-2-13",
    "pharmaceutical_therapy_drug_name": "GLEEVEC",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 184,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 214
  },
  {
    "bcr_patient_uuid": "4a85a43b-4dbc-4081-b552-df06eef1ad80",
    "patient_ID": "TCGA.06.0166",
    "bcr_drug_barcode": "TCGA-06-0166-D22687",
    "bcr_drug_uuid": "e89a761c-660b-4ec9-9299-b13331326520",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "OXALIPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 60,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 85,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "afd3a4dc-a2e5-4545-92b8-a18e72fc9e94",
    "patient_ID": "TCGA.06.0167",
    "bcr_drug_barcode": "TCGA-06-0167-D40209",
    "bcr_drug_uuid": "B4557645-D764-423F-9501-100BE5CA700D",
    "form_completion_date": "2013-2-13",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 68
  },
  {
    "bcr_patient_uuid": "afd3a4dc-a2e5-4545-92b8-a18e72fc9e94",
    "patient_ID": "TCGA.06.0167",
    "bcr_drug_barcode": "TCGA-06-0167-D40210",
    "bcr_drug_uuid": "38A39983-9DA0-4CB0-9CCA-CDEB2E642448",
    "form_completion_date": "2013-2-13",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 197
  },
  {
    "bcr_patient_uuid": "afd3a4dc-a2e5-4545-92b8-a18e72fc9e94",
    "patient_ID": "TCGA.06.0167",
    "bcr_drug_barcode": "TCGA-06-0167-D40211",
    "bcr_drug_uuid": "40FAA94B-6B53-453B-B030-091810610494",
    "form_completion_date": "2013-2-13",
    "pharmaceutical_therapy_drug_name": "PS341",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 258,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 289
  },
  {
    "bcr_patient_uuid": "224235c1-5b6e-48d5-a5d1-777dfede0f1e",
    "patient_ID": "TCGA.06.0168",
    "bcr_drug_barcode": "TCGA-06-0168-D22693",
    "bcr_drug_uuid": "6e1bfca6-d9c4-40f5-827a-07f71328c2e3",
    "form_completion_date": "2011-11-28",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 488,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 519,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 380
  },
  {
    "bcr_patient_uuid": "224235c1-5b6e-48d5-a5d1-777dfede0f1e",
    "patient_ID": "TCGA.06.0168",
    "bcr_drug_barcode": "TCGA-06-0168-D22692",
    "bcr_drug_uuid": "66781d87-c055-4454-b5e9-b93231930e86",
    "form_completion_date": "2011-11-28",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 136,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 458,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 380
  },
  {
    "bcr_patient_uuid": "224235c1-5b6e-48d5-a5d1-777dfede0f1e",
    "patient_ID": "TCGA.06.0168",
    "bcr_drug_barcode": "TCGA-06-0168-D22691",
    "bcr_drug_uuid": "1ecdb47e-2c54-41fc-9c22-03a976ed78d1",
    "form_completion_date": "2011-11-28",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 76,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "bcc72cf4-90ce-466e-a683-bb0ebfb3cf82",
    "patient_ID": "TCGA.06.0169",
    "bcr_drug_barcode": "TCGA-06-0169-D22698",
    "bcr_drug_uuid": "1a31b79f-7069-4481-8240-a057a730a3a0",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 78,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "01a92062-967a-4900-8dc7-a5ecd3b3f8e2",
    "patient_ID": "TCGA.06.0171",
    "bcr_drug_barcode": "TCGA-06-0171-D22703",
    "bcr_drug_uuid": "62871dae-a622-4334-a1af-fc5cded07388",
    "form_completion_date": "2011-11-28",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE (BCNU)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 231,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 273,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 394
  },
  {
    "bcr_patient_uuid": "01a92062-967a-4900-8dc7-a5ecd3b3f8e2",
    "patient_ID": "TCGA.06.0171",
    "bcr_drug_barcode": "TCGA-06-0171-D22702",
    "bcr_drug_uuid": "ee711ede-bac7-4d62-b043-48ac4493ae1a",
    "form_completion_date": "2011-11-28",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 81,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "ee3fc631-1e88-4f70-ab31-335851b38640",
    "patient_ID": "TCGA.06.0174",
    "bcr_drug_barcode": "TCGA-06-0174-D22709",
    "bcr_drug_uuid": "da38c277-79ad-4477-8608-3bd3073bff05",
    "form_completion_date": "2011-11-28",
    "pharmaceutical_therapy_drug_name": "TIPFARNIB (R115777)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 33,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "22297a8b-4761-4f5c-b080-60a39c3a0670",
    "patient_ID": "TCGA.06.0175",
    "bcr_drug_barcode": "TCGA-06-0175-D22713",
    "bcr_drug_uuid": "2bf89b93-f929-4a8c-8d2c-9d43f777993d",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "TIPIFARNIB (R115777)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 22,
    "drug_cycles": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7391f99d-9528-46a1-9799-c5f0a7bfc63e",
    "patient_ID": "TCGA.06.0176",
    "bcr_drug_barcode": "TCGA-06-0176-D19254",
    "bcr_drug_uuid": "929ffde3-8b3c-4530-80d0-4c44b13bec64",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 127,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 584,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "7391f99d-9528-46a1-9799-c5f0a7bfc63e",
    "patient_ID": "TCGA.06.0176",
    "bcr_drug_barcode": "TCGA-06-0176-D19253",
    "bcr_drug_uuid": "5de1a00d-bd11-4571-b701-d983abbcf3a4",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 93,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "53abce1d-7e33-4ebd-832f-f3789f67377f",
    "patient_ID": "TCGA.06.0178",
    "bcr_drug_barcode": "TCGA-06-0178-D20895",
    "bcr_drug_uuid": "c0d4abea-6571-4140-88bd-fbcc893cc934",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "BEVCIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 2572,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2614,
    "drug_cycles": 2,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 909
  },
  {
    "bcr_patient_uuid": "53abce1d-7e33-4ebd-832f-f3789f67377f",
    "patient_ID": "TCGA.06.0178",
    "bcr_drug_barcode": "TCGA-06-0178-D20893",
    "bcr_drug_uuid": "5f9d63d7-62e7-457f-8208-c5db7b743cfb",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 113,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 751,
    "drug_cycles": 24,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "53abce1d-7e33-4ebd-832f-f3789f67377f",
    "patient_ID": "TCGA.06.0178",
    "bcr_drug_barcode": "TCGA-06-0178-D20894",
    "bcr_drug_uuid": "2a90f5d3-64fb-47b0-9be1-689130598227",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "MEDT 575",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2530,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 2,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 25,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2340
  },
  {
    "bcr_patient_uuid": "53abce1d-7e33-4ebd-832f-f3789f67377f",
    "patient_ID": "TCGA.06.0178",
    "bcr_drug_barcode": "TCGA-06-0178-D20892",
    "bcr_drug_uuid": "7db74531-d99d-4392-a5dc-8510bf6c98b6",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 95,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "1f48f010-98fe-4b5a-b96a-14fb25eff23f",
    "patient_ID": "TCGA.06.0184",
    "bcr_drug_barcode": "TCGA-06-0184-D19259",
    "bcr_drug_uuid": "68848ab7-30f8-4275-85bc-f5512ae68d7e",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 670,
    "drug_cycles": 22,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 440
  },
  {
    "bcr_patient_uuid": "1f48f010-98fe-4b5a-b96a-14fb25eff23f",
    "patient_ID": "TCGA.06.0184",
    "bcr_drug_barcode": "TCGA-06-0184-D19260",
    "bcr_drug_uuid": "e685e22a-4693-4d7a-b168-f0cd86a7b3b4",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1311,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1646,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "1f48f010-98fe-4b5a-b96a-14fb25eff23f",
    "patient_ID": "TCGA.06.0184",
    "bcr_drug_barcode": "TCGA-06-0184-D19258",
    "bcr_drug_uuid": "502b5c3b-1207-4781-8f35-ef3d0e1b8190",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 72,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b",
    "patient_ID": "TCGA.06.0185",
    "bcr_drug_barcode": "TCGA-06-0185-D19267",
    "bcr_drug_uuid": "03e128de-a504-43dc-9a99-e9bddbf9643a",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 739,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1397,
    "drug_cycles": 24,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 125,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 232
  },
  {
    "bcr_patient_uuid": "8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b",
    "patient_ID": "TCGA.06.0185",
    "bcr_drug_barcode": "TCGA-06-0185-D19266",
    "bcr_drug_uuid": "2c95edf6-7f28-425c-b4e9-d61fb72bcb70",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 739,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1397,
    "drug_cycles": 24,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 689
  },
  {
    "bcr_patient_uuid": "8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b",
    "patient_ID": "TCGA.06.0185",
    "bcr_drug_barcode": "TCGA-06-0185-D19271",
    "bcr_drug_uuid": "0495d810-b7ae-4673-8332-288c71fe6a19",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2259,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b",
    "patient_ID": "TCGA.06.0185",
    "bcr_drug_barcode": "TCGA-06-0185-D19265",
    "bcr_drug_uuid": "5f103c93-1e65-42e6-8e7a-2223d99a7c23",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 249,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 370
  },
  {
    "bcr_patient_uuid": "8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b",
    "patient_ID": "TCGA.06.0185",
    "bcr_drug_barcode": "TCGA-06-0185-D19269",
    "bcr_drug_uuid": "2245203f-60eb-4fd3-8d0a-69d2be051f3c",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1664,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 791
  },
  {
    "bcr_patient_uuid": "8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b",
    "patient_ID": "TCGA.06.0185",
    "bcr_drug_barcode": "TCGA-06-0185-D19264",
    "bcr_drug_uuid": "c0ec5175-f85f-4ea4-89d8-52a4c7e9a541",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "ARSENIC TRIOXIDE (ATO)",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 56,
    "drug_cycles": 12,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 0.25,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 17.25
  },
  {
    "bcr_patient_uuid": "8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b",
    "patient_ID": "TCGA.06.0185",
    "bcr_drug_barcode": "TCGA-06-0185-D19268",
    "bcr_drug_uuid": "66424f53-9b9c-426b-9cbe-48fac9ef0dcf",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "XL184",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1502,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1636,
    "drug_cycles": 2,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 75,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b",
    "patient_ID": "TCGA.06.0185",
    "bcr_drug_barcode": "TCGA-06-0185-D19270",
    "bcr_drug_uuid": "b34b52d0-bf01-41b1-9a1a-4dd2cb94973b",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1986,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2228,
    "drug_cycles": 10,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 145
  },
  {
    "bcr_patient_uuid": "6573378a-ad14-4654-8810-9f3bd3597bc2",
    "patient_ID": "TCGA.06.0188",
    "bcr_drug_barcode": "TCGA-06-0188-D20857",
    "bcr_drug_uuid": "bb611c12-0f7b-4af8-a5ac-be45d6ed7b60",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 300,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 380
  },
  {
    "bcr_patient_uuid": "6573378a-ad14-4654-8810-9f3bd3597bc2",
    "patient_ID": "TCGA.06.0188",
    "bcr_drug_barcode": "TCGA-06-0188-D20864",
    "bcr_drug_uuid": "ca1f90cc-0dce-4fc7-aacb-4324cb975864",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1342,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1342,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "6573378a-ad14-4654-8810-9f3bd3597bc2",
    "patient_ID": "TCGA.06.0188",
    "bcr_drug_barcode": "TCGA-06-0188-D20860",
    "bcr_drug_uuid": "9498f200-53bc-40e0-8cc6-908ae2da695a",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 965,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1230,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 125,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 254
  },
  {
    "bcr_patient_uuid": "6573378a-ad14-4654-8810-9f3bd3597bc2",
    "patient_ID": "TCGA.06.0188",
    "bcr_drug_barcode": "TCGA-06-0188-D20862",
    "bcr_drug_uuid": "948e163e-c541-4922-8d53-83b2b6982f7e",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 965,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1342,
    "drug_cycles": 12,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 864
  },
  {
    "bcr_patient_uuid": "6573378a-ad14-4654-8810-9f3bd3597bc2",
    "patient_ID": "TCGA.06.0188",
    "bcr_drug_barcode": "TCGA-06-0188-D20863",
    "bcr_drug_uuid": "914dd177-6123-46c2-9acd-1c00faafc764",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1244,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1337,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "6573378a-ad14-4654-8810-9f3bd3597bc2",
    "patient_ID": "TCGA.06.0188",
    "bcr_drug_barcode": "TCGA-06-0188-D20858",
    "bcr_drug_uuid": "0a5a53d9-4a3b-4b74-b6b7-21c6c6554309",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "ERLOTINIB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 334,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 949,
    "drug_cycles": 22,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 75,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "6573378a-ad14-4654-8810-9f3bd3597bc2",
    "patient_ID": "TCGA.06.0188",
    "bcr_drug_barcode": "TCGA-06-0188-D20856",
    "bcr_drug_uuid": "d7523c46-c78a-4f93-8935-f11326f9d479",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 68,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "6573378a-ad14-4654-8810-9f3bd3597bc2",
    "patient_ID": "TCGA.06.0188",
    "bcr_drug_barcode": "TCGA-06-0188-D20859",
    "bcr_drug_uuid": "6b95f95b-2cd1-4f8d-81b0-369e9e257ac9",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "SORAFENIB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 334,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 949,
    "drug_cycles": 22,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 200,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "f08280d6-2c80-4dd7-93d3-a0c55f7da5b3",
    "patient_ID": "TCGA.06.0192",
    "bcr_drug_barcode": "TCGA-06-0192-D20873",
    "bcr_drug_uuid": "4af10e02-c74b-4fa0-bed2-3f5fb6e74689",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 816,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1153,
    "drug_cycles": 10,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 873
  },
  {
    "bcr_patient_uuid": "f08280d6-2c80-4dd7-93d3-a0c55f7da5b3",
    "patient_ID": "TCGA.06.0192",
    "bcr_drug_barcode": "TCGA-06-0192-D20871",
    "bcr_drug_uuid": "fa5e4006-f2a0-4122-b0ed-fba0201e0f1e",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 725,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 767,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "f08280d6-2c80-4dd7-93d3-a0c55f7da5b3",
    "patient_ID": "TCGA.06.0192",
    "bcr_drug_barcode": "TCGA-06-0192-D20875",
    "bcr_drug_uuid": "1c4ae90b-7bb6-4887-a4c1-4576c1f90f08",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 816,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 907,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_dose": 125,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 262.5
  },
  {
    "bcr_patient_uuid": "f08280d6-2c80-4dd7-93d3-a0c55f7da5b3",
    "patient_ID": "TCGA.06.0192",
    "bcr_drug_barcode": "TCGA-06-0192-D20872",
    "bcr_drug_uuid": "c21531d8-c97c-435f-b306-e577109bed0f",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "CEDIRANIB/PLACEBO",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 725,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 808,
    "drug_cycles": 2,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "f08280d6-2c80-4dd7-93d3-a0c55f7da5b3",
    "patient_ID": "TCGA.06.0192",
    "bcr_drug_barcode": "TCGA-06-0192-D20869",
    "bcr_drug_uuid": "a2291f31-1fec-4d97-acbc-5e24b84ee3a1",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 60,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "f08280d6-2c80-4dd7-93d3-a0c55f7da5b3",
    "patient_ID": "TCGA.06.0192",
    "bcr_drug_barcode": "TCGA-06-0192-D20876",
    "bcr_drug_uuid": "b1f4fa20-7a9f-4d81-91b7-fc1479be2ac4",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 919,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 980,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "f08280d6-2c80-4dd7-93d3-a0c55f7da5b3",
    "patient_ID": "TCGA.06.0192",
    "bcr_drug_barcode": "TCGA-06-0192-D20870",
    "bcr_drug_uuid": "fab6fdc5-e184-4d7b-b57a-49600b74beca",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 462,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 420
  },
  {
    "bcr_patient_uuid": "67e2af1c-3478-4652-8759-b9d5c5b6a3e0",
    "patient_ID": "TCGA.06.0195",
    "bcr_drug_barcode": "TCGA-06-0195-D22745",
    "bcr_drug_uuid": "f64b3f24-50c3-4c9b-8910-0f5106216c5f",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 169,
    "drug_cycles": 2,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "67e2af1c-3478-4652-8759-b9d5c5b6a3e0",
    "patient_ID": "TCGA.06.0195",
    "bcr_drug_barcode": "TCGA-06-0195-D22746",
    "bcr_drug_uuid": "47d0a8e7-6a06-4a12-bcdb-e19cd63c7f05",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "VP 16 (ETOPOSIDE)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 169,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "drug_cycles": 1,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "67e2af1c-3478-4652-8759-b9d5c5b6a3e0",
    "patient_ID": "TCGA.06.0195",
    "bcr_drug_barcode": "TCGA-06-0195-D22743",
    "bcr_drug_uuid": "a0b911a9-1e26-4745-b73e-be8da4e7995b",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 169,
    "drug_cycles": 2,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "67e2af1c-3478-4652-8759-b9d5c5b6a3e0",
    "patient_ID": "TCGA.06.0195",
    "bcr_drug_barcode": "TCGA-06-0195-D22744",
    "bcr_drug_uuid": "7f0ea126-94f4-4cdd-ad59-17589585a38d",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 169,
    "drug_cycles": 2,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "67e2af1c-3478-4652-8759-b9d5c5b6a3e0",
    "patient_ID": "TCGA.06.0195",
    "bcr_drug_barcode": "TCGA-06-0195-D22747",
    "bcr_drug_uuid": "b9612743-3757-4309-be97-863b1007bae3",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 169,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "drug_cycles": 1,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "9733968f-262f-4e97-9194-240cda8caf65",
    "patient_ID": "TCGA.06.0197",
    "bcr_drug_barcode": "TCGA-06-0197-D22751",
    "bcr_drug_uuid": "a925243f-86c3-43d5-8abc-393e9c1ab638",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 79,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4d04939f-9509-4e9b-9406-16051afecf82",
    "patient_ID": "TCGA.06.0206",
    "bcr_drug_barcode": "TCGA-06-0206-D22756",
    "bcr_drug_uuid": "776098d0-19be-4f7b-a6e0-d7e9dd126a81",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE (BCNU)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 138,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e3711a9b-6d4c-44df-bbab-0a675046a5df",
    "patient_ID": "TCGA.06.0208",
    "bcr_drug_barcode": "TCGA-06-0208-D22760",
    "bcr_drug_uuid": "abd127de-4081-4844-8715-79add07f6b4e",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e3711a9b-6d4c-44df-bbab-0a675046a5df",
    "patient_ID": "TCGA.06.0208",
    "bcr_drug_barcode": "TCGA-06-0208-D22761",
    "bcr_drug_uuid": "743e879c-c5ba-4391-a70d-1efaacbf3ea5",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE (BCNU)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "drug_cycles": 2,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5c984433-33cf-42fc-b3ba-511efcdcab19",
    "patient_ID": "TCGA.06.0211",
    "bcr_drug_barcode": "TCGA-06-0211-D22772",
    "bcr_drug_uuid": "6bd9bbe4-d9de-41cf-b3fa-810fa0119bac",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 149,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 210,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "5c984433-33cf-42fc-b3ba-511efcdcab19",
    "patient_ID": "TCGA.06.0211",
    "bcr_drug_barcode": "TCGA-06-0211-D22773",
    "bcr_drug_uuid": "759a71e3-46c1-44d2-8f9b-185cb37ff8d9",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFER",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 221,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 221,
    "drug_cycles": 1,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_dose": 8,
    "drug_route": "INTRATUMORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 8
  },
  {
    "bcr_patient_uuid": "5c984433-33cf-42fc-b3ba-511efcdcab19",
    "patient_ID": "TCGA.06.0211",
    "bcr_drug_barcode": "TCGA-06-0211-D22771",
    "bcr_drug_uuid": "84157643-f71e-48df-a39c-23601933d4c0",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "CI-980",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 44,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9853c6bb-a42c-4698-abe5-f3c897ebc8f6",
    "patient_ID": "TCGA.06.0214",
    "bcr_drug_barcode": "TCGA-06-0214-D22780",
    "bcr_drug_uuid": "74b04c6e-2125-48db-85fb-f90ba671ed74",
    "form_completion_date": "2011-11-28",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE (BCNU)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 331,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "9853c6bb-a42c-4698-abe5-f3c897ebc8f6",
    "patient_ID": "TCGA.06.0214",
    "bcr_drug_barcode": "TCGA-06-0214-D22779",
    "bcr_drug_uuid": "f21edf2f-2d4d-4850-860f-2c822f5a9798",
    "form_completion_date": "2011-11-28",
    "pharmaceutical_therapy_drug_name": "CI-980",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 52,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9853c6bb-a42c-4698-abe5-f3c897ebc8f6",
    "patient_ID": "TCGA.06.0214",
    "bcr_drug_barcode": "TCGA-06-0214-D22781",
    "bcr_drug_uuid": "a889796c-27c5-495e-bcfd-47986442b74f",
    "form_completion_date": "2011-11-28",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 331,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 453,
    "drug_cycles": 4,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 10,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "a8033f85-ac9b-41f3-b775-a1aee3f21b8f",
    "patient_ID": "TCGA.06.0216",
    "bcr_drug_barcode": "TCGA-06-0216-D22786",
    "bcr_drug_uuid": "3cc272ec-fba2-4492-8262-a6fc4c7e0e50",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 250,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 463,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 280
  },
  {
    "bcr_patient_uuid": "a8033f85-ac9b-41f3-b775-a1aee3f21b8f",
    "patient_ID": "TCGA.06.0216",
    "bcr_drug_barcode": "TCGA-06-0216-D22785",
    "bcr_drug_uuid": "923595d9-11a6-4c85-ac67-9c017449c9fa",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "CI 980",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 97,
    "drug_cycles": 4,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a8033f85-ac9b-41f3-b775-a1aee3f21b8f",
    "patient_ID": "TCGA.06.0216",
    "bcr_drug_barcode": "TCGA-06-0216-D22787",
    "bcr_drug_uuid": "28fc2476-c207-4a60-a53c-753c090fa845",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 586,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 586,
    "drug_cycles": 1,
    "drug_units": "MEQ",
    "drug_tota_dose_units": "MEQ",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "054f472f-98cb-4559-b2e2-b5f800fc8eef",
    "patient_ID": "TCGA.06.0221",
    "bcr_drug_barcode": "TCGA-06-0221-D22800",
    "bcr_drug_uuid": "4b17d81b-d5c1-4f69-bb5f-1c0bb0098807",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE (BCNU)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 502,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 532,
    "drug_cycles": 1,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "054f472f-98cb-4559-b2e2-b5f800fc8eef",
    "patient_ID": "TCGA.06.0221",
    "bcr_drug_barcode": "TCGA-06-0221-D22795",
    "bcr_drug_uuid": "14d68576-2d46-48e9-91c2-d5156d715433",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFER",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 280,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 280,
    "drug_cycles": 1,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_dose": 6,
    "drug_route": "INTRATUMORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "054f472f-98cb-4559-b2e2-b5f800fc8eef",
    "patient_ID": "TCGA.06.0221",
    "bcr_drug_barcode": "TCGA-06-0221-D22794",
    "bcr_drug_uuid": "d08ff5bb-27b0-4f09-ba06-843db1df5155",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "CAI (NABTT 97212)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 259,
    "drug_cycles": 8,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 250,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 250
  },
  {
    "bcr_patient_uuid": "054f472f-98cb-4559-b2e2-b5f800fc8eef",
    "patient_ID": "TCGA.06.0221",
    "bcr_drug_barcode": "TCGA-06-0221-D22796",
    "bcr_drug_uuid": "0736e5df-6ad1-442e-b54f-95809339145b",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "06-BG (NABTT 0803)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 280,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 285,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "054f472f-98cb-4559-b2e2-b5f800fc8eef",
    "patient_ID": "TCGA.06.0221",
    "bcr_drug_barcode": "TCGA-06-0221-D22799",
    "bcr_drug_uuid": "afd86caa-d628-467a-b95b-b971c5f6f8a9",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "VATALANIB (PTK787)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 471,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 502,
    "drug_cycles": 1,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "054f472f-98cb-4559-b2e2-b5f800fc8eef",
    "patient_ID": "TCGA.06.0221",
    "bcr_drug_barcode": "TCGA-06-0221-D22798",
    "bcr_drug_uuid": "7732fe67-16b8-439c-a842-2d4550ae661b",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "REINOID/CIS RETINOIC ACID",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 379,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 471,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "054f472f-98cb-4559-b2e2-b5f800fc8eef",
    "patient_ID": "TCGA.06.0221",
    "bcr_drug_barcode": "TCGA-06-0221-D22801",
    "bcr_drug_uuid": "46bc19b2-d79d-480b-b367-156fbb1ce11a",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "06-BG",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 502,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 532,
    "drug_cycles": 1,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "054f472f-98cb-4559-b2e2-b5f800fc8eef",
    "patient_ID": "TCGA.06.0221",
    "bcr_drug_barcode": "TCGA-06-0221-D22797",
    "bcr_drug_uuid": "215a60ad-ece2-4e5a-83bb-75a4bad84253",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 318,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 471,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "a0700d6d-df7b-4327-8738-97b8ad08fd4c",
    "patient_ID": "TCGA.06.0240",
    "bcr_drug_barcode": "TCGA-06-0240-D40214",
    "bcr_drug_uuid": "B174A8ED-3DC7-48D8-B624-4E20C131FEA6",
    "form_completion_date": "2013-2-13",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 65
  },
  {
    "bcr_patient_uuid": "a0700d6d-df7b-4327-8738-97b8ad08fd4c",
    "patient_ID": "TCGA.06.0240",
    "bcr_drug_barcode": "TCGA-06-0240-D40215",
    "bcr_drug_uuid": "AC89545B-B9D6-4C8C-BC96-5F76EE4B2048",
    "form_completion_date": "2013-2-13",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 320
  },
  {
    "bcr_patient_uuid": "a0700d6d-df7b-4327-8738-97b8ad08fd4c",
    "patient_ID": "TCGA.06.0240",
    "bcr_drug_barcode": "TCGA-06-0240-D40216",
    "bcr_drug_uuid": "B1B57089-EB7E-400B-91E1-29AC72454190",
    "form_completion_date": "2013-2-13",
    "pharmaceutical_therapy_drug_name": "CILENGITIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 320
  },
  {
    "bcr_patient_uuid": "a0700d6d-df7b-4327-8738-97b8ad08fd4c",
    "patient_ID": "TCGA.06.0240",
    "bcr_drug_barcode": "TCGA-06-0240-D40217",
    "bcr_drug_uuid": "AE41095E-F10E-4DF7-9FA9-005A4CE2A242",
    "form_completion_date": "2013-2-13",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 337,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 407
  },
  {
    "bcr_patient_uuid": "a0700d6d-df7b-4327-8738-97b8ad08fd4c",
    "patient_ID": "TCGA.06.0240",
    "bcr_drug_barcode": "TCGA-06-0240-D40218",
    "bcr_drug_uuid": "375AB109-E2E0-4188-8276-88E579F795AD",
    "form_completion_date": "2013-2-13",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 337,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 589
  },
  {
    "bcr_patient_uuid": "a0700d6d-df7b-4327-8738-97b8ad08fd4c",
    "patient_ID": "TCGA.06.0240",
    "bcr_drug_barcode": "TCGA-06-0240-D40219",
    "bcr_drug_uuid": "C401065A-A4D6-451B-9237-90977C90AD0B",
    "form_completion_date": "2013-2-13",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 435,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 511
  },
  {
    "bcr_patient_uuid": "a0700d6d-df7b-4327-8738-97b8ad08fd4c",
    "patient_ID": "TCGA.06.0240",
    "bcr_drug_barcode": "TCGA-06-0240-D40220",
    "bcr_drug_uuid": "347AFA57-8215-4FFF-8C8C-D8CC91ED1BDD",
    "form_completion_date": "2013-2-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 547,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 589
  },
  {
    "bcr_patient_uuid": "6d4ab866-ca0b-4455-898e-df8a6ac3e924",
    "patient_ID": "TCGA.06.0241",
    "bcr_drug_barcode": "TCGA-06-0241-D20960",
    "bcr_drug_uuid": "f53cd066-12bf-4342-abe4-91a6377735d3",
    "form_completion_date": "2011-12-5",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1324,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1383,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "6d4ab866-ca0b-4455-898e-df8a6ac3e924",
    "patient_ID": "TCGA.06.0241",
    "bcr_drug_barcode": "TCGA-06-0241-D20958",
    "bcr_drug_uuid": "3c9b20fd-115d-47d4-aee6-a05e598467f3",
    "form_completion_date": "2011-12-5",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 477,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 728,
    "drug_cycles": 17,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 125,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 773
  },
  {
    "bcr_patient_uuid": "6d4ab866-ca0b-4455-898e-df8a6ac3e924",
    "patient_ID": "TCGA.06.0241",
    "bcr_drug_barcode": "TCGA-06-0241-D20961",
    "bcr_drug_uuid": "5c6e9edb-8726-4309-8822-6b247c957c19",
    "form_completion_date": "2011-12-5",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1043,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1435,
    "drug_cycles": 10,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 822
  },
  {
    "bcr_patient_uuid": "6d4ab866-ca0b-4455-898e-df8a6ac3e924",
    "patient_ID": "TCGA.06.0241",
    "bcr_drug_barcode": "TCGA-06-0241-D20955",
    "bcr_drug_uuid": "5bb4a821-26f3-49de-9dc9-a4b4aabbaecf",
    "form_completion_date": "2011-12-5",
    "pharmaceutical_therapy_drug_name": "CILENGITIDE",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 192,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2000,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1600
  },
  {
    "bcr_patient_uuid": "6d4ab866-ca0b-4455-898e-df8a6ac3e924",
    "patient_ID": "TCGA.06.0241",
    "bcr_drug_barcode": "TCGA-06-0241-D20956",
    "bcr_drug_uuid": "2f9f7bf8-9dc1-46ac-a223-3cf31a0f90d4",
    "form_completion_date": "2011-12-5",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 81,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "6d4ab866-ca0b-4455-898e-df8a6ac3e924",
    "patient_ID": "TCGA.06.0241",
    "bcr_drug_barcode": "TCGA-06-0241-D20959",
    "bcr_drug_uuid": "ec62c0f3-1bbc-472a-9750-c1abbec94ffe",
    "form_completion_date": "2011-12-5",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 203,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 799,
    "drug_cycles": 20,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 773
  },
  {
    "bcr_patient_uuid": "6d4ab866-ca0b-4455-898e-df8a6ac3e924",
    "patient_ID": "TCGA.06.0241",
    "bcr_drug_barcode": "TCGA-06-0241-D20954",
    "bcr_drug_uuid": "9a9b2dc4-dd57-4100-9d6c-e1fa1e179ab2",
    "form_completion_date": "2011-12-5",
    "pharmaceutical_therapy_drug_name": "CILENGITIDE",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 81,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2000,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4000
  },
  {
    "bcr_patient_uuid": "6d4ab866-ca0b-4455-898e-df8a6ac3e924",
    "patient_ID": "TCGA.06.0241",
    "bcr_drug_barcode": "TCGA-06-0241-D20957",
    "bcr_drug_uuid": "d101d49d-1005-451b-bcbe-f30ba5f0d7fd",
    "form_completion_date": "2011-12-5",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 192,
    "drug_cycles": 4,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 390,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 390
  },
  {
    "bcr_patient_uuid": "7ffeaa19-61c5-4af1-aafd-36ec65cf4768",
    "patient_ID": "TCGA.06.0394",
    "bcr_drug_barcode": "TCGA-06-0394-D22813",
    "bcr_drug_uuid": "ef673f41-6149-4c4e-8c41-b16af9df3b93",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "6 THIOGUANINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "drug_cycles": 1,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "7ffeaa19-61c5-4af1-aafd-36ec65cf4768",
    "patient_ID": "TCGA.06.0394",
    "bcr_drug_barcode": "TCGA-06-0394-D22814",
    "bcr_drug_uuid": "7e64cded-ac59-4d66-be91-740e92fe25f0",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 158,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 281,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 80,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "7ffeaa19-61c5-4af1-aafd-36ec65cf4768",
    "patient_ID": "TCGA.06.0394",
    "bcr_drug_barcode": "TCGA-06-0394-D22812",
    "bcr_drug_uuid": "c251269a-92af-4b58-a68a-3d55c4f1f029",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "drug_cycles": 1,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "7ffeaa19-61c5-4af1-aafd-36ec65cf4768",
    "patient_ID": "TCGA.06.0394",
    "bcr_drug_barcode": "TCGA-06-0394-D22811",
    "bcr_drug_uuid": "fbfe5a21-f80f-420c-b031-a7ef1bc5e79f",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "ESTRAMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "drug_cycles": 1,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "28bf7388-f041-4ff6-ba70-4dcfa05805a3",
    "patient_ID": "TCGA.06.0397",
    "bcr_drug_barcode": "TCGA-06-0397-D22820",
    "bcr_drug_uuid": "ed0a62e2-6479-47cb-947d-0fafc4a4e897",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "drug_cycles": 2,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "28bf7388-f041-4ff6-ba70-4dcfa05805a3",
    "patient_ID": "TCGA.06.0397",
    "bcr_drug_barcode": "TCGA-06-0397-D22818",
    "bcr_drug_uuid": "87eab039-c36b-4aa5-8227-79b62a5fb4ab",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "drug_cycles": 2,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "28bf7388-f041-4ff6-ba70-4dcfa05805a3",
    "patient_ID": "TCGA.06.0397",
    "bcr_drug_barcode": "TCGA-06-0397-D22819",
    "bcr_drug_uuid": "5d2ec807-f295-4411-b216-ec13f2d8d835",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "drug_cycles": 2,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "6db66d6e-b44e-41fa-b904-aa61af0acf1c",
    "patient_ID": "TCGA.06.0409",
    "bcr_drug_barcode": "TCGA-06-0409-D22826",
    "bcr_drug_uuid": "77f56acb-5b7b-4db2-9994-e37e0b5a47ab",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "HYROXYUREA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149,
    "drug_cycles": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "6db66d6e-b44e-41fa-b904-aa61af0acf1c",
    "patient_ID": "TCGA.06.0409",
    "bcr_drug_barcode": "TCGA-06-0409-D22829",
    "bcr_drug_uuid": "d5c62680-dae5-4634-ad2c-c3cc59132478",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 168,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 348,
    "drug_cycles": 4,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "6db66d6e-b44e-41fa-b904-aa61af0acf1c",
    "patient_ID": "TCGA.06.0409",
    "bcr_drug_barcode": "TCGA-06-0409-D22831",
    "bcr_drug_uuid": "71f309f5-09c6-4be0-8508-d57b0d52dfd7",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFER",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1267,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1267,
    "drug_cycles": 1,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_route": "INTRATUMORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "6db66d6e-b44e-41fa-b904-aa61af0acf1c",
    "patient_ID": "TCGA.06.0409",
    "bcr_drug_barcode": "TCGA-06-0409-D22832",
    "bcr_drug_uuid": "22a6969c-40ff-4d12-b813-d08f7f36049d",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1294,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1779,
    "drug_cycles": 19,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "6db66d6e-b44e-41fa-b904-aa61af0acf1c",
    "patient_ID": "TCGA.06.0409",
    "bcr_drug_barcode": "TCGA-06-0409-D22834",
    "bcr_drug_uuid": "916495e6-cb05-4605-bd45-d22f95620573",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1845,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2114,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 125,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "6db66d6e-b44e-41fa-b904-aa61af0acf1c",
    "patient_ID": "TCGA.06.0409",
    "bcr_drug_barcode": "TCGA-06-0409-D22827",
    "bcr_drug_uuid": "7ba5a9b1-760b-4743-b977-af31b8c4d168",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 168,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 348,
    "drug_cycles": 4,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "6db66d6e-b44e-41fa-b904-aa61af0acf1c",
    "patient_ID": "TCGA.06.0409",
    "bcr_drug_barcode": "TCGA-06-0409-D22830",
    "bcr_drug_uuid": "b900a154-e45d-41af-a0a4-a1fc145bf019",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "9 IMMUNOAMINO CAMPTNETECIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 379,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 471,
    "drug_cycles": 6,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "6db66d6e-b44e-41fa-b904-aa61af0acf1c",
    "patient_ID": "TCGA.06.0409",
    "bcr_drug_barcode": "TCGA-06-0409-D22833",
    "bcr_drug_uuid": "c6ba58a3-c0f3-4f4e-8861-631242d450f1",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1294,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1628,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 50,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "6db66d6e-b44e-41fa-b904-aa61af0acf1c",
    "patient_ID": "TCGA.06.0409",
    "bcr_drug_barcode": "TCGA-06-0409-D22828",
    "bcr_drug_uuid": "0983038a-bfcb-4a28-89e8-a5f9dccb4a52",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 168,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 348,
    "drug_cycles": 4,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "98d3ae4b-1f14-4067-ac60-7eaace5007f2",
    "patient_ID": "TCGA.06.0412",
    "bcr_drug_barcode": "TCGA-06-0412-D22841",
    "bcr_drug_uuid": "46748223-93e9-4e26-97c4-649bc8b2f810",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "98d3ae4b-1f14-4067-ac60-7eaace5007f2",
    "patient_ID": "TCGA.06.0412",
    "bcr_drug_barcode": "TCGA-06-0412-D22842",
    "bcr_drug_uuid": "645d6a7d-d8c2-4f77-8c0f-5584ee23711d",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "9AC 9 AMINOCAMPLOTECIAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 106,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 137,
    "drug_cycles": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "98d3ae4b-1f14-4067-ac60-7eaace5007f2",
    "patient_ID": "TCGA.06.0412",
    "bcr_drug_barcode": "TCGA-06-0412-D22843",
    "bcr_drug_uuid": "65dd4eaf-842f-4dfa-ac44-10671cafe7fd",
    "form_completion_date": "2011-11-29",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 137,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 258,
    "drug_cycles": 2,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "a9601d20-d51d-4db3-9e82-7171f5f7e034",
    "patient_ID": "TCGA.06.0414",
    "bcr_drug_barcode": "TCGA-06-0414-D22849",
    "bcr_drug_uuid": "2021c1cb-a12d-4d7f-be7b-958e2ec4e153",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "BCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 5,
    "days_to_drug_end": 370,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a9601d20-d51d-4db3-9e82-7171f5f7e034",
    "patient_ID": "TCGA.06.0414",
    "bcr_drug_barcode": "TCGA-06-0414-D22850",
    "bcr_drug_uuid": "6ecb7887-46f8-48d6-99f9-a7d0103817e0",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CISPLATAIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 5,
    "days_to_drug_end": 370,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "652a39f0-c539-4303-bedc-f0d7f4669d9f",
    "patient_ID": "TCGA.06.0644",
    "bcr_drug_barcode": "TCGA-06-0644-D20900",
    "bcr_drug_uuid": "78a90b97-d6ab-417c-b7c7-717626de2443",
    "form_completion_date": "2011-12-5",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 106,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 263,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 125,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 270
  },
  {
    "bcr_patient_uuid": "652a39f0-c539-4303-bedc-f0d7f4669d9f",
    "patient_ID": "TCGA.06.0644",
    "bcr_drug_barcode": "TCGA-06-0644-D20901",
    "bcr_drug_uuid": "16f06a10-425f-43ac-bbf3-a335e697b5b9",
    "form_completion_date": "2011-12-5",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 333,
    "drug_cycles": 7,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 986
  },
  {
    "bcr_patient_uuid": "652a39f0-c539-4303-bedc-f0d7f4669d9f",
    "patient_ID": "TCGA.06.0644",
    "bcr_drug_barcode": "TCGA-06-0644-D20902",
    "bcr_drug_uuid": "54567449-052e-4f32-8b76-8db401052ea0",
    "form_completion_date": "2011-12-5",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 288,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 319,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 190
  },
  {
    "bcr_patient_uuid": "652a39f0-c539-4303-bedc-f0d7f4669d9f",
    "patient_ID": "TCGA.06.0644",
    "bcr_drug_barcode": "TCGA-06-0644-D20899",
    "bcr_drug_uuid": "fba0c9d9-1dd7-467b-b26b-59b031c4e296",
    "form_completion_date": "2011-12-5",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 65,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 165
  },
  {
    "bcr_patient_uuid": "522808a2-f19d-4fab-b67e-0c31ec54b757",
    "patient_ID": "TCGA.06.0650",
    "bcr_drug_barcode": "TCGA-06-0650-D23094",
    "bcr_drug_uuid": "bcacea2d-9846-4d57-b3a6-d0f69e0147d1",
    "form_completion_date": "2011-10-10",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 516,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 560,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 125,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "522808a2-f19d-4fab-b67e-0c31ec54b757",
    "patient_ID": "TCGA.06.0650",
    "bcr_drug_barcode": "TCGA-06-0650-D23095",
    "bcr_drug_uuid": "4bc0254f-d6c7-4dc5-b0bf-29f041c1434a",
    "form_completion_date": "2011-10-10",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 586,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 678,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "522808a2-f19d-4fab-b67e-0c31ec54b757",
    "patient_ID": "TCGA.06.0650",
    "bcr_drug_barcode": "TCGA-06-0650-D23090",
    "bcr_drug_uuid": "861bfd2d-6cee-4187-9abf-457f63539982",
    "form_completion_date": "2011-10-10",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 355,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 230
  },
  {
    "bcr_patient_uuid": "522808a2-f19d-4fab-b67e-0c31ec54b757",
    "patient_ID": "TCGA.06.0650",
    "bcr_drug_barcode": "TCGA-06-0650-D23093",
    "bcr_drug_uuid": "67185a38-48fc-4c42-9dff-403b7dd80eda",
    "form_completion_date": "2011-10-10",
    "pharmaceutical_therapy_drug_name": "ERLOTINIB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 495,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 513,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "522808a2-f19d-4fab-b67e-0c31ec54b757",
    "patient_ID": "TCGA.06.0650",
    "bcr_drug_barcode": "TCGA-06-0650-D23091",
    "bcr_drug_uuid": "04007984-e8ca-44ef-880b-6ec64d6154b9",
    "form_completion_date": "2011-10-10",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 389,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 389,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "522808a2-f19d-4fab-b67e-0c31ec54b757",
    "patient_ID": "TCGA.06.0650",
    "bcr_drug_barcode": "TCGA-06-0650-D23096",
    "bcr_drug_uuid": "f2d3b76e-c8f6-46d3-8c25-b918dd86776f",
    "form_completion_date": "2011-10-10",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 516,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 658,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 614
  },
  {
    "bcr_patient_uuid": "522808a2-f19d-4fab-b67e-0c31ec54b757",
    "patient_ID": "TCGA.06.0650",
    "bcr_drug_barcode": "TCGA-06-0650-D23089",
    "bcr_drug_uuid": "b4cff9f4-78ec-43df-a7f3-c6a8c79e8b24",
    "form_completion_date": "2011-10-10",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 67,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "522808a2-f19d-4fab-b67e-0c31ec54b757",
    "patient_ID": "TCGA.06.0650",
    "bcr_drug_barcode": "TCGA-06-0650-D23092",
    "bcr_drug_uuid": "a301e609-2782-4520-9640-095ba9e16eab",
    "form_completion_date": "2011-10-10",
    "pharmaceutical_therapy_drug_name": "AZD",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 389,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 431,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 20,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab",
    "patient_ID": "TCGA.06.0686",
    "bcr_drug_barcode": "TCGA-06-0686-D29193",
    "bcr_drug_uuid": "5fc64962-89a0-4cf1-b052-27a029341a14",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "ERLOTINIB (TARCEVA)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 309,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 370,
    "drug_cycles": 2,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 150,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab",
    "patient_ID": "TCGA.06.0686",
    "bcr_drug_barcode": "TCGA-06-0686-D29584",
    "bcr_drug_uuid": "41250619-20ea-4425-a60b-8686a67cc422",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "A4QN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 60,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 750,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1875
  },
  {
    "bcr_patient_uuid": "c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab",
    "patient_ID": "TCGA.06.0686",
    "bcr_drug_barcode": "TCGA-06-0686-D29189",
    "bcr_drug_uuid": "0b50b8e4-9453-4696-ab1f-b15a0e823f83",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 66,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 185
  },
  {
    "bcr_patient_uuid": "c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab",
    "patient_ID": "TCGA.06.0686",
    "bcr_drug_barcode": "TCGA-06-0686-D29191",
    "bcr_drug_uuid": "4d293449-89f5-4713-849c-02cddd5a638b",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "A4QN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 66,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1876
  },
  {
    "bcr_patient_uuid": "c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab",
    "patient_ID": "TCGA.06.0686",
    "bcr_drug_barcode": "TCGA-06-0686-D29194",
    "bcr_drug_uuid": "8629d509-03a5-4cf4-b835-6c6a189ccb08",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "IRINTOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 384,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 412,
    "drug_cycles": 1.5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 125,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 312
  },
  {
    "bcr_patient_uuid": "c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab",
    "patient_ID": "TCGA.06.0686",
    "bcr_drug_barcode": "TCGA-06-0686-D29195",
    "bcr_drug_uuid": "1956d556-0c14-441d-a02b-cec7dc3d8e7c",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 412,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 412,
    "drug_cycles": 0.5,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1182
  },
  {
    "bcr_patient_uuid": "c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab",
    "patient_ID": "TCGA.06.0686",
    "bcr_drug_barcode": "TCGA-06-0686-D29192",
    "bcr_drug_uuid": "414a05fe-a534-4db8-ab51-c5adcb8855bd",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "AT 101",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 175,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 279,
    "drug_cycles": 4,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab",
    "patient_ID": "TCGA.06.0686",
    "bcr_drug_barcode": "TCGA-06-0686-D29190",
    "bcr_drug_uuid": "f00748c8-96be-4d2f-9bce-8641b9845e90",
    "form_completion_date": "2011-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 380
  },
  {
    "bcr_patient_uuid": "e2e83064-7d1c-4dd5-993f-cc7a5ee228ed",
    "patient_ID": "TCGA.06.0743",
    "bcr_drug_barcode": "TCGA-06-0743-D29627",
    "bcr_drug_uuid": "AD88E1C7-333D-49D9-9319-667019B65531",
    "form_completion_date": "2011-12-1",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMODE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 122,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 178,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 280
  },
  {
    "bcr_patient_uuid": "e2e83064-7d1c-4dd5-993f-cc7a5ee228ed",
    "patient_ID": "TCGA.06.0743",
    "bcr_drug_barcode": "TCGA-06-0743-D29626",
    "bcr_drug_uuid": "103E8972-39DB-490E-B671-DEC694BF7EAC",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "e2e83064-7d1c-4dd5-993f-cc7a5ee228ed",
    "patient_ID": "TCGA.06.0743",
    "bcr_drug_barcode": "TCGA-06-0743-D29629",
    "bcr_drug_uuid": "BBCFB707-0CFD-494F-8FD3-613C4BD6F2E3",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 203,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 704,
    "drug_cycles": 16,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 125,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 224
  },
  {
    "bcr_patient_uuid": "e2e83064-7d1c-4dd5-993f-cc7a5ee228ed",
    "patient_ID": "TCGA.06.0743",
    "bcr_drug_barcode": "TCGA-06-0743-D29630",
    "bcr_drug_uuid": "5D6EE55D-C5BF-48B9-8314-F324646CF689",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 203,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 704,
    "drug_cycles": 16,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 655
  },
  {
    "bcr_patient_uuid": "e2e83064-7d1c-4dd5-993f-cc7a5ee228ed",
    "patient_ID": "TCGA.06.0743",
    "bcr_drug_barcode": "TCGA-06-0743-D29628",
    "bcr_drug_uuid": "D7CE9ABA-4249-4F59-89DA-96E2EA24DBA2",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "CILENGITIDE",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 178,
    "drug_cycles": 2,
    "drug_tota_dose_units": "MG",
    "drug_dose": 500,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 500
  },
  {
    "bcr_patient_uuid": "5613f5f6-086d-470b-8f77-6dcb7f8625b7",
    "patient_ID": "TCGA.06.0744",
    "bcr_drug_barcode": "TCGA-06-0744-D20888",
    "bcr_drug_uuid": "6f4317ca-0569-4558-aa12-06b0ed32a633",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 477,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 380
  },
  {
    "bcr_patient_uuid": "5613f5f6-086d-470b-8f77-6dcb7f8625b7",
    "patient_ID": "TCGA.06.0744",
    "bcr_drug_barcode": "TCGA-06-0744-D20887",
    "bcr_drug_uuid": "7eaf7f15-de91-43ef-877e-636b8b25abde",
    "form_completion_date": "2011-12-7",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 81,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 190
  },
  {
    "bcr_patient_uuid": "98e0344d-71c6-477c-a990-0bd0277606af",
    "patient_ID": "TCGA.06.0875",
    "bcr_drug_barcode": "TCGA-06-0875-D22878",
    "bcr_drug_uuid": "2aeca28a-f982-49f6-ac04-af50dec0df0a",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "98e0344d-71c6-477c-a990-0bd0277606af",
    "patient_ID": "TCGA.06.0875",
    "bcr_drug_barcode": "TCGA-06-0875-D31570",
    "bcr_drug_uuid": "38065438-b30a-40a0-a3d6-cd1d84215fee",
    "form_completion_date": "2012-5-6",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 454,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c5e08764-822b-4214-9ce6-f3ec2756190e",
    "patient_ID": "TCGA.06.0876",
    "bcr_drug_barcode": "TCGA-06-0876-D22882",
    "bcr_drug_uuid": "6b48f8bb-e45c-4f0c-b001-d9e38b01d1c0",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "days_to_drug_end": 271,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 350
  },
  {
    "bcr_patient_uuid": "c5e08764-822b-4214-9ce6-f3ec2756190e",
    "patient_ID": "TCGA.06.0876",
    "bcr_drug_barcode": "TCGA-06-0876-D31558",
    "bcr_drug_uuid": "c79f9ef1-9a66-4dc9-b1ad-1a5ae851ef4d",
    "form_completion_date": "2012-5-6",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 60,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c5e08764-822b-4214-9ce6-f3ec2756190e",
    "patient_ID": "TCGA.06.0876",
    "bcr_drug_barcode": "TCGA-06-0876-D31559",
    "bcr_drug_uuid": "9f203417-2412-441c-a903-11e0f24dbee6",
    "form_completion_date": "2012-5-6",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 416,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c5e08764-822b-4214-9ce6-f3ec2756190e",
    "patient_ID": "TCGA.06.0876",
    "bcr_drug_barcode": "TCGA-06-0876-D31560",
    "bcr_drug_uuid": "c35122f1-7318-4861-a4d5-58a1ae3f1f0c",
    "form_completion_date": "2012-5-6",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 462,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1146,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c5e08764-822b-4214-9ce6-f3ec2756190e",
    "patient_ID": "TCGA.06.0876",
    "bcr_drug_barcode": "TCGA-06-0876-D31561",
    "bcr_drug_uuid": "dd1ab83c-376d-4236-b55a-9d80171200a9",
    "form_completion_date": "2012-5-6",
    "pharmaceutical_therapy_drug_name": "IRINTOCEAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 462,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 560,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "98e2f2ec-bdcd-490a-bf45-600e3b6c7491",
    "patient_ID": "TCGA.06.0878",
    "bcr_drug_barcode": "TCGA-06-0878-D22889",
    "bcr_drug_uuid": "4d9eb796-2e8e-4496-ad96-598bd3e582b5",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "days_to_drug_end": 53,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 145
  },
  {
    "bcr_patient_uuid": "98e2f2ec-bdcd-490a-bf45-600e3b6c7491",
    "patient_ID": "TCGA.06.0878",
    "bcr_drug_barcode": "TCGA-06-0878-D22891",
    "bcr_drug_uuid": "0a0e15d5-0189-4f13-83c8-b0297ac6bb24",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 811
  },
  {
    "bcr_patient_uuid": "98e2f2ec-bdcd-490a-bf45-600e3b6c7491",
    "patient_ID": "TCGA.06.0878",
    "bcr_drug_barcode": "TCGA-06-0878-D22890",
    "bcr_drug_uuid": "c9366f9a-4f85-4709-a30b-2e0cfe441d2f",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 242
  },
  {
    "bcr_patient_uuid": "f9ce2045-2821-4843-b5e9-cf7cc7e783d4",
    "patient_ID": "TCGA.06.0879",
    "bcr_drug_barcode": "TCGA-06-0879-D22895",
    "bcr_drug_uuid": "337887e3-a6e3-4603-a8eb-720c4ada73e1",
    "form_completion_date": "2009-3-26",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "f9ce2045-2821-4843-b5e9-cf7cc7e783d4",
    "patient_ID": "TCGA.06.0879",
    "bcr_drug_barcode": "TCGA-06-0879-D22896",
    "bcr_drug_uuid": "83c0a015-4085-4859-94b0-42a965cf163e",
    "form_completion_date": "2009-3-26",
    "pharmaceutical_therapy_drug_name": "DCVAX",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f9ce2045-2821-4843-b5e9-cf7cc7e783d4",
    "patient_ID": "TCGA.06.0879",
    "bcr_drug_barcode": "TCGA-06-0879-D31531",
    "bcr_drug_uuid": "223c816c-79d9-4a8b-bdb1-3e1d0c958e57",
    "form_completion_date": "2012-5-5",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 60,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f9ce2045-2821-4843-b5e9-cf7cc7e783d4",
    "patient_ID": "TCGA.06.0879",
    "bcr_drug_barcode": "TCGA-06-0879-D31532",
    "bcr_drug_uuid": "96335edd-0b15-4b56-ace9-3ee429a34bb0",
    "form_completion_date": "2012-5-5",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 117,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 435,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f9ce2045-2821-4843-b5e9-cf7cc7e783d4",
    "patient_ID": "TCGA.06.0879",
    "bcr_drug_barcode": "TCGA-06-0879-D31533",
    "bcr_drug_uuid": "1b3f952f-1e64-4af4-8a76-b8016841bc5d",
    "form_completion_date": "2012-5-5",
    "pharmaceutical_therapy_drug_name": "DC VAX (DENDRITIC CELL VACCINE)",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 580,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f9ce2045-2821-4843-b5e9-cf7cc7e783d4",
    "patient_ID": "TCGA.06.0879",
    "bcr_drug_barcode": "TCGA-06-0879-D31534",
    "bcr_drug_uuid": "813a6fb9-f10f-49ab-91b3-c11af1f2062f",
    "form_completion_date": "2012-5-5",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 718,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 960,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f9ce2045-2821-4843-b5e9-cf7cc7e783d4",
    "patient_ID": "TCGA.06.0879",
    "bcr_drug_barcode": "TCGA-06-0879-D31535",
    "bcr_drug_uuid": "cb50cbb6-9a3b-4464-9a6b-a711d13a6eec",
    "form_completion_date": "2012-5-5",
    "pharmaceutical_therapy_drug_name": "DENDRITIC CELL VACCINE (DCVAX)",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 708,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 942,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f9ce2045-2821-4843-b5e9-cf7cc7e783d4",
    "patient_ID": "TCGA.06.0879",
    "bcr_drug_barcode": "TCGA-06-0879-D31536",
    "bcr_drug_uuid": "52920ce0-5439-440b-8c08-05b67545b8a5",
    "form_completion_date": "2012-5-5",
    "pharmaceutical_therapy_drug_name": "CEDICANIB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 998,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1025,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f9ce2045-2821-4843-b5e9-cf7cc7e783d4",
    "patient_ID": "TCGA.06.0879",
    "bcr_drug_barcode": "TCGA-06-0879-D31537",
    "bcr_drug_uuid": "d66830ee-5cd8-430a-bc60-43e0fa060ad4",
    "form_completion_date": "2012-5-5",
    "pharmaceutical_therapy_drug_name": "CILENGITIDE",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 998,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1025,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f9ce2045-2821-4843-b5e9-cf7cc7e783d4",
    "patient_ID": "TCGA.06.0879",
    "bcr_drug_barcode": "TCGA-06-0879-D31538",
    "bcr_drug_uuid": "94d4ccf8-667e-46be-b8b5-6d4c0cb271c1",
    "form_completion_date": "2012-5-5",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1029,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1029,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f9ce2045-2821-4843-b5e9-cf7cc7e783d4",
    "patient_ID": "TCGA.06.0879",
    "bcr_drug_barcode": "TCGA-06-0879-D31539",
    "bcr_drug_uuid": "9a14bb6f-b8e3-4251-bf76-a926634747ef",
    "form_completion_date": "2012-5-5",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1029,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1205,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f9ce2045-2821-4843-b5e9-cf7cc7e783d4",
    "patient_ID": "TCGA.06.0879",
    "bcr_drug_barcode": "TCGA-06-0879-D31540",
    "bcr_drug_uuid": "5da27735-6464-4318-aa78-c7ff252882c4",
    "form_completion_date": "2012-5-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1085,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1085,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1b6c184a-5868-4a51-8a82-aa16a7e65126",
    "patient_ID": "TCGA.06.0881",
    "bcr_drug_barcode": "TCGA-06-0881-D22900",
    "bcr_drug_uuid": "9e1571a0-22a5-49b8-9e63-18008c51eeb0",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "days_to_drug_end": 133,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "1b6c184a-5868-4a51-8a82-aa16a7e65126",
    "patient_ID": "TCGA.06.0881",
    "bcr_drug_barcode": "TCGA-06-0881-D22902",
    "bcr_drug_uuid": "61dcdd55-abda-4ba9-a57e-20757ca7ac5a",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 150,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 250
  },
  {
    "bcr_patient_uuid": "1b6c184a-5868-4a51-8a82-aa16a7e65126",
    "patient_ID": "TCGA.06.0881",
    "bcr_drug_barcode": "TCGA-06-0881-D22901",
    "bcr_drug_uuid": "47d51745-dbcb-4af9-a001-25fc13d1c771",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 150,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 747.7
  },
  {
    "bcr_patient_uuid": "2188c194-dfe4-4471-9b8b-050db1a1062c",
    "patient_ID": "TCGA.06.0882",
    "bcr_drug_barcode": "TCGA-06-0882-D22906",
    "bcr_drug_uuid": "c148a012-035c-415b-9876-d06f4c2a3e99",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 160,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "2188c194-dfe4-4471-9b8b-050db1a1062c",
    "patient_ID": "TCGA.06.0882",
    "bcr_drug_barcode": "TCGA-06-0882-D31544",
    "bcr_drug_uuid": "49f8b1a7-7a00-4bc9-a834-2bba0bf9f46c",
    "form_completion_date": "2012-5-5",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 60,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2188c194-dfe4-4471-9b8b-050db1a1062c",
    "patient_ID": "TCGA.06.0882",
    "bcr_drug_barcode": "TCGA-06-0882-D31545",
    "bcr_drug_uuid": "3eace622-2c0f-45e7-b568-568d417dab47",
    "form_completion_date": "2012-5-5",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 113,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 205,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2188c194-dfe4-4471-9b8b-050db1a1062c",
    "patient_ID": "TCGA.06.0882",
    "bcr_drug_barcode": "TCGA-06-0882-D31546",
    "bcr_drug_uuid": "b5b214d2-392d-4eb2-865c-2db25ba7758a",
    "form_completion_date": "2012-5-5",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 236,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 403,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2188c194-dfe4-4471-9b8b-050db1a1062c",
    "patient_ID": "TCGA.06.0882",
    "bcr_drug_barcode": "TCGA-06-0882-D31547",
    "bcr_drug_uuid": "90f14d54-76b2-477d-81f2-c1386e5f32c7",
    "form_completion_date": "2012-5-5",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 236,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 403,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2188c194-dfe4-4471-9b8b-050db1a1062c",
    "patient_ID": "TCGA.06.0882",
    "bcr_drug_barcode": "TCGA-06-0882-D31548",
    "bcr_drug_uuid": "647fec73-d982-445b-ad58-467a46f415f4",
    "form_completion_date": "2012-5-5",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 447,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 487,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2188c194-dfe4-4471-9b8b-050db1a1062c",
    "patient_ID": "TCGA.06.0882",
    "bcr_drug_barcode": "TCGA-06-0882-D31549",
    "bcr_drug_uuid": "ca648d90-6fc7-45c1-8105-4d0ef76a1c78",
    "form_completion_date": "2012-5-5",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 447,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 502,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2188c194-dfe4-4471-9b8b-050db1a1062c",
    "patient_ID": "TCGA.06.0882",
    "bcr_drug_barcode": "TCGA-06-0882-D31550",
    "bcr_drug_uuid": "df428185-e857-4af1-b10a-57a40fe16297",
    "form_completion_date": "2012-5-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 502,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 502,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "cb9f842c-9bf5-48c3-8d3e-b344b1b6c190",
    "patient_ID": "TCGA.06.0939",
    "bcr_drug_barcode": "TCGA-06-0939-D18621",
    "bcr_drug_uuid": "f7e7db9f-6b86-49e7-a19e-a1533b79ee8a",
    "form_completion_date": "2011-11-16",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 378,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 609,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 125,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "cb9f842c-9bf5-48c3-8d3e-b344b1b6c190",
    "patient_ID": "TCGA.06.0939",
    "bcr_drug_barcode": "TCGA-06-0939-D18622",
    "bcr_drug_uuid": "5e29015c-ddc0-4a18-8365-b700f81f3bfd",
    "form_completion_date": "2011-11-16",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 378,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 665,
    "drug_cycles": 10,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 516
  },
  {
    "bcr_patient_uuid": "ac3582a9-46b1-4322-95fa-9e8b149b8044",
    "patient_ID": "TCGA.06.1084",
    "bcr_drug_barcode": "TCGA-06-1084-D22912",
    "bcr_drug_uuid": "6173598e-2352-413d-8b05-68d07a3f1e01",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 209,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 500
  },
  {
    "bcr_patient_uuid": "ac3582a9-46b1-4322-95fa-9e8b149b8044",
    "patient_ID": "TCGA.06.1084",
    "bcr_drug_barcode": "TCGA-06-1084-D22913",
    "bcr_drug_uuid": "d443b491-6e6a-4915-aa39-0c4b7218da39",
    "form_completion_date": "2010-4-19",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 242,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 323,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1455
  },
  {
    "bcr_patient_uuid": "ac3582a9-46b1-4322-95fa-9e8b149b8044",
    "patient_ID": "TCGA.06.1084",
    "bcr_drug_barcode": "TCGA-06-1084-D18614",
    "bcr_drug_uuid": "7d1979a9-d0f6-400c-bd75-e906f7cf8f60",
    "form_completion_date": "2011-11-16",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 242,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 323,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1455
  },
  {
    "bcr_patient_uuid": "ac3582a9-46b1-4322-95fa-9e8b149b8044",
    "patient_ID": "TCGA.06.1084",
    "bcr_drug_barcode": "TCGA-06-1084-D18613",
    "bcr_drug_uuid": "2db55c80-88d5-4bc0-97af-8588f79a051c",
    "form_completion_date": "2011-11-16",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 246,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 288,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 125,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 337
  },
  {
    "bcr_patient_uuid": "ac3582a9-46b1-4322-95fa-9e8b149b8044",
    "patient_ID": "TCGA.06.1084",
    "bcr_drug_barcode": "TCGA-06-1084-D18618",
    "bcr_drug_uuid": "ce1edf02-8209-44e7-bf07-55b7675c3ac0",
    "form_completion_date": "2011-11-16",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 445,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 546,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 30,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 81
  },
  {
    "bcr_patient_uuid": "ac3582a9-46b1-4322-95fa-9e8b149b8044",
    "patient_ID": "TCGA.06.1084",
    "bcr_drug_barcode": "TCGA-06-1084-D18617",
    "bcr_drug_uuid": "4e1f489c-f1e3-454e-86de-ed01f81d4ca7",
    "form_completion_date": "2011-11-16",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 301,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 331,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 180
  },
  {
    "bcr_patient_uuid": "97686ab2-3b7e-4b21-9bf3-9a5a01709e04",
    "patient_ID": "TCGA.06.1086",
    "bcr_drug_barcode": "TCGA-06-1086-D22918",
    "bcr_drug_uuid": "13d9b153-ea61-4b4b-8e0e-118fb6b43ccb",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 73,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 194,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "98dd5ea6-8d40-4963-bbae-2d37001d71c8",
    "patient_ID": "TCGA.06.1087",
    "bcr_drug_barcode": "TCGA-06-1087-D22922",
    "bcr_drug_uuid": "86e3f83c-d7e2-4844-9f02-0d2ef7eb3efb",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 75,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "b1ce95bf-7441-4aac-8131-19a177d2b8ac",
    "patient_ID": "TCGA.06.1800",
    "bcr_drug_barcode": "TCGA-06-1800-D22926",
    "bcr_drug_uuid": "68c6d65a-f0b1-4c05-84cb-c3378581a543",
    "form_completion_date": "2009-8-19",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 275,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "bdc75722-1076-49f3-8dc7-f2b91e5a15eb",
    "patient_ID": "TCGA.06.1801",
    "bcr_drug_barcode": "TCGA-06-1801-D18590",
    "bcr_drug_uuid": "80bf8343-fe68-413a-90ec-ffa9720923da",
    "form_completion_date": "[Not Available]",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 80,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 231,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 280
  },
  {
    "bcr_patient_uuid": "bdc75722-1076-49f3-8dc7-f2b91e5a15eb",
    "patient_ID": "TCGA.06.1801",
    "bcr_drug_barcode": "TCGA-06-1801-D18604",
    "bcr_drug_uuid": "b7491d83-51db-4071-9447-1a6c901aab2f",
    "form_completion_date": "2011-11-16",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 238,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 323,
    "drug_cycles": 3,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 850
  },
  {
    "bcr_patient_uuid": "bdc75722-1076-49f3-8dc7-f2b91e5a15eb",
    "patient_ID": "TCGA.06.1801",
    "bcr_drug_barcode": "TCGA-06-1801-D18597",
    "bcr_drug_uuid": "4dd8b979-f41f-428b-989d-c0a3af2bcc92",
    "form_completion_date": "2011-11-16",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 238,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 323,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_dose": 125,
    "regimen_number": 2,
    "drug_route": "INTRAVESICAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 227
  },
  {
    "bcr_patient_uuid": "13d12179-3182-4f41-85a2-90fd50e51480",
    "patient_ID": "TCGA.06.1802",
    "bcr_drug_barcode": "TCGA-06-1802-D18607",
    "bcr_drug_uuid": "70f12cb8-cbb9-4afe-b0ba-826006b5e630",
    "form_completion_date": "2011-11-16",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 380,
    "drug_cycles": 10,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 125,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 646
  },
  {
    "bcr_patient_uuid": "13d12179-3182-4f41-85a2-90fd50e51480",
    "patient_ID": "TCGA.06.1802",
    "bcr_drug_barcode": "TCGA-06-1802-D18608",
    "bcr_drug_uuid": "403327ca-3505-4398-96b3-bea1034a856d",
    "form_completion_date": "2011-11-16",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 436,
    "drug_cycles": 11,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 845
  },
  {
    "bcr_patient_uuid": "13d12179-3182-4f41-85a2-90fd50e51480",
    "patient_ID": "TCGA.06.1802",
    "bcr_drug_barcode": "TCGA-06-1802-D18609",
    "bcr_drug_uuid": "c0e3d606-6893-489b-9ebd-073dcd047936",
    "form_completion_date": "2011-11-16",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 429,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 429,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "9f004b8a-f202-419d-a4d8-01f9430eaca5",
    "patient_ID": "TCGA.06.1805",
    "bcr_drug_barcode": "TCGA-06-1805-D22934",
    "bcr_drug_uuid": "bd190086-40a8-4252-9877-e607540544d0",
    "form_completion_date": "2009-8-19",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "9f004b8a-f202-419d-a4d8-01f9430eaca5",
    "patient_ID": "TCGA.06.1805",
    "bcr_drug_barcode": "TCGA-06-1805-D31553",
    "bcr_drug_uuid": "26d24a1b-c0f8-4fca-b46c-8ce8606d151b",
    "form_completion_date": "2012-5-6",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMODE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 76,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9f004b8a-f202-419d-a4d8-01f9430eaca5",
    "patient_ID": "TCGA.06.1805",
    "bcr_drug_barcode": "TCGA-06-1805-D31554",
    "bcr_drug_uuid": "6d899e36-462a-4e47-b15c-05aca3bca030",
    "form_completion_date": "2012-5-6",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMODE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 433,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a0339182-2fd6-459d-9703-422474222e76",
    "patient_ID": "TCGA.06.1806",
    "bcr_drug_barcode": "TCGA-06-1806-D48602",
    "bcr_drug_uuid": "B9697902-8BDC-41A3-B61C-E022F5E990DA",
    "form_completion_date": "2013-9-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 64,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a0339182-2fd6-459d-9703-422474222e76",
    "patient_ID": "TCGA.06.1806",
    "bcr_drug_barcode": "TCGA-06-1806-D48603",
    "bcr_drug_uuid": "3BCBB0AA-B506-4706-BA53-D0A0FDFF6653",
    "form_completion_date": "2013-9-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 81,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 256,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "a0339182-2fd6-459d-9703-422474222e76",
    "patient_ID": "TCGA.06.1806",
    "bcr_drug_barcode": "TCGA-06-1806-D48604",
    "bcr_drug_uuid": "2C19A5A3-9FFC-402C-ABCB-392DFCEA10A3",
    "form_completion_date": "2013-9-18",
    "pharmaceutical_therapy_drug_name": "ABT-888",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 81,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 256,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "a0339182-2fd6-459d-9703-422474222e76",
    "patient_ID": "TCGA.06.1806",
    "bcr_drug_barcode": "TCGA-06-1806-D48607",
    "bcr_drug_uuid": "3B54E64B-0638-43BC-9C8C-457B090374C8",
    "form_completion_date": "2013-9-18",
    "pharmaceutical_therapy_drug_name": "CABOZANTINIB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 293,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 455,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "ca893d12-3d6c-4e6f-b0e7-7f4eb8bb724b",
    "patient_ID": "TCGA.06.2559",
    "bcr_drug_barcode": "TCGA-06-2559-D22943",
    "bcr_drug_uuid": "875b5e0b-0c54-402a-bde2-47a631fbd183",
    "form_completion_date": "2010-3-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 49,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "d6a48eb1-7c20-4ae3-ae35-b6b641238ef1",
    "patient_ID": "TCGA.06.2561",
    "bcr_drug_barcode": "TCGA-06-2561-D22950",
    "bcr_drug_uuid": "4edf1eeb-81cf-4809-a442-7bfb25e878e5",
    "form_completion_date": "2010-3-22",
    "pharmaceutical_therapy_drug_name": "XL 184",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 125
  },
  {
    "bcr_patient_uuid": "d6a48eb1-7c20-4ae3-ae35-b6b641238ef1",
    "patient_ID": "TCGA.06.2561",
    "bcr_drug_barcode": "TCGA-06-2561-D22949",
    "bcr_drug_uuid": "2cb1d8cb-95b3-48cb-bf24-e247bcae5e94",
    "form_completion_date": "2010-3-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 63,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 120
  },
  {
    "bcr_patient_uuid": "d6a48eb1-7c20-4ae3-ae35-b6b641238ef1",
    "patient_ID": "TCGA.06.2561",
    "bcr_drug_barcode": "TCGA-06-2561-D22948",
    "bcr_drug_uuid": "b4950ded-4dff-4228-932c-815b0cf3227a",
    "form_completion_date": "2010-3-22",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 171,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 618
  },
  {
    "bcr_patient_uuid": "d6a48eb1-7c20-4ae3-ae35-b6b641238ef1",
    "patient_ID": "TCGA.06.2561",
    "bcr_drug_barcode": "TCGA-06-2561-D22947",
    "bcr_drug_uuid": "c90186ba-0519-4247-a0f3-225615f2c767",
    "form_completion_date": "2010-3-22",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 171,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 125,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 201.25
  },
  {
    "bcr_patient_uuid": "d6a48eb1-7c20-4ae3-ae35-b6b641238ef1",
    "patient_ID": "TCGA.06.2561",
    "bcr_drug_barcode": "TCGA-06-2561-D29204",
    "bcr_drug_uuid": "a0572472-f1a3-42af-b761-e8801d72d227",
    "form_completion_date": "2012-2-8",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 171,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 492,
    "drug_cycles": 9,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 618
  },
  {
    "bcr_patient_uuid": "d6a48eb1-7c20-4ae3-ae35-b6b641238ef1",
    "patient_ID": "TCGA.06.2561",
    "bcr_drug_barcode": "TCGA-06-2561-D29203",
    "bcr_drug_uuid": "6608dbbd-2941-44f1-9353-f69b7e3424eb",
    "form_completion_date": "2012-2-8",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 171,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 325,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 125,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 201.25
  },
  {
    "bcr_patient_uuid": "d6a48eb1-7c20-4ae3-ae35-b6b641238ef1",
    "patient_ID": "TCGA.06.2561",
    "bcr_drug_barcode": "TCGA-06-2561-D29206",
    "bcr_drug_uuid": "fe6e2b3e-60bf-4993-b04d-b70e8d33ac52",
    "form_completion_date": "2012-2-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 478,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 492,
    "drug_cycles": 1,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 6,
    "regimen_number": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 571
  },
  {
    "bcr_patient_uuid": "d6a48eb1-7c20-4ae3-ae35-b6b641238ef1",
    "patient_ID": "TCGA.06.2561",
    "bcr_drug_barcode": "TCGA-06-2561-D29205",
    "bcr_drug_uuid": "3dedc777-8676-47ae-aa69-498054d7e8e6",
    "form_completion_date": "2012-2-8",
    "pharmaceutical_therapy_drug_name": "TEMOZLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 348,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 471,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 25,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "e3251837-f6f3-4dad-856f-108e20d03dad",
    "patient_ID": "TCGA.06.2562",
    "bcr_drug_barcode": "TCGA-06-2562-D22954",
    "bcr_drug_uuid": "c28c63e3-e7c6-4ea9-818d-c0313e21b830",
    "form_completion_date": "2010-3-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 37,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "ba383ea6-c885-49f0-bddc-e00be0230a6b",
    "patient_ID": "TCGA.06.2563",
    "bcr_drug_barcode": "TCGA-06-2563-D22958",
    "bcr_drug_uuid": "7b5ee14d-cec5-4300-9d8d-9354ec8fb1e5",
    "form_completion_date": "2010-3-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 57,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 120
  },
  {
    "bcr_patient_uuid": "ba383ea6-c885-49f0-bddc-e00be0230a6b",
    "patient_ID": "TCGA.06.2563",
    "bcr_drug_barcode": "TCGA-06-2563-D29201",
    "bcr_drug_uuid": "79ad5fa0-76fe-4300-ae8f-d1e01d8acd6d",
    "form_completion_date": "2012-2-8",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 934,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 549
  },
  {
    "bcr_patient_uuid": "ba383ea6-c885-49f0-bddc-e00be0230a6b",
    "patient_ID": "TCGA.06.2563",
    "bcr_drug_barcode": "TCGA-06-2563-D29200",
    "bcr_drug_uuid": "abb35d1b-d581-41b1-8453-6ddb14b1f836",
    "form_completion_date": "2012-2-8",
    "pharmaceutical_therapy_drug_name": "R04929097",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 885,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 931,
    "drug_cycles": 2,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "8ff9f921-f9e9-41c1-a5d4-891fd4cfe979",
    "patient_ID": "TCGA.06.2564",
    "bcr_drug_barcode": "TCGA-06-2564-D22962",
    "bcr_drug_uuid": "6df7a740-06de-41da-8266-fccdae5abcae",
    "form_completion_date": "2010-3-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c7b4fd72-b45d-4524-8424-983120abfec0",
    "patient_ID": "TCGA.06.2565",
    "bcr_drug_barcode": "TCGA-06-2565-D22968",
    "bcr_drug_uuid": "10d32403-03ee-4362-8f7c-8626a6a7e6c1",
    "form_completion_date": "2010-3-22",
    "pharmaceutical_therapy_drug_name": "XL 184",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "c7b4fd72-b45d-4524-8424-983120abfec0",
    "patient_ID": "TCGA.06.2565",
    "bcr_drug_barcode": "TCGA-06-2565-D22967",
    "bcr_drug_uuid": "f58c8193-3ed5-4a87-a541-eb829d54f85a",
    "form_completion_date": "2010-3-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 320
  },
  {
    "bcr_patient_uuid": "c7b4fd72-b45d-4524-8424-983120abfec0",
    "patient_ID": "TCGA.06.2565",
    "bcr_drug_barcode": "TCGA-06-2565-D22969",
    "bcr_drug_uuid": "d5c1ed8f-9567-4e98-88b3-4e9f3a22e5db",
    "form_completion_date": "2010-3-22",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 193,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 550
  },
  {
    "bcr_patient_uuid": "c7b4fd72-b45d-4524-8424-983120abfec0",
    "patient_ID": "TCGA.06.2565",
    "bcr_drug_barcode": "TCGA-06-2565-D22966",
    "bcr_drug_uuid": "e48425a3-a5d5-4019-afee-6c0e744078a8",
    "form_completion_date": "2010-3-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 63,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "c7b4fd72-b45d-4524-8424-983120abfec0",
    "patient_ID": "TCGA.06.2565",
    "bcr_drug_barcode": "TCGA-06-2565-D31563",
    "bcr_drug_uuid": "a4b1ad42-b84c-47c9-99b0-4c56f2df14f6",
    "form_completion_date": "2012-5-6",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 193,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 406,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c7b4fd72-b45d-4524-8424-983120abfec0",
    "patient_ID": "TCGA.06.2565",
    "bcr_drug_barcode": "TCGA-06-2565-D31564",
    "bcr_drug_uuid": "2e01c6b1-63b3-4c84-b894-d4db2781690b",
    "form_completion_date": "2012-5-6",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 319,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 350,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c7b4fd72-b45d-4524-8424-983120abfec0",
    "patient_ID": "TCGA.06.2565",
    "bcr_drug_barcode": "TCGA-06-2565-D31565",
    "bcr_drug_uuid": "e5b1838d-a169-4197-8181-0a69dbc761ad",
    "form_completion_date": "2012-5-6",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 363,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 455,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ae5b2e48-d186-4e77-a797-dcc3b3ca4847",
    "patient_ID": "TCGA.06.2566",
    "bcr_drug_barcode": "TCGA-06-2566-D22977",
    "bcr_drug_uuid": "ca0b33fc-453c-4bda-8344-f4f08c690d4a",
    "form_completion_date": "2010-3-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 100,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 295
  },
  {
    "bcr_patient_uuid": "ae5b2e48-d186-4e77-a797-dcc3b3ca4847",
    "patient_ID": "TCGA.06.2566",
    "bcr_drug_barcode": "TCGA-06-2566-D22976",
    "bcr_drug_uuid": "03aa2a88-16fc-43a6-9480-e80701eb5c0b",
    "form_completion_date": "2010-3-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 69,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "55a063b0-98ad-4700-b3ce-61bfe364fec8",
    "patient_ID": "TCGA.06.2567",
    "bcr_drug_barcode": "TCGA-06-2567-D22981",
    "bcr_drug_uuid": "1b774ed0-21bc-4bfa-a573-0722f95fc018",
    "form_completion_date": "2010-3-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_cycles": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b37d944c-c65c-46d6-bb8b-3eb37cb85b68",
    "patient_ID": "TCGA.06.2570",
    "bcr_drug_barcode": "TCGA-06-2570-D22988",
    "bcr_drug_uuid": "fd6c8e61-af72-44cf-92f6-a18c9599ffe2",
    "form_completion_date": "2010-3-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 80,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 402,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 350
  },
  {
    "bcr_patient_uuid": "b37d944c-c65c-46d6-bb8b-3eb37cb85b68",
    "patient_ID": "TCGA.06.2570",
    "bcr_drug_barcode": "TCGA-06-2570-D22987",
    "bcr_drug_uuid": "f04d7f91-f0a4-4e19-ae6b-64921ba92f4d",
    "form_completion_date": "2010-3-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 61,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 130
  },
  {
    "bcr_patient_uuid": "af055b98-be6a-4012-ac64-f1b6539b23d0",
    "patient_ID": "TCGA.06.5408",
    "bcr_drug_barcode": "TCGA-06-5408-D22993",
    "bcr_drug_uuid": "228c59b5-422c-49ff-9c76-e2602ed8c826",
    "form_completion_date": "2011-1-24",
    "pharmaceutical_therapy_drug_name": "BS1-201",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 9.5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 652
  },
  {
    "bcr_patient_uuid": "af055b98-be6a-4012-ac64-f1b6539b23d0",
    "patient_ID": "TCGA.06.5408",
    "bcr_drug_barcode": "TCGA-06-5408-D22992",
    "bcr_drug_uuid": "57fd409d-ad1e-4663-b014-251d1a846aad",
    "form_completion_date": "2011-1-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 2,
    "drug_units": "MG/DL",
    "drug_tota_dose_units": "MG/DL",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 360
  },
  {
    "bcr_patient_uuid": "af055b98-be6a-4012-ac64-f1b6539b23d0",
    "patient_ID": "TCGA.06.5408",
    "bcr_drug_barcode": "TCGA-06-5408-D22994",
    "bcr_drug_uuid": "cbb7ba69-3e48-4785-9dfb-ed5a81a0623a",
    "form_completion_date": "2011-1-24",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 154,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 337,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 680
  },
  {
    "bcr_patient_uuid": "3f960d3b-a58c-43d0-a8a4-f3555b399c9d",
    "patient_ID": "TCGA.06.5411",
    "bcr_drug_barcode": "TCGA-06-5411-D23000",
    "bcr_drug_uuid": "ddbaa653-98e3-4e61-9bf8-40008626d52a",
    "form_completion_date": "2011-1-25",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 218,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "3f960d3b-a58c-43d0-a8a4-f3555b399c9d",
    "patient_ID": "TCGA.06.5411",
    "bcr_drug_barcode": "TCGA-06-5411-D23001",
    "bcr_drug_uuid": "61a2676a-391f-4b71-9868-c7e6b128f8df",
    "form_completion_date": "2011-1-25",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 213,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 235,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 726
  },
  {
    "bcr_patient_uuid": "e6e2d4c3-d37c-4de3-ac68-b301800770f0",
    "patient_ID": "TCGA.06.5412",
    "bcr_drug_barcode": "TCGA-06-5412-D23007",
    "bcr_drug_uuid": "3f2c87d3-aae6-42f7-98e5-19c3fc8a4aa2",
    "form_completion_date": "2011-1-25",
    "pharmaceutical_therapy_drug_name": "ABTC 0603 HYDROXYCHLOROQUINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 23,
    "drug_cycles": 0.5,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e6e2d4c3-d37c-4de3-ac68-b301800770f0",
    "patient_ID": "TCGA.06.5412",
    "bcr_drug_barcode": "TCGA-06-5412-D23006",
    "bcr_drug_uuid": "02a5f80e-d605-4bef-8a1e-04d431f20d4f",
    "form_completion_date": "2011-1-25",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 71,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "8d2e88d9-d8d0-4c42-8aa2-205a788dea58",
    "patient_ID": "TCGA.06.5413",
    "bcr_drug_barcode": "TCGA-06-5413-D23012",
    "bcr_drug_uuid": "3460ec2c-e614-4ead-bb06-e228d250d68f",
    "form_completion_date": "2011-1-25",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 261,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1059
  },
  {
    "bcr_patient_uuid": "8d2e88d9-d8d0-4c42-8aa2-205a788dea58",
    "patient_ID": "TCGA.06.5413",
    "bcr_drug_barcode": "TCGA-06-5413-D23011",
    "bcr_drug_uuid": "7ba339b8-b9a5-4924-8dd0-493ffa511e05",
    "form_completion_date": "2011-1-25",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 87,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 340
  },
  {
    "bcr_patient_uuid": "7a650a2c-bc3f-4e0c-820e-4f492977107b",
    "patient_ID": "TCGA.06.5414",
    "bcr_drug_barcode": "TCGA-06-5414-D23016",
    "bcr_drug_uuid": "e4ccdd13-07ac-4cb0-abbf-9fdf2e477f70",
    "form_completion_date": "2011-1-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "7a650a2c-bc3f-4e0c-820e-4f492977107b",
    "patient_ID": "TCGA.06.5414",
    "bcr_drug_barcode": "TCGA-06-5414-D23017",
    "bcr_drug_uuid": "0e1b1ad3-17b4-404e-a1d8-c6b6af4cb2b5",
    "form_completion_date": "2011-1-24",
    "pharmaceutical_therapy_drug_name": "HYDROCHOROQUINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 124,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "713190ed-c6c1-4695-814b-85ca9b95e6a0",
    "patient_ID": "TCGA.06.5415",
    "bcr_drug_barcode": "TCGA-06-5415-D23021",
    "bcr_drug_uuid": "6adb6807-6741-4d73-8e74-53895472089b",
    "form_completion_date": "2011-1-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 86,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 370
  },
  {
    "bcr_patient_uuid": "3a3fc890-1985-4353-861b-dc3abfb364b1",
    "patient_ID": "TCGA.06.5416",
    "bcr_drug_barcode": "TCGA-06-5416-D23025",
    "bcr_drug_uuid": "9afa5606-b833-4684-b041-dec26ec7da42",
    "form_completion_date": "2011-1-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 99,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 250
  },
  {
    "bcr_patient_uuid": "74ce7e7f-e214-4b6e-8551-114a153ab7fb",
    "patient_ID": "TCGA.06.5417",
    "bcr_drug_barcode": "TCGA-06-5417-D23029",
    "bcr_drug_uuid": "3affe5b2-9773-4dd5-903b-728c81a3c861",
    "form_completion_date": "2011-1-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 225
  },
  {
    "bcr_patient_uuid": "d1547b99-3c96-4c62-8261-5111bcf860a9",
    "patient_ID": "TCGA.06.5858",
    "bcr_drug_barcode": "TCGA-06-5858-D23039",
    "bcr_drug_uuid": "94e29e0f-1c03-4459-bcae-bec3209aad09",
    "form_completion_date": "2011-8-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 196,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 274
  },
  {
    "bcr_patient_uuid": "d1547b99-3c96-4c62-8261-5111bcf860a9",
    "patient_ID": "TCGA.06.5858",
    "bcr_drug_barcode": "TCGA-06-5858-D23040",
    "bcr_drug_uuid": "c30fdc4c-e126-4181-8c37-6a74ef489c22",
    "form_completion_date": "2011-8-8",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 196,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1014
  },
  {
    "bcr_patient_uuid": "d1547b99-3c96-4c62-8261-5111bcf860a9",
    "patient_ID": "TCGA.06.5858",
    "bcr_drug_barcode": "TCGA-06-5858-D23038",
    "bcr_drug_uuid": "521e04cd-cb47-427d-a684-0924d4569fcd",
    "form_completion_date": "2011-8-8",
    "pharmaceutical_therapy_drug_name": "ABT-888 PARP INHIBITOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 88,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "d1547b99-3c96-4c62-8261-5111bcf860a9",
    "patient_ID": "TCGA.06.5858",
    "bcr_drug_barcode": "TCGA-06-5858-D23037",
    "bcr_drug_uuid": "c2af3ffb-5509-46bd-a86d-4132da6bf69a",
    "form_completion_date": "2011-8-8",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 68,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "4644a15f-3115-4f27-86b2-b092419431e1",
    "patient_ID": "TCGA.06.5859",
    "bcr_drug_barcode": "TCGA-06-5859-D23044",
    "bcr_drug_uuid": "6b3c9af3-fcc0-4323-88a2-072b0c939a6c",
    "form_completion_date": "2011-8-9",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 42,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 180
  },
  {
    "bcr_patient_uuid": "4644a15f-3115-4f27-86b2-b092419431e1",
    "patient_ID": "TCGA.06.5859",
    "bcr_drug_barcode": "TCGA-06-5859-D23045",
    "bcr_drug_uuid": "50eed09d-5f8f-48fc-8287-805636d80042",
    "form_completion_date": "2011-8-9",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 460
  },
  {
    "bcr_patient_uuid": "7eb1d526-923d-4b31-b8be-27d83b3dd025",
    "patient_ID": "TCGA.06.6388",
    "bcr_drug_barcode": "TCGA-06-6388-D23051",
    "bcr_drug_uuid": "ea4254ea-d4f3-4c4d-856a-85bdc90b1b89",
    "form_completion_date": "2011-8-8",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 120,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "7eb1d526-923d-4b31-b8be-27d83b3dd025",
    "patient_ID": "TCGA.06.6388",
    "bcr_drug_barcode": "TCGA-06-6388-D23052",
    "bcr_drug_uuid": "4a6a6055-2813-4c5f-bae7-1ab2d39d8109",
    "form_completion_date": "2011-8-8",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 120,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 120,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 886
  },
  {
    "bcr_patient_uuid": "7eb1d526-923d-4b31-b8be-27d83b3dd025",
    "patient_ID": "TCGA.06.6388",
    "bcr_drug_barcode": "TCGA-06-6388-D23050",
    "bcr_drug_uuid": "4e557935-d022-4902-98f5-35168f1da2ed",
    "form_completion_date": "2011-8-8",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 63,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 125
  },
  {
    "bcr_patient_uuid": "7eb1d526-923d-4b31-b8be-27d83b3dd025",
    "patient_ID": "TCGA.06.6388",
    "bcr_drug_barcode": "TCGA-06-6388-D23049",
    "bcr_drug_uuid": "1b7d279a-bb50-4948-9b49-ee2945cabdb4",
    "form_completion_date": "2011-8-8",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 79,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "d9cae674-1100-44a4-8c61-2f15ea1b6214",
    "patient_ID": "TCGA.06.6389",
    "bcr_drug_barcode": "TCGA-06-6389-D23105",
    "bcr_drug_uuid": "6a338cf3-fce2-4538-addd-7ae040d1a2b4",
    "form_completion_date": "2011-11-7",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 240
  },
  {
    "bcr_patient_uuid": "d9cae674-1100-44a4-8c61-2f15ea1b6214",
    "patient_ID": "TCGA.06.6389",
    "bcr_drug_barcode": "TCGA-06-6389-D23104",
    "bcr_drug_uuid": "151a43bd-744c-4f4d-863c-f54239df2896",
    "form_completion_date": "2011-11-7",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 73,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "3ed101b5-0007-4957-a25d-4cf43bde08b6",
    "patient_ID": "TCGA.06.6390",
    "bcr_drug_barcode": "TCGA-06-6390-D23109",
    "bcr_drug_uuid": "5a73c484-726c-40fb-8816-2bbd38c654b6",
    "form_completion_date": "2011-11-7",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 69,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3ed101b5-0007-4957-a25d-4cf43bde08b6",
    "patient_ID": "TCGA.06.6390",
    "bcr_drug_barcode": "TCGA-06-6390-D23110",
    "bcr_drug_uuid": "e6240190-b034-4d4b-b1e5-82645391000c",
    "form_completion_date": "2011-11-7",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 96,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0628cb4a-c480-4b2f-bd2e-bb33e6994302",
    "patient_ID": "TCGA.06.6695",
    "bcr_drug_barcode": "TCGA-06-6695-D23059",
    "bcr_drug_uuid": "5b6352d1-cbe1-4204-8263-21dd3daf7c5e",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 280
  },
  {
    "bcr_patient_uuid": "0628cb4a-c480-4b2f-bd2e-bb33e6994302",
    "patient_ID": "TCGA.06.6695",
    "bcr_drug_barcode": "TCGA-06-6695-D23058",
    "bcr_drug_uuid": "5b8032e0-2dcb-42bb-a692-e03039c08eac",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 56,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "b28b3575-8097-4a97-b32a-5f0eeff64863",
    "patient_ID": "TCGA.06.6697",
    "bcr_drug_barcode": "TCGA-06-6697-D23063",
    "bcr_drug_uuid": "4657d327-7a25-4da4-abfd-4896365f412a",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 232,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 275,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "b28b3575-8097-4a97-b32a-5f0eeff64863",
    "patient_ID": "TCGA.06.6697",
    "bcr_drug_barcode": "TCGA-06-6697-D23065",
    "bcr_drug_uuid": "f9b7a5f7-63ee-418a-8ba4-d871a03a8af0",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 308,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 338,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "b28b3575-8097-4a97-b32a-5f0eeff64863",
    "patient_ID": "TCGA.06.6697",
    "bcr_drug_barcode": "TCGA-06-6697-D23066",
    "bcr_drug_uuid": "29f1f584-cc88-40b6-8034-9d7df7bb5e24",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "BEVACOZIMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 359,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 913
  },
  {
    "bcr_patient_uuid": "b28b3575-8097-4a97-b32a-5f0eeff64863",
    "patient_ID": "TCGA.06.6697",
    "bcr_drug_barcode": "TCGA-06-6697-D23064",
    "bcr_drug_uuid": "4dec4991-22e4-4502-bb2e-208d239eaf8f",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 277,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 308,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 320
  },
  {
    "bcr_patient_uuid": "c129c34a-8d40-4d98-b9ad-a10d3f7b3ee0",
    "patient_ID": "TCGA.06.6698",
    "bcr_drug_barcode": "TCGA-06-6698-D23071",
    "bcr_drug_uuid": "49da3aa1-a7e6-49e1-aa17-459c6956a16b",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c129c34a-8d40-4d98-b9ad-a10d3f7b3ee0",
    "patient_ID": "TCGA.06.6698",
    "bcr_drug_barcode": "TCGA-06-6698-D23070",
    "bcr_drug_uuid": "0ac944dd-94a1-4c0f-ad66-330ce4f57d68",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9848f14b-8eab-4ac9-89b0-99a5ebf14696",
    "patient_ID": "TCGA.06.6699",
    "bcr_drug_barcode": "TCGA-06-6699-D23075",
    "bcr_drug_uuid": "10a09877-6c24-42f7-b809-ddedbd61755a",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3dddfc44-7bb1-4974-8a65-a84fd4bac484",
    "patient_ID": "TCGA.06.6700",
    "bcr_drug_barcode": "TCGA-06-6700-D23081",
    "bcr_drug_uuid": "c802f949-c7d2-43e3-a1e5-eacad51d7e3e",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "VANDETANIB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 77,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "3dddfc44-7bb1-4974-8a65-a84fd4bac484",
    "patient_ID": "TCGA.06.6700",
    "bcr_drug_barcode": "TCGA-06-6700-D23080",
    "bcr_drug_uuid": "fae3233a-0ec0-44b3-ad6f-985fe2f35e45",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 100,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "3dddfc44-7bb1-4974-8a65-a84fd4bac484",
    "patient_ID": "TCGA.06.6700",
    "bcr_drug_barcode": "TCGA-06-6700-D23079",
    "bcr_drug_uuid": "aa25f328-3a4b-4f69-bd40-4548a3917dd2",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 60,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "13429a31-a193-4180-a8b2-cceaa21ecbfd",
    "patient_ID": "TCGA.06.6701",
    "bcr_drug_barcode": "TCGA-06-6701-D23085",
    "bcr_drug_uuid": "e2891780-108a-4ab1-855f-3aa19eb76dec",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 63,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "603D2B61-B636-4054-AC95-AB66DABB3B48",
    "patient_ID": "TCGA.06.A5U0",
    "bcr_drug_barcode": "TCGA-06-A5U0-D43096",
    "bcr_drug_uuid": "839EBD09-9CA4-40FB-8718-6F765D110F5D",
    "form_completion_date": "2013-5-13",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 74,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "603D2B61-B636-4054-AC95-AB66DABB3B48",
    "patient_ID": "TCGA.06.A5U0",
    "bcr_drug_barcode": "TCGA-06-A5U0-D43097",
    "bcr_drug_uuid": "5BDABD17-5670-4CF6-8F8E-F8CA0FB022B8",
    "form_completion_date": "2013-5-13",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 122,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "603D2B61-B636-4054-AC95-AB66DABB3B48",
    "patient_ID": "TCGA.06.A5U0",
    "bcr_drug_barcode": "TCGA-06-A5U0-D43098",
    "bcr_drug_uuid": "8D92D013-7BAF-41A1-AE22-CF33F99505EF",
    "form_completion_date": "2013-5-13",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 129,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E3953994-0299-4E04-9423-6153B142FB8E",
    "patient_ID": "TCGA.06.A6S1",
    "bcr_drug_barcode": "TCGA-06-A6S1-D49395",
    "bcr_drug_uuid": "6EC523DB-C4EE-4173-897D-8E4E70B19713",
    "form_completion_date": "2013-10-1",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 45,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "41685C5A-A548-483A-8A20-305AD8D61771",
    "patient_ID": "TCGA.06.A7TK",
    "bcr_drug_barcode": "TCGA-06-A7TK-D54854",
    "bcr_drug_uuid": "1BD28D05-6AD7-4688-B713-AE1A9928319F",
    "form_completion_date": "2013-12-23",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 76,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "41685C5A-A548-483A-8A20-305AD8D61771",
    "patient_ID": "TCGA.06.A7TK",
    "bcr_drug_barcode": "TCGA-06-A7TK-D54856",
    "bcr_drug_uuid": "D4BBC880-5580-4E50-B9B1-097423EBB153",
    "form_completion_date": "2013-12-23",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 113,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "41685C5A-A548-483A-8A20-305AD8D61771",
    "patient_ID": "TCGA.06.A7TK",
    "bcr_drug_barcode": "TCGA-06-A7TK-D71299",
    "bcr_drug_uuid": "57B3A1D0-627D-4914-B96A-F32E878EA3F5",
    "form_completion_date": "2015-3-24",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 342,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 419,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "41685C5A-A548-483A-8A20-305AD8D61771",
    "patient_ID": "TCGA.06.A7TK",
    "bcr_drug_barcode": "TCGA-06-A7TK-D71300",
    "bcr_drug_uuid": "934A8019-1F58-4BFD-B9EB-78B410074517",
    "form_completion_date": "2015-3-24",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 342,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 420,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0CA72EBD-FF33-45B8-A97C-3F1435603D71",
    "patient_ID": "TCGA.06.A7TL",
    "bcr_drug_barcode": "TCGA-06-A7TL-D56408",
    "bcr_drug_uuid": "A8EF3A75-75D1-4CBC-83EE-9C71A567BDF3",
    "form_completion_date": "2014-2-5",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "clinical_trial_drug_classification": "CHEMOTHERAPY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 71,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "0CA72EBD-FF33-45B8-A97C-3F1435603D71",
    "patient_ID": "TCGA.06.A7TL",
    "bcr_drug_barcode": "TCGA-06-A7TL-D56410",
    "bcr_drug_uuid": "C6CE2D4E-6AE6-40C9-A7AC-51D2F86BB862",
    "form_completion_date": "2014-2-5",
    "pharmaceutical_therapy_drug_name": "PLEXXIKON PLX3397",
    "clinical_trial_drug_classification": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": true,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "0CA72EBD-FF33-45B8-A97C-3F1435603D71",
    "patient_ID": "TCGA.06.A7TL",
    "bcr_drug_barcode": "TCGA-06-A7TL-D56411",
    "bcr_drug_uuid": "A822C259-3F22-40FB-AF6A-4E717693D06D",
    "form_completion_date": "2014-2-5",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "clinical_trial_drug_classification": "CHEMOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": true,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "0CA72EBD-FF33-45B8-A97C-3F1435603D71",
    "patient_ID": "TCGA.06.A7TL",
    "bcr_drug_barcode": "TCGA-06-A7TL-D71296",
    "bcr_drug_uuid": "B4B339D1-0D47-4536-938B-F6839B1430DB",
    "form_completion_date": "2015-3-24",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 209,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0CA72EBD-FF33-45B8-A97C-3F1435603D71",
    "patient_ID": "TCGA.06.A7TL",
    "bcr_drug_barcode": "TCGA-06-A7TL-D71297",
    "bcr_drug_uuid": "37A5DE3D-543B-43E1-9AF8-1A8FEC73BFC8",
    "form_completion_date": "2015-3-24",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 209,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1af5c959-0f36-4a14-8383-ebc0543db3bb",
    "patient_ID": "TCGA.08.0244",
    "bcr_drug_barcode": "TCGA-08-0244-D23118",
    "bcr_drug_uuid": "a838da42-a76b-4448-8074-dc3822ac1910",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "days_to_drug_end": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1af5c959-0f36-4a14-8383-ebc0543db3bb",
    "patient_ID": "TCGA.08.0244",
    "bcr_drug_barcode": "TCGA-08-0244-D23119",
    "bcr_drug_uuid": "2d87809d-bdd4-468e-ab38-f97899b88b15",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "THALIDOMIDE",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 483,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 500
  },
  {
    "bcr_patient_uuid": "e6dee2d7-ca05-44e2-bf25-1068a416bd14",
    "patient_ID": "TCGA.08.0245",
    "bcr_drug_barcode": "TCGA-08-0245-D23123",
    "bcr_drug_uuid": "4c59294b-be56-4189-af18-c983fa2960a0",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 560,
    "days_to_drug_end": 843,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "e6dee2d7-ca05-44e2-bf25-1068a416bd14",
    "patient_ID": "TCGA.08.0245",
    "bcr_drug_barcode": "TCGA-08-0245-D23126",
    "bcr_drug_uuid": "4c8885e2-1a02-47ca-866d-142e26af2d6c",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 878,
    "days_to_drug_end": 933,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "e6dee2d7-ca05-44e2-bf25-1068a416bd14",
    "patient_ID": "TCGA.08.0245",
    "bcr_drug_barcode": "TCGA-08-0245-D23124",
    "bcr_drug_uuid": "1f435cf6-7e43-4132-b098-d09017572da7",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "BCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 875,
    "days_to_drug_end": 933,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "e6dee2d7-ca05-44e2-bf25-1068a416bd14",
    "patient_ID": "TCGA.08.0245",
    "bcr_drug_barcode": "TCGA-08-0245-D23125",
    "bcr_drug_uuid": "4d79e3dd-d8bc-4eba-a8e1-fbb617a4b813",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "BCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 933,
    "days_to_drug_end": 1065,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "66d2e309-eaa1-4225-a34d-4565b4ef8019",
    "patient_ID": "TCGA.08.0246",
    "bcr_drug_barcode": "TCGA-08-0246-D23132",
    "bcr_drug_uuid": "0557d171-a8fd-4b40-961a-185e77661fc9",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "days_to_drug_end": 103,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bef21d11-f743-4d9d-8cba-fb5cd24b6927",
    "patient_ID": "TCGA.08.0344",
    "bcr_drug_barcode": "TCGA-08-0344-D23136",
    "bcr_drug_uuid": "7de0f2a9-af92-45b3-8b0b-7b1ff203bca0",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "BCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2577,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2850,
    "drug_cycles": 7,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "5536201c-e739-46e6-8200-0bdcc28ae9ef",
    "patient_ID": "TCGA.08.0346",
    "bcr_drug_barcode": "TCGA-08-0346-D23145",
    "bcr_drug_uuid": "c517757c-5421-428e-985a-c33b45578079",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "HYDROXYUREA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "days_to_drug_end": 68,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "dbb601ed-e39c-48a6-aa00-645f740fc6e2",
    "patient_ID": "TCGA.08.0347",
    "bcr_drug_barcode": "TCGA-08-0347-D23150",
    "bcr_drug_uuid": "f61a9d25-b2a9-47e1-b1c9-f72ca782cc39",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "BCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "days_to_drug_end": 419,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "dbb601ed-e39c-48a6-aa00-645f740fc6e2",
    "patient_ID": "TCGA.08.0347",
    "bcr_drug_barcode": "TCGA-08-0347-D23152",
    "bcr_drug_uuid": "64e750af-895b-4fcd-a77d-9e1bbe1200b0",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 486,
    "days_to_drug_end": 605,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 350
  },
  {
    "bcr_patient_uuid": "dbb601ed-e39c-48a6-aa00-645f740fc6e2",
    "patient_ID": "TCGA.08.0347",
    "bcr_drug_barcode": "TCGA-08-0347-D23149",
    "bcr_drug_uuid": "261a4177-1274-4ec4-9c02-a60417fa6954",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "HYDROXUREA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "days_to_drug_end": 54,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "dbb601ed-e39c-48a6-aa00-645f740fc6e2",
    "patient_ID": "TCGA.08.0347",
    "bcr_drug_barcode": "TCGA-08-0347-D23151",
    "bcr_drug_uuid": "d4c0f064-30ec-44cd-9bac-17931bdc90ac",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 422,
    "days_to_drug_end": 465,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "e1aabb11-f499-445e-a6fd-59a32b3c3531",
    "patient_ID": "TCGA.08.0348",
    "bcr_drug_barcode": "TCGA-08-0348-D23159",
    "bcr_drug_uuid": "1a86c44e-d9f0-4284-b77d-e71f3ddc0bd2",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 215,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 287,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "e1aabb11-f499-445e-a6fd-59a32b3c3531",
    "patient_ID": "TCGA.08.0348",
    "bcr_drug_barcode": "TCGA-08-0348-D23158",
    "bcr_drug_uuid": "76dd844a-473c-4fa2-8aac-6ee3a0c4cd6b",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 204,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e1aabb11-f499-445e-a6fd-59a32b3c3531",
    "patient_ID": "TCGA.08.0348",
    "bcr_drug_barcode": "TCGA-08-0348-D23160",
    "bcr_drug_uuid": "fd59d7a3-894a-4d41-a810-25154af87fbf",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "THALIDOMIDE",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 28,
    "days_to_drug_end": 136,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1000
  },
  {
    "bcr_patient_uuid": "e1aabb11-f499-445e-a6fd-59a32b3c3531",
    "patient_ID": "TCGA.08.0348",
    "bcr_drug_barcode": "TCGA-08-0348-D23161",
    "bcr_drug_uuid": "9015101c-037c-4096-8433-ef542913bc10",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 215,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 287,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 180
  },
  {
    "bcr_patient_uuid": "0645038d-8abe-4a79-8695-bf8824d33f67",
    "patient_ID": "TCGA.08.0349",
    "bcr_drug_barcode": "TCGA-08-0349-D23166",
    "bcr_drug_uuid": "cdc59f49-d267-4427-b84c-5fd7e707cca4",
    "form_completion_date": "2009-3-26",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 93,
    "drug_cycles": 1,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "0645038d-8abe-4a79-8695-bf8824d33f67",
    "patient_ID": "TCGA.08.0349",
    "bcr_drug_barcode": "TCGA-08-0349-D23169",
    "bcr_drug_uuid": "5f6c4610-c7b3-4810-88e0-989a769bea1c",
    "form_completion_date": "2009-3-26",
    "pharmaceutical_therapy_drug_name": "THALIDOMIDE",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 93,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "0645038d-8abe-4a79-8695-bf8824d33f67",
    "patient_ID": "TCGA.08.0349",
    "bcr_drug_barcode": "TCGA-08-0349-D23167",
    "bcr_drug_uuid": "b309f2d3-af1e-45cd-94c2-2e16fe14f1f8",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "BCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "days_to_drug_end": 183,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 480
  },
  {
    "bcr_patient_uuid": "0645038d-8abe-4a79-8695-bf8824d33f67",
    "patient_ID": "TCGA.08.0349",
    "bcr_drug_barcode": "TCGA-08-0349-D23168",
    "bcr_drug_uuid": "dbf995df-b25f-4801-ba7c-d7d7fd278092",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "FENRETINIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 231,
    "days_to_drug_end": 259,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2600
  },
  {
    "bcr_patient_uuid": "dc624b20-2854-4235-ae7e-672156ee30e3",
    "patient_ID": "TCGA.08.0350",
    "bcr_drug_barcode": "TCGA-08-0350-D23174",
    "bcr_drug_uuid": "bf9033fd-0c2c-4fac-89e3-6ccd90b1e437",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 678,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 838,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 450
  },
  {
    "bcr_patient_uuid": "dc624b20-2854-4235-ae7e-672156ee30e3",
    "patient_ID": "TCGA.08.0350",
    "bcr_drug_barcode": "TCGA-08-0350-D23173",
    "bcr_drug_uuid": "3441cfac-cebc-445b-978a-38b0986ed31a",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 446,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 629,
    "drug_cycles": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "91063e7e-60db-47a5-aeca-af7c37b1074e",
    "patient_ID": "TCGA.08.0351",
    "bcr_drug_barcode": "TCGA-08-0351-D23182",
    "bcr_drug_uuid": "dffca87e-cbeb-42e7-b2e6-278697b9c840",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "THALIDOMIDE",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1594,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "91063e7e-60db-47a5-aeca-af7c37b1074e",
    "patient_ID": "TCGA.08.0351",
    "bcr_drug_barcode": "TCGA-08-0351-D23181",
    "bcr_drug_uuid": "89b84e61-699e-4176-be30-02b2a9617f92",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "THALIDOMIDE",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 581,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "91063e7e-60db-47a5-aeca-af7c37b1074e",
    "patient_ID": "TCGA.08.0351",
    "bcr_drug_barcode": "TCGA-08-0351-D23179",
    "bcr_drug_uuid": "e9223f0b-2945-4679-b769-ecf78234d514",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "91063e7e-60db-47a5-aeca-af7c37b1074e",
    "patient_ID": "TCGA.08.0351",
    "bcr_drug_barcode": "TCGA-08-0351-D23180",
    "bcr_drug_uuid": "10fb7850-932c-4a66-ba6b-b6556d3097ce",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1594,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "872cb8e8-cd79-4c0b-9b54-5553b07a6ca6",
    "patient_ID": "TCGA.08.0353",
    "bcr_drug_barcode": "TCGA-08-0353-D23188",
    "bcr_drug_uuid": "6d8048ff-4849-46cc-b928-7dd435627f6a",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 76,
    "drug_cycles": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "872cb8e8-cd79-4c0b-9b54-5553b07a6ca6",
    "patient_ID": "TCGA.08.0353",
    "bcr_drug_barcode": "TCGA-08-0353-D23189",
    "bcr_drug_uuid": "b1a4241e-37fa-438e-b07b-47e726f0594c",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 174,
    "drug_cycles": 2,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "a23511df-ed31-4f3f-9fe5-87a3621c0de9",
    "patient_ID": "TCGA.08.0354",
    "bcr_drug_barcode": "TCGA-08-0354-D23194",
    "bcr_drug_uuid": "f1ab2c3a-b108-4f3d-8459-f53a2f3bcdb3",
    "form_completion_date": "2009-3-26",
    "pharmaceutical_therapy_drug_name": "TEMADOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 261,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 320,
    "drug_cycles": 2,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "a23511df-ed31-4f3f-9fe5-87a3621c0de9",
    "patient_ID": "TCGA.08.0354",
    "bcr_drug_barcode": "TCGA-08-0354-D23198",
    "bcr_drug_uuid": "d3c34d3e-bcd5-4fe3-bb75-491ecb8c77fc",
    "form_completion_date": "2009-3-26",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 261,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 320,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 450
  },
  {
    "bcr_patient_uuid": "a23511df-ed31-4f3f-9fe5-87a3621c0de9",
    "patient_ID": "TCGA.08.0354",
    "bcr_drug_barcode": "TCGA-08-0354-D23195",
    "bcr_drug_uuid": "f68f01cb-4e1b-4d61-a57c-1535e6d19e72",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "POLY LCLC",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 253,
    "drug_cycles": 8,
    "drug_units": "ML",
    "drug_tota_dose_units": "ML",
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 0.8
  },
  {
    "bcr_patient_uuid": "a23511df-ed31-4f3f-9fe5-87a3621c0de9",
    "patient_ID": "TCGA.08.0354",
    "bcr_drug_barcode": "TCGA-08-0354-D23197",
    "bcr_drug_uuid": "9671c964-bc72-4fe2-ab18-7baea00cad04",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CIS RETINOIC ACID",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 345,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 393,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 180
  },
  {
    "bcr_patient_uuid": "a23511df-ed31-4f3f-9fe5-87a3621c0de9",
    "patient_ID": "TCGA.08.0354",
    "bcr_drug_barcode": "TCGA-08-0354-D23196",
    "bcr_drug_uuid": "ca539ec6-0e57-4612-8370-6c7fb7950ea7",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "BCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 345,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 390,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 380
  },
  {
    "bcr_patient_uuid": "bb8230b5-f984-4d28-9f10-b3c89bab1c28",
    "patient_ID": "TCGA.08.0355",
    "bcr_drug_barcode": "TCGA-08-0355-D23207",
    "bcr_drug_uuid": "10297e0f-d3a7-4e3a-9fa3-22d48fa63966",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 573,
    "days_to_drug_end": 607,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 540
  },
  {
    "bcr_patient_uuid": "bb8230b5-f984-4d28-9f10-b3c89bab1c28",
    "patient_ID": "TCGA.08.0355",
    "bcr_drug_barcode": "TCGA-08-0355-D23202",
    "bcr_drug_uuid": "f69c5dec-e97f-4a4f-bb5d-6f1e84a4671e",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "days_to_drug_end": 68,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "bb8230b5-f984-4d28-9f10-b3c89bab1c28",
    "patient_ID": "TCGA.08.0355",
    "bcr_drug_barcode": "TCGA-08-0355-D23206",
    "bcr_drug_uuid": "348793dc-db8b-468b-bec3-dcf963fab0d9",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "THALOMID",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 531,
    "days_to_drug_end": 572,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1000
  },
  {
    "bcr_patient_uuid": "bb8230b5-f984-4d28-9f10-b3c89bab1c28",
    "patient_ID": "TCGA.08.0355",
    "bcr_drug_barcode": "TCGA-08-0355-D23203",
    "bcr_drug_uuid": "256feb0d-286a-4752-87aa-5d75a4b03387",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 498,
    "drug_cycles": 14,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "bb8230b5-f984-4d28-9f10-b3c89bab1c28",
    "patient_ID": "TCGA.08.0355",
    "bcr_drug_barcode": "TCGA-08-0355-D23208",
    "bcr_drug_uuid": "8eb073ca-67c9-4cfa-8c5f-f15e6a5f6eaa",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "ENZASTAURIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 638,
    "days_to_drug_end": 671,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "bb8230b5-f984-4d28-9f10-b3c89bab1c28",
    "patient_ID": "TCGA.08.0355",
    "bcr_drug_barcode": "TCGA-08-0355-D23204",
    "bcr_drug_uuid": "ee59349e-3019-40f5-bcde-bdd0fe6ee705",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "BCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 531,
    "days_to_drug_end": 531,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 210
  },
  {
    "bcr_patient_uuid": "bb8230b5-f984-4d28-9f10-b3c89bab1c28",
    "patient_ID": "TCGA.08.0355",
    "bcr_drug_barcode": "TCGA-08-0355-D23205",
    "bcr_drug_uuid": "bdd996ca-720b-40f1-b1c9-f2b8fe3ebea3",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 582,
    "days_to_drug_end": 582,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 590
  },
  {
    "bcr_patient_uuid": "f7532982-524f-4ed5-9e0d-50d3a7d72c3c",
    "patient_ID": "TCGA.08.0356",
    "bcr_drug_barcode": "TCGA-08-0356-D23213",
    "bcr_drug_uuid": "fde0eebc-e964-4060-a4e7-e91f0cafbda8",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 447,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "f7532982-524f-4ed5-9e0d-50d3a7d72c3c",
    "patient_ID": "TCGA.08.0356",
    "bcr_drug_barcode": "TCGA-08-0356-D23212",
    "bcr_drug_uuid": "3c5f687d-1205-4f36-be44-e08b7ced3321",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 82,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "548c3d4c-7993-40dc-bd02-5bb304188d28",
    "patient_ID": "TCGA.08.0357",
    "bcr_drug_barcode": "TCGA-08-0357-D23226",
    "bcr_drug_uuid": "3d8e0882-1bef-420b-b6fc-3dd7112636d0",
    "form_completion_date": "2009-3-26",
    "pharmaceutical_therapy_drug_name": "GLEEVAC",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 689,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 733,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1000
  },
  {
    "bcr_patient_uuid": "548c3d4c-7993-40dc-bd02-5bb304188d28",
    "patient_ID": "TCGA.08.0357",
    "bcr_drug_barcode": "TCGA-08-0357-D23222",
    "bcr_drug_uuid": "d7609321-572c-478c-9f19-173dd78fa045",
    "form_completion_date": "2009-3-26",
    "pharmaceutical_therapy_drug_name": "INTERFERON ALPHA",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 736,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 860,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "548c3d4c-7993-40dc-bd02-5bb304188d28",
    "patient_ID": "TCGA.08.0357",
    "bcr_drug_barcode": "TCGA-08-0357-D23217",
    "bcr_drug_uuid": "b92182ab-60f3-4902-ae8e-d659a83d0dff",
    "form_completion_date": "2009-3-26",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 736,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 860,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "548c3d4c-7993-40dc-bd02-5bb304188d28",
    "patient_ID": "TCGA.08.0357",
    "bcr_drug_barcode": "TCGA-08-0357-D23225",
    "bcr_drug_uuid": "7ba342c4-0f83-405a-a5a4-08b7a6d81ac0",
    "form_completion_date": "2009-3-26",
    "pharmaceutical_therapy_drug_name": "THALIDOMIDE",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "548c3d4c-7993-40dc-bd02-5bb304188d28",
    "patient_ID": "TCGA.08.0357",
    "bcr_drug_barcode": "TCGA-08-0357-D23224",
    "bcr_drug_uuid": "3ccbc13b-bc98-48af-8263-56ebba1c5d4d",
    "form_completion_date": "2009-3-26",
    "pharmaceutical_therapy_drug_name": "RAPAMYCIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 736,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 860,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "548c3d4c-7993-40dc-bd02-5bb304188d28",
    "patient_ID": "TCGA.08.0357",
    "bcr_drug_barcode": "TCGA-08-0357-D23218",
    "bcr_drug_uuid": "99c11925-ce58-4894-aaba-699b1e243d31",
    "form_completion_date": "2009-3-26",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "548c3d4c-7993-40dc-bd02-5bb304188d28",
    "patient_ID": "TCGA.08.0357",
    "bcr_drug_barcode": "TCGA-08-0357-D23219",
    "bcr_drug_uuid": "bef1f5c0-7826-41a8-b2e8-d1ac6975a14f",
    "form_completion_date": "2009-3-26",
    "pharmaceutical_therapy_drug_name": "HYRDROXYUREA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 689,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 733,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1000
  },
  {
    "bcr_patient_uuid": "548c3d4c-7993-40dc-bd02-5bb304188d28",
    "patient_ID": "TCGA.08.0357",
    "bcr_drug_barcode": "TCGA-08-0357-D23220",
    "bcr_drug_uuid": "a694da0f-ff13-473a-872c-2c6ee66fa7ef",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 71,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "548c3d4c-7993-40dc-bd02-5bb304188d28",
    "patient_ID": "TCGA.08.0357",
    "bcr_drug_barcode": "TCGA-08-0357-D23227",
    "bcr_drug_uuid": "375d4c00-07df-453d-a60c-c38265e9271f",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 471,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 688,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 775
  },
  {
    "bcr_patient_uuid": "548c3d4c-7993-40dc-bd02-5bb304188d28",
    "patient_ID": "TCGA.08.0357",
    "bcr_drug_barcode": "TCGA-08-0357-D23223",
    "bcr_drug_uuid": "a27af51d-409b-42a2-a5bf-5d3e29d7850d",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "IL-13 PSEUDOMONAS EXOTOXIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 184,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 188,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 36
  },
  {
    "bcr_patient_uuid": "548c3d4c-7993-40dc-bd02-5bb304188d28",
    "patient_ID": "TCGA.08.0357",
    "bcr_drug_barcode": "TCGA-08-0357-D23229",
    "bcr_drug_uuid": "1a6c1215-31e8-4b4e-8eb0-37cf0acca160",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1097,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 1112,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "548c3d4c-7993-40dc-bd02-5bb304188d28",
    "patient_ID": "TCGA.08.0357",
    "bcr_drug_barcode": "TCGA-08-0357-D23221",
    "bcr_drug_uuid": "6a8e0c94-eb69-49d8-898c-cfae7559a838",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 875,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 985,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "548c3d4c-7993-40dc-bd02-5bb304188d28",
    "patient_ID": "TCGA.08.0357",
    "bcr_drug_barcode": "TCGA-08-0357-D23228",
    "bcr_drug_uuid": "0fe3e11e-2877-4b60-b2cd-cdda901a691e",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "SORAFENIB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1007,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1084,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "548c3d4c-7993-40dc-bd02-5bb304188d28",
    "patient_ID": "TCGA.08.0357",
    "bcr_drug_barcode": "TCGA-08-0357-D23230",
    "bcr_drug_uuid": "d4fe4761-df61-47fd-b4c3-a4b7a42498a9",
    "form_completion_date": "2009-5-7",
    "pharmaceutical_therapy_drug_name": "TARVECA",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1007,
    "days_to_drug_end": 1084,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "548c3d4c-7993-40dc-bd02-5bb304188d28",
    "patient_ID": "TCGA.08.0357",
    "bcr_drug_barcode": "TCGA-08-0357-D23231",
    "bcr_drug_uuid": "b6d05d6f-46ce-45a4-90ba-8186e9011b65",
    "form_completion_date": "2009-5-22",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 471,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 688,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 475
  },
  {
    "bcr_patient_uuid": "ec504558-e96a-44e9-835a-7b12680681ed",
    "patient_ID": "TCGA.08.0358",
    "bcr_drug_barcode": "TCGA-08-0358-D23241",
    "bcr_drug_uuid": "27cdbcf7-ace5-400e-a9d4-c60f83f75af8",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 91,
    "days_to_drug_end": 264,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "ec504558-e96a-44e9-835a-7b12680681ed",
    "patient_ID": "TCGA.08.0358",
    "bcr_drug_barcode": "TCGA-08-0358-D23236",
    "bcr_drug_uuid": "44c9f712-4492-49fa-8a39-a260a6b7c458",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "days_to_drug_end": 264,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "ec504558-e96a-44e9-835a-7b12680681ed",
    "patient_ID": "TCGA.08.0358",
    "bcr_drug_barcode": "TCGA-08-0358-D23237",
    "bcr_drug_uuid": "38de7c79-302d-4ca6-b235-81b135b8cfcc",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 491,
    "days_to_drug_end": 548,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 220
  },
  {
    "bcr_patient_uuid": "ec504558-e96a-44e9-835a-7b12680681ed",
    "patient_ID": "TCGA.08.0358",
    "bcr_drug_barcode": "TCGA-08-0358-D23238",
    "bcr_drug_uuid": "4d3ea852-38f0-42c4-8bfc-0bb6fe5fe1f9",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "IL-13 WITH PSEUDOMONAS EXOTOXIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 288,
    "days_to_drug_end": 293,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 36
  },
  {
    "bcr_patient_uuid": "ec504558-e96a-44e9-835a-7b12680681ed",
    "patient_ID": "TCGA.08.0358",
    "bcr_drug_barcode": "TCGA-08-0358-D23239",
    "bcr_drug_uuid": "0a1e7b70-1747-42c8-ad6a-49b615ad2b91",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "HSPPC-96 VACCINE",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 341,
    "days_to_drug_end": 467,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 0.4
  },
  {
    "bcr_patient_uuid": "ec504558-e96a-44e9-835a-7b12680681ed",
    "patient_ID": "TCGA.08.0358",
    "bcr_drug_barcode": "TCGA-08-0358-D23235",
    "bcr_drug_uuid": "756123e8-ff61-486c-804a-34a9a92b48e1",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "days_to_drug_end": 75,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "ec504558-e96a-44e9-835a-7b12680681ed",
    "patient_ID": "TCGA.08.0358",
    "bcr_drug_barcode": "TCGA-08-0358-D23240",
    "bcr_drug_uuid": "a29f4049-b90d-4c2a-8f60-5473162ba8c6",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 33,
    "days_to_drug_end": 75,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "6d6dae20-431d-4fbe-ba47-e7ed8d73b4d8",
    "patient_ID": "TCGA.08.0360",
    "bcr_drug_barcode": "TCGA-08-0360-D23247",
    "bcr_drug_uuid": "abab65c4-8746-435d-b917-141a8ed0dcaf",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "IL-13 WITH PSEUDOMONAS EXOTOXIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 130,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 36
  },
  {
    "bcr_patient_uuid": "6fc40b53-5db2-4319-a039-b023e1bb1d64",
    "patient_ID": "TCGA.08.0380",
    "bcr_drug_barcode": "TCGA-08-0380-D23259",
    "bcr_drug_uuid": "bd96270d-54f2-453e-bdc1-3a3fc050c931",
    "form_completion_date": "2009-3-26",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 275,
    "days_to_drug_end": 330,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "6fc40b53-5db2-4319-a039-b023e1bb1d64",
    "patient_ID": "TCGA.08.0380",
    "bcr_drug_barcode": "TCGA-08-0380-D23256",
    "bcr_drug_uuid": "cf946024-3010-4731-9971-627fa2f71668",
    "form_completion_date": "2009-3-26",
    "pharmaceutical_therapy_drug_name": "VP16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 293,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 330,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "6fc40b53-5db2-4319-a039-b023e1bb1d64",
    "patient_ID": "TCGA.08.0380",
    "bcr_drug_barcode": "TCGA-08-0380-D23258",
    "bcr_drug_uuid": "7207fb18-9e10-4b45-8f5a-01453c10f483",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 216,
    "days_to_drug_end": 274,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 345
  },
  {
    "bcr_patient_uuid": "6fc40b53-5db2-4319-a039-b023e1bb1d64",
    "patient_ID": "TCGA.08.0380",
    "bcr_drug_barcode": "TCGA-08-0380-D23260",
    "bcr_drug_uuid": "0f52d72f-2ed9-42c6-ad05-09419d37cfd6",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "MARIMASTAT",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "6fc40b53-5db2-4319-a039-b023e1bb1d64",
    "patient_ID": "TCGA.08.0380",
    "bcr_drug_barcode": "TCGA-08-0380-D23257",
    "bcr_drug_uuid": "83a0190a-e7d1-487b-b781-dadfe5087a65",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "BCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 161,
    "days_to_drug_end": 193,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 375
  },
  {
    "bcr_patient_uuid": "314d9188-c8fd-43fc-905d-b6889de542c8",
    "patient_ID": "TCGA.08.0386",
    "bcr_drug_barcode": "TCGA-08-0386-D23267",
    "bcr_drug_uuid": "9d26e686-131c-42b6-ab3e-4d93cf188229",
    "form_completion_date": "2009-3-26",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 427,
    "drug_cycles": 11,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "314d9188-c8fd-43fc-905d-b6889de542c8",
    "patient_ID": "TCGA.08.0386",
    "bcr_drug_barcode": "TCGA-08-0386-D23269",
    "bcr_drug_uuid": "f620fa22-6a39-4f18-abf0-31b11375c701",
    "form_completion_date": "2009-3-26",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 76,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "314d9188-c8fd-43fc-905d-b6889de542c8",
    "patient_ID": "TCGA.08.0386",
    "bcr_drug_barcode": "TCGA-08-0386-D23266",
    "bcr_drug_uuid": "7f467abb-da6c-40e5-a568-6f431c158c83",
    "form_completion_date": "2009-3-26",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 76,
    "drug_cycles": 1,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "314d9188-c8fd-43fc-905d-b6889de542c8",
    "patient_ID": "TCGA.08.0386",
    "bcr_drug_barcode": "TCGA-08-0386-D23270",
    "bcr_drug_uuid": "d9b30b36-dbe1-4435-9c5a-9dacc057c6dd",
    "form_completion_date": "2009-3-26",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 106,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "314d9188-c8fd-43fc-905d-b6889de542c8",
    "patient_ID": "TCGA.08.0386",
    "bcr_drug_barcode": "TCGA-08-0386-D23268",
    "bcr_drug_uuid": "668dac3e-01d7-4e1a-8822-919990ff0b0f",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "HSPPC-96 VACCINE",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 113,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 0.4
  },
  {
    "bcr_patient_uuid": "ea980264-d64d-410a-86dd-c129d7d8d1ee",
    "patient_ID": "TCGA.08.0389",
    "bcr_drug_barcode": "TCGA-08-0389-D23275",
    "bcr_drug_uuid": "52b6a44a-3f4b-4740-b333-92f51dff9986",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "EMD",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 39,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ea980264-d64d-410a-86dd-c129d7d8d1ee",
    "patient_ID": "TCGA.08.0389",
    "bcr_drug_barcode": "TCGA-08-0389-D23274",
    "bcr_drug_uuid": "dd9af520-6133-43cf-978c-c3bc32eb3eda",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "108a8d8e-1ddb-4c0d-a05b-71573b33b9aa",
    "patient_ID": "TCGA.08.0390",
    "bcr_drug_barcode": "TCGA-08-0390-D23279",
    "bcr_drug_uuid": "f887296e-cb81-472a-932a-c4efe25583c0",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "days_to_drug_end": 69,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "108a8d8e-1ddb-4c0d-a05b-71573b33b9aa",
    "patient_ID": "TCGA.08.0390",
    "bcr_drug_barcode": "TCGA-08-0390-D23280",
    "bcr_drug_uuid": "80c63184-c068-4bef-868f-e1b0dee5e9cf",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "days_to_drug_end": 132,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "108a8d8e-1ddb-4c0d-a05b-71573b33b9aa",
    "patient_ID": "TCGA.08.0390",
    "bcr_drug_barcode": "TCGA-08-0390-D23281",
    "bcr_drug_uuid": "b3f16806-ffbf-4372-9601-7d606e1f7464",
    "form_completion_date": "2009-6-10",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 28,
    "days_to_drug_end": 69,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "108a8d8e-1ddb-4c0d-a05b-71573b33b9aa",
    "patient_ID": "TCGA.08.0390",
    "bcr_drug_barcode": "TCGA-08-0390-D23282",
    "bcr_drug_uuid": "650f54eb-f3f2-4d5b-a271-8ad74d026947",
    "form_completion_date": "2009-6-10",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 105,
    "days_to_drug_end": 132,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "06e32525-6043-45a1-9fef-fa24ab219a1f",
    "patient_ID": "TCGA.08.0510",
    "bcr_drug_barcode": "TCGA-08-0510-D23289",
    "bcr_drug_uuid": "6ca85588-01e5-4eca-90d4-e91fc02b888a",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 90,
    "drug_cycles": 2,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 330
  },
  {
    "bcr_patient_uuid": "06e32525-6043-45a1-9fef-fa24ab219a1f",
    "patient_ID": "TCGA.08.0510",
    "bcr_drug_barcode": "TCGA-08-0510-D23290",
    "bcr_drug_uuid": "b19565f4-5ff0-4aa2-91bf-ed05d4873ecd",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "THALIDOMIDE",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 64,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "13480f06-32ee-48b5-a729-a963a7979b90",
    "patient_ID": "TCGA.08.0511",
    "bcr_drug_barcode": "TCGA-08-0511-D23294",
    "bcr_drug_uuid": "f89ba681-e3e2-4dbf-8ff3-dcdccbff547a",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 210
  },
  {
    "bcr_patient_uuid": "9773acd0-e8bf-4991-8913-53f0d2adfc72",
    "patient_ID": "TCGA.08.0517",
    "bcr_drug_barcode": "TCGA-08-0517-D23309",
    "bcr_drug_uuid": "125ce2ce-53a3-4877-8229-b67a4335f361",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "ACCUTANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1754,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "9773acd0-e8bf-4991-8913-53f0d2adfc72",
    "patient_ID": "TCGA.08.0517",
    "bcr_drug_barcode": "TCGA-08-0517-D23308",
    "bcr_drug_uuid": "80bb4143-6775-4ad8-9b13-6db2df79c961",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE/CCNU/VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1086,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1359,
    "drug_cycles": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "e924d7c6-c98f-4469-8089-70e4ac3ca306",
    "patient_ID": "TCGA.08.0520",
    "bcr_drug_barcode": "TCGA-08-0520-D23316",
    "bcr_drug_uuid": "b57bc141-fc8a-49fc-bd12-ffa57079021e",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 175,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "b2a01580-d18f-40b5-875b-93e9c000b0e1",
    "patient_ID": "TCGA.08.0521",
    "bcr_drug_barcode": "TCGA-08-0521-D23322",
    "bcr_drug_uuid": "3e04ec4a-1e27-49cf-adf2-4401a99cbc9c",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 99,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "b2a01580-d18f-40b5-875b-93e9c000b0e1",
    "patient_ID": "TCGA.08.0521",
    "bcr_drug_barcode": "TCGA-08-0521-D23321",
    "bcr_drug_uuid": "680f2489-45ef-4bc9-8c53-1b187c4959dc",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 63,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "51e5a60f-e7b1-4b8b-b0b1-447c28940fe6",
    "patient_ID": "TCGA.08.0522",
    "bcr_drug_barcode": "TCGA-08-0522-D23328",
    "bcr_drug_uuid": "a8621f7d-26ea-40ce-a491-c54063176bcd",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 517,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 555,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "51e5a60f-e7b1-4b8b-b0b1-447c28940fe6",
    "patient_ID": "TCGA.08.0522",
    "bcr_drug_barcode": "TCGA-08-0522-D23330",
    "bcr_drug_uuid": "af652c34-1a2a-4971-8dd2-849b7dac1b67",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "LY317615",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 423,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 511,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "51e5a60f-e7b1-4b8b-b0b1-447c28940fe6",
    "patient_ID": "TCGA.08.0522",
    "bcr_drug_barcode": "TCGA-08-0522-D23326",
    "bcr_drug_uuid": "611d6606-63a8-4f55-a972-14849d854e06",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 65,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "51e5a60f-e7b1-4b8b-b0b1-447c28940fe6",
    "patient_ID": "TCGA.08.0522",
    "bcr_drug_barcode": "TCGA-08-0522-D23329",
    "bcr_drug_uuid": "d64f01af-86de-4fe6-841e-ed1449fe4591",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "IL-13-PE38QQR CYTOXIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 268,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 271,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "51e5a60f-e7b1-4b8b-b0b1-447c28940fe6",
    "patient_ID": "TCGA.08.0522",
    "bcr_drug_barcode": "TCGA-08-0522-D23327",
    "bcr_drug_uuid": "662d7ceb-c89c-447e-a6ad-a36a17aa7d5f",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 225,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 280
  },
  {
    "bcr_patient_uuid": "ea8b757b-3d33-47e1-8657-503cf69939bb",
    "patient_ID": "TCGA.08.0524",
    "bcr_drug_barcode": "TCGA-08-0524-D23334",
    "bcr_drug_uuid": "c2a40350-bf1a-4b73-80c9-0d802a7b3a6e",
    "form_completion_date": "2009-3-26",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 195,
    "days_to_drug_end": 199,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 170
  },
  {
    "bcr_patient_uuid": "ea8b757b-3d33-47e1-8657-503cf69939bb",
    "patient_ID": "TCGA.08.0524",
    "bcr_drug_barcode": "TCGA-08-0524-D23336",
    "bcr_drug_uuid": "fd5dd288-a7c6-4327-8ff7-3679383f3460",
    "form_completion_date": "2009-3-26",
    "pharmaceutical_therapy_drug_name": "THALIDOMIDE",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 195,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "ea8b757b-3d33-47e1-8657-503cf69939bb",
    "patient_ID": "TCGA.08.0524",
    "bcr_drug_barcode": "TCGA-08-0524-D23335",
    "bcr_drug_uuid": "b2ead0e8-200b-4a43-825f-85b98da68ecd",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "days_to_drug_end": 52,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 120
  },
  {
    "bcr_patient_uuid": "ea8b757b-3d33-47e1-8657-503cf69939bb",
    "patient_ID": "TCGA.08.0524",
    "bcr_drug_barcode": "TCGA-08-0524-D23338",
    "bcr_drug_uuid": "8c5542ae-94b5-4250-a509-cab4462f31a5",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "GLEEVEC",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 138,
    "days_to_drug_end": 189,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 350
  },
  {
    "bcr_patient_uuid": "ea8b757b-3d33-47e1-8657-503cf69939bb",
    "patient_ID": "TCGA.08.0524",
    "bcr_drug_barcode": "TCGA-08-0524-D23337",
    "bcr_drug_uuid": "4270b4e0-2b49-4d15-a2d2-a6cdccd03f73",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "SCH63666",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 73,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "1b042663-dcb1-4fc9-b813-7b90cc2eb392",
    "patient_ID": "TCGA.08.0525",
    "bcr_drug_barcode": "TCGA-08-0525-D23342",
    "bcr_drug_uuid": "3f0583ea-e3dd-407e-bd69-7195cfe1001d",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "days_to_drug_end": 39,
    "drug_cycles": 1,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "1b042663-dcb1-4fc9-b813-7b90cc2eb392",
    "patient_ID": "TCGA.08.0525",
    "bcr_drug_barcode": "TCGA-08-0525-D23343",
    "bcr_drug_uuid": "39882308-2a6a-4db3-aac0-e404b8e35454",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "days_to_drug_end": 341,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1b042663-dcb1-4fc9-b813-7b90cc2eb392",
    "patient_ID": "TCGA.08.0525",
    "bcr_drug_barcode": "TCGA-08-0525-D23344",
    "bcr_drug_uuid": "43f8b1d4-ff5c-4d9d-8fa0-4a2db86a2d07",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "OS1-774",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 370,
    "days_to_drug_end": 402,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "aaa7d45b-ce3c-4099-ab4a-377e3aee9f96",
    "patient_ID": "TCGA.08.0529",
    "bcr_drug_barcode": "TCGA-08-0529-D23348",
    "bcr_drug_uuid": "8edbabf9-11f1-4faa-9331-71bad6425735",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "aaa7d45b-ce3c-4099-ab4a-377e3aee9f96",
    "patient_ID": "TCGA.08.0529",
    "bcr_drug_barcode": "TCGA-08-0529-D23349",
    "bcr_drug_uuid": "8011d7f2-a247-4adc-85e1-539f022f7899",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 106,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 328,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "aaa7d45b-ce3c-4099-ab4a-377e3aee9f96",
    "patient_ID": "TCGA.08.0529",
    "bcr_drug_barcode": "TCGA-08-0529-D23350",
    "bcr_drug_uuid": "71e78233-8b19-463d-87a8-2aeebfe0b9bb",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "IL-13 PSEUDOMONAS EXOTOXIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 349,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 353,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 36
  },
  {
    "bcr_patient_uuid": "c7b317a4-f5ba-4bd5-bbde-fd09418d3dee",
    "patient_ID": "TCGA.08.0531",
    "bcr_drug_barcode": "TCGA-08-0531-D23354",
    "bcr_drug_uuid": "e2516eda-e23d-4bff-b103-de7cc4b01524",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 69,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "c7b317a4-f5ba-4bd5-bbde-fd09418d3dee",
    "patient_ID": "TCGA.08.0531",
    "bcr_drug_barcode": "TCGA-08-0531-D23355",
    "bcr_drug_uuid": "9743cbd0-782e-4e71-a8d4-1d2e38351e36",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 198,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "141a1ef1-9be6-46d1-b445-305b222727d2",
    "patient_ID": "TCGA.12.0615",
    "bcr_drug_barcode": "TCGA-12-0615-D23454",
    "bcr_drug_uuid": "2058a9df-53e5-41ea-9f92-8fb8c1675605",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "141a1ef1-9be6-46d1-b445-305b222727d2",
    "patient_ID": "TCGA.12.0615",
    "bcr_drug_barcode": "TCGA-12-0615-D23458",
    "bcr_drug_uuid": "fa620ada-f061-4a9f-87ac-23119ebf5d01",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 278,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 383,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "141a1ef1-9be6-46d1-b445-305b222727d2",
    "patient_ID": "TCGA.12.0615",
    "bcr_drug_barcode": "TCGA-12-0615-D23457",
    "bcr_drug_uuid": "3bdfb509-fda0-43bd-8086-8ddf44a2a793",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 195,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 278,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "141a1ef1-9be6-46d1-b445-305b222727d2",
    "patient_ID": "TCGA.12.0615",
    "bcr_drug_barcode": "TCGA-12-0615-D23456",
    "bcr_drug_uuid": "e1b25fc1-3ec6-47f6-9fcc-27f17452234b",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 195,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 278,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 125
  },
  {
    "bcr_patient_uuid": "141a1ef1-9be6-46d1-b445-305b222727d2",
    "patient_ID": "TCGA.12.0615",
    "bcr_drug_barcode": "TCGA-12-0615-D23453",
    "bcr_drug_uuid": "0c9a0b3e-adfb-4ae8-ba6c-9c1fe3d08310",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFERS",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 28,
    "drug_cycles": 1,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_route": "INTRATUMORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8
  },
  {
    "bcr_patient_uuid": "141a1ef1-9be6-46d1-b445-305b222727d2",
    "patient_ID": "TCGA.12.0615",
    "bcr_drug_barcode": "TCGA-12-0615-D23455",
    "bcr_drug_uuid": "f2b9aca2-dd5b-4256-bcd3-0ada2dfa3c59",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 172,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "edcfac32-adb4-4fe7-86a0-309d3c6430e5",
    "patient_ID": "TCGA.12.0616",
    "bcr_drug_barcode": "TCGA-12-0616-D23467",
    "bcr_drug_uuid": "1fb698c8-dfdb-4a63-8150-bba466ed72c4",
    "form_completion_date": "2009-3-26",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 260,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 348,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "edcfac32-adb4-4fe7-86a0-309d3c6430e5",
    "patient_ID": "TCGA.12.0616",
    "bcr_drug_barcode": "TCGA-12-0616-D23462",
    "bcr_drug_uuid": "5c7b6bc7-c0fe-45da-aa96-54bbe7e105c2",
    "form_completion_date": "2009-3-26",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 260,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 348,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 340
  },
  {
    "bcr_patient_uuid": "edcfac32-adb4-4fe7-86a0-309d3c6430e5",
    "patient_ID": "TCGA.12.0616",
    "bcr_drug_barcode": "TCGA-12-0616-D23468",
    "bcr_drug_uuid": "62e266bb-9683-49f3-b4cf-cfae84421be5",
    "form_completion_date": "2009-3-26",
    "pharmaceutical_therapy_drug_name": "GLEEVAC",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 407,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 433,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 700
  },
  {
    "bcr_patient_uuid": "edcfac32-adb4-4fe7-86a0-309d3c6430e5",
    "patient_ID": "TCGA.12.0616",
    "bcr_drug_barcode": "TCGA-12-0616-D23469",
    "bcr_drug_uuid": "17f27132-83fb-4825-8002-27cb5a843d24",
    "form_completion_date": "2009-3-26",
    "pharmaceutical_therapy_drug_name": "RAD001",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 407,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 433,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2.5
  },
  {
    "bcr_patient_uuid": "edcfac32-adb4-4fe7-86a0-309d3c6430e5",
    "patient_ID": "TCGA.12.0616",
    "bcr_drug_barcode": "TCGA-12-0616-D23463",
    "bcr_drug_uuid": "20cdff4b-2072-4629-b3e9-444c7c37f6a8",
    "form_completion_date": "2009-3-26",
    "pharmaceutical_therapy_drug_name": "HYDROXYUREA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 407,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 433,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1000
  },
  {
    "bcr_patient_uuid": "edcfac32-adb4-4fe7-86a0-309d3c6430e5",
    "patient_ID": "TCGA.12.0616",
    "bcr_drug_barcode": "TCGA-12-0616-D23466",
    "bcr_drug_uuid": "2fe8013b-55c0-4817-a832-628f5eb96d5b",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 362,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 407,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "edcfac32-adb4-4fe7-86a0-309d3c6430e5",
    "patient_ID": "TCGA.12.0616",
    "bcr_drug_barcode": "TCGA-12-0616-D23465",
    "bcr_drug_uuid": "04a3ed4c-d254-4846-8eb5-032b75040d66",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 106,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 259,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "edcfac32-adb4-4fe7-86a0-309d3c6430e5",
    "patient_ID": "TCGA.12.0616",
    "bcr_drug_barcode": "TCGA-12-0616-D23464",
    "bcr_drug_uuid": "e1cbbbf7-ee6a-4d6b-ab2d-625738905bce",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 75,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "f7ba48c8-46cf-40a9-8826-7e1f67d57171",
    "patient_ID": "TCGA.12.0618",
    "bcr_drug_barcode": "TCGA-12-0618-D23474",
    "bcr_drug_uuid": "444f1329-bd6b-4f79-a3e2-6318c1e54ccf",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 9,
    "days_to_drug_end": 65,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "f7ba48c8-46cf-40a9-8826-7e1f67d57171",
    "patient_ID": "TCGA.12.0618",
    "bcr_drug_barcode": "TCGA-12-0618-D23473",
    "bcr_drug_uuid": "ef68904b-ae04-4e6b-a596-941492bbb53d",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFERS",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "days_to_drug_end": 0,
    "drug_cycles": 1,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_route": "INTRATUMORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8
  },
  {
    "bcr_patient_uuid": "0389b35b-651b-4776-b12a-d315a100f47c",
    "patient_ID": "TCGA.12.0619",
    "bcr_drug_barcode": "TCGA-12-0619-D23478",
    "bcr_drug_uuid": "d4423692-0c30-47f0-8b1c-f2d8dc3d584a",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFERS",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 0,
    "drug_cycles": 1,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_route": "INTRATUMORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8
  },
  {
    "bcr_patient_uuid": "0389b35b-651b-4776-b12a-d315a100f47c",
    "patient_ID": "TCGA.12.0619",
    "bcr_drug_barcode": "TCGA-12-0619-D23483",
    "bcr_drug_uuid": "055624f8-2a14-4a95-8167-73fa4390da01",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 291,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 350,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "0389b35b-651b-4776-b12a-d315a100f47c",
    "patient_ID": "TCGA.12.0619",
    "bcr_drug_barcode": "TCGA-12-0619-D23479",
    "bcr_drug_uuid": "2c49dfbf-f75b-4a39-8b09-e66dc403bea7",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "0389b35b-651b-4776-b12a-d315a100f47c",
    "patient_ID": "TCGA.12.0619",
    "bcr_drug_barcode": "TCGA-12-0619-D23482",
    "bcr_drug_uuid": "a6a54b5b-168e-48d5-8f2a-94ed730f02c6",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 228,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 291,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "0389b35b-651b-4776-b12a-d315a100f47c",
    "patient_ID": "TCGA.12.0619",
    "bcr_drug_barcode": "TCGA-12-0619-D23484",
    "bcr_drug_uuid": "fa2a4628-c2af-46a0-8386-5d741e3f65fc",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 443,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 571,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "0389b35b-651b-4776-b12a-d315a100f47c",
    "patient_ID": "TCGA.12.0619",
    "bcr_drug_barcode": "TCGA-12-0619-D23480",
    "bcr_drug_uuid": "d9223402-48ef-4310-ba23-85f4242adbac",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "0389b35b-651b-4776-b12a-d315a100f47c",
    "patient_ID": "TCGA.12.0619",
    "bcr_drug_barcode": "TCGA-12-0619-D23481",
    "bcr_drug_uuid": "d2a508f4-9e2d-4e0e-a6ab-baa0ef1cde71",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 163,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 203,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 82.5
  },
  {
    "bcr_patient_uuid": "1dbfbff7-d048-4770-ae02-e6a287256210",
    "patient_ID": "TCGA.12.0620",
    "bcr_drug_barcode": "TCGA-12-0620-D23488",
    "bcr_drug_uuid": "4bbe6ac4-7aa5-4f73-9763-d3673ae1d11c",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 68,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "1dbfbff7-d048-4770-ae02-e6a287256210",
    "patient_ID": "TCGA.12.0620",
    "bcr_drug_barcode": "TCGA-12-0620-D23489",
    "bcr_drug_uuid": "80b5bea0-8ba7-49c8-ab89-8ca137201237",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 191,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "a7b55dae-c9b8-45c6-986f-fb1055f1c67b",
    "patient_ID": "TCGA.12.0653",
    "bcr_drug_barcode": "TCGA-12-0653-D33743",
    "bcr_drug_uuid": "0f41a530-6b84-4bcd-96e7-11fefe6aa31a",
    "form_completion_date": "2012-7-14",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFERS",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 0
  },
  {
    "bcr_patient_uuid": "a7b55dae-c9b8-45c6-986f-fb1055f1c67b",
    "patient_ID": "TCGA.12.0653",
    "bcr_drug_barcode": "TCGA-12-0653-D33744",
    "bcr_drug_uuid": "60045ecf-1594-412e-ba97-11a24191c3e0",
    "form_completion_date": "2012-7-14",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110
  },
  {
    "bcr_patient_uuid": "a7b55dae-c9b8-45c6-986f-fb1055f1c67b",
    "patient_ID": "TCGA.12.0653",
    "bcr_drug_barcode": "TCGA-12-0653-D33745",
    "bcr_drug_uuid": "fa2b8930-902e-42e7-ab2e-0abe87b1c1db",
    "form_completion_date": "2012-7-14",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 110,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155
  },
  {
    "bcr_patient_uuid": "a7b55dae-c9b8-45c6-986f-fb1055f1c67b",
    "patient_ID": "TCGA.12.0653",
    "bcr_drug_barcode": "TCGA-12-0653-D33746",
    "bcr_drug_uuid": "5b6ab215-11fe-4093-9444-529cd1f1fac6",
    "form_completion_date": "2012-7-14",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 155,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 210
  },
  {
    "bcr_patient_uuid": "a7b55dae-c9b8-45c6-986f-fb1055f1c67b",
    "patient_ID": "TCGA.12.0653",
    "bcr_drug_barcode": "TCGA-12-0653-D33747",
    "bcr_drug_uuid": "dd44d82e-d68f-4213-910d-c04bb08e7d5e",
    "form_completion_date": "2012-7-14",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 210,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 267
  },
  {
    "bcr_patient_uuid": "a7b55dae-c9b8-45c6-986f-fb1055f1c67b",
    "patient_ID": "TCGA.12.0653",
    "bcr_drug_barcode": "TCGA-12-0653-D33748",
    "bcr_drug_uuid": "5691d622-6e29-414f-bce3-87fe3d6ee417",
    "form_completion_date": "2012-7-14",
    "pharmaceutical_therapy_drug_name": "O6B6",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 281,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 283
  },
  {
    "bcr_patient_uuid": "a7b55dae-c9b8-45c6-986f-fb1055f1c67b",
    "patient_ID": "TCGA.12.0653",
    "bcr_drug_barcode": "TCGA-12-0653-D33749",
    "bcr_drug_uuid": "96e74b79-4a7c-4983-9c16-f1f9fb2628b7",
    "form_completion_date": "2012-7-14",
    "pharmaceutical_therapy_drug_name": "O6B6",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 281,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 283
  },
  {
    "bcr_patient_uuid": "e67edc2e-5de7-4d3c-ba47-e8558a0b9f5a",
    "patient_ID": "TCGA.12.0654",
    "bcr_drug_barcode": "TCGA-12-0654-D23493",
    "bcr_drug_uuid": "cd22b3a0-f35e-4408-8612-8373461f76d8",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "MAB I-131",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 216,
    "drug_units": "MCI",
    "drug_tota_dose_units": "MCI",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 120
  },
  {
    "bcr_patient_uuid": "e67edc2e-5de7-4d3c-ba47-e8558a0b9f5a",
    "patient_ID": "TCGA.12.0654",
    "bcr_drug_barcode": "TCGA-12-0654-D23494",
    "bcr_drug_uuid": "5ee384a9-304e-45e7-ae9b-5251252e49fd",
    "form_completion_date": "2009-5-22",
    "pharmaceutical_therapy_drug_name": "MU81C6",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 216,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "c4ff28e5-9de7-43df-89a2-6832b8a0c00b",
    "patient_ID": "TCGA.12.0656",
    "bcr_drug_barcode": "TCGA-12-0656-D23505",
    "bcr_drug_uuid": "9b3f9504-1f88-4ffe-953f-770f3c5a8df3",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "MAB I-131",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 22,
    "drug_units": "MCI",
    "drug_tota_dose_units": "MCI",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 120
  },
  {
    "bcr_patient_uuid": "c4ff28e5-9de7-43df-89a2-6832b8a0c00b",
    "patient_ID": "TCGA.12.0656",
    "bcr_drug_barcode": "TCGA-12-0656-D23499",
    "bcr_drug_uuid": "cd81ea56-89d5-4ae7-9029-1ad1fb4657f4",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 204,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 254,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 55
  },
  {
    "bcr_patient_uuid": "c4ff28e5-9de7-43df-89a2-6832b8a0c00b",
    "patient_ID": "TCGA.12.0656",
    "bcr_drug_barcode": "TCGA-12-0656-D23502",
    "bcr_drug_uuid": "68706cce-028f-40a0-9356-4a18685ada5a",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1758,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1817,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "c4ff28e5-9de7-43df-89a2-6832b8a0c00b",
    "patient_ID": "TCGA.12.0656",
    "bcr_drug_barcode": "TCGA-12-0656-D23503",
    "bcr_drug_uuid": "cad383d6-b665-4973-8323-e764718c6dd3",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1817,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1873,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 82.5
  },
  {
    "bcr_patient_uuid": "c4ff28e5-9de7-43df-89a2-6832b8a0c00b",
    "patient_ID": "TCGA.12.0656",
    "bcr_drug_barcode": "TCGA-12-0656-D23498",
    "bcr_drug_uuid": "831d594f-6292-4dc1-a2a9-0d371d17e6d1",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 135,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 204,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "c4ff28e5-9de7-43df-89a2-6832b8a0c00b",
    "patient_ID": "TCGA.12.0656",
    "bcr_drug_barcode": "TCGA-12-0656-D23500",
    "bcr_drug_uuid": "c26bd072-17a2-43e9-a719-2ab1b6b12201",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 301,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 443,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 37.5
  },
  {
    "bcr_patient_uuid": "c4ff28e5-9de7-43df-89a2-6832b8a0c00b",
    "patient_ID": "TCGA.12.0656",
    "bcr_drug_barcode": "TCGA-12-0656-D23501",
    "bcr_drug_uuid": "30489eb9-9c80-4381-b259-88134f92e385",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1488,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1758,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "c4ff28e5-9de7-43df-89a2-6832b8a0c00b",
    "patient_ID": "TCGA.12.0656",
    "bcr_drug_barcode": "TCGA-12-0656-D23504",
    "bcr_drug_uuid": "372e4e48-06d3-40be-961b-d5deace2e199",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1873,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1899,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "c4ff28e5-9de7-43df-89a2-6832b8a0c00b",
    "patient_ID": "TCGA.12.0656",
    "bcr_drug_barcode": "TCGA-12-0656-D23506",
    "bcr_drug_uuid": "f87abf1c-5c6a-4a72-9cb9-71649f3cb786",
    "form_completion_date": "2009-5-22",
    "pharmaceutical_therapy_drug_name": "MU81C6",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 22,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "a3cc2845-8a44-4b50-8a3e-17a3c2c3e077",
    "patient_ID": "TCGA.12.0662",
    "bcr_drug_barcode": "TCGA-12-0662-D23512",
    "bcr_drug_uuid": "e3b391ea-dfd9-4147-a7e5-eddea9a5ebb3",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 120,
    "days_to_drug_end": 221,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "a3cc2845-8a44-4b50-8a3e-17a3c2c3e077",
    "patient_ID": "TCGA.12.0662",
    "bcr_drug_barcode": "TCGA-12-0662-D23518",
    "bcr_drug_uuid": "871a9df8-31d3-4748-8798-a1f02b382ef7",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFERS",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 876,
    "days_to_drug_end": 876,
    "drug_cycles": 1,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_route": "INTRATUMORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 8
  },
  {
    "bcr_patient_uuid": "a3cc2845-8a44-4b50-8a3e-17a3c2c3e077",
    "patient_ID": "TCGA.12.0662",
    "bcr_drug_barcode": "TCGA-12-0662-D23521",
    "bcr_drug_uuid": "f5193ae4-5e1e-4036-874d-cee249a468cc",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1041,
    "days_to_drug_end": 1070,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "a3cc2845-8a44-4b50-8a3e-17a3c2c3e077",
    "patient_ID": "TCGA.12.0662",
    "bcr_drug_barcode": "TCGA-12-0662-D23516",
    "bcr_drug_uuid": "c1bc7091-bb6a-4181-aee4-27e00e8e53e4",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 600,
    "days_to_drug_end": 604,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "a3cc2845-8a44-4b50-8a3e-17a3c2c3e077",
    "patient_ID": "TCGA.12.0662",
    "bcr_drug_barcode": "TCGA-12-0662-D23519",
    "bcr_drug_uuid": "257762ca-7c89-42d1-9e44-b9ba36e91db0",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 889,
    "days_to_drug_end": 1028,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "a3cc2845-8a44-4b50-8a3e-17a3c2c3e077",
    "patient_ID": "TCGA.12.0662",
    "bcr_drug_barcode": "TCGA-12-0662-D23513",
    "bcr_drug_uuid": "cb38326f-fc0c-45e9-b73a-57de9eb4016f",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 224,
    "days_to_drug_end": 278,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "a3cc2845-8a44-4b50-8a3e-17a3c2c3e077",
    "patient_ID": "TCGA.12.0662",
    "bcr_drug_barcode": "TCGA-12-0662-D23520",
    "bcr_drug_uuid": "68e7e6e7-d891-4704-8a0a-ec8e89189ecf",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1041,
    "days_to_drug_end": 1070,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "a3cc2845-8a44-4b50-8a3e-17a3c2c3e077",
    "patient_ID": "TCGA.12.0662",
    "bcr_drug_barcode": "TCGA-12-0662-D23517",
    "bcr_drug_uuid": "9f7794d8-104c-4f2b-99fe-6a25bb07bea4",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 627,
    "days_to_drug_end": 844,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "a3cc2845-8a44-4b50-8a3e-17a3c2c3e077",
    "patient_ID": "TCGA.12.0662",
    "bcr_drug_barcode": "TCGA-12-0662-D23524",
    "bcr_drug_uuid": "14710bfe-83dc-4d5d-9860-06177f6ea14b",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 473,
    "days_to_drug_end": 600,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "a3cc2845-8a44-4b50-8a3e-17a3c2c3e077",
    "patient_ID": "TCGA.12.0662",
    "bcr_drug_barcode": "TCGA-12-0662-D23515",
    "bcr_drug_uuid": "d03e8d69-2316-40f4-b379-195d32908f4d",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 417,
    "days_to_drug_end": 473,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "a3cc2845-8a44-4b50-8a3e-17a3c2c3e077",
    "patient_ID": "TCGA.12.0662",
    "bcr_drug_barcode": "TCGA-12-0662-D23523",
    "bcr_drug_uuid": "eb7a9fee-6e99-4f75-bd60-66ca3cef6afd",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TAMOXITEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 278,
    "days_to_drug_end": 334,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "a3cc2845-8a44-4b50-8a3e-17a3c2c3e077",
    "patient_ID": "TCGA.12.0662",
    "bcr_drug_barcode": "TCGA-12-0662-D23514",
    "bcr_drug_uuid": "b1b1b418-dd4f-40fb-aea8-a74f0d5575a9",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 340,
    "days_to_drug_end": 417,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "a3cc2845-8a44-4b50-8a3e-17a3c2c3e077",
    "patient_ID": "TCGA.12.0662",
    "bcr_drug_barcode": "TCGA-12-0662-D23522",
    "bcr_drug_uuid": "fd54d4c9-418d-4fec-827d-70c2ae128d00",
    "form_completion_date": "2009-5-5",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1133,
    "days_to_drug_end": 1137,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "a3cc2845-8a44-4b50-8a3e-17a3c2c3e077",
    "patient_ID": "TCGA.12.0662",
    "bcr_drug_barcode": "TCGA-12-0662-D23527",
    "bcr_drug_uuid": "5271192b-62f2-41ec-9e08-fc86db337767",
    "form_completion_date": "2009-5-5",
    "pharmaceutical_therapy_drug_name": "06GB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1133,
    "days_to_drug_end": 1135,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 120
  },
  {
    "bcr_patient_uuid": "a3cc2845-8a44-4b50-8a3e-17a3c2c3e077",
    "patient_ID": "TCGA.12.0662",
    "bcr_drug_barcode": "TCGA-12-0662-D23528",
    "bcr_drug_uuid": "0dacad5b-d120-432b-ac72-3c591e4db8cd",
    "form_completion_date": "2009-5-5",
    "pharmaceutical_therapy_drug_name": "06GB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1133,
    "days_to_drug_end": 1135,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 30
  },
  {
    "bcr_patient_uuid": "a3cc2845-8a44-4b50-8a3e-17a3c2c3e077",
    "patient_ID": "TCGA.12.0662",
    "bcr_drug_barcode": "TCGA-12-0662-D23526",
    "bcr_drug_uuid": "a31610b6-b05a-4332-96e0-e6a5d8cbde9e",
    "form_completion_date": "2009-5-5",
    "pharmaceutical_therapy_drug_name": "THALIDOMIDE",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 1073,
    "days_to_drug_end": 1090,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "a3cc2845-8a44-4b50-8a3e-17a3c2c3e077",
    "patient_ID": "TCGA.12.0662",
    "bcr_drug_barcode": "TCGA-12-0662-D23525",
    "bcr_drug_uuid": "52230949-b4f3-4314-878c-6b19aa30ddc6",
    "form_completion_date": "2009-5-5",
    "pharmaceutical_therapy_drug_name": "CELBREX",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 1113,
    "days_to_drug_end": 1161,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "f7dd387f-eca9-4028-b296-2ca6d56d3bde",
    "patient_ID": "TCGA.12.0670",
    "bcr_drug_barcode": "TCGA-12-0670-D23542",
    "bcr_drug_uuid": "0b141c45-2c41-4ab3-b4d0-988521ba741b",
    "form_completion_date": "2009-5-28",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 578,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 601,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "f7dd387f-eca9-4028-b296-2ca6d56d3bde",
    "patient_ID": "TCGA.12.0670",
    "bcr_drug_barcode": "TCGA-12-0670-D23535",
    "bcr_drug_uuid": "0be12284-5c9f-4fbc-a4bc-16a33097e010",
    "form_completion_date": "2009-5-28",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 329,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 378,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 125
  },
  {
    "bcr_patient_uuid": "f7dd387f-eca9-4028-b296-2ca6d56d3bde",
    "patient_ID": "TCGA.12.0670",
    "bcr_drug_barcode": "TCGA-12-0670-D23551",
    "bcr_drug_uuid": "b16b7010-4713-4627-988b-b02feb755a02",
    "form_completion_date": "2009-5-28",
    "pharmaceutical_therapy_drug_name": "MAB I131",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 77,
    "drug_units": "MCI",
    "drug_tota_dose_units": "MCI",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 80
  },
  {
    "bcr_patient_uuid": "f7dd387f-eca9-4028-b296-2ca6d56d3bde",
    "patient_ID": "TCGA.12.0670",
    "bcr_drug_barcode": "TCGA-12-0670-D23540",
    "bcr_drug_uuid": "76777e34-20ed-4ffe-a982-21c7ba1c2983",
    "form_completion_date": "2009-5-28",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 448,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 516,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "f7dd387f-eca9-4028-b296-2ca6d56d3bde",
    "patient_ID": "TCGA.12.0670",
    "bcr_drug_barcode": "TCGA-12-0670-D23543",
    "bcr_drug_uuid": "f42edd3a-9f14-446d-b279-e671b2f7497c",
    "form_completion_date": "2009-5-28",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 601,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 722,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "f7dd387f-eca9-4028-b296-2ca6d56d3bde",
    "patient_ID": "TCGA.12.0670",
    "bcr_drug_barcode": "TCGA-12-0670-D23534",
    "bcr_drug_uuid": "17c7b5af-61d2-4836-b4db-24ff1f38887c",
    "form_completion_date": "2009-5-28",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 211,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 288,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "f7dd387f-eca9-4028-b296-2ca6d56d3bde",
    "patient_ID": "TCGA.12.0670",
    "bcr_drug_barcode": "TCGA-12-0670-D23537",
    "bcr_drug_uuid": "16253cb7-0d72-41ce-b650-b17eb6a9572b",
    "form_completion_date": "2009-5-28",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 448,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 516,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "f7dd387f-eca9-4028-b296-2ca6d56d3bde",
    "patient_ID": "TCGA.12.0670",
    "bcr_drug_barcode": "TCGA-12-0670-D23550",
    "bcr_drug_uuid": "888dc526-60c7-44ce-9fe9-de5128a8f5a9",
    "form_completion_date": "2009-5-28",
    "pharmaceutical_therapy_drug_name": "CELEBREX",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 722,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 770,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 125
  },
  {
    "bcr_patient_uuid": "f7dd387f-eca9-4028-b296-2ca6d56d3bde",
    "patient_ID": "TCGA.12.0670",
    "bcr_drug_barcode": "TCGA-12-0670-D23536",
    "bcr_drug_uuid": "6b93f331-1d67-49d2-afbd-72b4fc799ea7",
    "form_completion_date": "2009-5-28",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 407,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 448,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 125
  },
  {
    "bcr_patient_uuid": "f7dd387f-eca9-4028-b296-2ca6d56d3bde",
    "patient_ID": "TCGA.12.0670",
    "bcr_drug_barcode": "TCGA-12-0670-D23539",
    "bcr_drug_uuid": "c0b23a46-8a32-4ed5-8084-97cf367fd931",
    "form_completion_date": "2009-5-28",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 578,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 601,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "f7dd387f-eca9-4028-b296-2ca6d56d3bde",
    "patient_ID": "TCGA.12.0670",
    "bcr_drug_barcode": "TCGA-12-0670-D23549",
    "bcr_drug_uuid": "40c15b1f-c954-42f3-805a-f94d9fe2c89a",
    "form_completion_date": "2009-5-28",
    "pharmaceutical_therapy_drug_name": "CELEBREX",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 601,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 722,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 125
  },
  {
    "bcr_patient_uuid": "f7dd387f-eca9-4028-b296-2ca6d56d3bde",
    "patient_ID": "TCGA.12.0670",
    "bcr_drug_barcode": "TCGA-12-0670-D23544",
    "bcr_drug_uuid": "700ca24e-da97-4cff-b798-4d6f127be5e5",
    "form_completion_date": "2009-5-28",
    "pharmaceutical_therapy_drug_name": "CELEBREX",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 327,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 378,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 125
  },
  {
    "bcr_patient_uuid": "f7dd387f-eca9-4028-b296-2ca6d56d3bde",
    "patient_ID": "TCGA.12.0670",
    "bcr_drug_barcode": "TCGA-12-0670-D23545",
    "bcr_drug_uuid": "50f3f112-ee32-4917-a368-1f949d4b6e9e",
    "form_completion_date": "2009-5-28",
    "pharmaceutical_therapy_drug_name": "CELEBREX",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 407,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 448,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 125
  },
  {
    "bcr_patient_uuid": "f7dd387f-eca9-4028-b296-2ca6d56d3bde",
    "patient_ID": "TCGA.12.0670",
    "bcr_drug_barcode": "TCGA-12-0670-D23533",
    "bcr_drug_uuid": "e763e7d6-fc06-41d6-ad0c-e57ae828e655",
    "form_completion_date": "2009-5-28",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 183,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 203,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "f7dd387f-eca9-4028-b296-2ca6d56d3bde",
    "patient_ID": "TCGA.12.0670",
    "bcr_drug_barcode": "TCGA-12-0670-D23541",
    "bcr_drug_uuid": "bf50ef37-2a1f-4a63-9739-5972ca4ee607",
    "form_completion_date": "2009-5-28",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 516,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 576,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "f7dd387f-eca9-4028-b296-2ca6d56d3bde",
    "patient_ID": "TCGA.12.0670",
    "bcr_drug_barcode": "TCGA-12-0670-D23547",
    "bcr_drug_uuid": "b047e79b-8534-41db-a020-b40c3853e120",
    "form_completion_date": "2009-5-28",
    "pharmaceutical_therapy_drug_name": "CELEBREX",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 516,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 576,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 125
  },
  {
    "bcr_patient_uuid": "f7dd387f-eca9-4028-b296-2ca6d56d3bde",
    "patient_ID": "TCGA.12.0670",
    "bcr_drug_barcode": "TCGA-12-0670-D23538",
    "bcr_drug_uuid": "303fe799-e697-40f7-b703-1f9b585ed0c3",
    "form_completion_date": "2009-5-28",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 516,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 576,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "f7dd387f-eca9-4028-b296-2ca6d56d3bde",
    "patient_ID": "TCGA.12.0670",
    "bcr_drug_barcode": "TCGA-12-0670-D23548",
    "bcr_drug_uuid": "67a7c6ef-2066-4046-a8de-bb8d1bbac08b",
    "form_completion_date": "2009-5-28",
    "pharmaceutical_therapy_drug_name": "CELEBREX",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 578,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 601,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 125
  },
  {
    "bcr_patient_uuid": "f7dd387f-eca9-4028-b296-2ca6d56d3bde",
    "patient_ID": "TCGA.12.0670",
    "bcr_drug_barcode": "TCGA-12-0670-D23532",
    "bcr_drug_uuid": "3ecc40a3-dd80-4ab9-b419-821926283eff",
    "form_completion_date": "2009-5-28",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 148,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 183,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "f7dd387f-eca9-4028-b296-2ca6d56d3bde",
    "patient_ID": "TCGA.12.0670",
    "bcr_drug_barcode": "TCGA-12-0670-D23546",
    "bcr_drug_uuid": "add50244-52a7-4126-93be-f81ed9780855",
    "form_completion_date": "2009-5-28",
    "pharmaceutical_therapy_drug_name": "CELEBREX",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 448,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 516,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 125
  },
  {
    "bcr_patient_uuid": "f7dd387f-eca9-4028-b296-2ca6d56d3bde",
    "patient_ID": "TCGA.12.0670",
    "bcr_drug_barcode": "TCGA-12-0670-D23552",
    "bcr_drug_uuid": "c2e20295-9ec6-4eb7-86fa-3946cad99033",
    "form_completion_date": "2009-5-28",
    "pharmaceutical_therapy_drug_name": "CH81C6",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 77,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "65a48904-9532-4dfb-8e84-4deef1881197",
    "patient_ID": "TCGA.12.0688",
    "bcr_drug_barcode": "TCGA-12-0688-D23557",
    "bcr_drug_uuid": "0b8b262d-97d9-48ef-8641-8a8d0fa9f879",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 215,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 238,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 37.5
  },
  {
    "bcr_patient_uuid": "65a48904-9532-4dfb-8e84-4deef1881197",
    "patient_ID": "TCGA.12.0688",
    "bcr_drug_barcode": "TCGA-12-0688-D23561",
    "bcr_drug_uuid": "8f2a81d9-70cd-44b3-a6a3-b3279fe28479",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 649,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 734,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 25
  },
  {
    "bcr_patient_uuid": "65a48904-9532-4dfb-8e84-4deef1881197",
    "patient_ID": "TCGA.12.0688",
    "bcr_drug_barcode": "TCGA-12-0688-D23556",
    "bcr_drug_uuid": "195131f2-6287-4e94-a9d5-15b42098f0c9",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "65a48904-9532-4dfb-8e84-4deef1881197",
    "patient_ID": "TCGA.12.0688",
    "bcr_drug_barcode": "TCGA-12-0688-D23559",
    "bcr_drug_uuid": "df929dfb-37dc-4ebe-8de7-a6c46b193451",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 501,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 597,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "65a48904-9532-4dfb-8e84-4deef1881197",
    "patient_ID": "TCGA.12.0688",
    "bcr_drug_barcode": "TCGA-12-0688-D23560",
    "bcr_drug_uuid": "6610f7fa-41f3-44ff-a542-5bcf8e07cb48",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 605,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 649,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 340
  },
  {
    "bcr_patient_uuid": "65a48904-9532-4dfb-8e84-4deef1881197",
    "patient_ID": "TCGA.12.0688",
    "bcr_drug_barcode": "TCGA-12-0688-D23562",
    "bcr_drug_uuid": "d5e63f56-a668-4356-a3e5-a903ec9a8991",
    "form_completion_date": "2009-5-5",
    "pharmaceutical_therapy_drug_name": "TAMOXITEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 238,
    "days_to_drug_end": 353,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "65a48904-9532-4dfb-8e84-4deef1881197",
    "patient_ID": "TCGA.12.0688",
    "bcr_drug_barcode": "TCGA-12-0688-D23558",
    "bcr_drug_uuid": "4625b679-e4f3-4313-98b2-e27816b0edb2",
    "form_completion_date": "2009-6-3",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 238,
    "days_to_drug_end": 353,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 25
  },
  {
    "bcr_patient_uuid": "bb0aca6b-55ab-4b24-8e64-29e0c96a9862",
    "patient_ID": "TCGA.12.0691",
    "bcr_drug_barcode": "TCGA-12-0691-D23567",
    "bcr_drug_uuid": "df2315ba-0e8c-47e9-b7cb-34ac838284f8",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 159,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 186,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "bb0aca6b-55ab-4b24-8e64-29e0c96a9862",
    "patient_ID": "TCGA.12.0691",
    "bcr_drug_barcode": "TCGA-12-0691-D23566",
    "bcr_drug_uuid": "044f3ea1-65ca-4e70-8437-b8c1fae4d6df",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 117,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 159,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "24164e89-16ae-48c1-a464-9be94141deef",
    "patient_ID": "TCGA.12.0692",
    "bcr_drug_barcode": "TCGA-12-0692-D23571",
    "bcr_drug_uuid": "4d98309a-23d9-4329-8cce-8413e6bf2891",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 45,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "0a85c7b4-f07d-4727-b9d2-7b14c52edabb",
    "patient_ID": "TCGA.12.0703",
    "bcr_drug_barcode": "TCGA-12-0703-D23577",
    "bcr_drug_uuid": "25b7ffab-ad1d-471e-b1ff-50b595d8193d",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "MAB I-131",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "drug_units": "MCI",
    "drug_tota_dose_units": "MCI",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 120
  },
  {
    "bcr_patient_uuid": "0a85c7b4-f07d-4727-b9d2-7b14c52edabb",
    "patient_ID": "TCGA.12.0703",
    "bcr_drug_barcode": "TCGA-12-0703-D23574",
    "bcr_drug_uuid": "7c82d2a2-ac10-4721-ac98-08890d7ea9a3",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 215,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 302,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 125
  },
  {
    "bcr_patient_uuid": "0a85c7b4-f07d-4727-b9d2-7b14c52edabb",
    "patient_ID": "TCGA.12.0703",
    "bcr_drug_barcode": "TCGA-12-0703-D23575",
    "bcr_drug_uuid": "48784185-2f6b-41c9-ba98-b83f32f514f9",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 322,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 530,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "0a85c7b4-f07d-4727-b9d2-7b14c52edabb",
    "patient_ID": "TCGA.12.0703",
    "bcr_drug_barcode": "TCGA-12-0703-D23578",
    "bcr_drug_uuid": "ba795525-88e3-4ec2-9394-bed1bfbc9473",
    "form_completion_date": "2009-5-22",
    "pharmaceutical_therapy_drug_name": "MU81C6",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "0a85c7b4-f07d-4727-b9d2-7b14c52edabb",
    "patient_ID": "TCGA.12.0703",
    "bcr_drug_barcode": "TCGA-12-0703-D23576",
    "bcr_drug_uuid": "feb32385-2310-4a50-909a-04ccef06b767",
    "form_completion_date": "2009-5-29",
    "pharmaceutical_therapy_drug_name": "TOPECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 322,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 530,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 0.75
  },
  {
    "bcr_patient_uuid": "29b34909-9cdc-4a52-b0ab-fa99f3ab17bb",
    "patient_ID": "TCGA.12.0769",
    "bcr_drug_barcode": "TCGA-12-0769-D23585",
    "bcr_drug_uuid": "41686142-04cb-4865-9d58-530f5f9eff58",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 192,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 250,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "29b34909-9cdc-4a52-b0ab-fa99f3ab17bb",
    "patient_ID": "TCGA.12.0769",
    "bcr_drug_barcode": "TCGA-12-0769-D23586",
    "bcr_drug_uuid": "109c7892-b2fe-4770-b50f-9e8b4b4cf8f4",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 250,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 341,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "29b34909-9cdc-4a52-b0ab-fa99f3ab17bb",
    "patient_ID": "TCGA.12.0769",
    "bcr_drug_barcode": "TCGA-12-0769-D23584",
    "bcr_drug_uuid": "6679dd84-5607-487f-ae0a-0c665ae07410",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 192,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "29b34909-9cdc-4a52-b0ab-fa99f3ab17bb",
    "patient_ID": "TCGA.12.0769",
    "bcr_drug_barcode": "TCGA-12-0769-D23583",
    "bcr_drug_uuid": "dd7b2860-6657-4d84-ae01-f3588a4401b1",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 78,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "3726b315-6cf8-49a3-a581-b7f3f4ca6e16",
    "patient_ID": "TCGA.12.0772",
    "bcr_drug_barcode": "TCGA-12-0772-D23591",
    "bcr_drug_uuid": "a03d8a5f-3e27-4178-aa87-07e1a9660b80",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 120,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 489,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "3726b315-6cf8-49a3-a581-b7f3f4ca6e16",
    "patient_ID": "TCGA.12.0772",
    "bcr_drug_barcode": "TCGA-12-0772-D23593",
    "bcr_drug_uuid": "142445a2-9326-4d69-bad3-67ee59798549",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 670,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 951,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 125
  },
  {
    "bcr_patient_uuid": "3726b315-6cf8-49a3-a581-b7f3f4ca6e16",
    "patient_ID": "TCGA.12.0772",
    "bcr_drug_barcode": "TCGA-12-0772-D23596",
    "bcr_drug_uuid": "3a52a24f-1906-42ef-8eba-92485642f4f1",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1224,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1265,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 82.5
  },
  {
    "bcr_patient_uuid": "3726b315-6cf8-49a3-a581-b7f3f4ca6e16",
    "patient_ID": "TCGA.12.0772",
    "bcr_drug_barcode": "TCGA-12-0772-D23599",
    "bcr_drug_uuid": "41a12774-46a3-4102-a590-2eeac0e3901c",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1468,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1526,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "3726b315-6cf8-49a3-a581-b7f3f4ca6e16",
    "patient_ID": "TCGA.12.0772",
    "bcr_drug_barcode": "TCGA-12-0772-D23598",
    "bcr_drug_uuid": "90345bcd-6db0-47ff-8a77-3ff9c96848f2",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "ARIAD AP23573",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 621,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 670,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 12.5
  },
  {
    "bcr_patient_uuid": "3726b315-6cf8-49a3-a581-b7f3f4ca6e16",
    "patient_ID": "TCGA.12.0772",
    "bcr_drug_barcode": "TCGA-12-0772-D23590",
    "bcr_drug_uuid": "e4af3fcd-bdec-465e-b785-55454cb9802d",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 120,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "3726b315-6cf8-49a3-a581-b7f3f4ca6e16",
    "patient_ID": "TCGA.12.0772",
    "bcr_drug_barcode": "TCGA-12-0772-D23592",
    "bcr_drug_uuid": "1b595aef-2206-402c-8bef-2d2d832e66c2",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1307,
    "days_to_drug_end": 1468,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "3726b315-6cf8-49a3-a581-b7f3f4ca6e16",
    "patient_ID": "TCGA.12.0772",
    "bcr_drug_barcode": "TCGA-12-0772-D23594",
    "bcr_drug_uuid": "3cd67800-1fdd-4e14-8776-235166a9aeac",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 951,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1112,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "3726b315-6cf8-49a3-a581-b7f3f4ca6e16",
    "patient_ID": "TCGA.12.0772",
    "bcr_drug_barcode": "TCGA-12-0772-D23595",
    "bcr_drug_uuid": "76fc75d9-64ad-407f-96d1-cd54754cf5c8",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1174,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "3726b315-6cf8-49a3-a581-b7f3f4ca6e16",
    "patient_ID": "TCGA.12.0772",
    "bcr_drug_barcode": "TCGA-12-0772-D23602",
    "bcr_drug_uuid": "21d49897-504d-4fe4-9a5e-5c69f62a660e",
    "form_completion_date": "2009-5-5",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1529,
    "days_to_drug_end": 1616,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "3726b315-6cf8-49a3-a581-b7f3f4ca6e16",
    "patient_ID": "TCGA.12.0772",
    "bcr_drug_barcode": "TCGA-12-0772-D23600",
    "bcr_drug_uuid": "8bd1d1f3-5138-4055-9f5a-a7e3b18800d0",
    "form_completion_date": "2009-5-5",
    "pharmaceutical_therapy_drug_name": "SIROLIMUS",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1468,
    "days_to_drug_end": 1526,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "3726b315-6cf8-49a3-a581-b7f3f4ca6e16",
    "patient_ID": "TCGA.12.0772",
    "bcr_drug_barcode": "TCGA-12-0772-D23601",
    "bcr_drug_uuid": "4ef970fa-74c5-4d61-9b7e-247819f31bb7",
    "form_completion_date": "2009-5-5",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1468,
    "days_to_drug_end": 1526,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "3726b315-6cf8-49a3-a581-b7f3f4ca6e16",
    "patient_ID": "TCGA.12.0772",
    "bcr_drug_barcode": "TCGA-12-0772-D23603",
    "bcr_drug_uuid": "066136db-6169-4752-9dfd-704854b71831",
    "form_completion_date": "2009-5-5",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1307,
    "days_to_drug_end": 1468,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "3726b315-6cf8-49a3-a581-b7f3f4ca6e16",
    "patient_ID": "TCGA.12.0772",
    "bcr_drug_barcode": "TCGA-12-0772-D23597",
    "bcr_drug_uuid": "151d0ced-5d38-43ca-8460-434bfbc802db",
    "form_completion_date": "2009-6-3",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1529,
    "days_to_drug_end": 1616,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "df4168bd-9f94-4323-9c33-a446a9fae999",
    "patient_ID": "TCGA.12.0773",
    "bcr_drug_barcode": "TCGA-12-0773-D23609",
    "bcr_drug_uuid": "b6ecaadf-5096-423c-b6be-dfe5b3dc2575",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 150,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 245,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "df4168bd-9f94-4323-9c33-a446a9fae999",
    "patient_ID": "TCGA.12.0773",
    "bcr_drug_barcode": "TCGA-12-0773-D23610",
    "bcr_drug_uuid": "113be0a1-223a-4ec4-97de-0d2f6ac75096",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 235,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 326,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 82.5
  },
  {
    "bcr_patient_uuid": "df4168bd-9f94-4323-9c33-a446a9fae999",
    "patient_ID": "TCGA.12.0773",
    "bcr_drug_barcode": "TCGA-12-0773-D23615",
    "bcr_drug_uuid": "da4b3eff-572c-4631-abfd-f98c5d123191",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 892,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1015,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 82.5
  },
  {
    "bcr_patient_uuid": "df4168bd-9f94-4323-9c33-a446a9fae999",
    "patient_ID": "TCGA.12.0773",
    "bcr_drug_barcode": "TCGA-12-0773-D23616",
    "bcr_drug_uuid": "aae4428e-ea47-411c-a566-91a65e9a9d0f",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1015,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1036,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 37.5
  },
  {
    "bcr_patient_uuid": "df4168bd-9f94-4323-9c33-a446a9fae999",
    "patient_ID": "TCGA.12.0773",
    "bcr_drug_barcode": "TCGA-12-0773-D23619",
    "bcr_drug_uuid": "f0d1c15e-3465-493b-98eb-bc2c0bb7f24a",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 607,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 725,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "df4168bd-9f94-4323-9c33-a446a9fae999",
    "patient_ID": "TCGA.12.0773",
    "bcr_drug_barcode": "TCGA-12-0773-D23617",
    "bcr_drug_uuid": "c7546cc0-9899-4870-8162-553da8f6a29c",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1062,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1141,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "df4168bd-9f94-4323-9c33-a446a9fae999",
    "patient_ID": "TCGA.12.0773",
    "bcr_drug_barcode": "TCGA-12-0773-D23618",
    "bcr_drug_uuid": "9adb7cd6-6395-4579-9dde-6f07da7a64bc",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1274,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1311,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "df4168bd-9f94-4323-9c33-a446a9fae999",
    "patient_ID": "TCGA.12.0773",
    "bcr_drug_barcode": "TCGA-12-0773-D23608",
    "bcr_drug_uuid": "d6d34fd3-faa6-439c-a13c-aa70b69ec164",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1141,
    "days_to_drug_end": 1274,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "df4168bd-9f94-4323-9c33-a446a9fae999",
    "patient_ID": "TCGA.12.0773",
    "bcr_drug_barcode": "TCGA-12-0773-D23614",
    "bcr_drug_uuid": "80b126c4-7359-4f31-967a-f2b401df350b",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 773,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 875,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "df4168bd-9f94-4323-9c33-a446a9fae999",
    "patient_ID": "TCGA.12.0773",
    "bcr_drug_barcode": "TCGA-12-0773-D23612",
    "bcr_drug_uuid": "88e217c3-ac45-4349-85ae-e21b06c1ce8f",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 431,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 516,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "df4168bd-9f94-4323-9c33-a446a9fae999",
    "patient_ID": "TCGA.12.0773",
    "bcr_drug_barcode": "TCGA-12-0773-D23613",
    "bcr_drug_uuid": "e73c6da5-447d-4846-8e27-dfd98cfc04b4",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 516,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 607,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 82.5
  },
  {
    "bcr_patient_uuid": "df4168bd-9f94-4323-9c33-a446a9fae999",
    "patient_ID": "TCGA.12.0773",
    "bcr_drug_barcode": "TCGA-12-0773-D23620",
    "bcr_drug_uuid": "330a4cb7-3260-4524-b4fd-600d0dae7c77",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "MAB I-131",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 56,
    "drug_units": "MCI",
    "drug_tota_dose_units": "MCI",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 61
  },
  {
    "bcr_patient_uuid": "df4168bd-9f94-4323-9c33-a446a9fae999",
    "patient_ID": "TCGA.12.0773",
    "bcr_drug_barcode": "TCGA-12-0773-D23611",
    "bcr_drug_uuid": "1756b142-0b65-4176-b305-738b4b6f039f",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 326,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 431,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 125
  },
  {
    "bcr_patient_uuid": "df4168bd-9f94-4323-9c33-a446a9fae999",
    "patient_ID": "TCGA.12.0773",
    "bcr_drug_barcode": "TCGA-12-0773-D23621",
    "bcr_drug_uuid": "4d17ddf6-8f1e-4156-b5c1-0dbbe03db479",
    "form_completion_date": "2009-5-5",
    "pharmaceutical_therapy_drug_name": "MU81C6",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 55,
    "days_to_drug_end": 56,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "df4168bd-9f94-4323-9c33-a446a9fae999",
    "patient_ID": "TCGA.12.0773",
    "bcr_drug_barcode": "TCGA-12-0773-D23622",
    "bcr_drug_uuid": "a67dbdd4-6a9b-448f-98ff-95fe5784291b",
    "form_completion_date": "2009-5-5",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1141,
    "days_to_drug_end": 1274,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "df4168bd-9f94-4323-9c33-a446a9fae999",
    "patient_ID": "TCGA.12.0773",
    "bcr_drug_barcode": "TCGA-12-0773-D23623",
    "bcr_drug_uuid": "76066f9e-2cbd-433b-8e83-07dd811edc04",
    "form_completion_date": "2009-5-22",
    "pharmaceutical_therapy_drug_name": "MU81C6",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 56,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "7751fc13-ec33-4057-965d-3b2ac6183344",
    "patient_ID": "TCGA.12.0775",
    "bcr_drug_barcode": "TCGA-12-0775-D23627",
    "bcr_drug_uuid": "ea674d8e-6e27-4789-b18f-6210ed736112",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "days_to_drug_end": 94,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "7751fc13-ec33-4057-965d-3b2ac6183344",
    "patient_ID": "TCGA.12.0775",
    "bcr_drug_barcode": "TCGA-12-0775-D23628",
    "bcr_drug_uuid": "a3803fc0-a831-4930-a510-e8708fd47693",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 117,
    "days_to_drug_end": 158,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 90
  },
  {
    "bcr_patient_uuid": "c1a00516-091c-480b-991e-7db4e0a30aea",
    "patient_ID": "TCGA.12.0776",
    "bcr_drug_barcode": "TCGA-12-0776-D23632",
    "bcr_drug_uuid": "0ce8bde3-9f50-4dd3-85d6-d203e872ed72",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 74,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "c1a00516-091c-480b-991e-7db4e0a30aea",
    "patient_ID": "TCGA.12.0776",
    "bcr_drug_barcode": "TCGA-12-0776-D23633",
    "bcr_drug_uuid": "c94c63f6-a260-4a4f-bd4c-9e873f09edab",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "c1a00516-091c-480b-991e-7db4e0a30aea",
    "patient_ID": "TCGA.12.0776",
    "bcr_drug_barcode": "TCGA-12-0776-D23634",
    "bcr_drug_uuid": "25631faf-847b-4a1b-8796-5a1f4c466aff",
    "form_completion_date": "2009-5-6",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 140,
    "days_to_drug_end": 275,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 340
  },
  {
    "bcr_patient_uuid": "c1a00516-091c-480b-991e-7db4e0a30aea",
    "patient_ID": "TCGA.12.0776",
    "bcr_drug_barcode": "TCGA-12-0776-D23635",
    "bcr_drug_uuid": "d62458b0-db6b-4d41-9e96-9635f8778795",
    "form_completion_date": "2009-5-6",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 140,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 275,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "db5ea0e6-4cac-4f18-8643-32afb1e0287d",
    "patient_ID": "TCGA.12.0778",
    "bcr_drug_barcode": "TCGA-12-0778-D23640",
    "bcr_drug_uuid": "b59567e1-635e-44e5-a5ce-1c2cc389129d",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "db5ea0e6-4cac-4f18-8643-32afb1e0287d",
    "patient_ID": "TCGA.12.0778",
    "bcr_drug_barcode": "TCGA-12-0778-D23639",
    "bcr_drug_uuid": "8909339d-9203-4057-b833-56e2463f29b2",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 68,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "db5ea0e6-4cac-4f18-8643-32afb1e0287d",
    "patient_ID": "TCGA.12.0778",
    "bcr_drug_barcode": "TCGA-12-0778-D23641",
    "bcr_drug_uuid": "cac6d807-76ec-4b36-a18b-87b73d783a9f",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 147,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 232,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "db5ea0e6-4cac-4f18-8643-32afb1e0287d",
    "patient_ID": "TCGA.12.0778",
    "bcr_drug_barcode": "TCGA-12-0778-D23645",
    "bcr_drug_uuid": "997e0460-09cb-4eec-98aa-ae4e89c2e57f",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 250,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 329,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "db5ea0e6-4cac-4f18-8643-32afb1e0287d",
    "patient_ID": "TCGA.12.0778",
    "bcr_drug_barcode": "TCGA-12-0778-D23643",
    "bcr_drug_uuid": "359761a4-c0af-4ae6-b499-4b938fb79524",
    "form_completion_date": "2009-5-6",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 329,
    "days_to_drug_end": 352,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "db5ea0e6-4cac-4f18-8643-32afb1e0287d",
    "patient_ID": "TCGA.12.0778",
    "bcr_drug_barcode": "TCGA-12-0778-D23647",
    "bcr_drug_uuid": "2c2bb568-9204-41c7-b8c0-e5c31aabf372",
    "form_completion_date": "2009-5-6",
    "pharmaceutical_therapy_drug_name": "RAPAMYCIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 355,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 385,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 15
  },
  {
    "bcr_patient_uuid": "db5ea0e6-4cac-4f18-8643-32afb1e0287d",
    "patient_ID": "TCGA.12.0778",
    "bcr_drug_barcode": "TCGA-12-0778-D23644",
    "bcr_drug_uuid": "10c06be0-16ad-4c12-b8da-71413fbfd57f",
    "form_completion_date": "2009-5-6",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 250,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 329,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "db5ea0e6-4cac-4f18-8643-32afb1e0287d",
    "patient_ID": "TCGA.12.0778",
    "bcr_drug_barcode": "TCGA-12-0778-D23648",
    "bcr_drug_uuid": "0009ef9d-35eb-47eb-9a30-859b6b5087c7",
    "form_completion_date": "2009-5-6",
    "pharmaceutical_therapy_drug_name": "RAPAMCYIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 355,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 385,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "db5ea0e6-4cac-4f18-8643-32afb1e0287d",
    "patient_ID": "TCGA.12.0778",
    "bcr_drug_barcode": "TCGA-12-0778-D23646",
    "bcr_drug_uuid": "bdff6ebe-49de-4842-b983-8beacc2d77da",
    "form_completion_date": "2009-5-6",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 355,
    "days_to_drug_end": 385,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "db5ea0e6-4cac-4f18-8643-32afb1e0287d",
    "patient_ID": "TCGA.12.0778",
    "bcr_drug_barcode": "TCGA-12-0778-D23642",
    "bcr_drug_uuid": "02edb427-90d0-4845-b101-1f59c526e166",
    "form_completion_date": "2009-5-6",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 329,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 352,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "120e257d-1cf1-421f-9a6b-6a5681eaea2e",
    "patient_ID": "TCGA.12.0780",
    "bcr_drug_barcode": "TCGA-12-0780-D23657",
    "bcr_drug_uuid": "b7217e75-dff4-41ce-9388-aca0d8746370",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 360,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 388,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 37.5
  },
  {
    "bcr_patient_uuid": "120e257d-1cf1-421f-9a6b-6a5681eaea2e",
    "patient_ID": "TCGA.12.0780",
    "bcr_drug_barcode": "TCGA-12-0780-D23655",
    "bcr_drug_uuid": "76a461e4-83a9-4e2d-a36c-827495312e88",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 77,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "120e257d-1cf1-421f-9a6b-6a5681eaea2e",
    "patient_ID": "TCGA.12.0780",
    "bcr_drug_barcode": "TCGA-12-0780-D23658",
    "bcr_drug_uuid": "2c4203c3-7505-459e-a4a8-bf4380227b26",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 350,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "120e257d-1cf1-421f-9a6b-6a5681eaea2e",
    "patient_ID": "TCGA.12.0780",
    "bcr_drug_barcode": "TCGA-12-0780-D23656",
    "bcr_drug_uuid": "1957888f-00e4-4264-a01a-d940735f9eac",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 350,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 125
  },
  {
    "bcr_patient_uuid": "120e257d-1cf1-421f-9a6b-6a5681eaea2e",
    "patient_ID": "TCGA.12.0780",
    "bcr_drug_barcode": "TCGA-12-0780-D23659",
    "bcr_drug_uuid": "34293ddf-4475-4fa6-ba77-24263cd27469",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 360,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 388,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "120e257d-1cf1-421f-9a6b-6a5681eaea2e",
    "patient_ID": "TCGA.12.0780",
    "bcr_drug_barcode": "TCGA-12-0780-D23660",
    "bcr_drug_uuid": "a9b346ef-bf06-441d-ae30-24bdd0cff6a2",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 393,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 434,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "120e257d-1cf1-421f-9a6b-6a5681eaea2e",
    "patient_ID": "TCGA.12.0780",
    "bcr_drug_barcode": "TCGA-12-0780-D23661",
    "bcr_drug_uuid": "6190c533-8e4d-42e7-809d-d1c5b80609ff",
    "form_completion_date": "2009-5-7",
    "pharmaceutical_therapy_drug_name": "RAPAMYCIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 393,
    "days_to_drug_end": 434,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "e57b296a-80e9-4446-a3d1-3dbfeaf04f5e",
    "patient_ID": "TCGA.12.0818",
    "bcr_drug_barcode": "TCGA-12-0818-D23668",
    "bcr_drug_uuid": "34ce8de9-761e-4f10-b875-14d8e99974a9",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 255,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 296,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "e57b296a-80e9-4446-a3d1-3dbfeaf04f5e",
    "patient_ID": "TCGA.12.0818",
    "bcr_drug_barcode": "TCGA-12-0818-D23670",
    "bcr_drug_uuid": "cab47c3a-f5b7-4da5-8ad3-95930211ed8c",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "81C6",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 47,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "e57b296a-80e9-4446-a3d1-3dbfeaf04f5e",
    "patient_ID": "TCGA.12.0818",
    "bcr_drug_barcode": "TCGA-12-0818-D23669",
    "bcr_drug_uuid": "8b17871f-303d-475d-aa31-ef735bcea01f",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "MAB I-131",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 47,
    "drug_units": "MCI",
    "drug_tota_dose_units": "MCI",
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 80
  },
  {
    "bcr_patient_uuid": "e57b296a-80e9-4446-a3d1-3dbfeaf04f5e",
    "patient_ID": "TCGA.12.0818",
    "bcr_drug_barcode": "TCGA-12-0818-D23666",
    "bcr_drug_uuid": "3d9008a7-a174-4c12-b4dd-537b5454fb34",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 136,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1643,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "e57b296a-80e9-4446-a3d1-3dbfeaf04f5e",
    "patient_ID": "TCGA.12.0818",
    "bcr_drug_barcode": "TCGA-12-0818-D23667",
    "bcr_drug_uuid": "543cdb8a-55c5-4f56-8986-bc768644e0d2",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 213,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 255,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "e57b296a-80e9-4446-a3d1-3dbfeaf04f5e",
    "patient_ID": "TCGA.12.0818",
    "bcr_drug_barcode": "TCGA-12-0818-D23665",
    "bcr_drug_uuid": "9443964e-7e47-4c82-8cc2-59ce383808f5",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "025a7401-a65d-4ea0-8b4e-0ba775b0322a",
    "patient_ID": "TCGA.12.0819",
    "bcr_drug_barcode": "TCGA-12-0819-D23674",
    "bcr_drug_uuid": "bdd652c9-bc76-4ad7-8a7e-244a71d074e8",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "BCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 258,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 376,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "025a7401-a65d-4ea0-8b4e-0ba775b0322a",
    "patient_ID": "TCGA.12.0819",
    "bcr_drug_barcode": "TCGA-12-0819-D23675",
    "bcr_drug_uuid": "29885380-c8eb-4a19-86d4-fcff0f0b21f1",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "BCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 376,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 442,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "025a7401-a65d-4ea0-8b4e-0ba775b0322a",
    "patient_ID": "TCGA.12.0819",
    "bcr_drug_barcode": "TCGA-12-0819-D23678",
    "bcr_drug_uuid": "e4d5c46c-3dac-42ba-b168-286ff5fac37d",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "025a7401-a65d-4ea0-8b4e-0ba775b0322a",
    "patient_ID": "TCGA.12.0819",
    "bcr_drug_barcode": "TCGA-12-0819-D23676",
    "bcr_drug_uuid": "54e4593b-c1a9-4a70-ba5c-adfb5386b634",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 442,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 495,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2.6
  },
  {
    "bcr_patient_uuid": "025a7401-a65d-4ea0-8b4e-0ba775b0322a",
    "patient_ID": "TCGA.12.0819",
    "bcr_drug_barcode": "TCGA-12-0819-D23680",
    "bcr_drug_uuid": "45d04e69-c27a-4ce5-9f13-7b70ecc03e77",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "MU81C6",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 180,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 9.9
  },
  {
    "bcr_patient_uuid": "025a7401-a65d-4ea0-8b4e-0ba775b0322a",
    "patient_ID": "TCGA.12.0819",
    "bcr_drug_barcode": "TCGA-12-0819-D23679",
    "bcr_drug_uuid": "c6a1bb0d-2b82-4628-824f-cfd12c7cd147",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "MAB I 131",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 180,
    "drug_units": "MCI",
    "drug_tota_dose_units": "MCI",
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "025a7401-a65d-4ea0-8b4e-0ba775b0322a",
    "patient_ID": "TCGA.12.0819",
    "bcr_drug_barcode": "TCGA-12-0819-D23677",
    "bcr_drug_uuid": "704cbe44-37c7-47a4-bd63-7c668c223115",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 505,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 624,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "ca261ec9-888b-47c8-8e71-5a22545d7161",
    "patient_ID": "TCGA.12.0820",
    "bcr_drug_barcode": "TCGA-12-0820-D23686",
    "bcr_drug_uuid": "fd4e096c-b26f-4f4e-94a9-6bf4b5979475",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 342,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 363,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "ca261ec9-888b-47c8-8e71-5a22545d7161",
    "patient_ID": "TCGA.12.0820",
    "bcr_drug_barcode": "TCGA-12-0820-D23687",
    "bcr_drug_uuid": "558f8409-9d46-401f-824b-e698e4f6bc32",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 363,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 433,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 350
  },
  {
    "bcr_patient_uuid": "ca261ec9-888b-47c8-8e71-5a22545d7161",
    "patient_ID": "TCGA.12.0820",
    "bcr_drug_barcode": "TCGA-12-0820-D23684",
    "bcr_drug_uuid": "0fc6b3e2-e7e7-42a5-ad49-0d4a6f55f7dd",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 216,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 272,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "ca261ec9-888b-47c8-8e71-5a22545d7161",
    "patient_ID": "TCGA.12.0820",
    "bcr_drug_barcode": "TCGA-12-0820-D23688",
    "bcr_drug_uuid": "19c83926-bc09-4deb-911f-298d25ee5d54",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 433,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 502,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "ca261ec9-888b-47c8-8e71-5a22545d7161",
    "patient_ID": "TCGA.12.0820",
    "bcr_drug_barcode": "TCGA-12-0820-D23691",
    "bcr_drug_uuid": "66cb366f-3b2a-41dd-9831-7f730ca79ab2",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "06-BG",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": -1,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 0,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "ca261ec9-888b-47c8-8e71-5a22545d7161",
    "patient_ID": "TCGA.12.0820",
    "bcr_drug_barcode": "TCGA-12-0820-D23685",
    "bcr_drug_uuid": "1e9464fa-2d93-4c9c-a8df-2a086a85abe1",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "BCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 300,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 341,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 13.5
  },
  {
    "bcr_patient_uuid": "ca261ec9-888b-47c8-8e71-5a22545d7161",
    "patient_ID": "TCGA.12.0820",
    "bcr_drug_barcode": "TCGA-12-0820-D23689",
    "bcr_drug_uuid": "367647ec-d0e6-43b8-ae89-bc95036a6d98",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 502,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 543,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 62.5
  },
  {
    "bcr_patient_uuid": "ca261ec9-888b-47c8-8e71-5a22545d7161",
    "patient_ID": "TCGA.12.0820",
    "bcr_drug_barcode": "TCGA-12-0820-D23690",
    "bcr_drug_uuid": "eb3a5380-889c-40e7-aa95-b19baef831d3",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 502,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 543,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "ca261ec9-888b-47c8-8e71-5a22545d7161",
    "patient_ID": "TCGA.12.0820",
    "bcr_drug_barcode": "TCGA-12-0820-D23692",
    "bcr_drug_uuid": "d4c3b301-b7b2-43ff-8d3a-17ab21661215",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "06-BG",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 300,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 341,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "eae44c1c-1628-4b58-8b90-d3372e3577d5",
    "patient_ID": "TCGA.12.0821",
    "bcr_drug_barcode": "TCGA-12-0821-D23697",
    "bcr_drug_uuid": "8b81f1e8-172c-45b7-a13a-8ebc5dd5f81b",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 203,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 259,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "eae44c1c-1628-4b58-8b90-d3372e3577d5",
    "patient_ID": "TCGA.12.0821",
    "bcr_drug_barcode": "TCGA-12-0821-D23696",
    "bcr_drug_uuid": "d320a047-c4b2-458c-b237-a6d4a7a340ef",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "eae44c1c-1628-4b58-8b90-d3372e3577d5",
    "patient_ID": "TCGA.12.0821",
    "bcr_drug_barcode": "TCGA-12-0821-D23698",
    "bcr_drug_uuid": "507be99d-ad0d-4409-af76-eaf477856d45",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 271,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 296,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 190
  },
  {
    "bcr_patient_uuid": "151ca826-a4d7-42eb-8684-f9fe7b93543f",
    "patient_ID": "TCGA.12.0822",
    "bcr_drug_barcode": "TCGA-12-0822-D23707",
    "bcr_drug_uuid": "a919cddf-9cd4-4d04-9250-d98a16226e85",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "O6BG",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 190,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 281,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 40
  },
  {
    "bcr_patient_uuid": "151ca826-a4d7-42eb-8684-f9fe7b93543f",
    "patient_ID": "TCGA.12.0822",
    "bcr_drug_barcode": "TCGA-12-0822-D23704",
    "bcr_drug_uuid": "5dc0efa8-953b-49c8-b102-8e85a74404d7",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "BCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 190,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 281,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "151ca826-a4d7-42eb-8684-f9fe7b93543f",
    "patient_ID": "TCGA.12.0822",
    "bcr_drug_barcode": "TCGA-12-0822-D23705",
    "bcr_drug_uuid": "abbcda60-5abc-4783-a6e9-0ae0647e9926",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 281,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 583,
    "drug_cycles": 10,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "151ca826-a4d7-42eb-8684-f9fe7b93543f",
    "patient_ID": "TCGA.12.0822",
    "bcr_drug_barcode": "TCGA-12-0822-D23702",
    "bcr_drug_uuid": "ad25ce92-ecd9-4edf-9a98-2d831b79a7be",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "151ca826-a4d7-42eb-8684-f9fe7b93543f",
    "patient_ID": "TCGA.12.0822",
    "bcr_drug_barcode": "TCGA-12-0822-D23709",
    "bcr_drug_uuid": "2c3fb682-b1ff-4ced-b01e-556d2ec3ed40",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "SCH6636",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 625,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 652,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "151ca826-a4d7-42eb-8684-f9fe7b93543f",
    "patient_ID": "TCGA.12.0822",
    "bcr_drug_barcode": "TCGA-12-0822-D23703",
    "bcr_drug_uuid": "1b0c3999-4a59-4fd3-b348-58c233239c8f",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "BCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 40
  },
  {
    "bcr_patient_uuid": "151ca826-a4d7-42eb-8684-f9fe7b93543f",
    "patient_ID": "TCGA.12.0822",
    "bcr_drug_barcode": "TCGA-12-0822-D23708",
    "bcr_drug_uuid": "e24f8fbb-51cf-40cc-aa44-adf6b3f9a70f",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "SCH66336",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 625,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 625,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "151ca826-a4d7-42eb-8684-f9fe7b93543f",
    "patient_ID": "TCGA.12.0822",
    "bcr_drug_barcode": "TCGA-12-0822-D23706",
    "bcr_drug_uuid": "fa7e1b79-40be-40dd-b87c-587fef6b80b3",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 588,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 624,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "b75845ed-a19a-4caa-b362-e62b1e538152",
    "patient_ID": "TCGA.12.0827",
    "bcr_drug_barcode": "TCGA-12-0827-D23715",
    "bcr_drug_uuid": "11b7e332-e568-4ec4-b0e5-a13a16dafd6d",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 137,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "b75845ed-a19a-4caa-b362-e62b1e538152",
    "patient_ID": "TCGA.12.0827",
    "bcr_drug_barcode": "TCGA-12-0827-D23716",
    "bcr_drug_uuid": "c80a6406-d9c3-403d-baac-8611c098f830",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 181,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 258,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 82.5
  },
  {
    "bcr_patient_uuid": "b75845ed-a19a-4caa-b362-e62b1e538152",
    "patient_ID": "TCGA.12.0827",
    "bcr_drug_barcode": "TCGA-12-0827-D23719",
    "bcr_drug_uuid": "2bf02d6c-6b80-4a79-891d-a9a77a6e75f0",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 390,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 434,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 410
  },
  {
    "bcr_patient_uuid": "b75845ed-a19a-4caa-b362-e62b1e538152",
    "patient_ID": "TCGA.12.0827",
    "bcr_drug_barcode": "TCGA-12-0827-D23721",
    "bcr_drug_uuid": "d5057fae-9fdd-4f4e-91a5-33c225666d64",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 615,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 746,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "b75845ed-a19a-4caa-b362-e62b1e538152",
    "patient_ID": "TCGA.12.0827",
    "bcr_drug_barcode": "TCGA-12-0827-D23717",
    "bcr_drug_uuid": "de863c10-3632-407e-8b88-8cce9a41b3d1",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 258,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 350,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "b75845ed-a19a-4caa-b362-e62b1e538152",
    "patient_ID": "TCGA.12.0827",
    "bcr_drug_barcode": "TCGA-12-0827-D23718",
    "bcr_drug_uuid": "08005bb6-0486-4067-89da-81958cad3071",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 350,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 390,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "b75845ed-a19a-4caa-b362-e62b1e538152",
    "patient_ID": "TCGA.12.0827",
    "bcr_drug_barcode": "TCGA-12-0827-D23722",
    "bcr_drug_uuid": "eb968fc1-4f4f-4429-8c4f-cac388b1b48e",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "MABI131",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 76,
    "drug_units": "MCI",
    "drug_tota_dose_units": "MCI",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 120
  },
  {
    "bcr_patient_uuid": "b75845ed-a19a-4caa-b362-e62b1e538152",
    "patient_ID": "TCGA.12.0827",
    "bcr_drug_barcode": "TCGA-12-0827-D23723",
    "bcr_drug_uuid": "926845c9-026a-497a-a4d4-2a0111b6575d",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "81C6",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 76,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "b75845ed-a19a-4caa-b362-e62b1e538152",
    "patient_ID": "TCGA.12.0827",
    "bcr_drug_barcode": "TCGA-12-0827-D23720",
    "bcr_drug_uuid": "bdba77a2-bcee-4ce0-b6e3-b4610745bee2",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 466,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 615,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "dae7e5c3-0b17-419c-a5fc-3bb271222bce",
    "patient_ID": "TCGA.12.0828",
    "bcr_drug_barcode": "TCGA-12-0828-D23727",
    "bcr_drug_uuid": "34fad037-d0dd-48bf-b3ca-88f0fc65ad31",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 152,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "97094aed-69f7-4f4e-a87e-533979e11514",
    "patient_ID": "TCGA.12.0829",
    "bcr_drug_barcode": "TCGA-12-0829-D23734",
    "bcr_drug_uuid": "e0293e31-728f-44e8-9e90-d9fce0a48b5c",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 572,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 599,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 125
  },
  {
    "bcr_patient_uuid": "97094aed-69f7-4f4e-a87e-533979e11514",
    "patient_ID": "TCGA.12.0829",
    "bcr_drug_barcode": "TCGA-12-0829-D23735",
    "bcr_drug_uuid": "8ceafbdf-414e-4371-bfec-0e5a76465c86",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "ATTAC",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 115,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 473,
    "drug_units": "ML",
    "drug_tota_dose_units": "ML",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "97094aed-69f7-4f4e-a87e-533979e11514",
    "patient_ID": "TCGA.12.0829",
    "bcr_drug_barcode": "TCGA-12-0829-D23733",
    "bcr_drug_uuid": "6e1438c2-c63c-49f1-ae32-e8894834e8ae",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "TEMADOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 474,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 571,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "97094aed-69f7-4f4e-a87e-533979e11514",
    "patient_ID": "TCGA.12.0829",
    "bcr_drug_barcode": "TCGA-12-0829-D23736",
    "bcr_drug_uuid": "2e065829-7994-4567-bae2-cbb475683f43",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 474,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 571,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "97094aed-69f7-4f4e-a87e-533979e11514",
    "patient_ID": "TCGA.12.0829",
    "bcr_drug_barcode": "TCGA-12-0829-D23732",
    "bcr_drug_uuid": "54c39217-8670-4616-b98a-1424b27379fd",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "TEMADOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 473,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "97094aed-69f7-4f4e-a87e-533979e11514",
    "patient_ID": "TCGA.12.0829",
    "bcr_drug_barcode": "TCGA-12-0829-D23737",
    "bcr_drug_uuid": "bf59108d-03ca-46e3-b3a2-8b1abdbe5cac",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 572,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 599,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "97094aed-69f7-4f4e-a87e-533979e11514",
    "patient_ID": "TCGA.12.0829",
    "bcr_drug_barcode": "TCGA-12-0829-D23731",
    "bcr_drug_uuid": "64195d91-1112-4ac0-80e0-1d271fb00408",
    "form_completion_date": "2009-5-27",
    "pharmaceutical_therapy_drug_name": "TEMADOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 64,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "ac72738c-8b33-4f03-917c-86b114a2b9bd",
    "patient_ID": "TCGA.12.1088",
    "bcr_drug_barcode": "TCGA-12-1088-D23359",
    "bcr_drug_uuid": "36795c4e-ec0a-4ca9-bbf8-ae00614d788c",
    "form_completion_date": "2009-7-6",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3779,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3821,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 82.5
  },
  {
    "bcr_patient_uuid": "ac72738c-8b33-4f03-917c-86b114a2b9bd",
    "patient_ID": "TCGA.12.1088",
    "bcr_drug_barcode": "TCGA-12-1088-D23360",
    "bcr_drug_uuid": "029857ca-5177-49ad-90a4-83c14d8c40b8",
    "form_completion_date": "2009-7-6",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3735,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3779,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "4f50397e-c4bd-4408-b6e9-776b8a14c8a9",
    "patient_ID": "TCGA.12.1089",
    "bcr_drug_barcode": "TCGA-12-1089-D23364",
    "bcr_drug_uuid": "4f487e7e-6258-42d7-ae80-afa9ee0c0faa",
    "form_completion_date": "2009-7-2",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "aef8439b-2797-4c3a-b822-fcf640d200f6",
    "patient_ID": "TCGA.12.1090",
    "bcr_drug_barcode": "TCGA-12-1090-D23368",
    "bcr_drug_uuid": "3947e17f-e6f4-465d-9c1a-7974f42740bb",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "GLIADEL WATERS",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "days_to_drug_end": 46,
    "drug_cycles": 1,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_route": "INTRATUMORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8
  },
  {
    "bcr_patient_uuid": "aef8439b-2797-4c3a-b822-fcf640d200f6",
    "patient_ID": "TCGA.12.1090",
    "bcr_drug_barcode": "TCGA-12-1090-D23370",
    "bcr_drug_uuid": "d21ccf58-f63c-4d00-9f29-1f59bfba146a",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "days_to_drug_end": 191,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "aef8439b-2797-4c3a-b822-fcf640d200f6",
    "patient_ID": "TCGA.12.1090",
    "bcr_drug_barcode": "TCGA-12-1090-D23369",
    "bcr_drug_uuid": "035f7a27-682b-4d08-8515-99906bd52613",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "THALIDOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "days_to_drug_end": 191,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 800
  },
  {
    "bcr_patient_uuid": "f8a5b835-b00b-421e-bdf5-9adb4ee84730",
    "patient_ID": "TCGA.12.1091",
    "bcr_drug_barcode": "TCGA-12-1091-D23381",
    "bcr_drug_uuid": "be2edadc-356c-46e3-b333-7d026586b8d7",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 484,
    "days_to_drug_end": 521,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 125
  },
  {
    "bcr_patient_uuid": "f8a5b835-b00b-421e-bdf5-9adb4ee84730",
    "patient_ID": "TCGA.12.1091",
    "bcr_drug_barcode": "TCGA-12-1091-D23387",
    "bcr_drug_uuid": "cdd65a8a-02f9-42e9-b4bb-8a049b143d19",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "TAMOXITEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 521,
    "days_to_drug_end": 691,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 120
  },
  {
    "bcr_patient_uuid": "f8a5b835-b00b-421e-bdf5-9adb4ee84730",
    "patient_ID": "TCGA.12.1091",
    "bcr_drug_barcode": "TCGA-12-1091-D23378",
    "bcr_drug_uuid": "79673b73-4bc0-4b93-bc04-329081111a8d",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 331,
    "days_to_drug_end": 358,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "f8a5b835-b00b-421e-bdf5-9adb4ee84730",
    "patient_ID": "TCGA.12.1091",
    "bcr_drug_barcode": "TCGA-12-1091-D23384",
    "bcr_drug_uuid": "fa382069-ca6a-4ad1-937b-337899863271",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 358,
    "days_to_drug_end": 453,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "f8a5b835-b00b-421e-bdf5-9adb4ee84730",
    "patient_ID": "TCGA.12.1091",
    "bcr_drug_barcode": "TCGA-12-1091-D23380",
    "bcr_drug_uuid": "29a49a4d-032a-490f-9c7c-3806e571df6e",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 453,
    "days_to_drug_end": 484,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "f8a5b835-b00b-421e-bdf5-9adb4ee84730",
    "patient_ID": "TCGA.12.1091",
    "bcr_drug_barcode": "TCGA-12-1091-D23382",
    "bcr_drug_uuid": "d963963e-b3f9-420a-a5de-ba86781369b8",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 521,
    "days_to_drug_end": 691,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "f8a5b835-b00b-421e-bdf5-9adb4ee84730",
    "patient_ID": "TCGA.12.1091",
    "bcr_drug_barcode": "TCGA-12-1091-D23383",
    "bcr_drug_uuid": "1c92d56a-1304-4147-aeef-f52c50e42f57",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 819,
    "days_to_drug_end": 926,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "f8a5b835-b00b-421e-bdf5-9adb4ee84730",
    "patient_ID": "TCGA.12.1091",
    "bcr_drug_barcode": "TCGA-12-1091-D23374",
    "bcr_drug_uuid": "e59d232d-a49e-48fb-9046-ee901d951cba",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 143,
    "days_to_drug_end": 169,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "f8a5b835-b00b-421e-bdf5-9adb4ee84730",
    "patient_ID": "TCGA.12.1091",
    "bcr_drug_barcode": "TCGA-12-1091-D23386",
    "bcr_drug_uuid": "750a7d18-e6ca-4701-bbf6-44718e9736a4",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 484,
    "days_to_drug_end": 521,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "f8a5b835-b00b-421e-bdf5-9adb4ee84730",
    "patient_ID": "TCGA.12.1091",
    "bcr_drug_barcode": "TCGA-12-1091-D23376",
    "bcr_drug_uuid": "ffc5e3c2-c05c-4c78-b5dd-c628e2b869eb",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "CCNG",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 229,
    "days_to_drug_end": 287,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 90
  },
  {
    "bcr_patient_uuid": "f8a5b835-b00b-421e-bdf5-9adb4ee84730",
    "patient_ID": "TCGA.12.1091",
    "bcr_drug_barcode": "TCGA-12-1091-D23379",
    "bcr_drug_uuid": "743b1437-d61a-4ce1-950c-444be336c041",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 358,
    "days_to_drug_end": 453,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "f8a5b835-b00b-421e-bdf5-9adb4ee84730",
    "patient_ID": "TCGA.12.1091",
    "bcr_drug_barcode": "TCGA-12-1091-D23385",
    "bcr_drug_uuid": "300c0f0e-44d4-4e03-9507-fd64106f8fd8",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 453,
    "days_to_drug_end": 484,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "f8a5b835-b00b-421e-bdf5-9adb4ee84730",
    "patient_ID": "TCGA.12.1091",
    "bcr_drug_barcode": "TCGA-12-1091-D23375",
    "bcr_drug_uuid": "26953512-7580-495c-8e56-846ab72e4d25",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 179,
    "days_to_drug_end": 206,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "f8a5b835-b00b-421e-bdf5-9adb4ee84730",
    "patient_ID": "TCGA.12.1091",
    "bcr_drug_barcode": "TCGA-12-1091-D23377",
    "bcr_drug_uuid": "d1b8410a-b50d-419d-aa57-62e91e442d03",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "CCNG",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 288,
    "days_to_drug_end": 330,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 80
  },
  {
    "bcr_patient_uuid": "4c070166-025e-49b7-b4d0-fe25c8a355b1",
    "patient_ID": "TCGA.12.1092",
    "bcr_drug_barcode": "TCGA-12-1092-D23396",
    "bcr_drug_uuid": "3e0ce8f5-4a22-4937-9a1a-f517d6cfd8eb",
    "form_completion_date": "2009-7-2",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 551,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 637,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "4c070166-025e-49b7-b4d0-fe25c8a355b1",
    "patient_ID": "TCGA.12.1092",
    "bcr_drug_barcode": "TCGA-12-1092-D23391",
    "bcr_drug_uuid": "6a287679-7316-4389-9bec-9c1df97774ec",
    "form_completion_date": "2009-7-2",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 96,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "4c070166-025e-49b7-b4d0-fe25c8a355b1",
    "patient_ID": "TCGA.12.1092",
    "bcr_drug_barcode": "TCGA-12-1092-D23397",
    "bcr_drug_uuid": "62ba4c8b-7b1e-4c37-9261-50535180d9b9",
    "form_completion_date": "2009-7-2",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 204,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "4c070166-025e-49b7-b4d0-fe25c8a355b1",
    "patient_ID": "TCGA.12.1092",
    "bcr_drug_barcode": "TCGA-12-1092-D23395",
    "bcr_drug_uuid": "e8ef994b-f752-4b83-b9c7-9f14c9d44523",
    "form_completion_date": "2009-7-2",
    "pharmaceutical_therapy_drug_name": "CPT 11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 368,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 460,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 125
  },
  {
    "bcr_patient_uuid": "4c070166-025e-49b7-b4d0-fe25c8a355b1",
    "patient_ID": "TCGA.12.1092",
    "bcr_drug_barcode": "TCGA-12-1092-D23398",
    "bcr_drug_uuid": "d3ad0089-7068-4d8a-b73b-7eac3cbead82",
    "form_completion_date": "2009-7-2",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 460,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 551,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "4c070166-025e-49b7-b4d0-fe25c8a355b1",
    "patient_ID": "TCGA.12.1092",
    "bcr_drug_barcode": "TCGA-12-1092-D23394",
    "bcr_drug_uuid": "12d97238-a55e-4dd2-9ed7-4d29cb0acd36",
    "form_completion_date": "2009-7-2",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 232,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 367,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "4c070166-025e-49b7-b4d0-fe25c8a355b1",
    "patient_ID": "TCGA.12.1092",
    "bcr_drug_barcode": "TCGA-12-1092-D23393",
    "bcr_drug_uuid": "36a50f31-578b-4370-bbd9-53429f377461",
    "form_completion_date": "2009-7-2",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 205,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 232,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "4c070166-025e-49b7-b4d0-fe25c8a355b1",
    "patient_ID": "TCGA.12.1092",
    "bcr_drug_barcode": "TCGA-12-1092-D23399",
    "bcr_drug_uuid": "5a09a18b-51c3-431b-8771-b958549257c6",
    "form_completion_date": "2009-7-2",
    "pharmaceutical_therapy_drug_name": "RAPAMYCIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 460,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 551,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "4c070166-025e-49b7-b4d0-fe25c8a355b1",
    "patient_ID": "TCGA.12.1092",
    "bcr_drug_barcode": "TCGA-12-1092-D23392",
    "bcr_drug_uuid": "0462a7ee-967b-41ee-96bf-717aa9ee2851",
    "form_completion_date": "2009-7-2",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 204,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "77d4d3ef-3fe0-4f93-a863-b5840926576c",
    "patient_ID": "TCGA.12.1093",
    "bcr_drug_barcode": "TCGA-12-1093-D23407",
    "bcr_drug_uuid": "034f41e0-7722-42dc-92c9-9382fe9ab69d",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "ATTAC",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 126,
    "days_to_drug_end": 317,
    "drug_units": "ML",
    "drug_tota_dose_units": "ML",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "77d4d3ef-3fe0-4f93-a863-b5840926576c",
    "patient_ID": "TCGA.12.1093",
    "bcr_drug_barcode": "TCGA-12-1093-D23403",
    "bcr_drug_uuid": "74e20754-348f-4d18-96bf-518729e932ac",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "days_to_drug_end": 79,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "77d4d3ef-3fe0-4f93-a863-b5840926576c",
    "patient_ID": "TCGA.12.1093",
    "bcr_drug_barcode": "TCGA-12-1093-D23406",
    "bcr_drug_uuid": "98ef2454-90a4-4553-86d0-3dde38f1d246",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "PANZEM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 339,
    "days_to_drug_end": 364,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 6000
  },
  {
    "bcr_patient_uuid": "77d4d3ef-3fe0-4f93-a863-b5840926576c",
    "patient_ID": "TCGA.12.1093",
    "bcr_drug_barcode": "TCGA-12-1093-D23404",
    "bcr_drug_uuid": "5c758f09-1c42-4b89-917a-cf0672708bcc",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "days_to_drug_end": 317,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1000
  },
  {
    "bcr_patient_uuid": "77d4d3ef-3fe0-4f93-a863-b5840926576c",
    "patient_ID": "TCGA.12.1093",
    "bcr_drug_barcode": "TCGA-12-1093-D23405",
    "bcr_drug_uuid": "ff36d925-1ea9-4968-a97c-dc45ab1a5892",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "TEMOZOLAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 339,
    "days_to_drug_end": 364,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "dca3a016-5e89-4850-80bf-e78dc19a2453",
    "patient_ID": "TCGA.12.1094",
    "bcr_drug_barcode": "TCGA-12-1094-D23415",
    "bcr_drug_uuid": "99298c91-9f00-459f-a5dc-8507ef3e8021",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "ACT PEP3 KLH",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 104,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 215,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "dca3a016-5e89-4850-80bf-e78dc19a2453",
    "patient_ID": "TCGA.12.1094",
    "bcr_drug_barcode": "TCGA-12-1094-D23416",
    "bcr_drug_uuid": "30138724-8cf3-456d-97a5-afaae76b2e98",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 286,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 336,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "dca3a016-5e89-4850-80bf-e78dc19a2453",
    "patient_ID": "TCGA.12.1094",
    "bcr_drug_barcode": "TCGA-12-1094-D23412",
    "bcr_drug_uuid": "dc899a96-b6aa-4728-aea9-adba0a5a72ac",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 141,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 213,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "dca3a016-5e89-4850-80bf-e78dc19a2453",
    "patient_ID": "TCGA.12.1094",
    "bcr_drug_barcode": "TCGA-12-1094-D23414",
    "bcr_drug_uuid": "eb6d6165-3b48-42a6-8c40-9d66ef153c99",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 286,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 336,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "dca3a016-5e89-4850-80bf-e78dc19a2453",
    "patient_ID": "TCGA.12.1094",
    "bcr_drug_barcode": "TCGA-12-1094-D23411",
    "bcr_drug_uuid": "36b7dc9c-ea2b-47c6-aece-4dfa8d948295",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "days_to_drug_end": 67,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "dca3a016-5e89-4850-80bf-e78dc19a2453",
    "patient_ID": "TCGA.12.1094",
    "bcr_drug_barcode": "TCGA-12-1094-D23413",
    "bcr_drug_uuid": "707316c4-0c76-4128-b7b0-d366ae0e98d2",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "CCNG",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 231,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 269,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 125
  },
  {
    "bcr_patient_uuid": "82a3f532-ae59-4d06-9bfc-e5e7519c0a33",
    "patient_ID": "TCGA.12.1095",
    "bcr_drug_barcode": "TCGA-12-1095-D23423",
    "bcr_drug_uuid": "dc6534c8-5ee9-49e2-a551-2a8c1d27376b",
    "form_completion_date": "2009-7-6",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 291,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 370,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "82a3f532-ae59-4d06-9bfc-e5e7519c0a33",
    "patient_ID": "TCGA.12.1095",
    "bcr_drug_barcode": "TCGA-12-1095-D23424",
    "bcr_drug_uuid": "0ded9037-7830-4d8e-9d2d-7f2fcc3d2aec",
    "form_completion_date": "2009-7-6",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 404,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 412,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "82a3f532-ae59-4d06-9bfc-e5e7519c0a33",
    "patient_ID": "TCGA.12.1095",
    "bcr_drug_barcode": "TCGA-12-1095-D23422",
    "bcr_drug_uuid": "0c1db420-ef58-467e-b9c5-246b329ae2d9",
    "form_completion_date": "2009-7-6",
    "pharmaceutical_therapy_drug_name": "VP 16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 404,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 412,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 37.5
  },
  {
    "bcr_patient_uuid": "82a3f532-ae59-4d06-9bfc-e5e7519c0a33",
    "patient_ID": "TCGA.12.1095",
    "bcr_drug_barcode": "TCGA-12-1095-D23421",
    "bcr_drug_uuid": "8983c0af-1050-4464-a120-5c56eed1271b",
    "form_completion_date": "2009-7-6",
    "pharmaceutical_therapy_drug_name": "CPT 11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 286,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 340
  },
  {
    "bcr_patient_uuid": "82a3f532-ae59-4d06-9bfc-e5e7519c0a33",
    "patient_ID": "TCGA.12.1095",
    "bcr_drug_barcode": "TCGA-12-1095-D23420",
    "bcr_drug_uuid": "3f2e5e09-acf6-4e46-a279-7d1d56fa98f8",
    "form_completion_date": "2009-7-6",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 82,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "82a3f532-ae59-4d06-9bfc-e5e7519c0a33",
    "patient_ID": "TCGA.12.1095",
    "bcr_drug_barcode": "TCGA-12-1095-D23425",
    "bcr_drug_uuid": "ac30373c-bcc8-40a6-8398-c0ae61139dc3",
    "form_completion_date": "2009-7-6",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 286,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "b02aa13e-7fd9-40ba-9083-cbf7d4bfc948",
    "patient_ID": "TCGA.12.1096",
    "bcr_drug_barcode": "TCGA-12-1096-D23432",
    "bcr_drug_uuid": "9d624d7e-bff5-4f49-ad11-0f1871e28409",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 202,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 277,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b02aa13e-7fd9-40ba-9083-cbf7d4bfc948",
    "patient_ID": "TCGA.12.1096",
    "bcr_drug_barcode": "TCGA-12-1096-D23429",
    "bcr_drug_uuid": "14cff663-5ab8-4bc4-b16c-21052223c1cb",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "days_to_drug_end": 101,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "b02aa13e-7fd9-40ba-9083-cbf7d4bfc948",
    "patient_ID": "TCGA.12.1096",
    "bcr_drug_barcode": "TCGA-12-1096-D23430",
    "bcr_drug_uuid": "8d6ba9db-494e-4cfe-b28a-7ea825e7b1f0",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 130,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 201,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "b02aa13e-7fd9-40ba-9083-cbf7d4bfc948",
    "patient_ID": "TCGA.12.1096",
    "bcr_drug_barcode": "TCGA-12-1096-D23431",
    "bcr_drug_uuid": "761120bb-11a8-4985-9940-58f8b7dcf0a5",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 202,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 277,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 250
  },
  {
    "bcr_patient_uuid": "f7106bb6-332a-4542-bc08-59bba48f4b04",
    "patient_ID": "TCGA.12.1097",
    "bcr_drug_barcode": "TCGA-12-1097-D23436",
    "bcr_drug_uuid": "7a577acc-b4d5-4a07-a5a5-8ccbbe470afb",
    "form_completion_date": "2009-7-6",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 96,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "f7106bb6-332a-4542-bc08-59bba48f4b04",
    "patient_ID": "TCGA.12.1097",
    "bcr_drug_barcode": "TCGA-12-1097-D23438",
    "bcr_drug_uuid": "f03461e7-a23d-4c59-b7ec-48b5cb13174b",
    "form_completion_date": "2009-7-6",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 351,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 385,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "f7106bb6-332a-4542-bc08-59bba48f4b04",
    "patient_ID": "TCGA.12.1097",
    "bcr_drug_barcode": "TCGA-12-1097-D23437",
    "bcr_drug_uuid": "6cd4c536-12a7-4ab2-ab76-e2bc5a4bcd69",
    "form_completion_date": "2009-7-6",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 110,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "f7106bb6-332a-4542-bc08-59bba48f4b04",
    "patient_ID": "TCGA.12.1097",
    "bcr_drug_barcode": "TCGA-12-1097-D23439",
    "bcr_drug_uuid": "a0dc8f92-4f4c-4066-b52b-6ef969444753",
    "form_completion_date": "2009-7-6",
    "pharmaceutical_therapy_drug_name": "VP 16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 351,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 385,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "f7106bb6-332a-4542-bc08-59bba48f4b04",
    "patient_ID": "TCGA.12.1097",
    "bcr_drug_barcode": "TCGA-12-1097-D23440",
    "bcr_drug_uuid": "b218bd58-fdb5-4791-a92a-5a6abf8c3a87",
    "form_completion_date": "2009-7-6",
    "pharmaceutical_therapy_drug_name": "AMG 102",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 177,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 343,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "a05c4aca-5b7c-452a-a92c-f252539f9e9a",
    "patient_ID": "TCGA.12.1098",
    "bcr_drug_barcode": "TCGA-12-1098-D23444",
    "bcr_drug_uuid": "6da9105c-378e-417c-be27-e660c0975501",
    "form_completion_date": "2009-7-6",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 74,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "0d04d215-b709-40dd-9d18-d470cfb5bafd",
    "patient_ID": "TCGA.12.1099",
    "bcr_drug_barcode": "TCGA-12-1099-D23449",
    "bcr_drug_uuid": "24e45c1e-4983-4550-b9c0-3bcb0e4000e3",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "0d04d215-b709-40dd-9d18-d470cfb5bafd",
    "patient_ID": "TCGA.12.1099",
    "bcr_drug_barcode": "TCGA-12-1099-D23448",
    "bcr_drug_uuid": "b01e53b3-23d6-4480-8dc7-ab73a17341d0",
    "form_completion_date": "2009-3-17",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 101,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "2b82e941-1b16-444e-af41-24dbc0a7e8b5",
    "patient_ID": "TCGA.12.1597",
    "bcr_drug_barcode": "TCGA-12-1597-D23741",
    "bcr_drug_uuid": "ac76841f-2cfd-4780-8a33-5901b19b9239",
    "form_completion_date": "2011-3-9",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFER",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 0,
    "drug_cycles": 1,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_dose": 8,
    "drug_route": "INTRATUMORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8
  },
  {
    "bcr_patient_uuid": "2b82e941-1b16-444e-af41-24dbc0a7e8b5",
    "patient_ID": "TCGA.12.1597",
    "bcr_drug_barcode": "TCGA-12-1597-D23744",
    "bcr_drug_uuid": "88d4fab7-bbab-43bb-8416-0219cebd5d8a",
    "form_completion_date": "2011-3-9",
    "pharmaceutical_therapy_drug_name": "CPT 11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 181,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 308,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 125,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2880
  },
  {
    "bcr_patient_uuid": "2b82e941-1b16-444e-af41-24dbc0a7e8b5",
    "patient_ID": "TCGA.12.1597",
    "bcr_drug_barcode": "TCGA-12-1597-D23745",
    "bcr_drug_uuid": "79d23712-2fa4-4973-90d1-7c5b60a300d9",
    "form_completion_date": "2011-3-9",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 313,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 348,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1950
  },
  {
    "bcr_patient_uuid": "2b82e941-1b16-444e-af41-24dbc0a7e8b5",
    "patient_ID": "TCGA.12.1597",
    "bcr_drug_barcode": "TCGA-12-1597-D23743",
    "bcr_drug_uuid": "7c56a89a-427f-4a4e-92ca-28717a4bd5d6",
    "form_completion_date": "2011-3-9",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 545,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 220
  },
  {
    "bcr_patient_uuid": "2b82e941-1b16-444e-af41-24dbc0a7e8b5",
    "patient_ID": "TCGA.12.1597",
    "bcr_drug_barcode": "TCGA-12-1597-D23742",
    "bcr_drug_uuid": "8d4bb5f6-d811-4917-aa2f-e3e94cb90e6f",
    "form_completion_date": "2011-3-9",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 88,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1550
  },
  {
    "bcr_patient_uuid": "2b82e941-1b16-444e-af41-24dbc0a7e8b5",
    "patient_ID": "TCGA.12.1597",
    "bcr_drug_barcode": "TCGA-12-1597-D23746",
    "bcr_drug_uuid": "77a681b9-66a1-4141-a79f-acf39f99158d",
    "form_completion_date": "2011-3-9",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 355,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 427,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1500
  },
  {
    "bcr_patient_uuid": "2b90648c-c99e-4d4d-8d9b-67ff2c4e6115",
    "patient_ID": "TCGA.12.1598",
    "bcr_drug_barcode": "TCGA-12-1598-D23750",
    "bcr_drug_uuid": "609092bf-2689-4d1d-8602-34ba487625a7",
    "form_completion_date": "2009-11-16",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 82,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5000
  },
  {
    "bcr_patient_uuid": "2b90648c-c99e-4d4d-8d9b-67ff2c4e6115",
    "patient_ID": "TCGA.12.1598",
    "bcr_drug_barcode": "TCGA-12-1598-D23751",
    "bcr_drug_uuid": "b176ed23-5d80-414b-816c-83e4b0b10d7a",
    "form_completion_date": "2009-11-16",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 160,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 287,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4500
  },
  {
    "bcr_patient_uuid": "165b8f99-f7ba-4553-96ed-235e3f77e19c",
    "patient_ID": "TCGA.12.1599",
    "bcr_drug_barcode": "TCGA-12-1599-D23760",
    "bcr_drug_uuid": "11897f22-4fbd-4255-9616-39557ab7ac9d",
    "form_completion_date": "2009-11-16",
    "pharmaceutical_therapy_drug_name": "GLEEVAC",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 30000
  },
  {
    "bcr_patient_uuid": "165b8f99-f7ba-4553-96ed-235e3f77e19c",
    "patient_ID": "TCGA.12.1599",
    "bcr_drug_barcode": "TCGA-12-1599-D23764",
    "bcr_drug_uuid": "1753f19a-a50e-4883-9919-230e4603ac5f",
    "form_completion_date": "2009-11-16",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 438,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 602,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5520
  },
  {
    "bcr_patient_uuid": "165b8f99-f7ba-4553-96ed-235e3f77e19c",
    "patient_ID": "TCGA.12.1599",
    "bcr_drug_barcode": "TCGA-12-1599-D23758",
    "bcr_drug_uuid": "0c4016d7-a9d9-4199-982a-9a7879549898",
    "form_completion_date": "2009-11-16",
    "pharmaceutical_therapy_drug_name": "CPT 11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 621,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 671,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1600
  },
  {
    "bcr_patient_uuid": "165b8f99-f7ba-4553-96ed-235e3f77e19c",
    "patient_ID": "TCGA.12.1599",
    "bcr_drug_barcode": "TCGA-12-1599-D23759",
    "bcr_drug_uuid": "af324b51-c4db-46fe-ab60-a5543e596c2b",
    "form_completion_date": "2009-11-16",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 675,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 727,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5300
  },
  {
    "bcr_patient_uuid": "165b8f99-f7ba-4553-96ed-235e3f77e19c",
    "patient_ID": "TCGA.12.1599",
    "bcr_drug_barcode": "TCGA-12-1599-D23762",
    "bcr_drug_uuid": "9bbd54eb-d11c-4954-8176-470b383d76d8",
    "form_completion_date": "2009-11-16",
    "pharmaceutical_therapy_drug_name": "ERLOTINIB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 406,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 433,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 14000
  },
  {
    "bcr_patient_uuid": "165b8f99-f7ba-4553-96ed-235e3f77e19c",
    "patient_ID": "TCGA.12.1599",
    "bcr_drug_barcode": "TCGA-12-1599-D23763",
    "bcr_drug_uuid": "e051490a-56e8-4c86-9ea4-911209bec66a",
    "form_completion_date": "2009-11-16",
    "pharmaceutical_therapy_drug_name": "SIROLIMUS",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 406,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 433,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 280
  },
  {
    "bcr_patient_uuid": "165b8f99-f7ba-4553-96ed-235e3f77e19c",
    "patient_ID": "TCGA.12.1599",
    "bcr_drug_barcode": "TCGA-12-1599-D23765",
    "bcr_drug_uuid": "eb710218-b81e-4cdd-8117-e3833feaf2d1",
    "form_completion_date": "2009-11-16",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 621,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 671,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1840
  },
  {
    "bcr_patient_uuid": "165b8f99-f7ba-4553-96ed-235e3f77e19c",
    "patient_ID": "TCGA.12.1599",
    "bcr_drug_barcode": "TCGA-12-1599-D23757",
    "bcr_drug_uuid": "02f5bbc5-a33c-4f26-8b77-b6e33482c6ce",
    "form_completion_date": "2009-11-16",
    "pharmaceutical_therapy_drug_name": "HYDROXYUREA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 160,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 391,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 66750
  },
  {
    "bcr_patient_uuid": "165b8f99-f7ba-4553-96ed-235e3f77e19c",
    "patient_ID": "TCGA.12.1599",
    "bcr_drug_barcode": "TCGA-12-1599-D23761",
    "bcr_drug_uuid": "d85369f2-478e-453c-8a92-b9028c881f22",
    "form_completion_date": "2009-11-16",
    "pharmaceutical_therapy_drug_name": "GLEEVAC",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 160,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 391,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 90400
  },
  {
    "bcr_patient_uuid": "165b8f99-f7ba-4553-96ed-235e3f77e19c",
    "patient_ID": "TCGA.12.1599",
    "bcr_drug_barcode": "TCGA-12-1599-D23755",
    "bcr_drug_uuid": "5cb67fef-3646-404f-b988-ccfca2d4ffd3",
    "form_completion_date": "2009-11-16",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 59,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5880
  },
  {
    "bcr_patient_uuid": "165b8f99-f7ba-4553-96ed-235e3f77e19c",
    "patient_ID": "TCGA.12.1599",
    "bcr_drug_barcode": "TCGA-12-1599-D23766",
    "bcr_drug_uuid": "3fd69306-7fd3-4d59-92ed-d7d71e716145",
    "form_completion_date": "2009-11-16",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 675,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 727,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1760
  },
  {
    "bcr_patient_uuid": "165b8f99-f7ba-4553-96ed-235e3f77e19c",
    "patient_ID": "TCGA.12.1599",
    "bcr_drug_barcode": "TCGA-12-1599-D23756",
    "bcr_drug_uuid": "0a0da274-6f46-4820-9c0d-490e1610f0da",
    "form_completion_date": "2009-11-16",
    "pharmaceutical_therapy_drug_name": "HYDROXYUREA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 461,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 492,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 30000
  },
  {
    "bcr_patient_uuid": "165b8f99-f7ba-4553-96ed-235e3f77e19c",
    "patient_ID": "TCGA.12.1599",
    "bcr_drug_barcode": "TCGA-12-1599-D23767",
    "bcr_drug_uuid": "177069f9-7bd5-4c46-87d3-71657dfed220",
    "form_completion_date": "2010-1-15",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 438,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 602,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5520
  },
  {
    "bcr_patient_uuid": "12b67dc2-5e4c-48eb-92ba-8d91d2eadfe2",
    "patient_ID": "TCGA.12.1600",
    "bcr_drug_barcode": "TCGA-12-1600-D23772",
    "bcr_drug_uuid": "06cc5be1-4bd2-4bcc-aa10-f2e8e69b1a4d",
    "form_completion_date": "2009-11-16",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 106,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 218,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 12000
  },
  {
    "bcr_patient_uuid": "12b67dc2-5e4c-48eb-92ba-8d91d2eadfe2",
    "patient_ID": "TCGA.12.1600",
    "bcr_drug_barcode": "TCGA-12-1600-D23771",
    "bcr_drug_uuid": "64b25e1d-f06a-472b-999b-a8bf81400ce6",
    "form_completion_date": "2009-11-16",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5880
  },
  {
    "bcr_patient_uuid": "8ac5b22f-3925-47a9-8d09-d819c2e191e5",
    "patient_ID": "TCGA.12.1602",
    "bcr_drug_barcode": "TCGA-12-1602-D23777",
    "bcr_drug_uuid": "0d3bd815-a071-407c-8dc0-c5914e9e714c",
    "form_completion_date": "2009-11-16",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 86,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 8400
  },
  {
    "bcr_patient_uuid": "8ac5b22f-3925-47a9-8d09-d819c2e191e5",
    "patient_ID": "TCGA.12.1602",
    "bcr_drug_barcode": "TCGA-12-1602-D23776",
    "bcr_drug_uuid": "b446dca7-55f1-42a5-a694-cc5201208ae8",
    "form_completion_date": "2009-11-16",
    "pharmaceutical_therapy_drug_name": "TEMODOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 57,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6000
  },
  {
    "bcr_patient_uuid": "f6c6e2c9-a3d6-4b81-a421-04ffef6b8744",
    "patient_ID": "TCGA.12.3644",
    "bcr_drug_barcode": "TCGA-12-3644-D23786",
    "bcr_drug_uuid": "f608e57b-5a19-4c7b-a0ca-2374cc403f4c",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1030,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1142,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 50,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 10080
  },
  {
    "bcr_patient_uuid": "f6c6e2c9-a3d6-4b81-a421-04ffef6b8744",
    "patient_ID": "TCGA.12.3644",
    "bcr_drug_barcode": "TCGA-12-3644-D23797",
    "bcr_drug_uuid": "cacb1786-abd9-4536-a242-45540f791df9",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1194,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1583,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 18900
  },
  {
    "bcr_patient_uuid": "f6c6e2c9-a3d6-4b81-a421-04ffef6b8744",
    "patient_ID": "TCGA.12.3644",
    "bcr_drug_barcode": "TCGA-12-3644-D23785",
    "bcr_drug_uuid": "ccb25cca-36d9-4ff0-81fb-0f7fed05fce7",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 861,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 891,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1700
  },
  {
    "bcr_patient_uuid": "f6c6e2c9-a3d6-4b81-a421-04ffef6b8744",
    "patient_ID": "TCGA.12.3644",
    "bcr_drug_barcode": "TCGA-12-3644-D23791",
    "bcr_drug_uuid": "1e817328-0469-4ae7-b77c-939fc0027749",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "CPT 11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1639,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1722,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 125,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1200
  },
  {
    "bcr_patient_uuid": "f6c6e2c9-a3d6-4b81-a421-04ffef6b8744",
    "patient_ID": "TCGA.12.3644",
    "bcr_drug_barcode": "TCGA-12-3644-D23783",
    "bcr_drug_uuid": "0e157e59-e867-420c-9dd5-3a6b49c3a65a",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 134,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 190
  },
  {
    "bcr_patient_uuid": "f6c6e2c9-a3d6-4b81-a421-04ffef6b8744",
    "patient_ID": "TCGA.12.3644",
    "bcr_drug_barcode": "TCGA-12-3644-D23788",
    "bcr_drug_uuid": "419ba5be-e8c0-4fe8-9462-3576f6a42791",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "CPT 11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1194,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1583,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 125,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 5400
  },
  {
    "bcr_patient_uuid": "f6c6e2c9-a3d6-4b81-a421-04ffef6b8744",
    "patient_ID": "TCGA.12.3644",
    "bcr_drug_barcode": "TCGA-12-3644-D23792",
    "bcr_drug_uuid": "a8aa8cd6-160d-4545-b66d-5191e9153681",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1639,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1722,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1825
  },
  {
    "bcr_patient_uuid": "f6c6e2c9-a3d6-4b81-a421-04ffef6b8744",
    "patient_ID": "TCGA.12.3644",
    "bcr_drug_barcode": "TCGA-12-3644-D23806",
    "bcr_drug_uuid": "122e2df6-bcb0-4e33-b374-23e17d9de4ae",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "ACCTUANE",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1639,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1722,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 80,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1680
  },
  {
    "bcr_patient_uuid": "f6c6e2c9-a3d6-4b81-a421-04ffef6b8744",
    "patient_ID": "TCGA.12.3644",
    "bcr_drug_barcode": "TCGA-12-3644-D23803",
    "bcr_drug_uuid": "ea5ab866-6fd4-4f56-8810-469ec7f7e86d",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1611,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1639,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1400
  },
  {
    "bcr_patient_uuid": "f6c6e2c9-a3d6-4b81-a421-04ffef6b8744",
    "patient_ID": "TCGA.12.3644",
    "bcr_drug_barcode": "TCGA-12-3644-D23784",
    "bcr_drug_uuid": "5c66bde0-39fb-444d-b4c3-4c1628a36fcf",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 179,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 486,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 17000
  },
  {
    "bcr_patient_uuid": "f6c6e2c9-a3d6-4b81-a421-04ffef6b8744",
    "patient_ID": "TCGA.12.3644",
    "bcr_drug_barcode": "TCGA-12-3644-D23789",
    "bcr_drug_uuid": "cc42c290-fa86-4ad5-b0a0-c6db17608271",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "HYDROXYUEREA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1583,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1611,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 500,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 14000
  },
  {
    "bcr_patient_uuid": "f6c6e2c9-a3d6-4b81-a421-04ffef6b8744",
    "patient_ID": "TCGA.12.3644",
    "bcr_drug_barcode": "TCGA-12-3644-D23798",
    "bcr_drug_uuid": "3d4e6f17-20f9-48b3-9cd4-45e0fc5fc0c5",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "RAPAMYCIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1583,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1611,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "f6c6e2c9-a3d6-4b81-a421-04ffef6b8744",
    "patient_ID": "TCGA.12.3644",
    "bcr_drug_barcode": "TCGA-12-3644-D23804",
    "bcr_drug_uuid": "22cebc8f-829f-4a60-9b3f-98acd4f00ec2",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "ACCUTANE",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1611,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1639,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 80,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1680
  },
  {
    "bcr_patient_uuid": "f6c6e2c9-a3d6-4b81-a421-04ffef6b8744",
    "patient_ID": "TCGA.12.3644",
    "bcr_drug_barcode": "TCGA-12-3644-D23807",
    "bcr_drug_uuid": "559a610d-a662-4448-99cf-757acf75388b",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "CHLOROQUINE",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1639,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1722,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 500,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 21000
  },
  {
    "bcr_patient_uuid": "f6c6e2c9-a3d6-4b81-a421-04ffef6b8744",
    "patient_ID": "TCGA.12.3644",
    "bcr_drug_barcode": "TCGA-12-3644-D23805",
    "bcr_drug_uuid": "63b3fd1c-3e08-4f33-ad48-c6da51c84fe9",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1639,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1722,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 4200
  },
  {
    "bcr_patient_uuid": "f6c6e2c9-a3d6-4b81-a421-04ffef6b8744",
    "patient_ID": "TCGA.12.3644",
    "bcr_drug_barcode": "TCGA-12-3644-D23782",
    "bcr_drug_uuid": "6920cecb-924c-4d33-968f-be24c1f32dd6",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3200
  },
  {
    "bcr_patient_uuid": "f6c6e2c9-a3d6-4b81-a421-04ffef6b8744",
    "patient_ID": "TCGA.12.3644",
    "bcr_drug_barcode": "TCGA-12-3644-D23801",
    "bcr_drug_uuid": "701b8631-b4d3-46b1-9472-1fd8f5d000e2",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "RAPAMYCIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1611,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1639,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "f6c6e2c9-a3d6-4b81-a421-04ffef6b8744",
    "patient_ID": "TCGA.12.3644",
    "bcr_drug_barcode": "TCGA-12-3644-D23795",
    "bcr_drug_uuid": "9565f844-587f-4989-bb40-4a3abd3a2921",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "06BG",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1150,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1154,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 120,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "f6c6e2c9-a3d6-4b81-a421-04ffef6b8744",
    "patient_ID": "TCGA.12.3644",
    "bcr_drug_barcode": "TCGA-12-3644-D23802",
    "bcr_drug_uuid": "37cd6430-be4c-4272-86c6-8e4aa67835ee",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1611,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1639,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 4200
  },
  {
    "bcr_patient_uuid": "f6c6e2c9-a3d6-4b81-a421-04ffef6b8744",
    "patient_ID": "TCGA.12.3644",
    "bcr_drug_barcode": "TCGA-12-3644-D23808",
    "bcr_drug_uuid": "cc751e95-16ac-4d6f-8b71-2d1ab76b03fa",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1765,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1806,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2100
  },
  {
    "bcr_patient_uuid": "f6c6e2c9-a3d6-4b81-a421-04ffef6b8744",
    "patient_ID": "TCGA.12.3644",
    "bcr_drug_barcode": "TCGA-12-3644-D23790",
    "bcr_drug_uuid": "9257d812-89d6-4b0b-b773-f791a03ad624",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "HYDROXYUREA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1611,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1639,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 500,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 14000
  },
  {
    "bcr_patient_uuid": "f6c6e2c9-a3d6-4b81-a421-04ffef6b8744",
    "patient_ID": "TCGA.12.3644",
    "bcr_drug_barcode": "TCGA-12-3644-D23793",
    "bcr_drug_uuid": "53b7a091-db05-4e47-b98d-c687232fc378",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 891,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1030,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 21000
  },
  {
    "bcr_patient_uuid": "f6c6e2c9-a3d6-4b81-a421-04ffef6b8744",
    "patient_ID": "TCGA.12.3644",
    "bcr_drug_barcode": "TCGA-12-3644-D23799",
    "bcr_drug_uuid": "e0d1e921-4821-49a7-8864-38309c4cccaa",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1583,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1611,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 4200
  },
  {
    "bcr_patient_uuid": "f6c6e2c9-a3d6-4b81-a421-04ffef6b8744",
    "patient_ID": "TCGA.12.3644",
    "bcr_drug_barcode": "TCGA-12-3644-D23796",
    "bcr_drug_uuid": "84c5536c-0539-4ec1-9a5b-697bbce6c905",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "06BG",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1150,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1154,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 30,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 250
  },
  {
    "bcr_patient_uuid": "f6c6e2c9-a3d6-4b81-a421-04ffef6b8744",
    "patient_ID": "TCGA.12.3644",
    "bcr_drug_barcode": "TCGA-12-3644-D23781",
    "bcr_drug_uuid": "4b2e262d-a2cd-46a8-bee5-8fa0d81dc92d",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFER",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 37,
    "drug_cycles": 1,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_dose": 8,
    "drug_route": "INTRATUMORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 61.6
  },
  {
    "bcr_patient_uuid": "f6c6e2c9-a3d6-4b81-a421-04ffef6b8744",
    "patient_ID": "TCGA.12.3644",
    "bcr_drug_barcode": "TCGA-12-3644-D23794",
    "bcr_drug_uuid": "0bd9e4a8-c736-41ca-891b-f61a57232a1e",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "RAPAMYCIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 891,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1030,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 700
  },
  {
    "bcr_patient_uuid": "f6c6e2c9-a3d6-4b81-a421-04ffef6b8744",
    "patient_ID": "TCGA.12.3644",
    "bcr_drug_barcode": "TCGA-12-3644-D23800",
    "bcr_drug_uuid": "f6d74136-fd65-4e91-ae32-dc3364c3c7c2",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1583,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1611,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1400
  },
  {
    "bcr_patient_uuid": "f6c6e2c9-a3d6-4b81-a421-04ffef6b8744",
    "patient_ID": "TCGA.12.3644",
    "bcr_drug_barcode": "TCGA-12-3644-D23787",
    "bcr_drug_uuid": "0b9da5b6-4d79-4e48-99f4-e6923f3d2b2d",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1142,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1180,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 3500
  },
  {
    "bcr_patient_uuid": "e8e43a65-4ec8-4e07-a884-a6989eec28cc",
    "patient_ID": "TCGA.12.3646",
    "bcr_drug_barcode": "TCGA-12-3646-D23815",
    "bcr_drug_uuid": "0d8318ed-1889-48f9-a00b-11aa745ba257",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 151,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 234,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "e8e43a65-4ec8-4e07-a884-a6989eec28cc",
    "patient_ID": "TCGA.12.3646",
    "bcr_drug_barcode": "TCGA-12-3646-D23813",
    "bcr_drug_uuid": "ded65791-82d4-45b4-b114-5eaaf91ca529",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 66,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5670
  },
  {
    "bcr_patient_uuid": "e8e43a65-4ec8-4e07-a884-a6989eec28cc",
    "patient_ID": "TCGA.12.3646",
    "bcr_drug_barcode": "TCGA-12-3646-D23816",
    "bcr_drug_uuid": "65478c20-e59f-4263-96f7-1dc136e7a421",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "CPT 11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 248,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 334,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 340,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3610.8
  },
  {
    "bcr_patient_uuid": "e8e43a65-4ec8-4e07-a884-a6989eec28cc",
    "patient_ID": "TCGA.12.3646",
    "bcr_drug_barcode": "TCGA-12-3646-D23820",
    "bcr_drug_uuid": "d7cd23dc-b9e6-4675-9d9c-7409aa681386",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 248,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 334,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4182
  },
  {
    "bcr_patient_uuid": "e8e43a65-4ec8-4e07-a884-a6989eec28cc",
    "patient_ID": "TCGA.12.3646",
    "bcr_drug_barcode": "TCGA-12-3646-D23814",
    "bcr_drug_uuid": "4f326a90-754a-450e-81ba-ce814080283c",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "e8e43a65-4ec8-4e07-a884-a6989eec28cc",
    "patient_ID": "TCGA.12.3646",
    "bcr_drug_barcode": "TCGA-12-3646-D23817",
    "bcr_drug_uuid": "a7b59ab0-c0a5-4bc5-87fd-cbd2230f19ba",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 334,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 403,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3500
  },
  {
    "bcr_patient_uuid": "e8e43a65-4ec8-4e07-a884-a6989eec28cc",
    "patient_ID": "TCGA.12.3646",
    "bcr_drug_barcode": "TCGA-12-3646-D23819",
    "bcr_drug_uuid": "c2f3eeb0-7493-4d7a-adc5-5379e43d33c4",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1063,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1315,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 50,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 17920
  },
  {
    "bcr_patient_uuid": "e8e43a65-4ec8-4e07-a884-a6989eec28cc",
    "patient_ID": "TCGA.12.3646",
    "bcr_drug_barcode": "TCGA-12-3646-D23818",
    "bcr_drug_uuid": "3be3cd8a-b4ee-404b-ad31-7a7470df79c1",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 405,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 488,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 380
  },
  {
    "bcr_patient_uuid": "407849a8-8447-4ede-a9d1-c1dfb535222e",
    "patient_ID": "TCGA.12.3648",
    "bcr_drug_barcode": "TCGA-12-3648-D23831",
    "bcr_drug_uuid": "ae24f877-7bd9-41f6-95db-f5ad2d2abad5",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 738,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 784,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1400
  },
  {
    "bcr_patient_uuid": "407849a8-8447-4ede-a9d1-c1dfb535222e",
    "patient_ID": "TCGA.12.3648",
    "bcr_drug_barcode": "TCGA-12-3648-D23829",
    "bcr_drug_uuid": "4afa0a4f-a76b-4992-9412-f03a9f5f6daa",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "PEP3 KLH",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 83,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 452,
    "drug_units": "UG",
    "drug_tota_dose_units": "UG",
    "drug_dose": 500,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6500
  },
  {
    "bcr_patient_uuid": "407849a8-8447-4ede-a9d1-c1dfb535222e",
    "patient_ID": "TCGA.12.3648",
    "bcr_drug_barcode": "TCGA-12-3648-D23825",
    "bcr_drug_uuid": "f5c9814e-c6f3-4d1b-981e-5a5dcca91f5f",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 452,
    "drug_cycles": 11,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 46200
  },
  {
    "bcr_patient_uuid": "407849a8-8447-4ede-a9d1-c1dfb535222e",
    "patient_ID": "TCGA.12.3648",
    "bcr_drug_barcode": "TCGA-12-3648-D23826",
    "bcr_drug_uuid": "d30b5295-ea98-4025-98ca-0f80826c1d0c",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "CPT 11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 508,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 731,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 125,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 3450
  },
  {
    "bcr_patient_uuid": "407849a8-8447-4ede-a9d1-c1dfb535222e",
    "patient_ID": "TCGA.12.3648",
    "bcr_drug_barcode": "TCGA-12-3648-D23828",
    "bcr_drug_uuid": "03c34ab8-e12c-48d7-8450-85da94a350ae",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "VP 16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 738,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 784,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 50,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1575
  },
  {
    "bcr_patient_uuid": "407849a8-8447-4ede-a9d1-c1dfb535222e",
    "patient_ID": "TCGA.12.3648",
    "bcr_drug_barcode": "TCGA-12-3648-D23830",
    "bcr_drug_uuid": "45804fd5-8fc7-40af-be3e-ac3730731eba",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 508,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 731,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 10950
  },
  {
    "bcr_patient_uuid": "407849a8-8447-4ede-a9d1-c1dfb535222e",
    "patient_ID": "TCGA.12.3648",
    "bcr_drug_barcode": "TCGA-12-3648-D23824",
    "bcr_drug_uuid": "6d2837e0-54c1-46e8-9aaf-9c8cbf77b338",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 67,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5880
  },
  {
    "bcr_patient_uuid": "407849a8-8447-4ede-a9d1-c1dfb535222e",
    "patient_ID": "TCGA.12.3648",
    "bcr_drug_barcode": "TCGA-12-3648-D23827",
    "bcr_drug_uuid": "9de746fc-812e-4d9e-a725-ed252d061992",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 738,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 784,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 50,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2800
  },
  {
    "bcr_patient_uuid": "93737759-b088-4d64-adfe-c2d5ec715341",
    "patient_ID": "TCGA.12.3649",
    "bcr_drug_barcode": "TCGA-12-3649-D23835",
    "bcr_drug_uuid": "0895b796-1845-437d-90ae-0547189a770a",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6000
  },
  {
    "bcr_patient_uuid": "93737759-b088-4d64-adfe-c2d5ec715341",
    "patient_ID": "TCGA.12.3649",
    "bcr_drug_barcode": "TCGA-12-3649-D23837",
    "bcr_drug_uuid": "3b49d641-00d1-47e3-a119-4306b8a37548",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 240,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 350,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6000
  },
  {
    "bcr_patient_uuid": "93737759-b088-4d64-adfe-c2d5ec715341",
    "patient_ID": "TCGA.12.3649",
    "bcr_drug_barcode": "TCGA-12-3649-D23841",
    "bcr_drug_uuid": "e21ea1e6-69a7-4f19-8f60-44e66bc7d1ac",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 186,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 240,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "93737759-b088-4d64-adfe-c2d5ec715341",
    "patient_ID": "TCGA.12.3649",
    "bcr_drug_barcode": "TCGA-12-3649-D23840",
    "bcr_drug_uuid": "243dfa39-70ea-4f28-b227-810e9ceaa71e",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "93737759-b088-4d64-adfe-c2d5ec715341",
    "patient_ID": "TCGA.12.3649",
    "bcr_drug_barcode": "TCGA-12-3649-D23839",
    "bcr_drug_uuid": "e0ec0d9d-3f89-4dc1-9af1-63eb9f685d96",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "ATTAC",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 240,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 350,
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "93737759-b088-4d64-adfe-c2d5ec715341",
    "patient_ID": "TCGA.12.3649",
    "bcr_drug_barcode": "TCGA-12-3649-D23842",
    "bcr_drug_uuid": "65563c08-f717-4a43-b999-9263c5b5e1c4",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 240,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 347,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "93737759-b088-4d64-adfe-c2d5ec715341",
    "patient_ID": "TCGA.12.3649",
    "bcr_drug_barcode": "TCGA-12-3649-D23838",
    "bcr_drug_uuid": "bd0496a8-7fd5-4276-9fd8-67c7a0fcc72c",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "ATTAC",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 186,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 245,
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "93737759-b088-4d64-adfe-c2d5ec715341",
    "patient_ID": "TCGA.12.3649",
    "bcr_drug_barcode": "TCGA-12-3649-D23836",
    "bcr_drug_uuid": "eabdced4-3f7b-492f-8662-4495e12dff74",
    "form_completion_date": "2010-6-18",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 186,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 240,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2000
  },
  {
    "bcr_patient_uuid": "5ef9486a-aeff-421d-b620-03ef119d85a5",
    "patient_ID": "TCGA.12.3650",
    "bcr_drug_barcode": "TCGA-12-3650-D23849",
    "bcr_drug_uuid": "246693f0-6de9-4ae4-a8c3-f13dbbe107bc",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 152,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 239,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3000
  },
  {
    "bcr_patient_uuid": "5ef9486a-aeff-421d-b620-03ef119d85a5",
    "patient_ID": "TCGA.12.3650",
    "bcr_drug_barcode": "TCGA-12-3650-D23852",
    "bcr_drug_uuid": "e6a53131-3989-40af-8c4a-95471516f0e7",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3892
  },
  {
    "bcr_patient_uuid": "5ef9486a-aeff-421d-b620-03ef119d85a5",
    "patient_ID": "TCGA.12.3650",
    "bcr_drug_barcode": "TCGA-12-3650-D23851",
    "bcr_drug_uuid": "e49074c2-b3eb-4ed4-b4af-89360232674e",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 72,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3003
  },
  {
    "bcr_patient_uuid": "5ef9486a-aeff-421d-b620-03ef119d85a5",
    "patient_ID": "TCGA.12.3650",
    "bcr_drug_barcode": "TCGA-12-3650-D23854",
    "bcr_drug_uuid": "706aa7be-dcc6-41f7-a886-199ef9ffa051",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 239,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 307,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 11200
  },
  {
    "bcr_patient_uuid": "5ef9486a-aeff-421d-b620-03ef119d85a5",
    "patient_ID": "TCGA.12.3650",
    "bcr_drug_barcode": "TCGA-12-3650-D23850",
    "bcr_drug_uuid": "01e955be-e0e9-4342-8e59-ac85106a809b",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "VP 16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 307,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 333,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 50,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2100
  },
  {
    "bcr_patient_uuid": "5ef9486a-aeff-421d-b620-03ef119d85a5",
    "patient_ID": "TCGA.12.3650",
    "bcr_drug_barcode": "TCGA-12-3650-D23847",
    "bcr_drug_uuid": "fa813f9b-b40f-4020-a700-bece84e19194",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2000
  },
  {
    "bcr_patient_uuid": "5ef9486a-aeff-421d-b620-03ef119d85a5",
    "patient_ID": "TCGA.12.3650",
    "bcr_drug_barcode": "TCGA-12-3650-D23855",
    "bcr_drug_uuid": "08de5190-bfc0-43c9-bfe8-63eda0971a81",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 239,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 307,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 3860
  },
  {
    "bcr_patient_uuid": "5ef9486a-aeff-421d-b620-03ef119d85a5",
    "patient_ID": "TCGA.12.3650",
    "bcr_drug_barcode": "TCGA-12-3650-D23848",
    "bcr_drug_uuid": "c169ec13-9a6f-493d-8925-183ef375c76e",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "CPT 11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 152,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 239,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 125,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1620
  },
  {
    "bcr_patient_uuid": "5ef9486a-aeff-421d-b620-03ef119d85a5",
    "patient_ID": "TCGA.12.3650",
    "bcr_drug_barcode": "TCGA-12-3650-D23853",
    "bcr_drug_uuid": "037e6f21-a548-4321-befe-3d867d11da36",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 148,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 239,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5838
  },
  {
    "bcr_patient_uuid": "5ef9486a-aeff-421d-b620-03ef119d85a5",
    "patient_ID": "TCGA.12.3650",
    "bcr_drug_barcode": "TCGA-12-3650-D23856",
    "bcr_drug_uuid": "581c1128-6fdd-4589-a882-237544883f2e",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 307,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 333,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1894
  },
  {
    "bcr_patient_uuid": "5ef9486a-aeff-421d-b620-03ef119d85a5",
    "patient_ID": "TCGA.12.3650",
    "bcr_drug_barcode": "TCGA-12-3650-D23846",
    "bcr_drug_uuid": "cdcc6ebe-07f4-4d39-a8df-5606be5558a7",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "CPT 11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 340,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6120
  },
  {
    "bcr_patient_uuid": "5ef9486a-aeff-421d-b620-03ef119d85a5",
    "patient_ID": "TCGA.12.3650",
    "bcr_drug_barcode": "TCGA-12-3650-D23845",
    "bcr_drug_uuid": "21adc65e-cd5d-47b6-906d-c03361abd316",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 72,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6930
  },
  {
    "bcr_patient_uuid": "d540d6d2-266c-48f9-8e73-304389b2060b",
    "patient_ID": "TCGA.12.3651",
    "bcr_drug_barcode": "TCGA-12-3651-D23863",
    "bcr_drug_uuid": "63332f1a-e0c0-48fd-a1b5-67ae2ba725fd",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 221,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 358,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5600
  },
  {
    "bcr_patient_uuid": "d540d6d2-266c-48f9-8e73-304389b2060b",
    "patient_ID": "TCGA.12.3651",
    "bcr_drug_barcode": "TCGA-12-3651-D23865",
    "bcr_drug_uuid": "a2f979ae-4c6d-4518-a0fb-e202e967ee0e",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 221,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 358,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2840
  },
  {
    "bcr_patient_uuid": "d540d6d2-266c-48f9-8e73-304389b2060b",
    "patient_ID": "TCGA.12.3651",
    "bcr_drug_barcode": "TCGA-12-3651-D23861",
    "bcr_drug_uuid": "583ab4c3-7e47-4a7b-8a8a-2cc08f17f37b",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 186,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 212,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1400
  },
  {
    "bcr_patient_uuid": "d540d6d2-266c-48f9-8e73-304389b2060b",
    "patient_ID": "TCGA.12.3651",
    "bcr_drug_barcode": "TCGA-12-3651-D23864",
    "bcr_drug_uuid": "38bacb01-a0de-45d1-a96d-a3ef96b9187a",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2430
  },
  {
    "bcr_patient_uuid": "d540d6d2-266c-48f9-8e73-304389b2060b",
    "patient_ID": "TCGA.12.3651",
    "bcr_drug_barcode": "TCGA-12-3651-D23860",
    "bcr_drug_uuid": "17a463d2-46c6-4773-8946-410ff432aaed",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5880
  },
  {
    "bcr_patient_uuid": "d540d6d2-266c-48f9-8e73-304389b2060b",
    "patient_ID": "TCGA.12.3651",
    "bcr_drug_barcode": "TCGA-12-3651-D23862",
    "bcr_drug_uuid": "bfc5451f-2faa-4116-bdbc-017852173f4d",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "CPT 11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 221,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 358,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 40,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 592
  },
  {
    "bcr_patient_uuid": "159e0318-6173-440f-be07-8d956086e99d",
    "patient_ID": "TCGA.12.3652",
    "bcr_drug_barcode": "TCGA-12-3652-D23874",
    "bcr_drug_uuid": "5f497f85-81e6-4ee1-ad7e-1203c6a855a6",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "VP 16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 469,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 571,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 50,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 8400
  },
  {
    "bcr_patient_uuid": "159e0318-6173-440f-be07-8d956086e99d",
    "patient_ID": "TCGA.12.3652",
    "bcr_drug_barcode": "TCGA-12-3652-D23875",
    "bcr_drug_uuid": "5af365b3-d16b-4e52-9ec3-d4d2365abc34",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "HYDROXUREA",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 585,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 750,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 500,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 14000
  },
  {
    "bcr_patient_uuid": "159e0318-6173-440f-be07-8d956086e99d",
    "patient_ID": "TCGA.12.3652",
    "bcr_drug_barcode": "TCGA-12-3652-D23869",
    "bcr_drug_uuid": "a0258123-a051-411a-9438-e22823bc3e7c",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 67,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3000
  },
  {
    "bcr_patient_uuid": "159e0318-6173-440f-be07-8d956086e99d",
    "patient_ID": "TCGA.12.3652",
    "bcr_drug_barcode": "TCGA-12-3652-D23871",
    "bcr_drug_uuid": "13869b12-a6d5-492f-b447-21377d2a77ab",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 161,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 203,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 82.5,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "159e0318-6173-440f-be07-8d956086e99d",
    "patient_ID": "TCGA.12.3652",
    "bcr_drug_barcode": "TCGA-12-3652-D23870",
    "bcr_drug_uuid": "5971905b-fe49-4eb8-908f-5ef2a8104412",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 220
  },
  {
    "bcr_patient_uuid": "159e0318-6173-440f-be07-8d956086e99d",
    "patient_ID": "TCGA.12.3652",
    "bcr_drug_barcode": "TCGA-12-3652-D23878",
    "bcr_drug_uuid": "5a096ae9-d9da-491e-8551-3e96a6e013d5",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "GLEEVAC",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 750,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 792,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 300,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 8400
  },
  {
    "bcr_patient_uuid": "159e0318-6173-440f-be07-8d956086e99d",
    "patient_ID": "TCGA.12.3652",
    "bcr_drug_barcode": "TCGA-12-3652-D23877",
    "bcr_drug_uuid": "a1292253-d177-432c-9607-291a1ebdc85f",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "GLEEVAC",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 585,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 750,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 400,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 56000
  },
  {
    "bcr_patient_uuid": "159e0318-6173-440f-be07-8d956086e99d",
    "patient_ID": "TCGA.12.3652",
    "bcr_drug_barcode": "TCGA-12-3652-D23872",
    "bcr_drug_uuid": "5669a2bc-462d-4f0a-b841-c2b5c5330a39",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 228,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 288,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 4000
  },
  {
    "bcr_patient_uuid": "159e0318-6173-440f-be07-8d956086e99d",
    "patient_ID": "TCGA.12.3652",
    "bcr_drug_barcode": "TCGA-12-3652-D23873",
    "bcr_drug_uuid": "2f54f028-dfa1-4077-8487-5e6fd85eeb8d",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "VP 16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 291,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 358,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 50,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1575
  },
  {
    "bcr_patient_uuid": "159e0318-6173-440f-be07-8d956086e99d",
    "patient_ID": "TCGA.12.3652",
    "bcr_drug_barcode": "TCGA-12-3652-D23876",
    "bcr_drug_uuid": "97957116-80e0-4310-861a-78bb3de75922",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "HYDROXUREA",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 750,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 792,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 500,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2800
  },
  {
    "bcr_patient_uuid": "2f61ea6b-a3f2-477f-ab98-47ed07b3b2cd",
    "patient_ID": "TCGA.12.3653",
    "bcr_drug_barcode": "TCGA-12-3653-D23887",
    "bcr_drug_uuid": "c118be6f-5204-45bd-9046-d6c86537bda3",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 316,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 371,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 4000
  },
  {
    "bcr_patient_uuid": "2f61ea6b-a3f2-477f-ab98-47ed07b3b2cd",
    "patient_ID": "TCGA.12.3653",
    "bcr_drug_barcode": "TCGA-12-3653-D23885",
    "bcr_drug_uuid": "a434d91c-c3bc-4b6c-b6af-95698a9eac32",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "DACLIZUMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 128,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 224,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1,
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 406.4
  },
  {
    "bcr_patient_uuid": "2f61ea6b-a3f2-477f-ab98-47ed07b3b2cd",
    "patient_ID": "TCGA.12.3653",
    "bcr_drug_barcode": "TCGA-12-3653-D23886",
    "bcr_drug_uuid": "bcd6262c-7485-45bf-b4d1-c677ed0cc02c",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "ANGIOCEPT",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 287,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 315,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 199
  },
  {
    "bcr_patient_uuid": "2f61ea6b-a3f2-477f-ab98-47ed07b3b2cd",
    "patient_ID": "TCGA.12.3653",
    "bcr_drug_barcode": "TCGA-12-3653-D23884",
    "bcr_drug_uuid": "1e0635de-3c73-4912-a3f3-21b0108b4fa4",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "VP 16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 316,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 371,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 50,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 4200
  },
  {
    "bcr_patient_uuid": "2f61ea6b-a3f2-477f-ab98-47ed07b3b2cd",
    "patient_ID": "TCGA.12.3653",
    "bcr_drug_barcode": "TCGA-12-3653-D23883",
    "bcr_drug_uuid": "b2dbf473-11b7-485a-bb08-ec5721fc369d",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 128,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 224,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4500
  },
  {
    "bcr_patient_uuid": "2f61ea6b-a3f2-477f-ab98-47ed07b3b2cd",
    "patient_ID": "TCGA.12.3653",
    "bcr_drug_barcode": "TCGA-12-3653-D23882",
    "bcr_drug_uuid": "5dd248d8-710f-443b-9856-c90d45967747",
    "form_completion_date": "2010-6-17",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 87,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6300
  },
  {
    "bcr_patient_uuid": "c970240f-03e2-4395-85be-5eb81a69b710",
    "patient_ID": "TCGA.12.5295",
    "bcr_drug_barcode": "TCGA-12-5295-D23894",
    "bcr_drug_uuid": "e6443949-ba10-47c2-8cdf-d01f91874e6f",
    "form_completion_date": "2011-2-7",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 277,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 323,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1650
  },
  {
    "bcr_patient_uuid": "c970240f-03e2-4395-85be-5eb81a69b710",
    "patient_ID": "TCGA.12.5295",
    "bcr_drug_barcode": "TCGA-12-5295-D23891",
    "bcr_drug_uuid": "86be8937-7538-4a31-8d77-f65511d21df1",
    "form_completion_date": "2011-2-7",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 71,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4725
  },
  {
    "bcr_patient_uuid": "c970240f-03e2-4395-85be-5eb81a69b710",
    "patient_ID": "TCGA.12.5295",
    "bcr_drug_barcode": "TCGA-12-5295-D23892",
    "bcr_drug_uuid": "42cc5949-c34c-4ef4-81c5-6956fdc7d546",
    "form_completion_date": "2011-2-7",
    "pharmaceutical_therapy_drug_name": "CPT 11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 277,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 340,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4590
  },
  {
    "bcr_patient_uuid": "c970240f-03e2-4395-85be-5eb81a69b710",
    "patient_ID": "TCGA.12.5295",
    "bcr_drug_barcode": "TCGA-12-5295-D23893",
    "bcr_drug_uuid": "aa28eb4a-d590-485e-8241-304f794b847f",
    "form_completion_date": "2011-2-7",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 277,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4950
  },
  {
    "bcr_patient_uuid": "5327e899-a20d-4571-8236-98454bad574e",
    "patient_ID": "TCGA.12.5299",
    "bcr_drug_barcode": "TCGA-12-5299-D23898",
    "bcr_drug_uuid": "cd10eb41-3cb1-4c25-9b1e-7601dda8b0d2",
    "form_completion_date": "2011-2-7",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 80,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5250
  },
  {
    "bcr_patient_uuid": "5327e899-a20d-4571-8236-98454bad574e",
    "patient_ID": "TCGA.12.5299",
    "bcr_drug_barcode": "TCGA-12-5299-D23899",
    "bcr_drug_uuid": "af067cc9-96df-4fec-b88b-8910060babc0",
    "form_completion_date": "2011-2-7",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 73,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3000
  },
  {
    "bcr_patient_uuid": "10efeb3c-ef55-4227-91b9-8c2bb4ff43d5",
    "patient_ID": "TCGA.12.5301",
    "bcr_drug_barcode": "TCGA-12-5301-D23903",
    "bcr_drug_uuid": "78ffd0cc-e45e-4fa9-93d1-f382e466b6a6",
    "form_completion_date": "2011-2-7",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 59,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5400
  },
  {
    "bcr_patient_uuid": "cdfcf14d-ed6c-419f-88f5-e7dee96fcaf6",
    "patient_ID": "TCGA.14.0736",
    "bcr_drug_barcode": "TCGA-14-0736-D25027",
    "bcr_drug_uuid": "6109596d-0a70-4434-981b-33f59151bbec",
    "form_completion_date": "2009-6-4",
    "pharmaceutical_therapy_drug_name": "GLIADEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 207,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_route": "OTHER",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 8
  },
  {
    "bcr_patient_uuid": "cdfcf14d-ed6c-419f-88f5-e7dee96fcaf6",
    "patient_ID": "TCGA.14.0736",
    "bcr_drug_barcode": "TCGA-14-0736-D25029",
    "bcr_drug_uuid": "e5165449-e38a-49d1-935c-f07da09015fc",
    "form_completion_date": "2009-6-4",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "cdfcf14d-ed6c-419f-88f5-e7dee96fcaf6",
    "patient_ID": "TCGA.14.0736",
    "bcr_drug_barcode": "TCGA-14-0736-D25030",
    "bcr_drug_uuid": "df6d7ef0-9916-40ae-a56a-e2e49992a441",
    "form_completion_date": "2009-6-4",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 128,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "cdfcf14d-ed6c-419f-88f5-e7dee96fcaf6",
    "patient_ID": "TCGA.14.0736",
    "bcr_drug_barcode": "TCGA-14-0736-D25028",
    "bcr_drug_uuid": "dbcd231a-8b89-4538-af33-de66bf55fdab",
    "form_completion_date": "2009-6-4",
    "pharmaceutical_therapy_drug_name": "TEMADOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 371,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 376,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2000
  },
  {
    "bcr_patient_uuid": "70c887ce-43e1-4093-9a2f-a9d3dc62da78",
    "patient_ID": "TCGA.14.0740",
    "bcr_drug_barcode": "TCGA-14-0740-D25256",
    "bcr_drug_uuid": "313cebc5-142b-481d-85b5-96fe4cb15834",
    "form_completion_date": "2010-6-24",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9b9654c9-5a64-4a8e-b1f0-987437e6012e",
    "patient_ID": "TCGA.14.0781",
    "bcr_drug_barcode": "TCGA-14-0781-D25034",
    "bcr_drug_uuid": "1fa40719-7dd6-4d7d-8df5-fc148697adeb",
    "form_completion_date": "2010-6-24",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "27c8c458-eb2f-43e4-a06b-6cd61a9a3a28",
    "patient_ID": "TCGA.14.0783",
    "bcr_drug_barcode": "TCGA-14-0783-D25037",
    "bcr_drug_uuid": "a3c2c88a-34fc-459c-98f8-1d67d9639719",
    "form_completion_date": "2009-8-4",
    "pharmaceutical_therapy_drug_name": "CARBOXY AMIDO TRIAZOLE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 108450
  },
  {
    "bcr_patient_uuid": "27c8c458-eb2f-43e4-a06b-6cd61a9a3a28",
    "patient_ID": "TCGA.14.0783",
    "bcr_drug_barcode": "TCGA-14-0783-D25038",
    "bcr_drug_uuid": "9e758ea9-efd4-4235-aada-5321e9db46ff",
    "form_completion_date": "2009-8-4",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": -1,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "12824b2b-9c0a-4dcf-8941-34593a4e93da",
    "patient_ID": "TCGA.14.0786",
    "bcr_drug_barcode": "TCGA-14-0786-D25050",
    "bcr_drug_uuid": "461ce200-caf6-4662-9abd-34d1c7ea7134",
    "form_completion_date": "2009-8-4",
    "pharmaceutical_therapy_drug_name": "THALIDOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 574,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 651,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "12824b2b-9c0a-4dcf-8941-34593a4e93da",
    "patient_ID": "TCGA.14.0786",
    "bcr_drug_barcode": "TCGA-14-0786-D25042",
    "bcr_drug_uuid": "d5427ebb-67f8-4a4c-ad62-43094c6428cb",
    "form_completion_date": "2009-8-4",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 140,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "12824b2b-9c0a-4dcf-8941-34593a4e93da",
    "patient_ID": "TCGA.14.0786",
    "bcr_drug_barcode": "TCGA-14-0786-D25045",
    "bcr_drug_uuid": "ddec111c-4c05-431d-ae3f-0684c89a2f09",
    "form_completion_date": "2009-8-4",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 308,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 357,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 12600
  },
  {
    "bcr_patient_uuid": "12824b2b-9c0a-4dcf-8941-34593a4e93da",
    "patient_ID": "TCGA.14.0786",
    "bcr_drug_barcode": "TCGA-14-0786-D25043",
    "bcr_drug_uuid": "69c29c75-960b-44f5-a5dc-06ed4b78745b",
    "form_completion_date": "2009-8-4",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 140,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "12824b2b-9c0a-4dcf-8941-34593a4e93da",
    "patient_ID": "TCGA.14.0786",
    "bcr_drug_barcode": "TCGA-14-0786-D25053",
    "bcr_drug_uuid": "fd77ad49-1a88-4d43-9b6f-797eaa842f92",
    "form_completion_date": "2009-8-4",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "12824b2b-9c0a-4dcf-8941-34593a4e93da",
    "patient_ID": "TCGA.14.0786",
    "bcr_drug_barcode": "TCGA-14-0786-D25049",
    "bcr_drug_uuid": "eb117505-c3f4-446a-9c50-d9ef5c6cbe8b",
    "form_completion_date": "2009-8-4",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 567,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 570,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 69
  },
  {
    "bcr_patient_uuid": "12824b2b-9c0a-4dcf-8941-34593a4e93da",
    "patient_ID": "TCGA.14.0786",
    "bcr_drug_barcode": "TCGA-14-0786-D25051",
    "bcr_drug_uuid": "8783c1ea-bef3-4cd6-94ae-0b8994ccba65",
    "form_completion_date": "2009-8-4",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 659,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "12824b2b-9c0a-4dcf-8941-34593a4e93da",
    "patient_ID": "TCGA.14.0786",
    "bcr_drug_barcode": "TCGA-14-0786-D25052",
    "bcr_drug_uuid": "76d83075-6f7f-47df-9843-f203adbb2065",
    "form_completion_date": "2009-8-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 659,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "12824b2b-9c0a-4dcf-8941-34593a4e93da",
    "patient_ID": "TCGA.14.0786",
    "bcr_drug_barcode": "TCGA-14-0786-D25044",
    "bcr_drug_uuid": "2070bef0-46d9-462b-9e22-f7bf51fa970a",
    "form_completion_date": "2009-8-4",
    "pharmaceutical_therapy_drug_name": "CPT 11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 182,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 210,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1124
  },
  {
    "bcr_patient_uuid": "12824b2b-9c0a-4dcf-8941-34593a4e93da",
    "patient_ID": "TCGA.14.0786",
    "bcr_drug_barcode": "TCGA-14-0786-D25047",
    "bcr_drug_uuid": "fc37b272-3d0f-4fcb-88aa-62e795301ce1",
    "form_completion_date": "2009-8-4",
    "pharmaceutical_therapy_drug_name": "STREPTOZOCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 567,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 570,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3400
  },
  {
    "bcr_patient_uuid": "12824b2b-9c0a-4dcf-8941-34593a4e93da",
    "patient_ID": "TCGA.14.0786",
    "bcr_drug_barcode": "TCGA-14-0786-D25046",
    "bcr_drug_uuid": "888e88cd-c2cc-4c5e-aaeb-5a357b7d8e78",
    "form_completion_date": "2009-8-4",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 526,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 567,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "12824b2b-9c0a-4dcf-8941-34593a4e93da",
    "patient_ID": "TCGA.14.0786",
    "bcr_drug_barcode": "TCGA-14-0786-D25048",
    "bcr_drug_uuid": "86d4e0aa-8f20-4773-ab9a-fbbcc869c7bd",
    "form_completion_date": "2009-8-4",
    "pharmaceutical_therapy_drug_name": "6-MERCAPTOPURINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 567,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 570,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1200
  },
  {
    "bcr_patient_uuid": "12824b2b-9c0a-4dcf-8941-34593a4e93da",
    "patient_ID": "TCGA.14.0786",
    "bcr_drug_barcode": "TCGA-14-0786-D25054",
    "bcr_drug_uuid": "38525ebf-b281-4604-8c74-20eca4c862e7",
    "form_completion_date": "2009-8-4",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 127,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a2338b30-f511-4163-af3b-1e4a40ff00e1",
    "patient_ID": "TCGA.14.0787",
    "bcr_drug_barcode": "TCGA-14-0787-D25058",
    "bcr_drug_uuid": "ba759209-2fe1-4518-a456-d84ee0581d91",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "DEXMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 15,
    "days_to_drug_end": 41,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 720
  },
  {
    "bcr_patient_uuid": "a2338b30-f511-4163-af3b-1e4a40ff00e1",
    "patient_ID": "TCGA.14.0787",
    "bcr_drug_barcode": "TCGA-14-0787-D25059",
    "bcr_drug_uuid": "48acd207-c274-4686-bccd-7d749d195594",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7cbabf1d-ec38-4048-ae1c-7d0f3001691b",
    "patient_ID": "TCGA.14.0789",
    "bcr_drug_barcode": "TCGA-14-0789-D25062",
    "bcr_drug_uuid": "8691af67-9e42-422a-806b-0613902ed648",
    "form_completion_date": "2009-5-6",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "days_to_drug_end": 75,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 120
  },
  {
    "bcr_patient_uuid": "7cbabf1d-ec38-4048-ae1c-7d0f3001691b",
    "patient_ID": "TCGA.14.0789",
    "bcr_drug_barcode": "TCGA-14-0789-D25063",
    "bcr_drug_uuid": "dff8452d-ee4f-4b51-a7df-8aef2ce0f42e",
    "form_completion_date": "2009-5-6",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFER (BCNU)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_route": "OTHER",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 8
  },
  {
    "bcr_patient_uuid": "7cbabf1d-ec38-4048-ae1c-7d0f3001691b",
    "patient_ID": "TCGA.14.0789",
    "bcr_drug_barcode": "TCGA-14-0789-D25064",
    "bcr_drug_uuid": "c6d5e1e4-2ef1-49be-8332-9f935e0fd5a3",
    "form_completion_date": "2009-5-15",
    "pharmaceutical_therapy_drug_name": "DEXAMETHAZONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 118,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2000
  },
  {
    "bcr_patient_uuid": "7cbabf1d-ec38-4048-ae1c-7d0f3001691b",
    "patient_ID": "TCGA.14.0789",
    "bcr_drug_barcode": "TCGA-14-0789-D25065",
    "bcr_drug_uuid": "2ecc9c94-8a6b-4abd-ba50-701d85f627de",
    "form_completion_date": "2009-5-15",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 224,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1680
  },
  {
    "bcr_patient_uuid": "7fe37feb-e205-4524-8c98-1f9ac5fe0700",
    "patient_ID": "TCGA.14.0790",
    "bcr_drug_barcode": "TCGA-14-0790-D25069",
    "bcr_drug_uuid": "61376632-4435-467e-8225-20f4ffea46ec",
    "form_completion_date": "2010-2-5",
    "pharmaceutical_therapy_drug_name": "GLIADEL BCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8
  },
  {
    "bcr_patient_uuid": "7fe37feb-e205-4524-8c98-1f9ac5fe0700",
    "patient_ID": "TCGA.14.0790",
    "bcr_drug_barcode": "TCGA-14-0790-D25070",
    "bcr_drug_uuid": "08088403-9225-4775-8ad6-7d259dedc879",
    "form_completion_date": "2010-2-5",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 410,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 17700
  },
  {
    "bcr_patient_uuid": "7fe37feb-e205-4524-8c98-1f9ac5fe0700",
    "patient_ID": "TCGA.14.0790",
    "bcr_drug_barcode": "TCGA-14-0790-D25071",
    "bcr_drug_uuid": "057d0f15-9225-48f5-8103-2807f2c26b19",
    "form_completion_date": "2010-2-5",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "eff7f13b-ed32-4e85-a8d0-831b655d773f",
    "patient_ID": "TCGA.14.0812",
    "bcr_drug_barcode": "TCGA-14-0812-D25075",
    "bcr_drug_uuid": "daaeadab-1253-4a25-9955-d5d3c2bd9640",
    "form_completion_date": "2009-8-4",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFERS",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8
  },
  {
    "bcr_patient_uuid": "eff7f13b-ed32-4e85-a8d0-831b655d773f",
    "patient_ID": "TCGA.14.0812",
    "bcr_drug_barcode": "TCGA-14-0812-D25076",
    "bcr_drug_uuid": "efcb3681-d3d7-4126-8846-a5425cf96d4e",
    "form_completion_date": "2009-8-4",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "cb58b5fe-ee0d-46f1-8502-1c8bcf729f3b",
    "patient_ID": "TCGA.14.0813",
    "bcr_drug_barcode": "TCGA-14-0813-D25079",
    "bcr_drug_uuid": "03f5f468-22bf-43a1-9f77-bd2cc9017a28",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 41,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 16
  },
  {
    "bcr_patient_uuid": "5a86d9f1-d38d-4b78-9a23-c7855a20ca2d",
    "patient_ID": "TCGA.14.0817",
    "bcr_drug_barcode": "TCGA-14-0817-D25082",
    "bcr_drug_uuid": "b67f2d3e-c6bd-49e8-b816-5ea9a429e39e",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 15,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 176
  },
  {
    "bcr_patient_uuid": "31b21dcf-7e13-4522-8b34-a5eb6c0e5d1d",
    "patient_ID": "TCGA.14.0862",
    "bcr_drug_barcode": "TCGA-14-0862-D25260",
    "bcr_drug_uuid": "f837d61b-b4cd-4662-b4a4-8b5a2d044ee6",
    "form_completion_date": "2010-6-24",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7d5c3699-ce28-4129-8391-736f670e8beb",
    "patient_ID": "TCGA.14.0865",
    "bcr_drug_barcode": "TCGA-14-0865-D25086",
    "bcr_drug_uuid": "dc1c8dd3-d749-445e-b5b4-5ae0a52eb352",
    "form_completion_date": "2009-8-4",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "ADJUVANT AND PROGRESSION"
  },
  {
    "bcr_patient_uuid": "7d5c3699-ce28-4129-8391-736f670e8beb",
    "patient_ID": "TCGA.14.0865",
    "bcr_drug_barcode": "TCGA-14-0865-D25087",
    "bcr_drug_uuid": "57b0247a-48c4-4819-af9a-5db48d9712f4",
    "form_completion_date": "2009-8-4",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 205,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "7d5c3699-ce28-4129-8391-736f670e8beb",
    "patient_ID": "TCGA.14.0865",
    "bcr_drug_barcode": "TCGA-14-0865-D25085",
    "bcr_drug_uuid": "72832b4f-838a-4c6f-bafe-0da6f61161f0",
    "form_completion_date": "2009-8-4",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 9500
  },
  {
    "bcr_patient_uuid": "c3432b21-d2e9-4caf-9c8e-c6a8d92b195d",
    "patient_ID": "TCGA.14.0866",
    "bcr_drug_barcode": "TCGA-14-0866-D25092",
    "bcr_drug_uuid": "0e1d7b1b-7f15-43ee-b6e0-2072981abe83",
    "form_completion_date": "2009-9-1",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 325,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "ADJUVANT AND PROGRESSION",
    "drug_total_dose": 62415
  },
  {
    "bcr_patient_uuid": "c3432b21-d2e9-4caf-9c8e-c6a8d92b195d",
    "patient_ID": "TCGA.14.0866",
    "bcr_drug_barcode": "TCGA-14-0866-D25093",
    "bcr_drug_uuid": "db490c11-6d6f-40f4-ad4f-5cd2f31338fc",
    "form_completion_date": "2009-9-1",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "ADJUVANT AND PROGRESSION"
  },
  {
    "bcr_patient_uuid": "5c890137-e03c-4897-8af4-02aafa2fdb70",
    "patient_ID": "TCGA.14.0867",
    "bcr_drug_barcode": "TCGA-14-0867-D25097",
    "bcr_drug_uuid": "407fa4a7-c589-43e9-83e9-fb8d9312c09c",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 15,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 24
  },
  {
    "bcr_patient_uuid": "72f88d18-03be-4b51-9f4a-1151521b7292",
    "patient_ID": "TCGA.14.0871",
    "bcr_drug_barcode": "TCGA-14-0871-D25100",
    "bcr_drug_uuid": "0e5266b1-8bae-4167-bdcd-28e12c0d0637",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 281,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 288
  },
  {
    "bcr_patient_uuid": "0078b0c4-68a9-483b-9aab-61156d263213",
    "patient_ID": "TCGA.14.1034",
    "bcr_drug_barcode": "TCGA-14-1034-D25104",
    "bcr_drug_uuid": "481599a9-c1ab-4f91-948f-9cb624cfe760",
    "form_completion_date": "2009-6-18",
    "pharmaceutical_therapy_drug_name": "GLIADEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 448,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_route": "OTHER",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 8
  },
  {
    "bcr_patient_uuid": "0078b0c4-68a9-483b-9aab-61156d263213",
    "patient_ID": "TCGA.14.1034",
    "bcr_drug_barcode": "TCGA-14-1034-D25105",
    "bcr_drug_uuid": "1b9a44e0-77c7-4b67-b563-3959c50ee3a6",
    "form_completion_date": "2009-6-18",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0078b0c4-68a9-483b-9aab-61156d263213",
    "patient_ID": "TCGA.14.1034",
    "bcr_drug_barcode": "TCGA-14-1034-D25106",
    "bcr_drug_uuid": "0559b81b-1da8-4676-bc81-317d969df0d8",
    "form_completion_date": "2009-6-18",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 282,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "6a9d719d-249a-4756-adc8-e92fa60da229",
    "patient_ID": "TCGA.14.1037",
    "bcr_drug_barcode": "TCGA-14-1037-D25110",
    "bcr_drug_uuid": "5959163d-ba39-4460-b729-6e97ec9c9665",
    "form_completion_date": "2009-9-24",
    "pharmaceutical_therapy_drug_name": "OXALIPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 95,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "6a9d719d-249a-4756-adc8-e92fa60da229",
    "patient_ID": "TCGA.14.1037",
    "bcr_drug_barcode": "TCGA-14-1037-D25113",
    "bcr_drug_uuid": "651a26d2-4f94-440f-9b6a-becd3ea3c32b",
    "form_completion_date": "2009-9-24",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 326,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "6a9d719d-249a-4756-adc8-e92fa60da229",
    "patient_ID": "TCGA.14.1037",
    "bcr_drug_barcode": "TCGA-14-1037-D25114",
    "bcr_drug_uuid": "3a37ced8-55de-4546-b52b-dcad78ef1292",
    "form_completion_date": "2009-9-24",
    "pharmaceutical_therapy_drug_name": "PS 341",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 346,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 433,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 36.8
  },
  {
    "bcr_patient_uuid": "6a9d719d-249a-4756-adc8-e92fa60da229",
    "patient_ID": "TCGA.14.1037",
    "bcr_drug_barcode": "TCGA-14-1037-D25111",
    "bcr_drug_uuid": "8a78bfe4-b33a-4547-b155-2d3f7521511b",
    "form_completion_date": "2009-9-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 439,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 538,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 6000
  },
  {
    "bcr_patient_uuid": "6a9d719d-249a-4756-adc8-e92fa60da229",
    "patient_ID": "TCGA.14.1037",
    "bcr_drug_barcode": "TCGA-14-1037-D25112",
    "bcr_drug_uuid": "035a2a61-6b32-4764-8ee4-4b79ce2068fd",
    "form_completion_date": "2009-9-24",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASOME",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a6cda2a0-21d9-4b72-a4c5-de1142d7ddb8",
    "patient_ID": "TCGA.14.1043",
    "bcr_drug_barcode": "TCGA-14-1043-D25263",
    "bcr_drug_uuid": "4e61d7e2-a930-4d63-95a6-aacbb8207eb3",
    "form_completion_date": "2010-6-24",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "74331114-65b1-4697-abc4-4769ff377528",
    "patient_ID": "TCGA.14.1395",
    "bcr_drug_barcode": "TCGA-14-1395-D25268",
    "bcr_drug_uuid": "94673533-4398-4cca-9638-8e0e2a586706",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 41,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "74331114-65b1-4697-abc4-4769ff377528",
    "patient_ID": "TCGA.14.1395",
    "bcr_drug_barcode": "TCGA-14-1395-D25267",
    "bcr_drug_uuid": "3d56e39a-e1d0-42aa-afd9-a295597d2169",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "OXALIPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 28,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 679
  },
  {
    "bcr_patient_uuid": "aad2c954-39a4-4ef3-9940-e754619007a4",
    "patient_ID": "TCGA.14.1396",
    "bcr_drug_barcode": "TCGA-14-1396-D25118",
    "bcr_drug_uuid": "a4943fc9-ee68-46ea-8b2a-9c00c7500bcd",
    "form_completion_date": "2009-6-4",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "6176621d-8534-4fba-a0e7-74a5a78245a9",
    "patient_ID": "TCGA.14.1401",
    "bcr_drug_barcode": "TCGA-14-1401-D25121",
    "bcr_drug_uuid": "be419a3b-f37a-4ab5-b30d-61ea021bf0e6",
    "form_completion_date": "2009-6-4",
    "pharmaceutical_therapy_drug_name": "DEXAMETHSONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bf339349-062f-4ea9-a0b2-d87d3a21099e",
    "patient_ID": "TCGA.14.1402",
    "bcr_drug_barcode": "TCGA-14-1402-D25130",
    "bcr_drug_uuid": "80090a14-1345-4380-8b22-5f4fc05d7a5d",
    "form_completion_date": "2009-6-18",
    "pharmaceutical_therapy_drug_name": "SOVATENIB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 619,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 633,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 14000
  },
  {
    "bcr_patient_uuid": "bf339349-062f-4ea9-a0b2-d87d3a21099e",
    "patient_ID": "TCGA.14.1402",
    "bcr_drug_barcode": "TCGA-14-1402-D25131",
    "bcr_drug_uuid": "0d1c38bf-7c60-4fc2-9149-3c420c156104",
    "form_completion_date": "2009-6-18",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 659,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 832,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 11000
  },
  {
    "bcr_patient_uuid": "bf339349-062f-4ea9-a0b2-d87d3a21099e",
    "patient_ID": "TCGA.14.1402",
    "bcr_drug_barcode": "TCGA-14-1402-D25128",
    "bcr_drug_uuid": "132cdd53-5eb7-455e-a8d5-e2b3cfab2777",
    "form_completion_date": "2009-6-18",
    "pharmaceutical_therapy_drug_name": "PREDNISONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 316,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bf339349-062f-4ea9-a0b2-d87d3a21099e",
    "patient_ID": "TCGA.14.1402",
    "bcr_drug_barcode": "TCGA-14-1402-D25129",
    "bcr_drug_uuid": "79ffa9e0-b3bc-4ac0-befa-d05356efa51f",
    "form_completion_date": "2009-6-18",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 333,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "bf339349-062f-4ea9-a0b2-d87d3a21099e",
    "patient_ID": "TCGA.14.1402",
    "bcr_drug_barcode": "TCGA-14-1402-D25126",
    "bcr_drug_uuid": "c43bd7d3-1348-4e91-be1f-d66bd46b498e",
    "form_completion_date": "2009-6-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 659,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 832,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 4969
  },
  {
    "bcr_patient_uuid": "bf339349-062f-4ea9-a0b2-d87d3a21099e",
    "patient_ID": "TCGA.14.1402",
    "bcr_drug_barcode": "TCGA-14-1402-D25125",
    "bcr_drug_uuid": "b9b0a238-9a8f-4771-8e21-950bc8bbfe7c",
    "form_completion_date": "2009-6-18",
    "pharmaceutical_therapy_drug_name": "ARSENIC TRIOXIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 66,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 63
  },
  {
    "bcr_patient_uuid": "bf339349-062f-4ea9-a0b2-d87d3a21099e",
    "patient_ID": "TCGA.14.1402",
    "bcr_drug_barcode": "TCGA-14-1402-D25124",
    "bcr_drug_uuid": "50d9ad33-4de6-4c2a-bd24-0232c3a88065",
    "form_completion_date": "2009-6-18",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 344,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 529,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 9500
  },
  {
    "bcr_patient_uuid": "bf339349-062f-4ea9-a0b2-d87d3a21099e",
    "patient_ID": "TCGA.14.1402",
    "bcr_drug_barcode": "TCGA-14-1402-D25127",
    "bcr_drug_uuid": "98c55c34-612a-4d84-b7de-4deda9083cad",
    "form_completion_date": "2009-6-18",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 316,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f2ec3b94-cb92-4335-bdf9-02c046130bab",
    "patient_ID": "TCGA.14.1450",
    "bcr_drug_barcode": "TCGA-14-1450-D25271",
    "bcr_drug_uuid": "267353ea-784c-4e54-81c8-59ffbf029f67",
    "form_completion_date": "2010-6-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 65,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5160
  },
  {
    "bcr_patient_uuid": "f2ec3b94-cb92-4335-bdf9-02c046130bab",
    "patient_ID": "TCGA.14.1450",
    "bcr_drug_barcode": "TCGA-14-1450-D25272",
    "bcr_drug_uuid": "aab4da5f-682f-45b4-b2ae-c3b54ff29f11",
    "form_completion_date": "2010-6-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 127,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 961,
    "drug_cycles": 15,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 19450
  },
  {
    "bcr_patient_uuid": "f2ec3b94-cb92-4335-bdf9-02c046130bab",
    "patient_ID": "TCGA.14.1450",
    "bcr_drug_barcode": "TCGA-14-1450-D25274",
    "bcr_drug_uuid": "64f42684-0e2d-4d1b-aee8-02de9b860760",
    "form_completion_date": "2010-6-24",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 826,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "f2ec3b94-cb92-4335-bdf9-02c046130bab",
    "patient_ID": "TCGA.14.1450",
    "bcr_drug_barcode": "TCGA-14-1450-D25275",
    "bcr_drug_uuid": "5b5d48a7-0ce2-4999-bd68-7c532e641977",
    "form_completion_date": "2010-6-24",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1024,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1233,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 7800
  },
  {
    "bcr_patient_uuid": "f2ec3b94-cb92-4335-bdf9-02c046130bab",
    "patient_ID": "TCGA.14.1450",
    "bcr_drug_barcode": "TCGA-14-1450-D25273",
    "bcr_drug_uuid": "b300de81-feae-414d-911a-2a226c532909",
    "form_completion_date": "2010-6-24",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "06c427a1-8c2d-4003-b744-139114a04440",
    "patient_ID": "TCGA.14.1451",
    "bcr_drug_barcode": "TCGA-14-1451-D25136",
    "bcr_drug_uuid": "8a0dd3aa-91c8-49dd-8d30-99e4013e0a6d",
    "form_completion_date": "2009-9-1",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 59,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 101,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5880
  },
  {
    "bcr_patient_uuid": "06c427a1-8c2d-4003-b744-139114a04440",
    "patient_ID": "TCGA.14.1451",
    "bcr_drug_barcode": "TCGA-14-1451-D25135",
    "bcr_drug_uuid": "5a723aeb-fd73-4767-893b-81b9cdfe6a20",
    "form_completion_date": "2009-9-1",
    "pharmaceutical_therapy_drug_name": "OXALIPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 34,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 641
  },
  {
    "bcr_patient_uuid": "06c427a1-8c2d-4003-b744-139114a04440",
    "patient_ID": "TCGA.14.1451",
    "bcr_drug_barcode": "TCGA-14-1451-D25142",
    "bcr_drug_uuid": "7098c34d-95e8-4888-809e-16106791c34c",
    "form_completion_date": "2009-9-1",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "06c427a1-8c2d-4003-b744-139114a04440",
    "patient_ID": "TCGA.14.1451",
    "bcr_drug_barcode": "TCGA-14-1451-D25137",
    "bcr_drug_uuid": "d4f8aaaf-7484-46be-8ef5-551c6bc1d4e5",
    "form_completion_date": "2009-9-1",
    "pharmaceutical_therapy_drug_name": "GLIADEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 153,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_route": "OTHER",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 8
  },
  {
    "bcr_patient_uuid": "06c427a1-8c2d-4003-b744-139114a04440",
    "patient_ID": "TCGA.14.1451",
    "bcr_drug_barcode": "TCGA-14-1451-D25144",
    "bcr_drug_uuid": "8455c774-2b7d-48a7-981b-e32355952b07",
    "form_completion_date": "2009-9-1",
    "pharmaceutical_therapy_drug_name": "ERLOTINIB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 382,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 504,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 9000
  },
  {
    "bcr_patient_uuid": "06c427a1-8c2d-4003-b744-139114a04440",
    "patient_ID": "TCGA.14.1451",
    "bcr_drug_barcode": "TCGA-14-1451-D25138",
    "bcr_drug_uuid": "64107214-f1c0-4a37-a317-beffdbb5c893",
    "form_completion_date": "2009-9-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 411,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 480,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 780
  },
  {
    "bcr_patient_uuid": "06c427a1-8c2d-4003-b744-139114a04440",
    "patient_ID": "TCGA.14.1451",
    "bcr_drug_barcode": "TCGA-14-1451-D25141",
    "bcr_drug_uuid": "635bb303-629a-4498-9447-d853d11cbd6a",
    "form_completion_date": "2009-9-1",
    "pharmaceutical_therapy_drug_name": "BCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 501,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 566,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 720
  },
  {
    "bcr_patient_uuid": "06c427a1-8c2d-4003-b744-139114a04440",
    "patient_ID": "TCGA.14.1451",
    "bcr_drug_barcode": "TCGA-14-1451-D25143",
    "bcr_drug_uuid": "2ed70821-6738-4ab2-8489-8ec4634af692",
    "form_completion_date": "2009-9-1",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "06c427a1-8c2d-4003-b744-139114a04440",
    "patient_ID": "TCGA.14.1451",
    "bcr_drug_barcode": "TCGA-14-1451-D25139",
    "bcr_drug_uuid": "0ff96534-8ac4-4e82-ad17-5afd2a0a6c43",
    "form_completion_date": "2009-9-1",
    "pharmaceutical_therapy_drug_name": "VINCRISTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 411,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 480,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 8
  },
  {
    "bcr_patient_uuid": "06c427a1-8c2d-4003-b744-139114a04440",
    "patient_ID": "TCGA.14.1451",
    "bcr_drug_barcode": "TCGA-14-1451-D25140",
    "bcr_drug_uuid": "717c058e-3cde-4fb3-8de4-d71c1ecfbc20",
    "form_completion_date": "2009-9-1",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 411,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 480,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 780
  },
  {
    "bcr_patient_uuid": "f82bfa67-4e72-4a09-8022-a2fe0050090f",
    "patient_ID": "TCGA.14.1452",
    "bcr_drug_barcode": "TCGA-14-1452-D25151",
    "bcr_drug_uuid": "b8cf7105-d43c-43e0-be07-d80fc3624355",
    "form_completion_date": "2009-6-4",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 172,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 216,
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "ADJUVANT AND PROGRESSION"
  },
  {
    "bcr_patient_uuid": "f82bfa67-4e72-4a09-8022-a2fe0050090f",
    "patient_ID": "TCGA.14.1452",
    "bcr_drug_barcode": "TCGA-14-1452-D25149",
    "bcr_drug_uuid": "056a20e0-882c-4296-b3dd-3fe5f4473c9c",
    "form_completion_date": "2009-6-4",
    "pharmaceutical_therapy_drug_name": "TEMADOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 185,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "ADJUVANT AND PROGRESSION"
  },
  {
    "bcr_patient_uuid": "f82bfa67-4e72-4a09-8022-a2fe0050090f",
    "patient_ID": "TCGA.14.1452",
    "bcr_drug_barcode": "TCGA-14-1452-D25150",
    "bcr_drug_uuid": "fc581937-ec09-4b9a-8bbd-fae1140ac772",
    "form_completion_date": "2009-6-4",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f82bfa67-4e72-4a09-8022-a2fe0050090f",
    "patient_ID": "TCGA.14.1452",
    "bcr_drug_barcode": "TCGA-14-1452-D25148",
    "bcr_drug_uuid": "c46ea9ec-9719-4328-83b4-76478e9d987c",
    "form_completion_date": "2009-6-4",
    "pharmaceutical_therapy_drug_name": "GLIADEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8
  },
  {
    "bcr_patient_uuid": "a9597785-a1d3-4788-a431-d25d69025690",
    "patient_ID": "TCGA.14.1453",
    "bcr_drug_barcode": "TCGA-14-1453-D25155",
    "bcr_drug_uuid": "f6bcbe10-beb8-4e99-9919-de0a8e481690",
    "form_completion_date": "2009-6-4",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c2399f5d-dc29-42e9-81f1-1d164d4cc55d",
    "patient_ID": "TCGA.14.1454",
    "bcr_drug_barcode": "TCGA-14-1454-D25161",
    "bcr_drug_uuid": "9e7607d0-7f2f-4af3-937c-b544f1fac185",
    "form_completion_date": "2009-6-4",
    "pharmaceutical_therapy_drug_name": "HYDROXYUREA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 309,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 900,
    "drug_cycles": 18,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "c2399f5d-dc29-42e9-81f1-1d164d4cc55d",
    "patient_ID": "TCGA.14.1454",
    "bcr_drug_barcode": "TCGA-14-1454-D25159",
    "bcr_drug_uuid": "5d5b80f4-0959-4c73-b2ea-15710d63c4fd",
    "form_completion_date": "2009-6-4",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 235,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 15370
  },
  {
    "bcr_patient_uuid": "c2399f5d-dc29-42e9-81f1-1d164d4cc55d",
    "patient_ID": "TCGA.14.1454",
    "bcr_drug_barcode": "TCGA-14-1454-D25158",
    "bcr_drug_uuid": "4d123551-7e26-4274-9b1f-4f0a2a52c65b",
    "form_completion_date": "2009-6-4",
    "pharmaceutical_therapy_drug_name": "GLIADEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8
  },
  {
    "bcr_patient_uuid": "c2399f5d-dc29-42e9-81f1-1d164d4cc55d",
    "patient_ID": "TCGA.14.1454",
    "bcr_drug_barcode": "TCGA-14-1454-D25163",
    "bcr_drug_uuid": "26b6e536-2974-4765-9de7-866c5d2f919d",
    "form_completion_date": "2009-6-4",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 291,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "c2399f5d-dc29-42e9-81f1-1d164d4cc55d",
    "patient_ID": "TCGA.14.1454",
    "bcr_drug_barcode": "TCGA-14-1454-D25160",
    "bcr_drug_uuid": "b1aeba62-ae4a-4e78-98c4-763d7f496455",
    "form_completion_date": "2009-6-4",
    "pharmaceutical_therapy_drug_name": "GLEEVAC",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 309,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 900,
    "drug_cycles": 18,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "c2399f5d-dc29-42e9-81f1-1d164d4cc55d",
    "patient_ID": "TCGA.14.1454",
    "bcr_drug_barcode": "TCGA-14-1454-D25162",
    "bcr_drug_uuid": "c9c13316-6fcf-4444-9a2c-11453a167fb2",
    "form_completion_date": "2009-6-4",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "04b4ebb4-6780-42d8-a980-711cd10cfe14",
    "patient_ID": "TCGA.14.1455",
    "bcr_drug_barcode": "TCGA-14-1455-D25168",
    "bcr_drug_uuid": "7a1e2a51-d117-48fe-b2a5-e8d911f09812",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 28,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "04b4ebb4-6780-42d8-a980-711cd10cfe14",
    "patient_ID": "TCGA.14.1455",
    "bcr_drug_barcode": "TCGA-14-1455-D25167",
    "bcr_drug_uuid": "4b7d9d48-cc66-4756-b880-f9db54273088",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFER",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8
  },
  {
    "bcr_patient_uuid": "0fe6684a-5ab2-4999-b69d-d99aa5679c97",
    "patient_ID": "TCGA.14.1456",
    "bcr_drug_barcode": "TCGA-14-1456-D25171",
    "bcr_drug_uuid": "e7e06d7b-44bd-401d-8a20-70cff0e9b4fc",
    "form_completion_date": "2010-5-28",
    "pharmaceutical_therapy_drug_name": "ARSENIC TNOXIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70,
    "drug_cycles": 13,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 290.94
  },
  {
    "bcr_patient_uuid": "0fe6684a-5ab2-4999-b69d-d99aa5679c97",
    "patient_ID": "TCGA.14.1456",
    "bcr_drug_barcode": "TCGA-14-1456-D25173",
    "bcr_drug_uuid": "ad7bfeb2-d697-4a1e-870a-9b7aff74eacb",
    "form_completion_date": "2010-5-28",
    "pharmaceutical_therapy_drug_name": "DEXAMTHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "0fe6684a-5ab2-4999-b69d-d99aa5679c97",
    "patient_ID": "TCGA.14.1456",
    "bcr_drug_barcode": "TCGA-14-1456-D25175",
    "bcr_drug_uuid": "fbd2e658-a19f-42cc-a91f-8ee37d2451f5",
    "form_completion_date": "2010-5-28",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 549,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "0fe6684a-5ab2-4999-b69d-d99aa5679c97",
    "patient_ID": "TCGA.14.1456",
    "bcr_drug_barcode": "TCGA-14-1456-D25172",
    "bcr_drug_uuid": "24842149-423e-4afa-8fb2-36c79f9f3041",
    "form_completion_date": "2010-5-28",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0fe6684a-5ab2-4999-b69d-d99aa5679c97",
    "patient_ID": "TCGA.14.1456",
    "bcr_drug_barcode": "TCGA-14-1456-D25176",
    "bcr_drug_uuid": "c5f32374-290a-460d-b172-558dd6b9ccaf",
    "form_completion_date": "2010-5-28",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1129,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 1246,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3344
  },
  {
    "bcr_patient_uuid": "0fe6684a-5ab2-4999-b69d-d99aa5679c97",
    "patient_ID": "TCGA.14.1456",
    "bcr_drug_barcode": "TCGA-14-1456-D25174",
    "bcr_drug_uuid": "657bea6d-6fdc-4b59-a9eb-2a9d5fd704bb",
    "form_completion_date": "2010-5-28",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1128,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 11704
  },
  {
    "bcr_patient_uuid": "5d2487b9-e0cd-40fc-a158-7b1803c8dc88",
    "patient_ID": "TCGA.14.1458",
    "bcr_drug_barcode": "TCGA-14-1458-D25183",
    "bcr_drug_uuid": "c3b771dc-8898-4007-a4b3-4e0f11139bd8",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 81,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "5d2487b9-e0cd-40fc-a158-7b1803c8dc88",
    "patient_ID": "TCGA.14.1458",
    "bcr_drug_barcode": "TCGA-14-1458-D25182",
    "bcr_drug_uuid": "d777e33e-b425-44cf-a8e1-0c10862d2164",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "DEXAETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5d2487b9-e0cd-40fc-a158-7b1803c8dc88",
    "patient_ID": "TCGA.14.1458",
    "bcr_drug_barcode": "TCGA-14-1458-D25180",
    "bcr_drug_uuid": "0fb75b64-638f-4e15-99f4-f14e872ad34a",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 61,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8400
  },
  {
    "bcr_patient_uuid": "5d2487b9-e0cd-40fc-a158-7b1803c8dc88",
    "patient_ID": "TCGA.14.1458",
    "bcr_drug_barcode": "TCGA-14-1458-D25184",
    "bcr_drug_uuid": "c260921d-74dd-4f7f-83b8-855ce5d89b68",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10400
  },
  {
    "bcr_patient_uuid": "5d2487b9-e0cd-40fc-a158-7b1803c8dc88",
    "patient_ID": "TCGA.14.1458",
    "bcr_drug_barcode": "TCGA-14-1458-D25181",
    "bcr_drug_uuid": "45443fa9-2905-401d-ac82-a4e7b0437a53",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 83,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 6450
  },
  {
    "bcr_patient_uuid": "0798dbe2-1914-427c-a2fe-2a865d0d6eda",
    "patient_ID": "TCGA.14.1459",
    "bcr_drug_barcode": "TCGA-14-1459-D25190",
    "bcr_drug_uuid": "35ae9d89-ffc3-4aef-804f-60befa00a363",
    "form_completion_date": "2009-6-18",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "0798dbe2-1914-427c-a2fe-2a865d0d6eda",
    "patient_ID": "TCGA.14.1459",
    "bcr_drug_barcode": "TCGA-14-1459-D25189",
    "bcr_drug_uuid": "77ded3d0-e5c6-4d1e-b2fc-8ca615849d72",
    "form_completion_date": "2009-6-18",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0798dbe2-1914-427c-a2fe-2a865d0d6eda",
    "patient_ID": "TCGA.14.1459",
    "bcr_drug_barcode": "TCGA-14-1459-D25188",
    "bcr_drug_uuid": "37db2378-7803-4e64-a9f7-5a85ed041075",
    "form_completion_date": "2009-6-18",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 9000
  },
  {
    "bcr_patient_uuid": "eb9c8e66-6710-4141-ae28-1e5c88eaee47",
    "patient_ID": "TCGA.14.1794",
    "bcr_drug_barcode": "TCGA-14-1794-D25194",
    "bcr_drug_uuid": "6225f9b2-5bbc-4687-93e9-fad600edf8ac",
    "form_completion_date": "2009-8-4",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7db115ea-082b-45bb-97d2-4254270b8bb6",
    "patient_ID": "TCGA.14.1795",
    "bcr_drug_barcode": "TCGA-14-1795-D25199",
    "bcr_drug_uuid": "867e343c-b596-4161-9e35-a0e13eb00078",
    "form_completion_date": "2009-8-4",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 60,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7db115ea-082b-45bb-97d2-4254270b8bb6",
    "patient_ID": "TCGA.14.1795",
    "bcr_drug_barcode": "TCGA-14-1795-D25198",
    "bcr_drug_uuid": "20469a2e-398e-4c85-9e9b-0ef302b804df",
    "form_completion_date": "2009-8-4",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFER",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8
  },
  {
    "bcr_patient_uuid": "38dd826d-06dc-4a73-b852-c3d78c9c3ff4",
    "patient_ID": "TCGA.14.1821",
    "bcr_drug_barcode": "TCGA-14-1821-D25204",
    "bcr_drug_uuid": "f92eda1c-eb5b-4931-a78d-c67ed469b91b",
    "form_completion_date": "2009-9-1",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 331,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "38dd826d-06dc-4a73-b852-c3d78c9c3ff4",
    "patient_ID": "TCGA.14.1821",
    "bcr_drug_barcode": "TCGA-14-1821-D25203",
    "bcr_drug_uuid": "c3b96b1d-5927-4053-9d0c-643ec9d447e5",
    "form_completion_date": "2009-9-1",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "38dd826d-06dc-4a73-b852-c3d78c9c3ff4",
    "patient_ID": "TCGA.14.1821",
    "bcr_drug_barcode": "TCGA-14-1821-D25202",
    "bcr_drug_uuid": "5ba80971-a029-4f90-b541-362e9c41cdf0",
    "form_completion_date": "2009-9-1",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 69,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5400
  },
  {
    "bcr_patient_uuid": "a515cf2d-e918-4958-9bf6-e611b425a97e",
    "patient_ID": "TCGA.14.1823",
    "bcr_drug_barcode": "TCGA-14-1823-D25210",
    "bcr_drug_uuid": "cc7fead6-2362-4d18-8365-789dd481e745",
    "form_completion_date": "2009-9-1",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 450,
    "drug_cycles": 12,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "a515cf2d-e918-4958-9bf6-e611b425a97e",
    "patient_ID": "TCGA.14.1823",
    "bcr_drug_barcode": "TCGA-14-1823-D25212",
    "bcr_drug_uuid": "ddb76e62-002b-4cd0-ba5d-0a23fca25385",
    "form_completion_date": "2009-9-1",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 140,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "a515cf2d-e918-4958-9bf6-e611b425a97e",
    "patient_ID": "TCGA.14.1823",
    "bcr_drug_barcode": "TCGA-14-1823-D25211",
    "bcr_drug_uuid": "8aeb5e41-29fe-4927-b642-57a663284ce4",
    "form_completion_date": "2009-9-1",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a515cf2d-e918-4958-9bf6-e611b425a97e",
    "patient_ID": "TCGA.14.1823",
    "bcr_drug_barcode": "TCGA-14-1823-D25213",
    "bcr_drug_uuid": "013524ad-d67f-442b-9e30-786a97a0a844",
    "form_completion_date": "2009-9-1",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 378,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 478,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 6400
  },
  {
    "bcr_patient_uuid": "a515cf2d-e918-4958-9bf6-e611b425a97e",
    "patient_ID": "TCGA.14.1823",
    "bcr_drug_barcode": "TCGA-14-1823-D25209",
    "bcr_drug_uuid": "497f874d-9a15-4bba-a92c-5fb30dc5c8c5",
    "form_completion_date": "2009-9-1",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFERS",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8
  },
  {
    "bcr_patient_uuid": "a515cf2d-e918-4958-9bf6-e611b425a97e",
    "patient_ID": "TCGA.14.1823",
    "bcr_drug_barcode": "TCGA-14-1823-D25208",
    "bcr_drug_uuid": "ed86c9b7-dd08-4e44-8640-ab68b0cc5aac",
    "form_completion_date": "2009-9-1",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 450,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 11150
  },
  {
    "bcr_patient_uuid": "e0e1b5b3-6e3c-4b79-aa2a-32b320c3e45a",
    "patient_ID": "TCGA.14.1825",
    "bcr_drug_barcode": "TCGA-14-1825-D25218",
    "bcr_drug_uuid": "6cea8846-84fd-4280-9857-ad3448aa5721",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "e0e1b5b3-6e3c-4b79-aa2a-32b320c3e45a",
    "patient_ID": "TCGA.14.1825",
    "bcr_drug_barcode": "TCGA-14-1825-D25217",
    "bcr_drug_uuid": "68d713bb-3122-4dd6-9d84-95ed36649c8b",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "61ed8fbd-b753-451e-9683-edd4b266b0f3",
    "patient_ID": "TCGA.14.1827",
    "bcr_drug_barcode": "TCGA-14-1827-D25223",
    "bcr_drug_uuid": "c442e895-f214-41ab-a3c2-9659b3de3cd9",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "BCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 46,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "61ed8fbd-b753-451e-9683-edd4b266b0f3",
    "patient_ID": "TCGA.14.1827",
    "bcr_drug_barcode": "TCGA-14-1827-D25224",
    "bcr_drug_uuid": "761df7b6-6aef-46d2-8c2d-128e9cf76cc0",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "61ed8fbd-b753-451e-9683-edd4b266b0f3",
    "patient_ID": "TCGA.14.1827",
    "bcr_drug_barcode": "TCGA-14-1827-D25222",
    "bcr_drug_uuid": "7310a57a-0583-448c-bb6f-988c4a54a2b3",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 46,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "47a4161c-9c61-48f5-b9bc-a6d1acad4e5a",
    "patient_ID": "TCGA.14.1829",
    "bcr_drug_barcode": "TCGA-14-1829-D25227",
    "bcr_drug_uuid": "c10a50b8-82ee-4a71-8e50-167ffed274e9",
    "form_completion_date": "2009-9-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 10040
  },
  {
    "bcr_patient_uuid": "47a4161c-9c61-48f5-b9bc-a6d1acad4e5a",
    "patient_ID": "TCGA.14.1829",
    "bcr_drug_barcode": "TCGA-14-1829-D25228",
    "bcr_drug_uuid": "f8f4e4dc-4709-4604-8d62-a0dba0b985b6",
    "form_completion_date": "2009-9-24",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b1c4579c-72fa-4974-830c-b6a81ace45f4",
    "patient_ID": "TCGA.14.2554",
    "bcr_drug_barcode": "TCGA-14-2554-D25232",
    "bcr_drug_uuid": "bfc2a2aa-a7c2-4655-bdfa-33fcf7c67d4d",
    "form_completion_date": "2010-2-5",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5aa15b7f-35c7-4022-b1b2-74a4f6d3ea85",
    "patient_ID": "TCGA.14.2555",
    "bcr_drug_barcode": "TCGA-14-2555-D25236",
    "bcr_drug_uuid": "d8218c10-efee-45cf-8eea-846db9fa0344",
    "form_completion_date": "2010-5-11",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 242,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 12600
  },
  {
    "bcr_patient_uuid": "5aa15b7f-35c7-4022-b1b2-74a4f6d3ea85",
    "patient_ID": "TCGA.14.2555",
    "bcr_drug_barcode": "TCGA-14-2555-D25237",
    "bcr_drug_uuid": "d17bb6b6-d2b3-4bca-90a6-bc2800ffe5dc",
    "form_completion_date": "2010-5-11",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "872511fb-98cd-4fba-82f6-4c3689c75ae2",
    "patient_ID": "TCGA.14.3476",
    "bcr_drug_barcode": "TCGA-14-3476-D25241",
    "bcr_drug_uuid": "25c1218c-52a6-44e7-8615-aaa67959e335",
    "form_completion_date": "2010-7-12",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "60e47b7d-c664-46c0-ac13-db688d4b8a58",
    "patient_ID": "TCGA.14.3477",
    "bcr_drug_barcode": "TCGA-14-3477-D25245",
    "bcr_drug_uuid": "7bc687c3-8e74-4257-b92f-fbb03f27aac6",
    "form_completion_date": "2010-5-11",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "60e47b7d-c664-46c0-ac13-db688d4b8a58",
    "patient_ID": "TCGA.14.3477",
    "bcr_drug_barcode": "TCGA-14-3477-D25246",
    "bcr_drug_uuid": "cfef5cf5-f87f-47d5-9c2b-daedec621936",
    "form_completion_date": "2010-5-11",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1480
  },
  {
    "bcr_patient_uuid": "60e47b7d-c664-46c0-ac13-db688d4b8a58",
    "patient_ID": "TCGA.14.3477",
    "bcr_drug_barcode": "TCGA-14-3477-D25244",
    "bcr_drug_uuid": "e496775a-7f9e-4268-a03a-37fbac6adf30",
    "form_completion_date": "2010-5-11",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 67,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4480
  },
  {
    "bcr_patient_uuid": "38acdfc8-8abc-4d89-a68b-58c493650b48",
    "patient_ID": "TCGA.14.4157",
    "bcr_drug_barcode": "TCGA-14-4157-D25252",
    "bcr_drug_uuid": "90cabd44-8b4f-4c75-a5df-20af442aaf3e",
    "form_completion_date": "2010-7-12",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "38acdfc8-8abc-4d89-a68b-58c493650b48",
    "patient_ID": "TCGA.14.4157",
    "bcr_drug_barcode": "TCGA-14-4157-D25250",
    "bcr_drug_uuid": "c3e0e6df-f66f-479e-9cd2-1d7e3730919c",
    "form_completion_date": "2010-7-12",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 67,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "38acdfc8-8abc-4d89-a68b-58c493650b48",
    "patient_ID": "TCGA.14.4157",
    "bcr_drug_barcode": "TCGA-14-4157-D25251",
    "bcr_drug_uuid": "ee3325c2-5318-4dd7-8c21-098249464fdd",
    "form_completion_date": "2010-7-12",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 355
  },
  {
    "bcr_patient_uuid": "f19850cb-50c4-4f3a-ba80-b1464958ffa8",
    "patient_ID": "TCGA.15.0742",
    "bcr_drug_barcode": "TCGA-15-0742-D25280",
    "bcr_drug_uuid": "a8f06a13-5d95-484e-af93-7ca10c8c280d",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "SAHA",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 259,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 300,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "f19850cb-50c4-4f3a-ba80-b1464958ffa8",
    "patient_ID": "TCGA.15.0742",
    "bcr_drug_barcode": "TCGA-15-0742-D25279",
    "bcr_drug_uuid": "899b41e7-c294-4a04-92a4-9f0ee787a22f",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 59,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "4c42dc4e-66b7-40bf-9fbe-b92543248198",
    "patient_ID": "TCGA.15.1444",
    "bcr_drug_barcode": "TCGA-15-1444-D41928",
    "bcr_drug_uuid": "A7691528-3F1B-43A5-A3CC-994A237A391C",
    "form_completion_date": "2013-4-4",
    "pharmaceutical_therapy_drug_name": "BCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 72,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "4c42dc4e-66b7-40bf-9fbe-b92543248198",
    "patient_ID": "TCGA.15.1444",
    "bcr_drug_barcode": "TCGA-15-1444-D46090",
    "bcr_drug_uuid": "9A137468-4D2D-42E0-AAA8-076A86B46974",
    "form_completion_date": "2013-7-31",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 72,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "05d5da50-52fe-4342-9c15-9ee4c1d6662e",
    "patient_ID": "TCGA.15.1446",
    "bcr_drug_barcode": "TCGA-15-1446-D25284",
    "bcr_drug_uuid": "d98d9b83-5d4c-4629-9afc-bb51df4de4ea",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 280,
    "drug_cycles": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "03e9a354-7c95-4484-9ead-ed04acce7cb6",
    "patient_ID": "TCGA.15.1447",
    "bcr_drug_barcode": "TCGA-15-1447-D25290",
    "bcr_drug_uuid": "e1170fd5-43e8-4a6f-8b20-7e4f7db8106f",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 9,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 130,
    "drug_cycles": 2,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "03e9a354-7c95-4484-9ead-ed04acce7cb6",
    "patient_ID": "TCGA.15.1447",
    "bcr_drug_barcode": "TCGA-15-1447-D25289",
    "bcr_drug_uuid": "ce1dd0d5-8c93-4518-8dcb-1ff16640068b",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "BCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 9,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 130,
    "drug_cycles": 2,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "03e9a354-7c95-4484-9ead-ed04acce7cb6",
    "patient_ID": "TCGA.15.1447",
    "bcr_drug_barcode": "TCGA-15-1447-D25288",
    "bcr_drug_uuid": "d618cb6a-5390-4e65-9d86-fcc7d5be0737",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 9,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 130,
    "drug_cycles": 2,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2749c671-dee1-4d91-b3fa-4b50accf7a11",
    "patient_ID": "TCGA.15.1449",
    "bcr_drug_barcode": "TCGA-15-1449-D25294",
    "bcr_drug_uuid": "3e384279-b84a-4a41-b916-91c6b0233497",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 74,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f473a0d0-72b6-465e-93f7-122224960e80",
    "patient_ID": "TCGA.19.0955",
    "bcr_drug_barcode": "TCGA-19-0955-D25336",
    "bcr_drug_uuid": "26fd8e07-facd-4b36-a5b2-cbd20f8131b2",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 277,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 360
  },
  {
    "bcr_patient_uuid": "a589e2dc-7649-492c-9569-592698acaa6f",
    "patient_ID": "TCGA.19.0957",
    "bcr_drug_barcode": "TCGA-19-0957-D25342",
    "bcr_drug_uuid": "14ca8af8-9943-4c2d-b0ca-de8f24430edd",
    "form_completion_date": "2009-9-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 81,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "CONCURRENT",
    "drug_total_dose": 5880
  },
  {
    "bcr_patient_uuid": "a589e2dc-7649-492c-9569-592698acaa6f",
    "patient_ID": "TCGA.19.0957",
    "bcr_drug_barcode": "TCGA-19-0957-D25345",
    "bcr_drug_uuid": "360c973d-54ec-4d7d-8cdb-d3d5668ff31e",
    "form_completion_date": "2009-9-18",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 538,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 552,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1660
  },
  {
    "bcr_patient_uuid": "a589e2dc-7649-492c-9569-592698acaa6f",
    "patient_ID": "TCGA.19.0957",
    "bcr_drug_barcode": "TCGA-19-0957-D25348",
    "bcr_drug_uuid": "1850ca9d-14e8-42d8-955a-3c27864531e3",
    "form_completion_date": "2009-9-18",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 594,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 608,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 470
  },
  {
    "bcr_patient_uuid": "a589e2dc-7649-492c-9569-592698acaa6f",
    "patient_ID": "TCGA.19.0957",
    "bcr_drug_barcode": "TCGA-19-0957-D25341",
    "bcr_drug_uuid": "04d630b3-57ba-470a-8bed-10679de0cf64",
    "form_completion_date": "2009-9-18",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 566,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 580,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1660
  },
  {
    "bcr_patient_uuid": "a589e2dc-7649-492c-9569-592698acaa6f",
    "patient_ID": "TCGA.19.0957",
    "bcr_drug_barcode": "TCGA-19-0957-D25343",
    "bcr_drug_uuid": "24409f69-b2c5-43ac-88a7-0754faa77c84",
    "form_completion_date": "2009-9-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 120,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 273,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 9000
  },
  {
    "bcr_patient_uuid": "a589e2dc-7649-492c-9569-592698acaa6f",
    "patient_ID": "TCGA.19.0957",
    "bcr_drug_barcode": "TCGA-19-0957-D25347",
    "bcr_drug_uuid": "9c93da98-3825-4f5c-bbaa-14f56cc91754",
    "form_completion_date": "2009-9-18",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 594,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 608,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1660
  },
  {
    "bcr_patient_uuid": "a589e2dc-7649-492c-9569-592698acaa6f",
    "patient_ID": "TCGA.19.0957",
    "bcr_drug_barcode": "TCGA-19-0957-D25344",
    "bcr_drug_uuid": "6d8eb8d5-11fe-4242-a274-5d40ffd7e152",
    "form_completion_date": "2009-9-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 368,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 372,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1500
  },
  {
    "bcr_patient_uuid": "a589e2dc-7649-492c-9569-592698acaa6f",
    "patient_ID": "TCGA.19.0957",
    "bcr_drug_barcode": "TCGA-19-0957-D25346",
    "bcr_drug_uuid": "be2852c1-7820-410b-b8ef-905b166e6f62",
    "form_completion_date": "2009-9-18",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 538,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 552,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 470
  },
  {
    "bcr_patient_uuid": "37a47ea2-1daa-44a4-ade5-84d383c2b13c",
    "patient_ID": "TCGA.19.0960",
    "bcr_drug_barcode": "TCGA-19-0960-D25352",
    "bcr_drug_uuid": "b938861f-4bdc-4ea0-b0cf-a3fb1945bf28",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "163e93a7-4d8d-4f28-a9f6-4d0ed16630cd",
    "patient_ID": "TCGA.19.0963",
    "bcr_drug_barcode": "TCGA-19-0963-D25358",
    "bcr_drug_uuid": "96f4d7fa-78d9-4b37-a7db-055104bb6ea1",
    "form_completion_date": "2011-5-23",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 120,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5160
  },
  {
    "bcr_patient_uuid": "163e93a7-4d8d-4f28-a9f6-4d0ed16630cd",
    "patient_ID": "TCGA.19.0963",
    "bcr_drug_barcode": "TCGA-19-0963-D25359",
    "bcr_drug_uuid": "aef5b565-0635-4d4a-8b39-17171e573aff",
    "form_completion_date": "2011-5-23",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 129,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 270,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 260,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6500
  },
  {
    "bcr_patient_uuid": "746aa9fb-0af2-4719-9d48-56e9bf21260c",
    "patient_ID": "TCGA.19.0964",
    "bcr_drug_barcode": "TCGA-19-0964-D25363",
    "bcr_drug_uuid": "3d52a89f-8403-4463-965f-0141778e4c4b",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 82,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "a79b97df-d7f7-4df4-861b-936f94a1ab30",
    "patient_ID": "TCGA.19.1385",
    "bcr_drug_barcode": "TCGA-19-1385-D25367",
    "bcr_drug_uuid": "9e055320-82a9-46d5-8d65-5eaf85562740",
    "form_completion_date": "2009-9-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 93,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1600
  },
  {
    "bcr_patient_uuid": "a79b97df-d7f7-4df4-861b-936f94a1ab30",
    "patient_ID": "TCGA.19.1385",
    "bcr_drug_barcode": "TCGA-19-1385-D25368",
    "bcr_drug_uuid": "ed13e1a1-fa5d-4c8d-b02f-61d4a7821134",
    "form_completion_date": "2009-9-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 57,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "CONCURRENT",
    "drug_total_dose": 6300
  },
  {
    "bcr_patient_uuid": "fb86044c-161e-41d7-a49e-3d5ec18294ef",
    "patient_ID": "TCGA.19.1386",
    "bcr_drug_barcode": "TCGA-19-1386-D25374",
    "bcr_drug_uuid": "14955f76-9f30-4b23-afd7-f87bc7d0a5e7",
    "form_completion_date": "2009-9-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 93,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1500
  },
  {
    "bcr_patient_uuid": "fb86044c-161e-41d7-a49e-3d5ec18294ef",
    "patient_ID": "TCGA.19.1386",
    "bcr_drug_barcode": "TCGA-19-1386-D25372",
    "bcr_drug_uuid": "4022af6a-7755-4d96-9e5f-b344d5535609",
    "form_completion_date": "2009-9-18",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 230,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 236,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1050
  },
  {
    "bcr_patient_uuid": "fb86044c-161e-41d7-a49e-3d5ec18294ef",
    "patient_ID": "TCGA.19.1386",
    "bcr_drug_barcode": "TCGA-19-1386-D25375",
    "bcr_drug_uuid": "39301c45-4b69-469f-b8d1-283d326f9b87",
    "form_completion_date": "2009-9-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 142,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 234,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6000
  },
  {
    "bcr_patient_uuid": "fb86044c-161e-41d7-a49e-3d5ec18294ef",
    "patient_ID": "TCGA.19.1386",
    "bcr_drug_barcode": "TCGA-19-1386-D25376",
    "bcr_drug_uuid": "43d0e9ed-9b50-4d43-8947-28a56fc44214",
    "form_completion_date": "2009-9-18",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 216,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 229,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1800
  },
  {
    "bcr_patient_uuid": "fb86044c-161e-41d7-a49e-3d5ec18294ef",
    "patient_ID": "TCGA.19.1386",
    "bcr_drug_barcode": "TCGA-19-1386-D25373",
    "bcr_drug_uuid": "31dcf874-913a-43bb-8f61-89a333c12aa3",
    "form_completion_date": "2009-9-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 62,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5880
  },
  {
    "bcr_patient_uuid": "2f8b698a-cbd0-4cab-a814-dc683e0e9305",
    "patient_ID": "TCGA.19.1387",
    "bcr_drug_barcode": "TCGA-19-1387-D25380",
    "bcr_drug_uuid": "3877b4a8-5327-42fe-bdde-8b1d4625b419",
    "form_completion_date": "2009-9-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 58,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "CONCURRENT",
    "drug_total_dose": 5600
  },
  {
    "bcr_patient_uuid": "166e76db-ccd8-4760-a517-d2bc8937ea29",
    "patient_ID": "TCGA.19.1388",
    "bcr_drug_barcode": "TCGA-19-1388-D25386",
    "bcr_drug_uuid": "cf7374cb-a6a9-42f1-931c-954fc1816e9b",
    "form_completion_date": "2009-9-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 250,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "MAINTENANCE",
    "drug_total_dose": 9000
  },
  {
    "bcr_patient_uuid": "166e76db-ccd8-4760-a517-d2bc8937ea29",
    "patient_ID": "TCGA.19.1388",
    "bcr_drug_barcode": "TCGA-19-1388-D25387",
    "bcr_drug_uuid": "0fc6b81d-48d8-4452-a177-a2f6e0a00739",
    "form_completion_date": "2009-9-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 269,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 328,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 6000
  },
  {
    "bcr_patient_uuid": "166e76db-ccd8-4760-a517-d2bc8937ea29",
    "patient_ID": "TCGA.19.1388",
    "bcr_drug_barcode": "TCGA-19-1388-D25385",
    "bcr_drug_uuid": "0a9211ea-5201-497e-b0e7-2a5ada1265b0",
    "form_completion_date": "2009-9-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 63,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "CONCURRENT",
    "drug_total_dose": 6020
  },
  {
    "bcr_patient_uuid": "166e76db-ccd8-4760-a517-d2bc8937ea29",
    "patient_ID": "TCGA.19.1388",
    "bcr_drug_barcode": "TCGA-19-1388-D25384",
    "bcr_drug_uuid": "d543db84-0ece-4c38-88fc-808f302c136c",
    "form_completion_date": "2009-9-18",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 363,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 377,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1750
  },
  {
    "bcr_patient_uuid": "309005a2-93a8-4566-b8d3-6b9310144266",
    "patient_ID": "TCGA.19.1389",
    "bcr_drug_barcode": "TCGA-19-1389-D25391",
    "bcr_drug_uuid": "7ecb0132-2d24-46f6-bb0c-e7e5c02f164f",
    "form_completion_date": "2009-9-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 67,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "309005a2-93a8-4566-b8d3-6b9310144266",
    "patient_ID": "TCGA.19.1389",
    "bcr_drug_barcode": "TCGA-19-1389-D25393",
    "bcr_drug_uuid": "235380ac-cead-4233-b72a-4a3e8ce912ed",
    "form_completion_date": "2009-9-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 41,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2880
  },
  {
    "bcr_patient_uuid": "309005a2-93a8-4566-b8d3-6b9310144266",
    "patient_ID": "TCGA.19.1389",
    "bcr_drug_barcode": "TCGA-19-1389-D25392",
    "bcr_drug_uuid": "7eacf5b1-a361-4278-b6ff-9f1079b12195",
    "form_completion_date": "2009-9-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 20,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1980
  },
  {
    "bcr_patient_uuid": "456bcab3-165d-456f-94e3-f34f81a61d2e",
    "patient_ID": "TCGA.19.1787",
    "bcr_drug_barcode": "TCGA-19-1787-D25404",
    "bcr_drug_uuid": "2d3e555d-c826-4d8b-87c9-06c8fcabc165",
    "form_completion_date": "2010-8-31",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5880
  },
  {
    "bcr_patient_uuid": "456bcab3-165d-456f-94e3-f34f81a61d2e",
    "patient_ID": "TCGA.19.1787",
    "bcr_drug_barcode": "TCGA-19-1787-D25406",
    "bcr_drug_uuid": "d4937992-314a-42b9-921a-6d6e28f7fe4d",
    "form_completion_date": "2010-8-31",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 312,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 347,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 900
  },
  {
    "bcr_patient_uuid": "456bcab3-165d-456f-94e3-f34f81a61d2e",
    "patient_ID": "TCGA.19.1787",
    "bcr_drug_barcode": "TCGA-19-1787-D25407",
    "bcr_drug_uuid": "34552695-2d81-4bde-b1e8-e64618e270de",
    "form_completion_date": "2010-9-1",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5880
  },
  {
    "bcr_patient_uuid": "456bcab3-165d-456f-94e3-f34f81a61d2e",
    "patient_ID": "TCGA.19.1787",
    "bcr_drug_barcode": "TCGA-19-1787-D25405",
    "bcr_drug_uuid": "043b39cc-a8ba-48c0-b8c1-be1f39a79b57",
    "form_completion_date": "2010-8-31",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 264,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 280,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 9200
  },
  {
    "bcr_patient_uuid": "9a41f05b-19b1-4269-9997-4b59e378280c",
    "patient_ID": "TCGA.19.1788",
    "bcr_drug_barcode": "TCGA-19-1788-D25411",
    "bcr_drug_uuid": "6020fe07-bd82-42b4-b5e8-1e0a78bbe3dc",
    "form_completion_date": "2009-9-21",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 95,
    "drug_cycles": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3a56ef5c-9259-4cdc-905e-5fcf21dac09b",
    "patient_ID": "TCGA.19.1789",
    "bcr_drug_barcode": "TCGA-19-1789-D25415",
    "bcr_drug_uuid": "5b539549-8052-478a-ab35-55a0b95c5567",
    "form_completion_date": "2009-9-21",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 32,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 980
  },
  {
    "bcr_patient_uuid": "aeeaf19a-3b0d-4c79-a029-44642581f4d8",
    "patient_ID": "TCGA.19.1790",
    "bcr_drug_barcode": "TCGA-19-1790-D25419",
    "bcr_drug_uuid": "09a73d22-88d6-418e-9a82-bc80773c6f8c",
    "form_completion_date": "2010-6-7",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 66,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5880
  },
  {
    "bcr_patient_uuid": "f2de4316-026c-4c2d-b091-47bc0ec8612a",
    "patient_ID": "TCGA.19.2619",
    "bcr_drug_barcode": "TCGA-19-2619-D25426",
    "bcr_drug_uuid": "ba1a26d3-22c9-4f3b-b132-8b049a04c798",
    "form_completion_date": "2010-5-14",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 113,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 117,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 250,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1250
  },
  {
    "bcr_patient_uuid": "f2de4316-026c-4c2d-b091-47bc0ec8612a",
    "patient_ID": "TCGA.19.2619",
    "bcr_drug_barcode": "TCGA-19-2619-D25427",
    "bcr_drug_uuid": "ff015cdc-b5e4-47e7-9a29-c0e3ceb2e408",
    "form_completion_date": "2010-5-14",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 153,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 295,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 630,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 630
  },
  {
    "bcr_patient_uuid": "f2de4316-026c-4c2d-b091-47bc0ec8612a",
    "patient_ID": "TCGA.19.2619",
    "bcr_drug_barcode": "TCGA-19-2619-D25425",
    "bcr_drug_uuid": "7b0ae2f8-51aa-4c3f-a860-5b6b6763e6cd",
    "form_completion_date": "2010-5-14",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 125,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3625
  },
  {
    "bcr_patient_uuid": "352768f9-3ce1-419c-beef-6515c78f5d7a",
    "patient_ID": "TCGA.19.2620",
    "bcr_drug_barcode": "TCGA-19-2620-D25432",
    "bcr_drug_uuid": "b13b00a7-5216-4c87-a6dd-3acaf18dca53",
    "form_completion_date": "2010-5-12",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 51,
    "drug_cycles": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c01ae0ee-fa58-45d2-ac33-d7f64d053bbb",
    "patient_ID": "TCGA.19.2623",
    "bcr_drug_barcode": "TCGA-19-2623-D25438",
    "bcr_drug_uuid": "2f5f297f-99e8-423f-894b-44055a57b381",
    "form_completion_date": "2010-5-12",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 53,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4060
  },
  {
    "bcr_patient_uuid": "c01ae0ee-fa58-45d2-ac33-d7f64d053bbb",
    "patient_ID": "TCGA.19.2623",
    "bcr_drug_barcode": "TCGA-19-2623-D25440",
    "bcr_drug_uuid": "dc93a9f5-ba29-495a-80de-b93944c63ba1",
    "form_completion_date": "2010-5-12",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 240,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1200
  },
  {
    "bcr_patient_uuid": "c01ae0ee-fa58-45d2-ac33-d7f64d053bbb",
    "patient_ID": "TCGA.19.2623",
    "bcr_drug_barcode": "TCGA-19-2623-D25439",
    "bcr_drug_uuid": "6689f023-ff02-4b0c-aeaa-52e2f6356e5c",
    "form_completion_date": "2010-5-12",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 110,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 114,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 280,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1400
  },
  {
    "bcr_patient_uuid": "e17a6048-7a72-42c0-ad3f-97cbff02bc9f",
    "patient_ID": "TCGA.19.2629",
    "bcr_drug_barcode": "TCGA-19-2629-D25450",
    "bcr_drug_uuid": "37f44132-8d6e-4fac-a9f7-6b585818d149",
    "form_completion_date": "2010-5-12",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 148,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 198,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "e17a6048-7a72-42c0-ad3f-97cbff02bc9f",
    "patient_ID": "TCGA.19.2629",
    "bcr_drug_barcode": "TCGA-19-2629-D25448",
    "bcr_drug_uuid": "d04a8256-7480-48b0-9c5f-f9c2518a664b",
    "form_completion_date": "2010-5-12",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 69,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 180,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7560
  },
  {
    "bcr_patient_uuid": "e17a6048-7a72-42c0-ad3f-97cbff02bc9f",
    "patient_ID": "TCGA.19.2629",
    "bcr_drug_barcode": "TCGA-19-2629-D25449",
    "bcr_drug_uuid": "9984f16f-f51d-4442-b8a0-a062b31a3d7e",
    "form_completion_date": "2010-5-12",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 104,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 350,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3500
  },
  {
    "bcr_patient_uuid": "a262928c-e20a-4c02-8114-1227e05c43e1",
    "patient_ID": "TCGA.19.4065",
    "bcr_drug_barcode": "TCGA-19-4065-D25515",
    "bcr_drug_uuid": "76440094-05a1-44a1-9521-83116d548629",
    "form_completion_date": "2010-6-8",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 166,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 480,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2400
  },
  {
    "bcr_patient_uuid": "a262928c-e20a-4c02-8114-1227e05c43e1",
    "patient_ID": "TCGA.19.4065",
    "bcr_drug_barcode": "TCGA-19-4065-D25512",
    "bcr_drug_uuid": "51b3924b-67b9-4de7-bf7d-d4287a358898",
    "form_completion_date": "2010-6-8",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 180,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5400
  },
  {
    "bcr_patient_uuid": "a262928c-e20a-4c02-8114-1227e05c43e1",
    "patient_ID": "TCGA.19.4065",
    "bcr_drug_barcode": "TCGA-19-4065-D25514",
    "bcr_drug_uuid": "303c8d9e-20a9-4504-a4b7-54e01b834c49",
    "form_completion_date": "2010-6-8",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 360,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1800
  },
  {
    "bcr_patient_uuid": "a262928c-e20a-4c02-8114-1227e05c43e1",
    "patient_ID": "TCGA.19.4065",
    "bcr_drug_barcode": "TCGA-19-4065-D25513",
    "bcr_drug_uuid": "67c05236-39f1-4a0c-8767-f97ded3430df",
    "form_completion_date": "2010-6-8",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 89,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 180,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2160
  },
  {
    "bcr_patient_uuid": "ef646014-78a9-43af-b6fa-85fa288cd51b",
    "patient_ID": "TCGA.19.4068",
    "bcr_drug_barcode": "TCGA-19-4068-D25457",
    "bcr_drug_uuid": "fd73b404-953e-4f64-af37-6d0e7474032f",
    "form_completion_date": "2010-6-8",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 75,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 105,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1200
  },
  {
    "bcr_patient_uuid": "ef646014-78a9-43af-b6fa-85fa288cd51b",
    "patient_ID": "TCGA.19.4068",
    "bcr_drug_barcode": "TCGA-19-4068-D25458",
    "bcr_drug_uuid": "edc32b9c-63bc-400a-a291-cacfdb1fcbc9",
    "form_completion_date": "2010-6-8",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 83,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 109,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 105,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2835
  },
  {
    "bcr_patient_uuid": "ec56b685-022b-44b4-8051-d8bbbcc17ee0",
    "patient_ID": "TCGA.19.5950",
    "bcr_drug_barcode": "TCGA-19-5950-D25466",
    "bcr_drug_uuid": "e19dbcd6-12ea-40b2-b94f-2dcd77b09391",
    "form_completion_date": "2011-6-3",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6020
  },
  {
    "bcr_patient_uuid": "ec56b685-022b-44b4-8051-d8bbbcc17ee0",
    "patient_ID": "TCGA.19.5950",
    "bcr_drug_barcode": "TCGA-19-5950-D25467",
    "bcr_drug_uuid": "1d8af6d1-a953-4f5d-9b0c-9c657bcfa94a",
    "form_completion_date": "2011-6-3",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 106,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 270,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1350
  },
  {
    "bcr_patient_uuid": "ec56b685-022b-44b4-8051-d8bbbcc17ee0",
    "patient_ID": "TCGA.19.5950",
    "bcr_drug_barcode": "TCGA-19-5950-D25468",
    "bcr_drug_uuid": "6ef81d3d-16e6-4ad7-a863-8700da4d54fe",
    "form_completion_date": "2011-6-3",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 134,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 249,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 350,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8750
  },
  {
    "bcr_patient_uuid": "ec56b685-022b-44b4-8051-d8bbbcc17ee0",
    "patient_ID": "TCGA.19.5950",
    "bcr_drug_barcode": "TCGA-19-5950-D43162",
    "bcr_drug_uuid": "2C539CE1-CC3E-4905-8A17-AD6A9264C101",
    "form_completion_date": "2013-5-14",
    "pharmaceutical_therapy_drug_name": "GDC-0449",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 287,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 343,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "61e00782-b709-43b1-a164-ee7f89c867e4",
    "patient_ID": "TCGA.19.5951",
    "bcr_drug_barcode": "TCGA-19-5951-D25472",
    "bcr_drug_uuid": "2a6557e5-ff9c-46b4-877c-2ab3d48c943a",
    "form_completion_date": "2011-6-3",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 165,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6270
  },
  {
    "bcr_patient_uuid": "18e04edc-04a3-4d1c-b536-3797e1924f48",
    "patient_ID": "TCGA.19.5954",
    "bcr_drug_barcode": "TCGA-19-5954-D25479",
    "bcr_drug_uuid": "b9970d7e-6632-4f63-9919-9db3ad537cc8",
    "form_completion_date": "2011-6-3",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 75,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 135,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5805
  },
  {
    "bcr_patient_uuid": "18e04edc-04a3-4d1c-b536-3797e1924f48",
    "patient_ID": "TCGA.19.5954",
    "bcr_drug_barcode": "TCGA-19-5954-D25480",
    "bcr_drug_uuid": "ddfbee37-3f23-42bf-8af6-d618d9813169",
    "form_completion_date": "2011-6-3",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 270,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1350
  },
  {
    "bcr_patient_uuid": "7e70a318-3acc-42f3-8287-158a2199f0bc",
    "patient_ID": "TCGA.19.5956",
    "bcr_drug_barcode": "TCGA-19-5956-D25486",
    "bcr_drug_uuid": "0c8a9763-627b-4ea0-a1ce-4f8f81b0be43",
    "form_completion_date": "2011-6-3",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7e70a318-3acc-42f3-8287-158a2199f0bc",
    "patient_ID": "TCGA.19.5956",
    "bcr_drug_barcode": "TCGA-19-5956-D43173",
    "bcr_drug_uuid": "7D9F81E7-0165-42C9-843A-7D958DE2A177",
    "form_completion_date": "2013-5-14",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "7e70a318-3acc-42f3-8287-158a2199f0bc",
    "patient_ID": "TCGA.19.5956",
    "bcr_drug_barcode": "TCGA-19-5956-D43174",
    "bcr_drug_uuid": "69C3BFF8-BA08-408D-A17D-5DFEC97FD097",
    "form_completion_date": "2013-5-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 202,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 604,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "81622677-9742-40ea-ad60-5f9b2a624ea7",
    "patient_ID": "TCGA.19.5958",
    "bcr_drug_barcode": "TCGA-19-5958-D25494",
    "bcr_drug_uuid": "08c91128-f3c9-4081-9c92-f6bdbe7b1306",
    "form_completion_date": "2011-6-3",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 265,
    "drug_cycles": 15,
    "drug_units": "MG",
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "81622677-9742-40ea-ad60-5f9b2a624ea7",
    "patient_ID": "TCGA.19.5958",
    "bcr_drug_barcode": "TCGA-19-5958-D25491",
    "bcr_drug_uuid": "8082d031-c08e-4b0c-bc63-35c0b9d76cf9",
    "form_completion_date": "2011-6-3",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 80,
    "pharma_type_other": "DAILY FOR 42 DAYS",
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 145,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6090
  },
  {
    "bcr_patient_uuid": "81622677-9742-40ea-ad60-5f9b2a624ea7",
    "patient_ID": "TCGA.19.5958",
    "bcr_drug_barcode": "TCGA-19-5958-D25492",
    "bcr_drug_uuid": "c867cce3-42de-4a00-88f6-f963826b5179",
    "form_completion_date": "2011-6-3",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 248,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 11500
  },
  {
    "bcr_patient_uuid": "42e92d73-29eb-4508-a653-9b77f36021c0",
    "patient_ID": "TCGA.19.5959",
    "bcr_drug_barcode": "TCGA-19-5959-D25498",
    "bcr_drug_uuid": "ed8a260c-eb91-4795-a7a1-e60be7ac811d",
    "form_completion_date": "2011-6-3",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 73,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 88,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 125,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2125
  },
  {
    "bcr_patient_uuid": "42e92d73-29eb-4508-a653-9b77f36021c0",
    "patient_ID": "TCGA.19.5959",
    "bcr_drug_barcode": "TCGA-19-5959-D43168",
    "bcr_drug_uuid": "AF6F45E1-FED9-4D8B-A318-53B5C6B5AE09",
    "form_completion_date": "2013-5-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 131,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 290,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "42e92d73-29eb-4508-a653-9b77f36021c0",
    "patient_ID": "TCGA.19.5959",
    "bcr_drug_barcode": "TCGA-19-5959-D43170",
    "bcr_drug_uuid": "8A86EEA6-9502-49CD-8954-12E4EA3D373D",
    "form_completion_date": "2013-5-14",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 360,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 388,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "93ed7a2b-b0cb-4a84-871f-5c34a0b6a640",
    "patient_ID": "TCGA.19.5960",
    "bcr_drug_barcode": "TCGA-19-5960-D25504",
    "bcr_drug_uuid": "85a6db91-61ec-4dd6-a0de-f2942ae7d388",
    "form_completion_date": "2011-6-3",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 71,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 135,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5670
  },
  {
    "bcr_patient_uuid": "93ed7a2b-b0cb-4a84-871f-5c34a0b6a640",
    "patient_ID": "TCGA.19.5960",
    "bcr_drug_barcode": "TCGA-19-5960-D43339",
    "bcr_drug_uuid": "CF998836-C6A7-47AB-9E6F-37FB6C4AD0E8",
    "form_completion_date": "2013-5-17",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "93ed7a2b-b0cb-4a84-871f-5c34a0b6a640",
    "patient_ID": "TCGA.19.5960",
    "bcr_drug_barcode": "TCGA-19-5960-D43340",
    "bcr_drug_uuid": "43A79D6C-2827-4F1A-9617-E8914021F046",
    "form_completion_date": "2013-5-17",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D8628D35-C4C6-443F-9DA2-8517A157F137",
    "patient_ID": "TCGA.19.A60I",
    "bcr_drug_barcode": "TCGA-19-A60I-D44821",
    "bcr_drug_uuid": "15424BD5-F749-44D9-806C-95E202121030",
    "form_completion_date": "2013-6-27",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 114,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D8628D35-C4C6-443F-9DA2-8517A157F137",
    "patient_ID": "TCGA.19.A60I",
    "bcr_drug_barcode": "TCGA-19-A60I-D44871",
    "bcr_drug_uuid": "8EB69170-5175-4473-A351-7DC1414CE949",
    "form_completion_date": "2013-6-28",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 154,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7638E294-2DCF-4C03-B238-24E40491C2AD",
    "patient_ID": "TCGA.19.A6J5",
    "bcr_drug_barcode": "TCGA-19-A6J5-D48305",
    "bcr_drug_uuid": "C9D47DBD-E306-48C4-83A6-9492BAE51ED8",
    "form_completion_date": "2013-9-11",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 76,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7638E294-2DCF-4C03-B238-24E40491C2AD",
    "patient_ID": "TCGA.19.A6J5",
    "bcr_drug_barcode": "TCGA-19-A6J5-D48502",
    "bcr_drug_uuid": "49415F3D-B8E2-4FBB-A06A-5FF03071921B",
    "form_completion_date": "2013-9-16",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 658,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7638E294-2DCF-4C03-B238-24E40491C2AD",
    "patient_ID": "TCGA.19.A6J5",
    "bcr_drug_barcode": "TCGA-19-A6J5-D64481",
    "bcr_drug_uuid": "00822EDC-0A9A-4288-AB7F-B03AB3F60B28",
    "form_completion_date": "2014-9-3",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 812,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7638E294-2DCF-4C03-B238-24E40491C2AD",
    "patient_ID": "TCGA.19.A6J5",
    "bcr_drug_barcode": "TCGA-19-A6J5-D64482",
    "bcr_drug_uuid": "CD363BD7-A6B2-4B9A-9834-33B2A740DEE6",
    "form_completion_date": "2014-9-3",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 847,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "17dffffc-65d6-4209-9075-18a441001f0f",
    "patient_ID": "TCGA.26.1438",
    "bcr_drug_barcode": "TCGA-26-1438-D26848",
    "bcr_drug_uuid": "d5375217-87b8-4f00-8918-a2d0ae61d11a",
    "form_completion_date": "2009-5-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 104,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 206,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1440
  },
  {
    "bcr_patient_uuid": "17dffffc-65d6-4209-9075-18a441001f0f",
    "patient_ID": "TCGA.26.1438",
    "bcr_drug_barcode": "TCGA-26-1438-D26847",
    "bcr_drug_uuid": "9468f9ce-e4ca-4912-bd29-62aa4aa7a54a",
    "form_completion_date": "2009-5-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 73,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5670
  },
  {
    "bcr_patient_uuid": "17dffffc-65d6-4209-9075-18a441001f0f",
    "patient_ID": "TCGA.26.1438",
    "bcr_drug_barcode": "TCGA-26-1438-D26849",
    "bcr_drug_uuid": "253b07f7-62de-48e3-992c-f928fafdeed6",
    "form_completion_date": "2009-6-23",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 221,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 221,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 210
  },
  {
    "bcr_patient_uuid": "17dffffc-65d6-4209-9075-18a441001f0f",
    "patient_ID": "TCGA.26.1438",
    "bcr_drug_barcode": "TCGA-26-1438-D26850",
    "bcr_drug_uuid": "2e35b72c-97ad-4a1c-a6c0-621811f07537",
    "form_completion_date": "2009-6-23",
    "pharmaceutical_therapy_drug_name": "RECENTIN PLACEBO AXDX2171",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 221,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 264,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 880
  },
  {
    "bcr_patient_uuid": "a6312802-12ad-4545-8109-178a7ebd618f",
    "patient_ID": "TCGA.26.1439",
    "bcr_drug_barcode": "TCGA-26-1439-D26854",
    "bcr_drug_uuid": "e3bf77a2-3cab-4e49-9e27-4946fb333045",
    "form_completion_date": "2010-12-27",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 81,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9b775a6a-242a-4bfa-818d-d2d2f5bac5bf",
    "patient_ID": "TCGA.26.1440",
    "bcr_drug_barcode": "TCGA-26-1440-D26859",
    "bcr_drug_uuid": "30692c50-0aa5-4a53-a481-a90e8a55041a",
    "form_completion_date": "2009-6-23",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 108,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3140
  },
  {
    "bcr_patient_uuid": "9b775a6a-242a-4bfa-818d-d2d2f5bac5bf",
    "patient_ID": "TCGA.26.1440",
    "bcr_drug_barcode": "TCGA-26-1440-D26858",
    "bcr_drug_uuid": "f9969583-7be7-4bfe-a5d8-8259ab6ac89f",
    "form_completion_date": "2009-6-23",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 78,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6300
  },
  {
    "bcr_patient_uuid": "c29d73c0-c885-4105-bf74-38e9178e71c9",
    "patient_ID": "TCGA.26.1442",
    "bcr_drug_barcode": "TCGA-26-1442-D26892",
    "bcr_drug_uuid": "39900ada-9a3e-45a4-9018-cf057212934e",
    "form_completion_date": "2011-7-5",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 872,
    "drug_cycles": 27,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 27000
  },
  {
    "bcr_patient_uuid": "c29d73c0-c885-4105-bf74-38e9178e71c9",
    "patient_ID": "TCGA.26.1442",
    "bcr_drug_barcode": "TCGA-26-1442-D26890",
    "bcr_drug_uuid": "31bf12a2-9754-4572-b3de-dae983256b6b",
    "form_completion_date": "2011-7-5",
    "pharmaceutical_therapy_drug_name": "MOTEXAFIN GADOLINIUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 66,
    "drug_cycles": 22,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 340,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7480
  },
  {
    "bcr_patient_uuid": "c29d73c0-c885-4105-bf74-38e9178e71c9",
    "patient_ID": "TCGA.26.1442",
    "bcr_drug_barcode": "TCGA-26-1442-D26891",
    "bcr_drug_uuid": "92b35e00-e3e3-494a-90c0-161c572ef50f",
    "form_completion_date": "2011-7-5",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 66,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5600
  },
  {
    "bcr_patient_uuid": "e4aafd82-fd32-4a52-96fe-21a21297849f",
    "patient_ID": "TCGA.26.1443",
    "bcr_drug_barcode": "TCGA-26-1443-D26863",
    "bcr_drug_uuid": "abf596c4-01e5-4504-b968-c8e46cccfa22",
    "form_completion_date": "2009-6-23",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 79,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5460
  },
  {
    "bcr_patient_uuid": "e4aafd82-fd32-4a52-96fe-21a21297849f",
    "patient_ID": "TCGA.26.1443",
    "bcr_drug_barcode": "TCGA-26-1443-D26864",
    "bcr_drug_uuid": "d626d73e-12b3-4068-9fee-63e593bfa0ef",
    "form_completion_date": "2009-6-23",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 195,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 915
  },
  {
    "bcr_patient_uuid": "ff61d536-b505-47e7-9d3c-a7252e9037a1",
    "patient_ID": "TCGA.26.1799",
    "bcr_drug_barcode": "TCGA-26-1799-D26868",
    "bcr_drug_uuid": "6dc20c0b-09c1-4ee2-a72d-b544f2e4b7ad",
    "form_completion_date": "2009-9-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4150
  },
  {
    "bcr_patient_uuid": "2c5fa2d4-8e35-42e4-8bca-9fb3371a19c8",
    "patient_ID": "TCGA.26.5132",
    "bcr_drug_barcode": "TCGA-26-5132-D26873",
    "bcr_drug_uuid": "1aa188e4-092a-44cf-996c-22c274586bc8",
    "form_completion_date": "2010-12-21",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 205,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 205,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "2c5fa2d4-8e35-42e4-8bca-9fb3371a19c8",
    "patient_ID": "TCGA.26.5132",
    "bcr_drug_barcode": "TCGA-26-5132-D26872",
    "bcr_drug_uuid": "b05ec676-af92-4bc5-948f-26834129de35",
    "form_completion_date": "2010-12-21",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 83,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4620
  },
  {
    "bcr_patient_uuid": "a28b256e-e085-467d-bdba-5c39718012d7",
    "patient_ID": "TCGA.26.5133",
    "bcr_drug_barcode": "TCGA-26-5133-D26878",
    "bcr_drug_uuid": "b8390c6f-deba-4a86-81c3-0a7207035d67",
    "form_completion_date": "2010-12-21",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 116,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 120,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 750
  },
  {
    "bcr_patient_uuid": "a28b256e-e085-467d-bdba-5c39718012d7",
    "patient_ID": "TCGA.26.5133",
    "bcr_drug_barcode": "TCGA-26-5133-D26877",
    "bcr_drug_uuid": "77720aaf-5891-415c-951f-7c746b28074e",
    "form_completion_date": "2010-12-21",
    "pharmaceutical_therapy_drug_name": "TEMOZOLAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 68,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3300
  },
  {
    "bcr_patient_uuid": "a28b256e-e085-467d-bdba-5c39718012d7",
    "patient_ID": "TCGA.26.5133",
    "bcr_drug_barcode": "TCGA-26-5133-D26879",
    "bcr_drug_uuid": "54671333-2c7a-4090-8642-777a9ea17783",
    "form_completion_date": "2010-12-21",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 144,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 351,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8000
  },
  {
    "bcr_patient_uuid": "60e69f41-571e-4a1b-ae75-9d49eed620ca",
    "patient_ID": "TCGA.26.6173",
    "bcr_drug_barcode": "TCGA-26-6173-D26897",
    "bcr_drug_uuid": "91c193e3-82fa-487c-856a-70690b7ab426",
    "form_completion_date": "2011-5-2",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70,
    "drug_cycles": 75,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2250
  },
  {
    "bcr_patient_uuid": "60e69f41-571e-4a1b-ae75-9d49eed620ca",
    "patient_ID": "TCGA.26.6173",
    "bcr_drug_barcode": "TCGA-26-6173-D26898",
    "bcr_drug_uuid": "3b71ed9a-67f0-4f73-aa77-8b327be6efd3",
    "form_completion_date": "2011-5-2",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 105,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 750
  },
  {
    "bcr_patient_uuid": "60e69f41-571e-4a1b-ae75-9d49eed620ca",
    "patient_ID": "TCGA.26.6173",
    "bcr_drug_barcode": "TCGA-26-6173-D26899",
    "bcr_drug_uuid": "f4a3cae0-1e06-41bc-80e7-685fba3d5c2c",
    "form_completion_date": "2011-5-2",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 129,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 245,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1000
  },
  {
    "bcr_patient_uuid": "60e69f41-571e-4a1b-ae75-9d49eed620ca",
    "patient_ID": "TCGA.26.6173",
    "bcr_drug_barcode": "TCGA-26-6173-D26896",
    "bcr_drug_uuid": "5f5f67b2-0d94-4150-8c99-7b70d5510dda",
    "form_completion_date": "2011-5-2",
    "pharmaceutical_therapy_drug_name": "CILENGITIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 30,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 4000,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 120000
  },
  {
    "bcr_patient_uuid": "4b606edf-07fc-4665-a7cd-a794004e5aca",
    "patient_ID": "TCGA.26.6174",
    "bcr_drug_barcode": "TCGA-26-6174-D26903",
    "bcr_drug_uuid": "a2dd9e71-1aff-463d-9eea-2c9ff3eeb9ff",
    "form_completion_date": "2011-5-2",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 66,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2850
  },
  {
    "bcr_patient_uuid": "5F9BAF9B-6D2D-495A-83A1-77F7E4CB9CCD",
    "patient_ID": "TCGA.26.A7UX",
    "bcr_drug_barcode": "TCGA-26-A7UX-D65038",
    "bcr_drug_uuid": "24F3A9ED-5D77-4562-8F8C-6E50E2ED3B6B",
    "form_completion_date": "2014-9-18",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 235,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5F9BAF9B-6D2D-495A-83A1-77F7E4CB9CCD",
    "patient_ID": "TCGA.26.A7UX",
    "bcr_drug_barcode": "TCGA-26-A7UX-D68867",
    "bcr_drug_uuid": "409EEF90-A050-4B3A-8ECC-0247DF4E9D26",
    "form_completion_date": "2014-12-22",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 511,
    "pharmaceutical_tx_ongoing_indicator": true,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5F9BAF9B-6D2D-495A-83A1-77F7E4CB9CCD",
    "patient_ID": "TCGA.26.A7UX",
    "bcr_drug_barcode": "TCGA-26-A7UX-D68868",
    "bcr_drug_uuid": "8876CD9B-D87F-4DA0-9B31-50D6F7CEEB4F",
    "form_completion_date": "2014-12-22",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 511,
    "pharmaceutical_tx_ongoing_indicator": true,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6e72d2e2-96fe-4fbb-9fe6-39ec28753eb6",
    "patient_ID": "TCGA.27.1830",
    "bcr_drug_barcode": "TCGA-27-1830-D26907",
    "bcr_drug_uuid": "d7b406d6-5e84-4b17-8abb-e5e35d5163fe",
    "form_completion_date": "2009-10-2",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 86,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 420
  },
  {
    "bcr_patient_uuid": "6e72d2e2-96fe-4fbb-9fe6-39ec28753eb6",
    "patient_ID": "TCGA.27.1830",
    "bcr_drug_barcode": "TCGA-27-1830-D26909",
    "bcr_drug_uuid": "5b5b9f37-57e0-4e38-a80e-09074f499715",
    "form_completion_date": "2009-10-2",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": -1,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4
  },
  {
    "bcr_patient_uuid": "6e72d2e2-96fe-4fbb-9fe6-39ec28753eb6",
    "patient_ID": "TCGA.27.1830",
    "bcr_drug_barcode": "TCGA-27-1830-D26908",
    "bcr_drug_uuid": "bb31a0d1-b24d-4427-b42f-5ad87f384959",
    "form_completion_date": "2009-10-2",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 86,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3750
  },
  {
    "bcr_patient_uuid": "f45f4a30-6b4c-4f15-9140-959d6a25a45f",
    "patient_ID": "TCGA.27.1831",
    "bcr_drug_barcode": "TCGA-27-1831-D26914",
    "bcr_drug_uuid": "497fd61d-6918-4ad8-8ed0-cb9b70dc2711",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 4,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 420
  },
  {
    "bcr_patient_uuid": "f45f4a30-6b4c-4f15-9140-959d6a25a45f",
    "patient_ID": "TCGA.27.1831",
    "bcr_drug_barcode": "TCGA-27-1831-D26917",
    "bcr_drug_uuid": "d2f5a955-3a99-4b88-8d08-0e8bc0de67cf",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "OXCARBAZEPINE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": -8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 505,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 307800
  },
  {
    "bcr_patient_uuid": "f45f4a30-6b4c-4f15-9140-959d6a25a45f",
    "patient_ID": "TCGA.27.1831",
    "bcr_drug_barcode": "TCGA-27-1831-D26916",
    "bcr_drug_uuid": "c13e764e-0f29-4f9d-ae69-59c18b788d10",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": -8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 505,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 8,
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4104
  },
  {
    "bcr_patient_uuid": "f45f4a30-6b4c-4f15-9140-959d6a25a45f",
    "patient_ID": "TCGA.27.1831",
    "bcr_drug_barcode": "TCGA-27-1831-D26915",
    "bcr_drug_uuid": "59c66bff-d29b-401e-9638-7f600ac4d629",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 103,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3400
  },
  {
    "bcr_patient_uuid": "dd76930a-1678-4b70-9864-730534174d41",
    "patient_ID": "TCGA.27.1832",
    "bcr_drug_barcode": "TCGA-27-1832-D26922",
    "bcr_drug_uuid": "51f6e02f-ae84-4db3-8db6-d541fe241ba2",
    "form_completion_date": "2009-10-2",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 207,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 207,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1200
  },
  {
    "bcr_patient_uuid": "dd76930a-1678-4b70-9864-730534174d41",
    "patient_ID": "TCGA.27.1832",
    "bcr_drug_barcode": "TCGA-27-1832-D26921",
    "bcr_drug_uuid": "f341ad9e-47e3-4d8b-8ea7-fa1b2172b296",
    "form_completion_date": "2009-10-2",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 207,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "dd76930a-1678-4b70-9864-730534174d41",
    "patient_ID": "TCGA.27.1832",
    "bcr_drug_barcode": "TCGA-27-1832-D26923",
    "bcr_drug_uuid": "a5790756-374e-419e-ba5e-c3bfde4ff05b",
    "form_completion_date": "2009-10-2",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 300,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8
  },
  {
    "bcr_patient_uuid": "f40e45c8-2042-4844-99b5-b629f20afd58",
    "patient_ID": "TCGA.27.1833",
    "bcr_drug_barcode": "TCGA-27-1833-D26930",
    "bcr_drug_uuid": "ca5f3895-331f-48f0-80bd-468417a80ba9",
    "form_completion_date": "2009-10-2",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 171,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 725,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1300
  },
  {
    "bcr_patient_uuid": "f40e45c8-2042-4844-99b5-b629f20afd58",
    "patient_ID": "TCGA.27.1833",
    "bcr_drug_barcode": "TCGA-27-1833-D26928",
    "bcr_drug_uuid": "ce3f62ad-32b5-4bd6-a17e-966e76673f47",
    "form_completion_date": "2009-10-2",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 171,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 596,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3500
  },
  {
    "bcr_patient_uuid": "f40e45c8-2042-4844-99b5-b629f20afd58",
    "patient_ID": "TCGA.27.1833",
    "bcr_drug_barcode": "TCGA-27-1833-D26927",
    "bcr_drug_uuid": "1912f605-8108-419c-a157-771459774202",
    "form_completion_date": "2009-10-2",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 171,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 596,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 320
  },
  {
    "bcr_patient_uuid": "f40e45c8-2042-4844-99b5-b629f20afd58",
    "patient_ID": "TCGA.27.1833",
    "bcr_drug_barcode": "TCGA-27-1833-D26931",
    "bcr_drug_uuid": "3f8d12fa-7717-4de5-a369-69ad985f311a",
    "form_completion_date": "2009-10-2",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": -6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 737,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8
  },
  {
    "bcr_patient_uuid": "f40e45c8-2042-4844-99b5-b629f20afd58",
    "patient_ID": "TCGA.27.1833",
    "bcr_drug_barcode": "TCGA-27-1833-D26929",
    "bcr_drug_uuid": "787400d2-0959-4e3d-937b-cf74836feab1",
    "form_completion_date": "2009-10-2",
    "pharmaceutical_therapy_drug_name": "FOTEMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 171,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 359,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 208
  },
  {
    "bcr_patient_uuid": "7340f325-579f-4b90-96aa-3a7b362129ca",
    "patient_ID": "TCGA.27.1834",
    "bcr_drug_barcode": "TCGA-27-1834-D26936",
    "bcr_drug_uuid": "a325e73e-bc7e-45dc-ad3d-1350266bad6b",
    "form_completion_date": "2009-10-2",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 352,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 662,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 35000
  },
  {
    "bcr_patient_uuid": "7340f325-579f-4b90-96aa-3a7b362129ca",
    "patient_ID": "TCGA.27.1834",
    "bcr_drug_barcode": "TCGA-27-1834-D26939",
    "bcr_drug_uuid": "e168251a-0405-4dd9-bf97-2f229c557e15",
    "form_completion_date": "2009-10-2",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 168,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 320
  },
  {
    "bcr_patient_uuid": "7340f325-579f-4b90-96aa-3a7b362129ca",
    "patient_ID": "TCGA.27.1834",
    "bcr_drug_barcode": "TCGA-27-1834-D26935",
    "bcr_drug_uuid": "7747c480-15aa-44c1-88b7-df4598f08265",
    "form_completion_date": "2009-10-2",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 352,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 540,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1248
  },
  {
    "bcr_patient_uuid": "7340f325-579f-4b90-96aa-3a7b362129ca",
    "patient_ID": "TCGA.27.1834",
    "bcr_drug_barcode": "TCGA-27-1834-D26937",
    "bcr_drug_uuid": "f5afb153-8271-4de4-9f6b-a125ea422890",
    "form_completion_date": "2009-10-2",
    "pharmaceutical_therapy_drug_name": "FOTEMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 352,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 540,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1200
  },
  {
    "bcr_patient_uuid": "7340f325-579f-4b90-96aa-3a7b362129ca",
    "patient_ID": "TCGA.27.1834",
    "bcr_drug_barcode": "TCGA-27-1834-D26938",
    "bcr_drug_uuid": "3510fe07-111c-44ce-8413-c36dc1889288",
    "form_completion_date": "2009-10-2",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMOIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 168,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6250
  },
  {
    "bcr_patient_uuid": "7340f325-579f-4b90-96aa-3a7b362129ca",
    "patient_ID": "TCGA.27.1834",
    "bcr_drug_barcode": "TCGA-27-1834-D26940",
    "bcr_drug_uuid": "f14698b7-373a-4b42-b9e1-b5bf4745cab5",
    "form_completion_date": "2009-10-2",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": -5,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1233,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7302
  },
  {
    "bcr_patient_uuid": "987cb702-057b-4198-8ef3-9cf6a9c51989",
    "patient_ID": "TCGA.27.1835",
    "bcr_drug_barcode": "TCGA-27-1835-D26945",
    "bcr_drug_uuid": "8426a3d9-288d-432e-b448-7eaecfe12626",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 4,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 158,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 300,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4300
  },
  {
    "bcr_patient_uuid": "987cb702-057b-4198-8ef3-9cf6a9c51989",
    "patient_ID": "TCGA.27.1835",
    "bcr_drug_barcode": "TCGA-27-1835-D26944",
    "bcr_drug_uuid": "f1d3d501-cabb-4bea-9c8f-673c26863c84",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "987cb702-057b-4198-8ef3-9cf6a9c51989",
    "patient_ID": "TCGA.27.1835",
    "bcr_drug_barcode": "TCGA-27-1835-D26950",
    "bcr_drug_uuid": "9ec3beba-e9f2-4f33-abd9-c2ecb0f1a5f3",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": -7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 648,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1308
  },
  {
    "bcr_patient_uuid": "987cb702-057b-4198-8ef3-9cf6a9c51989",
    "patient_ID": "TCGA.27.1835",
    "bcr_drug_barcode": "TCGA-27-1835-D26946",
    "bcr_drug_uuid": "02ec0fdd-25af-40c8-b76b-6164c9a8bfa9",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "PC2",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 206,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 462,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 300,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 8400
  },
  {
    "bcr_patient_uuid": "987cb702-057b-4198-8ef3-9cf6a9c51989",
    "patient_ID": "TCGA.27.1835",
    "bcr_drug_barcode": "TCGA-27-1835-D26949",
    "bcr_drug_uuid": "05abfffd-767d-4c6c-a5b7-2527ba635c94",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "LEVETIRACETAM",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": -7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 648,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1000,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 654000
  },
  {
    "bcr_patient_uuid": "987cb702-057b-4198-8ef3-9cf6a9c51989",
    "patient_ID": "TCGA.27.1835",
    "bcr_drug_barcode": "TCGA-27-1835-D26948",
    "bcr_drug_uuid": "68c4baf4-8c51-41f4-8689-fd339dc8a717",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "BCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 270,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 270,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "987cb702-057b-4198-8ef3-9cf6a9c51989",
    "patient_ID": "TCGA.27.1835",
    "bcr_drug_barcode": "TCGA-27-1835-D26947",
    "bcr_drug_uuid": "90179c52-58fa-4d89-9277-6858c2639759",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "FT",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 208,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 208,
    "drug_cycles": 1,
    "drug_units": "ML",
    "drug_tota_dose_units": "ML",
    "drug_dose": 12,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 12
  },
  {
    "bcr_patient_uuid": "4d18f820-6396-46ae-b5d6-4ba446279be8",
    "patient_ID": "TCGA.27.1836",
    "bcr_drug_barcode": "TCGA-27-1836-D26959",
    "bcr_drug_uuid": "8e00002c-bc99-44df-89f8-249f7f2548b5",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 655,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 760,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 800,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6720
  },
  {
    "bcr_patient_uuid": "4d18f820-6396-46ae-b5d6-4ba446279be8",
    "patient_ID": "TCGA.27.1836",
    "bcr_drug_barcode": "TCGA-27-1836-D26958",
    "bcr_drug_uuid": "76fee391-6810-4735-bf11-cfc6fd058a49",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 472,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 562,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8400
  },
  {
    "bcr_patient_uuid": "4d18f820-6396-46ae-b5d6-4ba446279be8",
    "patient_ID": "TCGA.27.1836",
    "bcr_drug_barcode": "TCGA-27-1836-D26961",
    "bcr_drug_uuid": "3f0cba42-5e54-42fa-9a15-516217c8df96",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": -7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 914,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 24,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 22080
  },
  {
    "bcr_patient_uuid": "4d18f820-6396-46ae-b5d6-4ba446279be8",
    "patient_ID": "TCGA.27.1836",
    "bcr_drug_barcode": "TCGA-27-1836-D26954",
    "bcr_drug_uuid": "a4b5b960-95ca-4ceb-83f1-d436d1543b25",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 90,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5880
  },
  {
    "bcr_patient_uuid": "4d18f820-6396-46ae-b5d6-4ba446279be8",
    "patient_ID": "TCGA.27.1836",
    "bcr_drug_barcode": "TCGA-27-1836-D26955",
    "bcr_drug_uuid": "88851fbc-e6e6-49b5-a55a-e56f61e81820",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 120,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8400
  },
  {
    "bcr_patient_uuid": "4d18f820-6396-46ae-b5d6-4ba446279be8",
    "patient_ID": "TCGA.27.1836",
    "bcr_drug_barcode": "TCGA-27-1836-D26956",
    "bcr_drug_uuid": "f54c392a-9c4f-4fc3-838e-ae243a17b8c1",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "PCB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 245,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 399,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 500,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3550
  },
  {
    "bcr_patient_uuid": "4d18f820-6396-46ae-b5d6-4ba446279be8",
    "patient_ID": "TCGA.27.1836",
    "bcr_drug_barcode": "TCGA-27-1836-D26960",
    "bcr_drug_uuid": "c14434d9-a3e2-4e16-a7e8-0d712f3d18d8",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 655,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 760,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1440
  },
  {
    "bcr_patient_uuid": "4d18f820-6396-46ae-b5d6-4ba446279be8",
    "patient_ID": "TCGA.27.1836",
    "bcr_drug_barcode": "TCGA-27-1836-D26957",
    "bcr_drug_uuid": "14eebe1d-8a00-4f7c-a85e-64435f86956c",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "FOTEMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 247,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 399,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 896
  },
  {
    "bcr_patient_uuid": "4d18f820-6396-46ae-b5d6-4ba446279be8",
    "patient_ID": "TCGA.27.1836",
    "bcr_drug_barcode": "TCGA-27-1836-D26962",
    "bcr_drug_uuid": "8ae3a100-c2c6-473d-8af8-1df4134389f0",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "VALPROIC ACID",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": -7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 914,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 900,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 828000
  },
  {
    "bcr_patient_uuid": "bc7a0c8f-c1c1-447c-8019-389e52525081",
    "patient_ID": "TCGA.27.1837",
    "bcr_drug_barcode": "TCGA-27-1837-D26969",
    "bcr_drug_uuid": "2d9c4ae5-5cd1-4707-bff9-07975187e626",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": -6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 427,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2592
  },
  {
    "bcr_patient_uuid": "bc7a0c8f-c1c1-447c-8019-389e52525081",
    "patient_ID": "TCGA.27.1837",
    "bcr_drug_barcode": "TCGA-27-1837-D26968",
    "bcr_drug_uuid": "77f882ab-ef9f-4982-97fa-671a37ffa566",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 106,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 4,
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 16
  },
  {
    "bcr_patient_uuid": "bc7a0c8f-c1c1-447c-8019-389e52525081",
    "patient_ID": "TCGA.27.1837",
    "bcr_drug_barcode": "TCGA-27-1837-D26966",
    "bcr_drug_uuid": "b07132d2-d261-4b2b-8db1-376ca0949a55",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "CDDP",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": -1,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 800
  },
  {
    "bcr_patient_uuid": "bc7a0c8f-c1c1-447c-8019-389e52525081",
    "patient_ID": "TCGA.27.1837",
    "bcr_drug_barcode": "TCGA-27-1837-D26967",
    "bcr_drug_uuid": "770a6955-d9ba-40c6-937d-7e53b52422bc",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 350,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8750
  },
  {
    "bcr_patient_uuid": "6fc6b9ca-84d8-4647-bbc8-c5ab472b1c02",
    "patient_ID": "TCGA.27.1838",
    "bcr_drug_barcode": "TCGA-27-1838-D26977",
    "bcr_drug_uuid": "280f1c21-b53a-456a-aef6-0a027d4b6750",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "OXCARBAZEPINE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": -11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 350,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 216600
  },
  {
    "bcr_patient_uuid": "6fc6b9ca-84d8-4647-bbc8-c5ab472b1c02",
    "patient_ID": "TCGA.27.1838",
    "bcr_drug_barcode": "TCGA-27-1838-D26974",
    "bcr_drug_uuid": "a9e40363-1a48-4dc3-8d8f-1d9fe3de8503",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "6fc6b9ca-84d8-4647-bbc8-c5ab472b1c02",
    "patient_ID": "TCGA.27.1838",
    "bcr_drug_barcode": "TCGA-27-1838-D26976",
    "bcr_drug_uuid": "979ac63c-de71-461c-ae0d-2840cf17a80b",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": -11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 350,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 4,
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2214
  },
  {
    "bcr_patient_uuid": "6fc6b9ca-84d8-4647-bbc8-c5ab472b1c02",
    "patient_ID": "TCGA.27.1838",
    "bcr_drug_barcode": "TCGA-27-1838-D26975",
    "bcr_drug_uuid": "6f2a70d9-e4f6-4af5-90c2-9702756c501e",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 7,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 300,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1500
  },
  {
    "bcr_patient_uuid": "d3d27286-73e1-4cdd-914a-34c210fd6398",
    "patient_ID": "TCGA.27.2518",
    "bcr_drug_barcode": "TCGA-27-2518-D26985",
    "bcr_drug_uuid": "90f73be0-f06c-48aa-8899-ac351e98fad5",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 753,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 8,
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5576
  },
  {
    "bcr_patient_uuid": "d3d27286-73e1-4cdd-914a-34c210fd6398",
    "patient_ID": "TCGA.27.2518",
    "bcr_drug_barcode": "TCGA-27-2518-D26984",
    "bcr_drug_uuid": "53c0cbc2-add7-4f30-a2d8-15030bd04304",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "FOTEMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 627,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 700,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 180,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 580
  },
  {
    "bcr_patient_uuid": "d3d27286-73e1-4cdd-914a-34c210fd6398",
    "patient_ID": "TCGA.27.2518",
    "bcr_drug_barcode": "TCGA-27-2518-D26983",
    "bcr_drug_uuid": "5377ade0-6c25-43fc-a62c-b1622d04e810",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "PC2",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 627,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 700,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 300,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "d3d27286-73e1-4cdd-914a-34c210fd6398",
    "patient_ID": "TCGA.27.2518",
    "bcr_drug_barcode": "TCGA-27-2518-D26986",
    "bcr_drug_uuid": "2da94d35-f768-49b4-af4f-381f86d5986a",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "LEVENRACETAM",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 753,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1500,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1045500
  },
  {
    "bcr_patient_uuid": "d3d27286-73e1-4cdd-914a-34c210fd6398",
    "patient_ID": "TCGA.27.2518",
    "bcr_drug_barcode": "TCGA-27-2518-D26982",
    "bcr_drug_uuid": "cf8651b4-47f0-4f7f-bc25-f8172a89ef96",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 500
  },
  {
    "bcr_patient_uuid": "d3d27286-73e1-4cdd-914a-34c210fd6398",
    "patient_ID": "TCGA.27.2518",
    "bcr_drug_barcode": "TCGA-27-2518-D26981",
    "bcr_drug_uuid": "bc218003-fa48-4b3d-acc6-04e993d5f4b9",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 350,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8750
  },
  {
    "bcr_patient_uuid": "6ff96a7e-1b96-4530-b8a8-7f2e9e541955",
    "patient_ID": "TCGA.27.2519",
    "bcr_drug_barcode": "TCGA-27-2519-D26991",
    "bcr_drug_uuid": "054b0154-c0fc-4a4b-ba87-8f9a4194a4e7",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 133,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 259,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 300,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7500
  },
  {
    "bcr_patient_uuid": "6ff96a7e-1b96-4530-b8a8-7f2e9e541955",
    "patient_ID": "TCGA.27.2519",
    "bcr_drug_barcode": "TCGA-27-2519-D26993",
    "bcr_drug_uuid": "22fe087d-0d98-4c6b-a6d1-fa622e225ba9",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": -10,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 16,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "6ff96a7e-1b96-4530-b8a8-7f2e9e541955",
    "patient_ID": "TCGA.27.2519",
    "bcr_drug_barcode": "TCGA-27-2519-D26992",
    "bcr_drug_uuid": "38b4dd8f-f469-4d0e-8cc2-da031ed50f0a",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "FOTEMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 302,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 130,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 390
  },
  {
    "bcr_patient_uuid": "6ff96a7e-1b96-4530-b8a8-7f2e9e541955",
    "patient_ID": "TCGA.27.2519",
    "bcr_drug_barcode": "TCGA-27-2519-D26994",
    "bcr_drug_uuid": "930be66e-45b7-4e4c-8fcc-c1377e6c9794",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "LEVETIRACETAM",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": -10,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1500,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "6ff96a7e-1b96-4530-b8a8-7f2e9e541955",
    "patient_ID": "TCGA.27.2519",
    "bcr_drug_barcode": "TCGA-27-2519-D26990",
    "bcr_drug_uuid": "6b516de8-700d-4246-bb7d-26ea6920fad7",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 95,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6440
  },
  {
    "bcr_patient_uuid": "4776b959-d5f5-41ad-ab39-dba6031f6884",
    "patient_ID": "TCGA.27.2521",
    "bcr_drug_barcode": "TCGA-27-2521-D26999",
    "bcr_drug_uuid": "febea3d3-c51a-42ec-bb3f-6725cc55eb8e",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": -15,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4776b959-d5f5-41ad-ab39-dba6031f6884",
    "patient_ID": "TCGA.27.2521",
    "bcr_drug_barcode": "TCGA-27-2521-D27000",
    "bcr_drug_uuid": "bd0142c7-c8dd-4341-a0aa-f5b7deef8097",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "LEVETIRACETAM",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": -15,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1000,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4776b959-d5f5-41ad-ab39-dba6031f6884",
    "patient_ID": "TCGA.27.2521",
    "bcr_drug_barcode": "TCGA-27-2521-D26998",
    "bcr_drug_uuid": "c5e44945-242a-4443-9b7e-c9363c3e5482",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 104,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 350,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 14000
  },
  {
    "bcr_patient_uuid": "737b35e1-d668-4fce-9b6e-76946c7952b6",
    "patient_ID": "TCGA.27.2523",
    "bcr_drug_barcode": "TCGA-27-2523-D27005",
    "bcr_drug_uuid": "158df29a-ed83-4985-9274-248c5ac380d6",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "LUMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 11,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "737b35e1-d668-4fce-9b6e-76946c7952b6",
    "patient_ID": "TCGA.27.2523",
    "bcr_drug_barcode": "TCGA-27-2523-D27006",
    "bcr_drug_uuid": "3407ded6-d27c-4bbe-b083-811ca6627856",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 380,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 300,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 15000
  },
  {
    "bcr_patient_uuid": "737b35e1-d668-4fce-9b6e-76946c7952b6",
    "patient_ID": "TCGA.27.2523",
    "bcr_drug_barcode": "TCGA-27-2523-D27004",
    "bcr_drug_uuid": "26a7576c-9c9e-4569-b0f2-a2df1697b401",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 59,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 90,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 315
  },
  {
    "bcr_patient_uuid": "737b35e1-d668-4fce-9b6e-76946c7952b6",
    "patient_ID": "TCGA.27.2523",
    "bcr_drug_barcode": "TCGA-27-2523-D27009",
    "bcr_drug_uuid": "761ea42a-1ed5-4232-b593-1290feb6162f",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "PHENYTOIN SODIUM",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": -6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 489,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 300,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 148500
  },
  {
    "bcr_patient_uuid": "737b35e1-d668-4fce-9b6e-76946c7952b6",
    "patient_ID": "TCGA.27.2523",
    "bcr_drug_barcode": "TCGA-27-2523-D27007",
    "bcr_drug_uuid": "39ff9267-265f-4281-8a19-f77be3a9d334",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "ERLOTINIB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 386,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1500
  },
  {
    "bcr_patient_uuid": "737b35e1-d668-4fce-9b6e-76946c7952b6",
    "patient_ID": "TCGA.27.2523",
    "bcr_drug_barcode": "TCGA-27-2523-D27008",
    "bcr_drug_uuid": "c572b79f-3627-4145-bd94-fc2d64558e1d",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": -6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 489,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 8,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3960
  },
  {
    "bcr_patient_uuid": "a597bfa8-8c4d-4f8e-9d85-8a9fdc2c56ff",
    "patient_ID": "TCGA.27.2524",
    "bcr_drug_barcode": "TCGA-27-2524-D27016",
    "bcr_drug_uuid": "372a5ac3-0f43-4694-8d93-b0b71d80b1e9",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": -6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 231,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 4,
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 948
  },
  {
    "bcr_patient_uuid": "a597bfa8-8c4d-4f8e-9d85-8a9fdc2c56ff",
    "patient_ID": "TCGA.27.2524",
    "bcr_drug_barcode": "TCGA-27-2524-D27015",
    "bcr_drug_uuid": "1e14366d-ff0f-4113-9cc7-5fcfaa73f087",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 300,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7500
  },
  {
    "bcr_patient_uuid": "a597bfa8-8c4d-4f8e-9d85-8a9fdc2c56ff",
    "patient_ID": "TCGA.27.2524",
    "bcr_drug_barcode": "TCGA-27-2524-D27014",
    "bcr_drug_uuid": "ded13931-39b4-4aa7-ae44-579d518ab56e",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFER",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": -6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": -6,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_dose": 8,
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 61.6
  },
  {
    "bcr_patient_uuid": "a597bfa8-8c4d-4f8e-9d85-8a9fdc2c56ff",
    "patient_ID": "TCGA.27.2524",
    "bcr_drug_barcode": "TCGA-27-2524-D27017",
    "bcr_drug_uuid": "4f1509d4-fc32-4fd8-8775-cc5ac1f7db2e",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "OXCARBAZEPINE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": -6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 231,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 142200
  },
  {
    "bcr_patient_uuid": "69d0a566-5fbf-45f6-a240-649b06868e27",
    "patient_ID": "TCGA.27.2526",
    "bcr_drug_barcode": "TCGA-27-2526-D27022",
    "bcr_drug_uuid": "ad2c9dad-a0d6-482d-b9da-828ecc9f0f02",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": -6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 87,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 8,
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 744
  },
  {
    "bcr_patient_uuid": "a61e88cd-5121-4e6e-9319-2978071547c3",
    "patient_ID": "TCGA.27.2527",
    "bcr_drug_barcode": "TCGA-27-2527-D27026",
    "bcr_drug_uuid": "51423afa-43b6-40f2-a5e4-91557c8b5cb9",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "VALPROIC ACID",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": -7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 438,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1000,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 444000
  },
  {
    "bcr_patient_uuid": "a61e88cd-5121-4e6e-9319-2978071547c3",
    "patient_ID": "TCGA.27.2527",
    "bcr_drug_barcode": "TCGA-27-2527-D27025",
    "bcr_drug_uuid": "6bd9896b-d80e-41f2-ae06-5a9bc4d364b9",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": -7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 438,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 8,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3552
  },
  {
    "bcr_patient_uuid": "be3a7ef3-34ed-40e1-9d9c-187940596b26",
    "patient_ID": "TCGA.27.2528",
    "bcr_drug_barcode": "TCGA-27-2528-D27035",
    "bcr_drug_uuid": "e451f611-8345-4c41-bcba-12e88bdad3e7",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "LEVETIRACETAM",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": -12,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 480,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1000,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 603500
  },
  {
    "bcr_patient_uuid": "be3a7ef3-34ed-40e1-9d9c-187940596b26",
    "patient_ID": "TCGA.27.2528",
    "bcr_drug_barcode": "TCGA-27-2528-D27033",
    "bcr_drug_uuid": "fd948429-f8c4-4c5c-95f1-bf8b9758e5df",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 445,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 465,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1960
  },
  {
    "bcr_patient_uuid": "be3a7ef3-34ed-40e1-9d9c-187940596b26",
    "patient_ID": "TCGA.27.2528",
    "bcr_drug_barcode": "TCGA-27-2528-D27032",
    "bcr_drug_uuid": "7668113c-c82f-4bce-8a0f-34b36aa3e665",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 300,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6000
  },
  {
    "bcr_patient_uuid": "be3a7ef3-34ed-40e1-9d9c-187940596b26",
    "patient_ID": "TCGA.27.2528",
    "bcr_drug_barcode": "TCGA-27-2528-D27031",
    "bcr_drug_uuid": "07529714-e599-44b7-b343-f73097786ec4",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": -2,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 150,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 510
  },
  {
    "bcr_patient_uuid": "be3a7ef3-34ed-40e1-9d9c-187940596b26",
    "patient_ID": "TCGA.27.2528",
    "bcr_drug_barcode": "TCGA-27-2528-D27034",
    "bcr_drug_uuid": "49a652e6-acd2-4da0-90c3-e43a27d40340",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "DEXAMETHASONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": -12,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 480,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 8,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3928
  },
  {
    "bcr_patient_uuid": "1e2108e8-b620-4865-a8d8-77f9a0fe28a2",
    "patient_ID": "TCGA.28.1745",
    "bcr_drug_barcode": "TCGA-28-1745-D27041",
    "bcr_drug_uuid": "bbf9afd3-e8b7-40d6-a344-53f30e46b441",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 180,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2000
  },
  {
    "bcr_patient_uuid": "1e2108e8-b620-4865-a8d8-77f9a0fe28a2",
    "patient_ID": "TCGA.28.1745",
    "bcr_drug_barcode": "TCGA-28-1745-D27040",
    "bcr_drug_uuid": "b5843d8b-64e0-4be7-9af5-a88184de1cbe",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 180,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4500
  },
  {
    "bcr_patient_uuid": "1e2108e8-b620-4865-a8d8-77f9a0fe28a2",
    "patient_ID": "TCGA.28.1745",
    "bcr_drug_barcode": "TCGA-28-1745-D27039",
    "bcr_drug_uuid": "c529e7ff-ed78-414f-8cf4-14419b6df1d0",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 180,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7000
  },
  {
    "bcr_patient_uuid": "35a7e49e-747b-45ce-9a07-3a5faba0ca94",
    "patient_ID": "TCGA.28.1747",
    "bcr_drug_barcode": "TCGA-28-1747-D27048",
    "bcr_drug_uuid": "806a64cb-04da-4fc3-8f61-0e3421f0e737",
    "form_completion_date": "2010-3-3",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 36,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b92047e1-8a76-46dd-baa7-6e629cfaebdb",
    "patient_ID": "TCGA.28.1749",
    "bcr_drug_barcode": "TCGA-28-1749-D27053",
    "bcr_drug_uuid": "52628903-6a1f-44e7-b901-60ef095ea2e8",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 159,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7560
  },
  {
    "bcr_patient_uuid": "b92047e1-8a76-46dd-baa7-6e629cfaebdb",
    "patient_ID": "TCGA.28.1749",
    "bcr_drug_barcode": "TCGA-28-1749-D27052",
    "bcr_drug_uuid": "cd823ffa-72df-4277-b9da-3d863f877503",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 159,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4400
  },
  {
    "bcr_patient_uuid": "b92047e1-8a76-46dd-baa7-6e629cfaebdb",
    "patient_ID": "TCGA.28.1749",
    "bcr_drug_barcode": "TCGA-28-1749-D27054",
    "bcr_drug_uuid": "d7645386-0538-40e1-9a8d-d5c6dbb9f70f",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 159,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3800
  },
  {
    "bcr_patient_uuid": "f077df02-5056-402f-8522-7198c42bcc98",
    "patient_ID": "TCGA.28.1750",
    "bcr_drug_barcode": "TCGA-28-1750-D27058",
    "bcr_drug_uuid": "17b02707-6584-4ac8-bbe7-e2c5e80ab9a6",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 116,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5040
  },
  {
    "bcr_patient_uuid": "f077df02-5056-402f-8522-7198c42bcc98",
    "patient_ID": "TCGA.28.1750",
    "bcr_drug_barcode": "TCGA-28-1750-D27059",
    "bcr_drug_uuid": "6984ad06-04cc-491a-9f72-96c98e18bcf9",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 116,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1250
  },
  {
    "bcr_patient_uuid": "f077df02-5056-402f-8522-7198c42bcc98",
    "patient_ID": "TCGA.28.1750",
    "bcr_drug_barcode": "TCGA-28-1750-D27060",
    "bcr_drug_uuid": "afa173bd-e750-4c6d-81ee-fc443979d5c3",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 116,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1700
  },
  {
    "bcr_patient_uuid": "28df4629-204f-4352-a19f-303a2e067633",
    "patient_ID": "TCGA.28.1751",
    "bcr_drug_barcode": "TCGA-28-1751-D27065",
    "bcr_drug_uuid": "6616f149-0f1f-424e-a233-e85d9c89eef2",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 208,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6300
  },
  {
    "bcr_patient_uuid": "28df4629-204f-4352-a19f-303a2e067633",
    "patient_ID": "TCGA.28.1751",
    "bcr_drug_barcode": "TCGA-28-1751-D27067",
    "bcr_drug_uuid": "99fc6bac-8a21-46f2-b898-cd2bd3cbfae5",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 208,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2100
  },
  {
    "bcr_patient_uuid": "28df4629-204f-4352-a19f-303a2e067633",
    "patient_ID": "TCGA.28.1751",
    "bcr_drug_barcode": "TCGA-28-1751-D27066",
    "bcr_drug_uuid": "9b28579d-7954-4478-add1-83a173f519a0",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 208,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2600
  },
  {
    "bcr_patient_uuid": "28df4629-204f-4352-a19f-303a2e067633",
    "patient_ID": "TCGA.28.1751",
    "bcr_drug_barcode": "TCGA-28-1751-D27068",
    "bcr_drug_uuid": "67555c1e-94d0-4d77-bbec-3c877cd82953",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "DENDRITICCELL VACCINE",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 114,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3
  },
  {
    "bcr_patient_uuid": "68f6976e-d3f2-432d-a121-274e228735b0",
    "patient_ID": "TCGA.28.1752",
    "bcr_drug_barcode": "TCGA-28-1752-D27074",
    "bcr_drug_uuid": "74048dab-3f43-4f2c-8a3c-ef7166049a98",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 272,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1440
  },
  {
    "bcr_patient_uuid": "68f6976e-d3f2-432d-a121-274e228735b0",
    "patient_ID": "TCGA.28.1752",
    "bcr_drug_barcode": "TCGA-28-1752-D27075",
    "bcr_drug_uuid": "3ebccaa0-bca5-48d7-80f8-931e0536c80e",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 272,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3000
  },
  {
    "bcr_patient_uuid": "68f6976e-d3f2-432d-a121-274e228735b0",
    "patient_ID": "TCGA.28.1752",
    "bcr_drug_barcode": "TCGA-28-1752-D27076",
    "bcr_drug_uuid": "820d8a68-e195-4e3d-bcb7-9ffc99819c14",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "DENDRITICCELL VACCINE",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3
  },
  {
    "bcr_patient_uuid": "68f6976e-d3f2-432d-a121-274e228735b0",
    "patient_ID": "TCGA.28.1752",
    "bcr_drug_barcode": "TCGA-28-1752-D27072",
    "bcr_drug_uuid": "39720aac-a855-4883-878b-bdbd7e39d450",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 272,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5880
  },
  {
    "bcr_patient_uuid": "68f6976e-d3f2-432d-a121-274e228735b0",
    "patient_ID": "TCGA.28.1752",
    "bcr_drug_barcode": "TCGA-28-1752-D27073",
    "bcr_drug_uuid": "7a0e3cd5-2a4d-4930-afaa-9c0cbcfcac13",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 272,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1800
  },
  {
    "bcr_patient_uuid": "3c5e7a3f-29b3-4af4-9023-dc7b151f0445",
    "patient_ID": "TCGA.28.1755",
    "bcr_drug_barcode": "TCGA-28-1755-D27083",
    "bcr_drug_uuid": "eefae1ae-b1e5-48a2-ad7c-f957d272d02d",
    "form_completion_date": "2010-1-7",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5040
  },
  {
    "bcr_patient_uuid": "0c0333c9-60dc-4487-baa2-7ec27acced27",
    "patient_ID": "TCGA.28.1756",
    "bcr_drug_barcode": "TCGA-28-1756-D27087",
    "bcr_drug_uuid": "75eb9def-c7ef-4d1b-b08d-5c4ae51e968c",
    "form_completion_date": "2010-3-3",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 69,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b7b86c1f-9688-4129-891c-843e3a37b3e5",
    "patient_ID": "TCGA.28.1760",
    "bcr_drug_barcode": "TCGA-28-1760-D27093",
    "bcr_drug_uuid": "5a874847-109f-410f-a8a2-41016ee87984",
    "form_completion_date": "2010-1-7",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "b7b86c1f-9688-4129-891c-843e3a37b3e5",
    "patient_ID": "TCGA.28.1760",
    "bcr_drug_barcode": "TCGA-28-1760-D27094",
    "bcr_drug_uuid": "6319bc3a-f044-4e37-b371-fd4aa136963b",
    "form_completion_date": "2010-1-7",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1100
  },
  {
    "bcr_patient_uuid": "b7b86c1f-9688-4129-891c-843e3a37b3e5",
    "patient_ID": "TCGA.28.1760",
    "bcr_drug_barcode": "TCGA-28-1760-D27095",
    "bcr_drug_uuid": "61b192e4-d1ca-4691-bfef-8df3b015c88e",
    "form_completion_date": "2010-1-7",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 250,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "ec1791b3-0192-45da-89c1-f942a6736704",
    "patient_ID": "TCGA.28.2506",
    "bcr_drug_barcode": "TCGA-28-2506-D27103",
    "bcr_drug_uuid": "429562c2-0f8d-46b1-bf6d-48e419003eaf",
    "form_completion_date": "2010-3-5",
    "pharmaceutical_therapy_drug_name": "TUMOR VACCINE",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 107,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_units": "ML",
    "drug_tota_dose_units": "ML",
    "drug_dose": 1.1,
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ec1791b3-0192-45da-89c1-f942a6736704",
    "patient_ID": "TCGA.28.2506",
    "bcr_drug_barcode": "TCGA-28-2506-D27102",
    "bcr_drug_uuid": "777e44a6-c875-48eb-9dc9-dd0c4af9edbf",
    "form_completion_date": "2010-3-5",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 72,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 100,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ec1791b3-0192-45da-89c1-f942a6736704",
    "patient_ID": "TCGA.28.2506",
    "bcr_drug_barcode": "TCGA-28-2506-D27104",
    "bcr_drug_uuid": "a4d04704-9263-4fac-87a3-075bb7b1c993",
    "form_completion_date": "2010-3-5",
    "pharmaceutical_therapy_drug_name": "BIBW 2992",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 177,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 40,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "aa7ad106-eadc-489e-83b2-5698652434ea",
    "patient_ID": "TCGA.28.2509",
    "bcr_drug_barcode": "TCGA-28-2509-D27108",
    "bcr_drug_uuid": "dd10383e-bf28-4809-b66e-21c7985f9737",
    "form_completion_date": "2010-3-5",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "aa7ad106-eadc-489e-83b2-5698652434ea",
    "patient_ID": "TCGA.28.2509",
    "bcr_drug_barcode": "TCGA-28-2509-D27109",
    "bcr_drug_uuid": "14279a1e-b318-4be0-a943-efdea31c0652",
    "form_completion_date": "2010-3-5",
    "pharmaceutical_therapy_drug_name": "CILENAITIDE",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 2000,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4ca9c0f2-1be9-4376-aa27-d9db948d3f68",
    "patient_ID": "TCGA.28.2512",
    "bcr_drug_barcode": "TCGA-28-2512-D30234",
    "bcr_drug_uuid": "85952210-1f03-4fd4-9a19-ee2451d72a3f",
    "form_completion_date": "2012-1-17",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_cycles": 2,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "4ca9c0f2-1be9-4376-aa27-d9db948d3f68",
    "patient_ID": "TCGA.28.2512",
    "bcr_drug_barcode": "TCGA-28-2512-D30233",
    "bcr_drug_uuid": "7bc1772c-6800-4b0d-bde7-bf2e38b2716c",
    "form_completion_date": "2012-1-17",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "30256f61-7be9-4d47-8afd-afafa7a079c0",
    "patient_ID": "TCGA.28.2513",
    "bcr_drug_barcode": "TCGA-28-2513-D27115",
    "bcr_drug_uuid": "0f29aee4-dfd4-4b7f-a9d1-8d21fb5c08ef",
    "form_completion_date": "2010-3-5",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 280,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "30256f61-7be9-4d47-8afd-afafa7a079c0",
    "patient_ID": "TCGA.28.2513",
    "bcr_drug_barcode": "TCGA-28-2513-D27116",
    "bcr_drug_uuid": "739b689e-cffb-4e28-b9f5-9e3123161578",
    "form_completion_date": "2010-3-5",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 460
  },
  {
    "bcr_patient_uuid": "30256f61-7be9-4d47-8afd-afafa7a079c0",
    "patient_ID": "TCGA.28.2513",
    "bcr_drug_barcode": "TCGA-28-2513-D27114",
    "bcr_drug_uuid": "8947a763-53b2-40a0-a9ce-3045abe3762d",
    "form_completion_date": "2010-3-5",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 57,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 280,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "350232cb-b9ba-465b-be9a-81afbc6a92e9",
    "patient_ID": "TCGA.28.2514",
    "bcr_drug_barcode": "TCGA-28-2514-D27121",
    "bcr_drug_uuid": "1ffeff3a-bdb6-4243-a5e9-98db4c78b318",
    "form_completion_date": "2010-3-5",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "28da11ec-f46a-4abc-b4c8-bbb784419c71",
    "patient_ID": "TCGA.28.5204",
    "bcr_drug_barcode": "TCGA-28-5204-D15042",
    "bcr_drug_uuid": "f15fd67b-7c1d-4a06-83bb-045299cf6d2f",
    "form_completion_date": "2011-7-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 9,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 448,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8160
  },
  {
    "bcr_patient_uuid": "28da11ec-f46a-4abc-b4c8-bbb784419c71",
    "patient_ID": "TCGA.28.5204",
    "bcr_drug_barcode": "TCGA-28-5204-D28859",
    "bcr_drug_uuid": "f826b8bc-7ff9-4eb3-af4e-25a46d7d2a41",
    "form_completion_date": "2011-7-25",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 9,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 448,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8160
  },
  {
    "bcr_patient_uuid": "d9fcf27f-48e3-43fd-a8cf-3db246cf4221",
    "patient_ID": "TCGA.28.5207",
    "bcr_drug_barcode": "TCGA-28-5207-D15034",
    "bcr_drug_uuid": "dfedfcb7-239f-4d6d-8e0f-1d5c27c67c61",
    "form_completion_date": "2011-7-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d9fcf27f-48e3-43fd-a8cf-3db246cf4221",
    "patient_ID": "TCGA.28.5207",
    "bcr_drug_barcode": "TCGA-28-5207-D28863",
    "bcr_drug_uuid": "d3e4bb96-77bf-4132-83a2-6e8eb2ff279d",
    "form_completion_date": "2011-7-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d9fcf27f-48e3-43fd-a8cf-3db246cf4221",
    "patient_ID": "TCGA.28.5207",
    "bcr_drug_barcode": "TCGA-28-5207-D28864",
    "bcr_drug_uuid": "994e0573-de17-448c-bcae-921b60cf0143",
    "form_completion_date": "2011-8-29",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "46bfebf4-0ef6-4348-81dc-d7d3cb52c08f",
    "patient_ID": "TCGA.28.5208",
    "bcr_drug_barcode": "TCGA-28-5208-D15029",
    "bcr_drug_uuid": "08b63faf-8283-4fd4-8a9d-34e58353221a",
    "form_completion_date": "2011-7-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 49,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5320
  },
  {
    "bcr_patient_uuid": "46bfebf4-0ef6-4348-81dc-d7d3cb52c08f",
    "patient_ID": "TCGA.28.5208",
    "bcr_drug_barcode": "TCGA-28-5208-D28869",
    "bcr_drug_uuid": "c2f92122-7e4d-4bbd-8270-8cb0e357cd11",
    "form_completion_date": "2011-7-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 49,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5320
  },
  {
    "bcr_patient_uuid": "46bfebf4-0ef6-4348-81dc-d7d3cb52c08f",
    "patient_ID": "TCGA.28.5208",
    "bcr_drug_barcode": "TCGA-28-5208-D15531",
    "bcr_drug_uuid": "1321e800-1342-41f5-ae14-192e2f62ad40",
    "form_completion_date": "2011-8-23",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 287,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 435,
    "drug_cycles": 5,
    "drug_units": "MG/KG",
    "drug_dose": 10,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "46bfebf4-0ef6-4348-81dc-d7d3cb52c08f",
    "patient_ID": "TCGA.28.5208",
    "bcr_drug_barcode": "TCGA-28-5208-D28870",
    "bcr_drug_uuid": "158c3206-0163-441e-811b-fbbc2f29f4a1",
    "form_completion_date": "2011-8-24",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 287,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 435,
    "drug_cycles": 5,
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "46bfebf4-0ef6-4348-81dc-d7d3cb52c08f",
    "patient_ID": "TCGA.28.5208",
    "bcr_drug_barcode": "TCGA-28-5208-D16142",
    "bcr_drug_uuid": "fa0d7a8e-eeda-40fd-9f07-5818987777a4",
    "form_completion_date": "2011-9-6",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 149,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 285,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 390,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 9750
  },
  {
    "bcr_patient_uuid": "46bfebf4-0ef6-4348-81dc-d7d3cb52c08f",
    "patient_ID": "TCGA.28.5208",
    "bcr_drug_barcode": "TCGA-28-5208-D28871",
    "bcr_drug_uuid": "058a67ec-61c3-47d5-9dac-2de21b2d148a",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "CPT11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 287,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 435,
    "drug_cycles": 5,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "46bfebf4-0ef6-4348-81dc-d7d3cb52c08f",
    "patient_ID": "TCGA.28.5208",
    "bcr_drug_barcode": "TCGA-28-5208-D28872",
    "bcr_drug_uuid": "cee5e39d-9590-4e49-8d50-f5295a4b4e3e",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 149,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 285,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 390,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 9750
  },
  {
    "bcr_patient_uuid": "46bfebf4-0ef6-4348-81dc-d7d3cb52c08f",
    "patient_ID": "TCGA.28.5208",
    "bcr_drug_barcode": "TCGA-28-5208-D16141",
    "bcr_drug_uuid": "633d8ae7-29e0-4f8e-a24c-4f8fffc2fb80",
    "form_completion_date": "2011-9-16",
    "pharmaceutical_therapy_drug_name": "CPT11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 287,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 435,
    "drug_cycles": 5,
    "regimen_number": 3,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "153c2442-ea61-4b5e-8c5c-c71d287c6055",
    "patient_ID": "TCGA.28.5209",
    "bcr_drug_barcode": "TCGA-28-5209-D15025",
    "bcr_drug_uuid": "a87875f1-378a-466a-a2e7-2f39634724e9",
    "form_completion_date": "2011-7-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "153c2442-ea61-4b5e-8c5c-c71d287c6055",
    "patient_ID": "TCGA.28.5209",
    "bcr_drug_barcode": "TCGA-28-5209-D28877",
    "bcr_drug_uuid": "e8b6763b-1995-4e30-bbea-09c63123dede",
    "form_completion_date": "2011-7-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "cf6689b9-d0fa-4461-a6b7-db477629e258",
    "patient_ID": "TCGA.28.5211",
    "bcr_drug_barcode": "TCGA-28-5211-D15038",
    "bcr_drug_uuid": "87940d98-44ec-4352-ba33-c767d0441a46",
    "form_completion_date": "2011-7-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": -1,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 57,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8360
  },
  {
    "bcr_patient_uuid": "cf6689b9-d0fa-4461-a6b7-db477629e258",
    "patient_ID": "TCGA.28.5211",
    "bcr_drug_barcode": "TCGA-28-5211-D28881",
    "bcr_drug_uuid": "b5249e40-0eff-4e36-9275-11553d290d59",
    "form_completion_date": "2011-7-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": -1,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 57,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8360
  },
  {
    "bcr_patient_uuid": "cf6689b9-d0fa-4461-a6b7-db477629e258",
    "patient_ID": "TCGA.28.5211",
    "bcr_drug_barcode": "TCGA-28-5211-D15532",
    "bcr_drug_uuid": "26c394c9-c6a5-4f7b-a079-d49da78d9ba2",
    "form_completion_date": "2011-8-23",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 239,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 307,
    "drug_cycles": 2,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "cf6689b9-d0fa-4461-a6b7-db477629e258",
    "patient_ID": "TCGA.28.5211",
    "bcr_drug_barcode": "TCGA-28-5211-D28882",
    "bcr_drug_uuid": "6d629d3f-a747-4f2c-b286-ba86a4fa3e3d",
    "form_completion_date": "2011-8-24",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 239,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 307,
    "drug_cycles": 2,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "cf6689b9-d0fa-4461-a6b7-db477629e258",
    "patient_ID": "TCGA.28.5211",
    "bcr_drug_barcode": "TCGA-28-5211-D16144",
    "bcr_drug_uuid": "40061326-41ee-4202-a88c-02cfdc9d3101",
    "form_completion_date": "2011-9-6",
    "pharmaceutical_therapy_drug_name": "CPT11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 239,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 307,
    "drug_cycles": 2,
    "regimen_number": 2,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "cf6689b9-d0fa-4461-a6b7-db477629e258",
    "patient_ID": "TCGA.28.5211",
    "bcr_drug_barcode": "TCGA-28-5211-D28883",
    "bcr_drug_uuid": "5ecc75e0-9e8c-4eb0-aa38-e9fd225f00e1",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "CPT11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 239,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 307,
    "drug_cycles": 2,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "7338e476-10ff-444a-a16f-429d28355f65",
    "patient_ID": "TCGA.28.5213",
    "bcr_drug_barcode": "TCGA-28-5213-D15020",
    "bcr_drug_uuid": "3ac95a2c-03d1-4ccf-a546-7f3f91d3722b",
    "form_completion_date": "2011-7-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/KG/DAY",
    "drug_dose": 1800,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7338e476-10ff-444a-a16f-429d28355f65",
    "patient_ID": "TCGA.28.5213",
    "bcr_drug_barcode": "TCGA-28-5213-D28887",
    "bcr_drug_uuid": "f1c6e33c-134a-4f69-94ac-9b6d0b685931",
    "form_completion_date": "2011-7-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_dose": 140,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7338e476-10ff-444a-a16f-429d28355f65",
    "patient_ID": "TCGA.28.5213",
    "bcr_drug_barcode": "TCGA-28-5213-D45679",
    "bcr_drug_uuid": "C33AEB98-A562-4A68-9DE9-07C959EE1F8B",
    "form_completion_date": "2013-7-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 9,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 50
  },
  {
    "bcr_patient_uuid": "cb4f4617-8260-475d-a650-2f049474b001",
    "patient_ID": "TCGA.28.5214",
    "bcr_drug_barcode": "TCGA-28-5214-D14984",
    "bcr_drug_uuid": "cafa9d69-4906-4db6-a3ef-0ec280d5aae8",
    "form_completion_date": "2011-7-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 2,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_dose": 1750,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "cb4f4617-8260-475d-a650-2f049474b001",
    "patient_ID": "TCGA.28.5214",
    "bcr_drug_barcode": "TCGA-28-5214-D28891",
    "bcr_drug_uuid": "eb0f0db2-54e3-4e8b-9e18-5ad851ecebe8",
    "form_completion_date": "2011-7-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 2,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2/DAY",
    "drug_dose": 1750,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "cb4f4617-8260-475d-a650-2f049474b001",
    "patient_ID": "TCGA.28.5214",
    "bcr_drug_barcode": "TCGA-28-5214-D16137",
    "bcr_drug_uuid": "a47ec641-5d90-4ab3-97ea-d3280dfea7bb",
    "form_completion_date": "2011-8-23",
    "pharmaceutical_therapy_drug_name": "CPT 11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 262,
    "pharmaceutical_tx_ongoing_indicator": true,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "cb4f4617-8260-475d-a650-2f049474b001",
    "patient_ID": "TCGA.28.5214",
    "bcr_drug_barcode": "TCGA-28-5214-D15533",
    "bcr_drug_uuid": "8deb61b6-2782-4b98-a72f-9f387b8f1a73",
    "form_completion_date": "2011-8-23",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 262,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/KG",
    "drug_dose": 10,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "cb4f4617-8260-475d-a650-2f049474b001",
    "patient_ID": "TCGA.28.5214",
    "bcr_drug_barcode": "TCGA-28-5214-D28892",
    "bcr_drug_uuid": "df4a2641-3134-4707-8a6b-ae20aafe007c",
    "form_completion_date": "2011-8-24",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 262,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "cb4f4617-8260-475d-a650-2f049474b001",
    "patient_ID": "TCGA.28.5214",
    "bcr_drug_barcode": "TCGA-28-5214-D28893",
    "bcr_drug_uuid": "93072190-87a7-4b1b-ba78-f8d42a784b19",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "CPT 11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 262,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "cb4f4617-8260-475d-a650-2f049474b001",
    "patient_ID": "TCGA.28.5214",
    "bcr_drug_barcode": "TCGA-28-5214-D45678",
    "bcr_drug_uuid": "6A87CF40-AAB3-40BC-9730-C4D442696300",
    "form_completion_date": "2013-7-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 62
  },
  {
    "bcr_patient_uuid": "c9e4f0bf-48fc-4600-9e03-314bc575273f",
    "patient_ID": "TCGA.28.5215",
    "bcr_drug_barcode": "TCGA-28-5215-D14980",
    "bcr_drug_uuid": "45bf8e0d-0055-4510-9ea7-5731b2042988",
    "form_completion_date": "2011-7-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c9e4f0bf-48fc-4600-9e03-314bc575273f",
    "patient_ID": "TCGA.28.5215",
    "bcr_drug_barcode": "TCGA-28-5215-D28898",
    "bcr_drug_uuid": "46c53037-75c3-47ff-aa55-c53618028097",
    "form_completion_date": "2011-7-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c9e4f0bf-48fc-4600-9e03-314bc575273f",
    "patient_ID": "TCGA.28.5215",
    "bcr_drug_barcode": "TCGA-28-5215-D15535",
    "bcr_drug_uuid": "dca8fe37-54d0-4150-bb28-35abf620db4f",
    "form_completion_date": "2011-8-23",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "c9e4f0bf-48fc-4600-9e03-314bc575273f",
    "patient_ID": "TCGA.28.5215",
    "bcr_drug_barcode": "TCGA-28-5215-D28899",
    "bcr_drug_uuid": "22456782-eacd-445a-8dfa-a5160e482bf9",
    "form_completion_date": "2011-8-24",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "c2f7f72f-13ae-4efc-9cda-69ca037b4498",
    "patient_ID": "TCGA.28.5216",
    "bcr_drug_barcode": "TCGA-28-5216-D14978",
    "bcr_drug_uuid": "9586497c-daab-45b2-bdb6-1289fb48e2df",
    "form_completion_date": "2011-7-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5880
  },
  {
    "bcr_patient_uuid": "c2f7f72f-13ae-4efc-9cda-69ca037b4498",
    "patient_ID": "TCGA.28.5216",
    "bcr_drug_barcode": "TCGA-28-5216-D28903",
    "bcr_drug_uuid": "677fdeab-e273-4253-8ecf-c4033574dbe7",
    "form_completion_date": "2011-7-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5880
  },
  {
    "bcr_patient_uuid": "c2f7f72f-13ae-4efc-9cda-69ca037b4498",
    "patient_ID": "TCGA.28.5216",
    "bcr_drug_barcode": "TCGA-28-5216-D45770",
    "bcr_drug_uuid": "F8BE08BA-5F55-40D6-B6F1-0C0F4D20FFD9",
    "form_completion_date": "2013-7-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70
  },
  {
    "bcr_patient_uuid": "d558203d-3f70-42d4-accb-008ace280f48",
    "patient_ID": "TCGA.28.5218",
    "bcr_drug_barcode": "TCGA-28-5218-D14973",
    "bcr_drug_uuid": "73ec135b-0979-40c6-a70e-a0cb22a0f163",
    "form_completion_date": "2011-7-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_dose": 100,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d558203d-3f70-42d4-accb-008ace280f48",
    "patient_ID": "TCGA.28.5218",
    "bcr_drug_barcode": "TCGA-28-5218-D28907",
    "bcr_drug_uuid": "3dbbcdd2-8034-488a-94ae-b6061850d23c",
    "form_completion_date": "2011-7-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "567a8bf1-3793-46bc-9943-16302df056ce",
    "patient_ID": "TCGA.28.5219",
    "bcr_drug_barcode": "TCGA-28-5219-D14963",
    "bcr_drug_uuid": "2980a09c-4fdf-40f2-9a0d-73e65f80cdb7",
    "form_completion_date": "2011-7-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "567a8bf1-3793-46bc-9943-16302df056ce",
    "patient_ID": "TCGA.28.5219",
    "bcr_drug_barcode": "TCGA-28-5219-D28911",
    "bcr_drug_uuid": "be000c06-f2a2-4c17-98e2-89e9a13f222d",
    "form_completion_date": "2011-7-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8e6b9705-e9d2-4fbc-ac03-35c1a5115eef",
    "patient_ID": "TCGA.28.5220",
    "bcr_drug_barcode": "TCGA-28-5220-D14968",
    "bcr_drug_uuid": "754176da-6696-40ea-9c22-c9af774b78c7",
    "form_completion_date": "2011-7-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8e6b9705-e9d2-4fbc-ac03-35c1a5115eef",
    "patient_ID": "TCGA.28.5220",
    "bcr_drug_barcode": "TCGA-28-5220-D28915",
    "bcr_drug_uuid": "b6ac74e6-7590-4cbb-9045-5dfb55c86cca",
    "form_completion_date": "2011-7-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8e6b9705-e9d2-4fbc-ac03-35c1a5115eef",
    "patient_ID": "TCGA.28.5220",
    "bcr_drug_barcode": "TCGA-28-5220-D45778",
    "bcr_drug_uuid": "45D35AC4-6410-4D35-856A-6BD660552781",
    "form_completion_date": "2013-7-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "days_to_drug_start": 138,
    "pharmaceutical_tx_ongoing_indicator": false
  },
  {
    "bcr_patient_uuid": "82ecf2ce-0782-4238-be0a-668a2b22c57c",
    "patient_ID": "TCGA.28.6450",
    "bcr_drug_barcode": "TCGA-28-6450-D15046",
    "bcr_drug_uuid": "dee8d206-85e3-46d4-ad9c-a6a909ab3066",
    "form_completion_date": "2011-7-14",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 41,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 123,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2125
  },
  {
    "bcr_patient_uuid": "82ecf2ce-0782-4238-be0a-668a2b22c57c",
    "patient_ID": "TCGA.28.6450",
    "bcr_drug_barcode": "TCGA-28-6450-D28919",
    "bcr_drug_uuid": "70c4d10f-b3c9-44e8-8385-36ad7aaa2392",
    "form_completion_date": "2011-7-22",
    "pharmaceutical_therapy_drug_name": "TEMOXOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 41,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 125,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2125
  },
  {
    "bcr_patient_uuid": "6c5154d2-af36-492f-b520-d925528824e4",
    "patient_ID": "TCGA.32.1970",
    "bcr_drug_barcode": "TCGA-32-1970-D27720",
    "bcr_drug_uuid": "5a56bde4-e248-481d-949d-2a2081c5e84a",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 67,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 170,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6800
  },
  {
    "bcr_patient_uuid": "6c5154d2-af36-492f-b520-d925528824e4",
    "patient_ID": "TCGA.32.1970",
    "bcr_drug_barcode": "TCGA-32-1970-D27721",
    "bcr_drug_uuid": "22a1e898-e102-4e88-a0da-a1e31d13a020",
    "form_completion_date": "2010-7-6",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f6d64459-e639-4557-bf10-a9148263ee26",
    "patient_ID": "TCGA.32.1973",
    "bcr_drug_barcode": "TCGA-32-1973-D27727",
    "bcr_drug_uuid": "92c146a5-ed33-460e-a27e-999907f50690",
    "form_completion_date": "2011-6-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 64,
    "drug_dose": 300,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f6d64459-e639-4557-bf10-a9148263ee26",
    "patient_ID": "TCGA.32.1973",
    "bcr_drug_barcode": "TCGA-32-1973-D27729",
    "bcr_drug_uuid": "1ab2fc02-68f8-4fb9-8194-ac9aa7706fca",
    "form_completion_date": "2011-6-15",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 549,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 631,
    "drug_cycles": 6,
    "drug_dose": 949,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "f6d64459-e639-4557-bf10-a9148263ee26",
    "patient_ID": "TCGA.32.1973",
    "bcr_drug_barcode": "TCGA-32-1973-D27730",
    "bcr_drug_uuid": "e902c34d-b887-4d7e-a999-5ac5955c0eea",
    "form_completion_date": "2011-6-15",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 549,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 631,
    "drug_cycles": 6,
    "drug_dose": 125,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "f6d64459-e639-4557-bf10-a9148263ee26",
    "patient_ID": "TCGA.32.1973",
    "bcr_drug_barcode": "TCGA-32-1973-D27726",
    "bcr_drug_uuid": "1914aeb1-3d99-4896-b81a-5ed5e5362d9a",
    "form_completion_date": "2011-6-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 521,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 542,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "f6d64459-e639-4557-bf10-a9148263ee26",
    "patient_ID": "TCGA.32.1973",
    "bcr_drug_barcode": "TCGA-32-1973-D27725",
    "bcr_drug_uuid": "6770b085-082a-4d02-84a3-27e1604c9488",
    "form_completion_date": "2011-6-15",
    "pharmaceutical_therapy_drug_name": "BIBW2992",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 521,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 542,
    "drug_cycles": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "f6d64459-e639-4557-bf10-a9148263ee26",
    "patient_ID": "TCGA.32.1973",
    "bcr_drug_barcode": "TCGA-32-1973-D27728",
    "bcr_drug_uuid": "23a0a6a7-9fd2-4eec-a9a5-774a34e51303",
    "form_completion_date": "2011-6-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 99,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 417,
    "drug_cycles": 12,
    "drug_dose": 390,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f6d64459-e639-4557-bf10-a9148263ee26",
    "patient_ID": "TCGA.32.1973",
    "bcr_drug_barcode": "TCGA-32-1973-D27731",
    "bcr_drug_uuid": "a93fe9c1-ad81-4585-88a1-5d8786b4ddc8",
    "form_completion_date": "2012-1-24",
    "pharmaceutical_therapy_drug_name": "METEXAFIN GADOLINIUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 32,
    "drug_cycles": 2,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_dose": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c34760a2-f70e-48c4-a7c2-eb359f8aeb71",
    "patient_ID": "TCGA.32.1982",
    "bcr_drug_barcode": "TCGA-32-1982-D27740",
    "bcr_drug_uuid": "4a36d971-b0df-4fd6-9ace-da9a1a671b69",
    "form_completion_date": "2010-4-7",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFER",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PERI-OPERATIVE PLACEMENT"
  },
  {
    "bcr_patient_uuid": "7ac80045-7c05-4e8f-8217-a380544a6125",
    "patient_ID": "TCGA.32.1986",
    "bcr_drug_barcode": "TCGA-32-1986-D27743",
    "bcr_drug_uuid": "4d4ed8e9-a057-47ab-a5ee-5c691e916f27",
    "form_completion_date": "2010-3-8",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "582f0912-20e9-4790-afd9-1e858728223e",
    "patient_ID": "TCGA.32.1987",
    "bcr_drug_barcode": "TCGA-32-1987-D27748",
    "bcr_drug_uuid": "59a6a444-f694-4213-9f91-be66bd1dd655",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "GLIADLE WAFER",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 68,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_dose": 5,
    "drug_route": "OTHER",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "582f0912-20e9-4790-afd9-1e858728223e",
    "patient_ID": "TCGA.32.1987",
    "bcr_drug_barcode": "TCGA-32-1987-D27747",
    "bcr_drug_uuid": "d968cd26-5505-40c6-8704-3557fa0f654c",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 67,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 120
  },
  {
    "bcr_patient_uuid": "582f0912-20e9-4790-afd9-1e858728223e",
    "patient_ID": "TCGA.32.1987",
    "bcr_drug_barcode": "TCGA-32-1987-D27749",
    "bcr_drug_uuid": "25bd592b-de2d-4135-9b24-45b8b2aca523",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 130,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 250,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "582f0912-20e9-4790-afd9-1e858728223e",
    "patient_ID": "TCGA.32.1987",
    "bcr_drug_barcode": "TCGA-32-1987-D27750",
    "bcr_drug_uuid": "ea58f330-7359-469a-9eca-224c12f649b2",
    "form_completion_date": "2011-1-7",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 222,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "73655446-bbf3-4cc9-a032-2c95051bc3e7",
    "patient_ID": "TCGA.32.1991",
    "bcr_drug_barcode": "TCGA-32-1991-D27755",
    "bcr_drug_uuid": "3e651692-ea42-4c93-8c1a-96bf3304b71e",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 65,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 165,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "73655446-bbf3-4cc9-a032-2c95051bc3e7",
    "patient_ID": "TCGA.32.1991",
    "bcr_drug_barcode": "TCGA-32-1991-D27757",
    "bcr_drug_uuid": "1085f111-0ec1-4dab-94f0-750fa2b1207b",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 124,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 341,
    "drug_cycles": 8,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 425,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "73655446-bbf3-4cc9-a032-2c95051bc3e7",
    "patient_ID": "TCGA.32.1991",
    "bcr_drug_barcode": "TCGA-32-1991-D27754",
    "bcr_drug_uuid": "4d1502ed-6b1a-4c5f-a6b8-36cbb1a14eea",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFER",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 0,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_dose": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "73655446-bbf3-4cc9-a032-2c95051bc3e7",
    "patient_ID": "TCGA.32.1991",
    "bcr_drug_barcode": "TCGA-32-1991-D27756",
    "bcr_drug_uuid": "39c7a0ed-9b64-4257-b0af-e7cc077a23e1",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 330,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "73655446-bbf3-4cc9-a032-2c95051bc3e7",
    "patient_ID": "TCGA.32.1991",
    "bcr_drug_barcode": "TCGA-32-1991-D27758",
    "bcr_drug_uuid": "8c0fc1ef-9971-4683-95a6-c0a8ac6c8c97",
    "form_completion_date": "2010-12-29",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 330,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "73655446-bbf3-4cc9-a032-2c95051bc3e7",
    "patient_ID": "TCGA.32.1991",
    "bcr_drug_barcode": "TCGA-32-1991-D27759",
    "bcr_drug_uuid": "993e3736-742e-497f-8708-e52433246b2c",
    "form_completion_date": "2012-1-24",
    "pharmaceutical_therapy_drug_name": "MOTEXAFIN GADOLINIUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 65,
    "drug_cycles": 6,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_dose": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ace727ec-036b-4ddc-9af8-eecf70ec6b46",
    "patient_ID": "TCGA.32.2491",
    "bcr_drug_barcode": "TCGA-32-2491-D27763",
    "bcr_drug_uuid": "a1a09f4b-70ab-4b99-b68b-241a27ee282b",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 59,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 160,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6720
  },
  {
    "bcr_patient_uuid": "ace727ec-036b-4ddc-9af8-eecf70ec6b46",
    "patient_ID": "TCGA.32.2491",
    "bcr_drug_barcode": "TCGA-32-2491-D27764",
    "bcr_drug_uuid": "98c6f9e3-f0c7-4982-a591-0f6e38cfd900",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 117,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "c50998f6-369c-48fe-a8e7-a4c5a4cef0e6",
    "patient_ID": "TCGA.32.2494",
    "bcr_drug_barcode": "TCGA-32-2494-D27772",
    "bcr_drug_uuid": "2a332a3a-ca7f-4da6-ac47-152c0d7d6758",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 620,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 632,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 140,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "c50998f6-369c-48fe-a8e7-a4c5a4cef0e6",
    "patient_ID": "TCGA.32.2494",
    "bcr_drug_barcode": "TCGA-32-2494-D27770",
    "bcr_drug_uuid": "e219e486-472b-48ab-850c-fec4200c4587",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 120,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 403,
    "drug_cycles": 11,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 360,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "c50998f6-369c-48fe-a8e7-a4c5a4cef0e6",
    "patient_ID": "TCGA.32.2494",
    "bcr_drug_barcode": "TCGA-32-2494-D27768",
    "bcr_drug_uuid": "1e3c0434-c474-4a96-9144-9c9432099042",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 62,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 140,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "c50998f6-369c-48fe-a8e7-a4c5a4cef0e6",
    "patient_ID": "TCGA.32.2494",
    "bcr_drug_barcode": "TCGA-32-2494-D27769",
    "bcr_drug_uuid": "1eeb1090-c56d-446f-8625-60a84daeb2b9",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 270,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "c50998f6-369c-48fe-a8e7-a4c5a4cef0e6",
    "patient_ID": "TCGA.32.2494",
    "bcr_drug_barcode": "TCGA-32-2494-D27771",
    "bcr_drug_uuid": "c24fcaeb-2e4c-41fc-8992-b796383b575a",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 488,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 550,
    "drug_cycles": 4,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 160,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "c50998f6-369c-48fe-a8e7-a4c5a4cef0e6",
    "patient_ID": "TCGA.32.2494",
    "bcr_drug_barcode": "TCGA-32-2494-D27773",
    "bcr_drug_uuid": "96787b91-a0da-495a-a13c-40b622e695d4",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 488,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 550,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "c50998f6-369c-48fe-a8e7-a4c5a4cef0e6",
    "patient_ID": "TCGA.32.2494",
    "bcr_drug_barcode": "TCGA-32-2494-D27774",
    "bcr_drug_uuid": "3516c9ee-ab98-4cd4-a9f6-8eecd977d1e7",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 620,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 620,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "e7d728e5-1a9f-4f27-9604-272e1235e08a",
    "patient_ID": "TCGA.32.2495",
    "bcr_drug_barcode": "TCGA-32-2495-D27780",
    "bcr_drug_uuid": "482fa70c-54dc-4643-9a6d-474e56b43982",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 75,
    "drug_cycles": 1,
    "drug_dose": 140,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e7d728e5-1a9f-4f27-9604-272e1235e08a",
    "patient_ID": "TCGA.32.2495",
    "bcr_drug_barcode": "TCGA-32-2495-D27783",
    "bcr_drug_uuid": "e596888d-1a05-4bf9-afe6-bd0e175b9be0",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFER",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 252,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 252,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_dose": 5,
    "drug_route": "OTHER",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "e7d728e5-1a9f-4f27-9604-272e1235e08a",
    "patient_ID": "TCGA.32.2495",
    "bcr_drug_barcode": "TCGA-32-2495-D27784",
    "bcr_drug_uuid": "9e7affcd-7903-4f1c-9350-91e217ee5238",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 278,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 429,
    "drug_cycles": 5,
    "drug_dose": 380,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "e7d728e5-1a9f-4f27-9604-272e1235e08a",
    "patient_ID": "TCGA.32.2495",
    "bcr_drug_barcode": "TCGA-32-2495-D27782",
    "bcr_drug_uuid": "ed1ee8a5-93e1-41b9-8b4f-4bf7f59e7d6f",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 131,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 192,
    "drug_cycles": 3,
    "drug_dose": 380,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e7d728e5-1a9f-4f27-9604-272e1235e08a",
    "patient_ID": "TCGA.32.2495",
    "bcr_drug_barcode": "TCGA-32-2495-D27781",
    "bcr_drug_uuid": "36802f7d-4ae4-4ad3-ab0e-cade10373128",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "drug_cycles": 1,
    "drug_dose": 290,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "30011f30-2926-47f2-a8f3-4f1b58ffa227",
    "patient_ID": "TCGA.32.2615",
    "bcr_drug_barcode": "TCGA-32-2615-D27791",
    "bcr_drug_uuid": "582aa494-34c7-47ca-ba58-f426d71a2953",
    "form_completion_date": "2010-6-1",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 100,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "30011f30-2926-47f2-a8f3-4f1b58ffa227",
    "patient_ID": "TCGA.32.2615",
    "bcr_drug_barcode": "TCGA-32-2615-D27789",
    "bcr_drug_uuid": "9d0f512f-7989-4862-b7ba-d4a3408cd70a",
    "form_completion_date": "2010-6-1",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 65,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 160,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "30011f30-2926-47f2-a8f3-4f1b58ffa227",
    "patient_ID": "TCGA.32.2615",
    "bcr_drug_barcode": "TCGA-32-2615-D27793",
    "bcr_drug_uuid": "b9b1765a-c2af-43cd-beff-0fc69aaec23f",
    "form_completion_date": "2010-6-1",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFERS",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 285,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 285,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_route": "OTHER"
  },
  {
    "bcr_patient_uuid": "30011f30-2926-47f2-a8f3-4f1b58ffa227",
    "patient_ID": "TCGA.32.2615",
    "bcr_drug_barcode": "TCGA-32-2615-D27796",
    "bcr_drug_uuid": "d9e68353-6b88-4800-8754-296aea6c596e",
    "form_completion_date": "2010-6-1",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 301,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "30011f30-2926-47f2-a8f3-4f1b58ffa227",
    "patient_ID": "TCGA.32.2615",
    "bcr_drug_barcode": "TCGA-32-2615-D27790",
    "bcr_drug_uuid": "007d3e5a-507e-4dfa-81eb-439bc7a6dd02",
    "form_completion_date": "2010-6-1",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFER",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 0,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "30011f30-2926-47f2-a8f3-4f1b58ffa227",
    "patient_ID": "TCGA.32.2615",
    "bcr_drug_barcode": "TCGA-32-2615-D27792",
    "bcr_drug_uuid": "dc873395-2359-4e2c-99fe-9d44278518b5",
    "form_completion_date": "2010-6-1",
    "pharmaceutical_therapy_drug_name": "METRONOMIC TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 161,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 273,
    "drug_cycles": 4,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 155
  },
  {
    "bcr_patient_uuid": "30011f30-2926-47f2-a8f3-4f1b58ffa227",
    "patient_ID": "TCGA.32.2615",
    "bcr_drug_barcode": "TCGA-32-2615-D27795",
    "bcr_drug_uuid": "ff336389-7288-40cd-8dca-6e3e471eb4d3",
    "form_completion_date": "2010-6-1",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 301,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "30011f30-2926-47f2-a8f3-4f1b58ffa227",
    "patient_ID": "TCGA.32.2615",
    "bcr_drug_barcode": "TCGA-32-2615-D27794",
    "bcr_drug_uuid": "3b19be5f-2bc7-421a-8614-ede3652c5f26",
    "form_completion_date": "2010-10-14",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFER",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 285,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 285,
    "drug_route": "OTHER",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "52408d9f-2637-4952-9b90-cb607a860f23",
    "patient_ID": "TCGA.32.2616",
    "bcr_drug_barcode": "TCGA-32-2616-D30228",
    "bcr_drug_uuid": "c8b4b9a7-cea5-4d49-98a7-8916039fc5fd",
    "form_completion_date": "2010-7-6",
    "pharmaceutical_therapy_drug_name": "MOTEXATIN GADOINIUM",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 51,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 50167
  },
  {
    "bcr_patient_uuid": "52408d9f-2637-4952-9b90-cb607a860f23",
    "patient_ID": "TCGA.32.2616",
    "bcr_drug_barcode": "TCGA-32-2616-D30225",
    "bcr_drug_uuid": "b36e4390-7f11-45a9-a266-b7e3135a7730",
    "form_completion_date": "2010-7-6",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 71,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5590
  },
  {
    "bcr_patient_uuid": "52408d9f-2637-4952-9b90-cb607a860f23",
    "patient_ID": "TCGA.32.2616",
    "bcr_drug_barcode": "TCGA-32-2616-D30227",
    "bcr_drug_uuid": "94ef4eb7-70aa-4d22-83ab-e192b3504fb8",
    "form_completion_date": "2010-7-6",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 129,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 360
  },
  {
    "bcr_patient_uuid": "52408d9f-2637-4952-9b90-cb607a860f23",
    "patient_ID": "TCGA.32.2616",
    "bcr_drug_barcode": "TCGA-32-2616-D30226",
    "bcr_drug_uuid": "0d32cb36-431d-4b6d-b6e8-3973fdc53252",
    "form_completion_date": "2010-7-6",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 105,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 270,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1350
  },
  {
    "bcr_patient_uuid": "1030a6b9-0df8-4d60-b69f-2a36e630a6ad",
    "patient_ID": "TCGA.32.2634",
    "bcr_drug_barcode": "TCGA-32-2634-D27802",
    "bcr_drug_uuid": "1b38b4c7-7cc1-4d36-8d39-ab4e7d546337",
    "form_completion_date": "2010-7-30",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFER",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 0,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_route": "OTHER"
  },
  {
    "bcr_patient_uuid": "1030a6b9-0df8-4d60-b69f-2a36e630a6ad",
    "patient_ID": "TCGA.32.2634",
    "bcr_drug_barcode": "TCGA-32-2634-D27801",
    "bcr_drug_uuid": "add3771c-2c0e-4ab7-84bc-df8f62747058",
    "form_completion_date": "2010-7-30",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 59,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "1030a6b9-0df8-4d60-b69f-2a36e630a6ad",
    "patient_ID": "TCGA.32.2634",
    "bcr_drug_barcode": "TCGA-32-2634-D27803",
    "bcr_drug_uuid": "490e02e6-76ed-4669-a268-f1f558371b0d",
    "form_completion_date": "2010-9-16",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 108,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 11,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "MAINTAINENCE"
  },
  {
    "bcr_patient_uuid": "1b25795e-69ad-47fd-bb2f-94ff0910fae1",
    "patient_ID": "TCGA.32.2638",
    "bcr_drug_barcode": "TCGA-32-2638-D27809",
    "bcr_drug_uuid": "90bfcd5e-eea7-40b7-bf20-e78b8b99204f",
    "form_completion_date": "2010-8-31",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB OR PLACEBO RTOG 0825",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1b25795e-69ad-47fd-bb2f-94ff0910fae1",
    "patient_ID": "TCGA.32.2638",
    "bcr_drug_barcode": "TCGA-32-2638-D27807",
    "bcr_drug_uuid": "ec5d9310-7853-4497-9be0-12860c642cae",
    "form_completion_date": "2010-8-31",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 68,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 190
  },
  {
    "bcr_patient_uuid": "1b25795e-69ad-47fd-bb2f-94ff0910fae1",
    "patient_ID": "TCGA.32.2638",
    "bcr_drug_barcode": "TCGA-32-2638-D27808",
    "bcr_drug_uuid": "34681eed-1319-4185-93b7-7ddea7bfdc42",
    "form_completion_date": "2010-10-6",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 110,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 114,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 380
  },
  {
    "bcr_patient_uuid": "581e04f9-4d0b-4ed2-97f5-2f97ace24928",
    "patient_ID": "TCGA.32.4208",
    "bcr_drug_barcode": "TCGA-32-4208-D27814",
    "bcr_drug_uuid": "261e05ff-2058-4315-92af-a17b7df4acd8",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 146,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 150,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 300,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "581e04f9-4d0b-4ed2-97f5-2f97ace24928",
    "patient_ID": "TCGA.32.4208",
    "bcr_drug_barcode": "TCGA-32-4208-D27813",
    "bcr_drug_uuid": "2e92825d-18c1-4950-a770-75a54f507122",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 140,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "581e04f9-4d0b-4ed2-97f5-2f97ace24928",
    "patient_ID": "TCGA.32.4208",
    "bcr_drug_barcode": "TCGA-32-4208-D27815",
    "bcr_drug_uuid": "14130a24-dc74-4da4-8d76-676c9cbc3c31",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 174,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 300,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5438322c-9db0-4974-ba01-801020559f97",
    "patient_ID": "TCGA.32.4209",
    "bcr_drug_barcode": "TCGA-32-4209-D27819",
    "bcr_drug_uuid": "071dac56-27f1-4506-93e0-c68bbb93a043",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "5438322c-9db0-4974-ba01-801020559f97",
    "patient_ID": "TCGA.32.4209",
    "bcr_drug_barcode": "TCGA-32-4209-D15702",
    "bcr_drug_uuid": "48ce23ce-d98b-4075-b3e0-fbda78dd4ac7",
    "form_completion_date": "2011-8-16",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 503,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 532,
    "drug_cycles": 2,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "5438322c-9db0-4974-ba01-801020559f97",
    "patient_ID": "TCGA.32.4209",
    "bcr_drug_barcode": "TCGA-32-4209-D15701",
    "bcr_drug_uuid": "ced759d1-9f51-4d4c-ac47-b32f89ea6d2a",
    "form_completion_date": "2011-8-16",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 503,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 553,
    "drug_cycles": 4,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "516194e7-2143-4049-be54-141f515bcee5",
    "patient_ID": "TCGA.32.4211",
    "bcr_drug_barcode": "TCGA-32-4211-D27826",
    "bcr_drug_uuid": "3a3e8c58-3ab2-42d6-92b4-56fab58864ec",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 97,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 330,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "516194e7-2143-4049-be54-141f515bcee5",
    "patient_ID": "TCGA.32.4211",
    "bcr_drug_barcode": "TCGA-32-4211-D27827",
    "bcr_drug_uuid": "6db77e7e-7c16-4870-8a80-9179a3c3d386",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 127,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 440,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "516194e7-2143-4049-be54-141f515bcee5",
    "patient_ID": "TCGA.32.4211",
    "bcr_drug_barcode": "TCGA-32-4211-D27825",
    "bcr_drug_uuid": "cb98caea-22bb-45f2-9292-ced22975dff8",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 65,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 160,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "22e0c3ea-9f6d-4d73-9282-17ee4553f436",
    "patient_ID": "TCGA.32.4213",
    "bcr_drug_barcode": "TCGA-32-4213-D27831",
    "bcr_drug_uuid": "865a82af-3fc7-43e0-917d-4d944cfcc0f3",
    "form_completion_date": "2010-12-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 130
  },
  {
    "bcr_patient_uuid": "22e0c3ea-9f6d-4d73-9282-17ee4553f436",
    "patient_ID": "TCGA.32.4213",
    "bcr_drug_barcode": "TCGA-32-4213-D27832",
    "bcr_drug_uuid": "39690c3e-a90a-4837-ad5b-b507484a97d3",
    "form_completion_date": "2010-12-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 130,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 390
  },
  {
    "bcr_patient_uuid": "22e0c3ea-9f6d-4d73-9282-17ee4553f436",
    "patient_ID": "TCGA.32.4213",
    "bcr_drug_barcode": "TCGA-32-4213-D27833",
    "bcr_drug_uuid": "cde26995-85fe-4eed-8de5-d6bdd50d364b",
    "form_completion_date": "2010-12-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 155,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 289,
    "drug_cycles": 5,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "22e0c3ea-9f6d-4d73-9282-17ee4553f436",
    "patient_ID": "TCGA.32.4213",
    "bcr_drug_barcode": "TCGA-32-4213-D15679",
    "bcr_drug_uuid": "20a88f18-2146-46f0-8db1-6211fedf59f2",
    "form_completion_date": "2011-8-15",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 561,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 944,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3776
  },
  {
    "bcr_patient_uuid": "71bb1ef7-2bda-4478-b5b8-318f2e1bf5ac",
    "patient_ID": "TCGA.32.4719",
    "bcr_drug_barcode": "TCGA-32-4719-D27838",
    "bcr_drug_uuid": "177bd4e1-745f-44c9-802e-80d6fc30484e",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 140,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "71bb1ef7-2bda-4478-b5b8-318f2e1bf5ac",
    "patient_ID": "TCGA.32.4719",
    "bcr_drug_barcode": "TCGA-32-4719-D27839",
    "bcr_drug_uuid": "462da949-9f2b-4637-906b-8d44bcda53a0",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 245,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 380,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "e876dd29-68b0-4bf1-83d1-488c40068a35",
    "patient_ID": "TCGA.32.5222",
    "bcr_drug_barcode": "TCGA-32-5222-D27843",
    "bcr_drug_uuid": "c6cbe0c0-a19b-45c9-bd7e-87d3fe7c6780",
    "form_completion_date": "2011-1-4",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 77,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5880
  },
  {
    "bcr_patient_uuid": "722f462d-f939-4bc1-aae4-8f78b1335a87",
    "patient_ID": "TCGA.41.2571",
    "bcr_drug_barcode": "TCGA-41-2571-D27981",
    "bcr_drug_uuid": "859dbe3d-138e-4209-b273-439380cfcf98",
    "form_completion_date": "2010-6-3",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 25,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "drug_route": "ORAL",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 640
  },
  {
    "bcr_patient_uuid": "1e80ccf6-ef81-4662-bf5e-392f092c1e67",
    "patient_ID": "TCGA.41.2572",
    "bcr_drug_barcode": "TCGA-41-2572-D27985",
    "bcr_drug_uuid": "bf068f08-f341-47c3-b512-53c5700e4ff5",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 76,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 180,
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "CONCURRENT CHEMORADIATION",
    "drug_total_dose": 7740
  },
  {
    "bcr_patient_uuid": "1e80ccf6-ef81-4662-bf5e-392f092c1e67",
    "patient_ID": "TCGA.41.2572",
    "bcr_drug_barcode": "TCGA-41-2572-D27984",
    "bcr_drug_uuid": "007ce491-6d9c-4f0e-9caa-cd5995906d1e",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 133,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 351,
    "drug_cycles": 13,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1200,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 15600
  },
  {
    "bcr_patient_uuid": "12084e89-dbc2-43b3-a6d0-0e71e53d0eac",
    "patient_ID": "TCGA.41.2573",
    "bcr_drug_barcode": "TCGA-41-2573-D27991",
    "bcr_drug_uuid": "a3d18c13-e136-4a2b-87bf-5044a815f002",
    "form_completion_date": "2010-6-3",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 100,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6880
  },
  {
    "bcr_patient_uuid": "12084e89-dbc2-43b3-a6d0-0e71e53d0eac",
    "patient_ID": "TCGA.41.2573",
    "bcr_drug_barcode": "TCGA-41-2573-D27992",
    "bcr_drug_uuid": "dca3ad96-1573-4f51-b941-8658a79b4585",
    "form_completion_date": "2010-6-3",
    "pharmaceutical_therapy_drug_name": "BSI-201",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 127,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "12084e89-dbc2-43b3-a6d0-0e71e53d0eac",
    "patient_ID": "TCGA.41.2573",
    "bcr_drug_barcode": "TCGA-41-2573-D27990",
    "bcr_drug_uuid": "f4692860-da70-472d-82c2-6f318eb44ae8",
    "form_completion_date": "2010-6-3",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 71,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6720
  },
  {
    "bcr_patient_uuid": "12084e89-dbc2-43b3-a6d0-0e71e53d0eac",
    "patient_ID": "TCGA.41.2573",
    "bcr_drug_barcode": "TCGA-41-2573-D27993",
    "bcr_drug_uuid": "c4068185-3336-49fd-99d6-957b2c325c4d",
    "form_completion_date": "2010-6-3",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 171,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "2c922593-d94d-4e8f-b68b-b4b8cfcbf3e4",
    "patient_ID": "TCGA.41.2575",
    "bcr_drug_barcode": "TCGA-41-2575-D27998",
    "bcr_drug_uuid": "73405d0f-18d3-43f3-9647-a7b392e6b4fb",
    "form_completion_date": "2010-6-3",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 166,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 800,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 800
  },
  {
    "bcr_patient_uuid": "2c922593-d94d-4e8f-b68b-b4b8cfcbf3e4",
    "patient_ID": "TCGA.41.2575",
    "bcr_drug_barcode": "TCGA-41-2575-D27997",
    "bcr_drug_uuid": "35d81a9a-4706-4bba-a29b-4fbd5ca51e15",
    "form_completion_date": "2010-6-3",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7140
  },
  {
    "bcr_patient_uuid": "6fac5bce-2bc0-4234-9e3e-11891c2fe00e",
    "patient_ID": "TCGA.41.3393",
    "bcr_drug_barcode": "TCGA-41-3393-D28005",
    "bcr_drug_uuid": "5040f925-eee6-4347-af3b-cebf0cec314c",
    "form_completion_date": "2010-11-18",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 95,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 120,
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "CONCURRENT CHEMORADIATION",
    "drug_total_dose": 5040
  },
  {
    "bcr_patient_uuid": "43d98306-8b1f-4840-a1a0-146ba0c36400",
    "patient_ID": "TCGA.41.3915",
    "bcr_drug_barcode": "TCGA-41-3915-D28010",
    "bcr_drug_uuid": "0d531287-7767-4564-be4c-99ee0c56afa0",
    "form_completion_date": "2010-10-26",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 115,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 320,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5200
  },
  {
    "bcr_patient_uuid": "43d98306-8b1f-4840-a1a0-146ba0c36400",
    "patient_ID": "TCGA.41.3915",
    "bcr_drug_barcode": "TCGA-41-3915-D28009",
    "bcr_drug_uuid": "52655b5c-d821-4647-a51a-45e34ed7383b",
    "form_completion_date": "2010-10-26",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 71,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "CONCURRENT CHEMORADIATION",
    "drug_total_dose": 6880
  },
  {
    "bcr_patient_uuid": "43d98306-8b1f-4840-a1a0-146ba0c36400",
    "patient_ID": "TCGA.41.3915",
    "bcr_drug_barcode": "TCGA-41-3915-D15059",
    "bcr_drug_uuid": "e5656f8e-19c3-436b-817c-50a2641c993c",
    "form_completion_date": "2011-5-5",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 202,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 289,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 400,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8000
  },
  {
    "bcr_patient_uuid": "c184c3ca-7ad3-4202-b108-cb9fd5f5d947",
    "patient_ID": "TCGA.41.5651",
    "bcr_drug_barcode": "TCGA-41-5651-D28019",
    "bcr_drug_uuid": "9c394e26-2496-4a2a-beae-f115e84937d8",
    "form_completion_date": "2011-7-21",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 345,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 800,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 800
  },
  {
    "bcr_patient_uuid": "c184c3ca-7ad3-4202-b108-cb9fd5f5d947",
    "patient_ID": "TCGA.41.5651",
    "bcr_drug_barcode": "TCGA-41-5651-D28018",
    "bcr_drug_uuid": "4de58769-cb3c-4929-8f4f-7517a228ce43",
    "form_completion_date": "2011-7-21",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFER CARMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 231,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_route": "OTHER",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "c184c3ca-7ad3-4202-b108-cb9fd5f5d947",
    "patient_ID": "TCGA.41.5651",
    "bcr_drug_barcode": "TCGA-41-5651-D28017",
    "bcr_drug_uuid": "cc7a3d94-37a3-453a-bd42-14500a5d8f30",
    "form_completion_date": "2011-7-21",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 195,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 350,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6600
  },
  {
    "bcr_patient_uuid": "c184c3ca-7ad3-4202-b108-cb9fd5f5d947",
    "patient_ID": "TCGA.41.5651",
    "bcr_drug_barcode": "TCGA-41-5651-D28016",
    "bcr_drug_uuid": "60baa3a3-2134-4002-ad3b-3c0204da5b42",
    "form_completion_date": "2011-7-21",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 77,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6580
  },
  {
    "bcr_patient_uuid": "c184c3ca-7ad3-4202-b108-cb9fd5f5d947",
    "patient_ID": "TCGA.41.5651",
    "bcr_drug_barcode": "TCGA-41-5651-D19527",
    "bcr_drug_uuid": "f335ba4c-5253-4b79-aafa-a55277c8bda3",
    "form_completion_date": "2011-12-6",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 359,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 387,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 850,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2550
  },
  {
    "bcr_patient_uuid": "a8d708ab-6388-4d42-bc6e-05a8a718ecff",
    "patient_ID": "TCGA.41.6646",
    "bcr_drug_barcode": "TCGA-41-6646-D28024",
    "bcr_drug_uuid": "e3083c20-1ad0-4e48-af69-06f619ebaf21",
    "form_completion_date": "2011-10-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 196,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 320,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5600
  },
  {
    "bcr_patient_uuid": "a8d708ab-6388-4d42-bc6e-05a8a718ecff",
    "patient_ID": "TCGA.41.6646",
    "bcr_drug_barcode": "TCGA-41-6646-D28023",
    "bcr_drug_uuid": "e380dac2-eab0-4fcf-a1c3-d9aa7f9ac98c",
    "form_completion_date": "2011-10-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 81,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6720
  },
  {
    "bcr_patient_uuid": "7A8D2E13-315E-4512-85CE-B018D11C3BD3",
    "patient_ID": "TCGA.4W.AA9S",
    "bcr_drug_barcode": "TCGA-4W-AA9S-D57927",
    "bcr_drug_uuid": "C1336EBF-B2BD-46FC-BEA2-30355BFE49F7",
    "form_completion_date": "2014-3-28",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 105,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "998C8517-89C1-43B2-84E4-B60905787BF6",
    "patient_ID": "TCGA.4W.AA9T",
    "bcr_drug_barcode": "TCGA-4W-AA9T-D57622",
    "bcr_drug_uuid": "51F91701-01EF-4C07-B456-A046F5A4CC49",
    "form_completion_date": "2014-3-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8d0d7a7e-8fae-437d-9b39-f2f17d0f5e4f",
    "patient_ID": "TCGA.74.6573",
    "bcr_drug_barcode": "TCGA-74-6573-D16945",
    "bcr_drug_uuid": "5158357e-c66f-4194-8966-f0fca1fb9522",
    "form_completion_date": "2011-8-22",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 66,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6020
  },
  {
    "bcr_patient_uuid": "66a03e91-77c7-4aef-a825-6deef805640c",
    "patient_ID": "TCGA.74.6575",
    "bcr_drug_barcode": "TCGA-74-6575-D16936",
    "bcr_drug_uuid": "a393e4d1-27bc-408b-84d9-5947abec5d4e",
    "form_completion_date": "2011-8-22",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 498,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 1,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_dose": 10,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "66a03e91-77c7-4aef-a825-6deef805640c",
    "patient_ID": "TCGA.74.6575",
    "bcr_drug_barcode": "TCGA-74-6575-D16933",
    "bcr_drug_uuid": "a282c037-9736-4ebc-84bb-b65a5f23594f",
    "form_completion_date": "2011-8-22",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "drug_cycles": 2,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2000
  },
  {
    "bcr_patient_uuid": "66a03e91-77c7-4aef-a825-6deef805640c",
    "patient_ID": "TCGA.74.6575",
    "bcr_drug_barcode": "TCGA-74-6575-D16934",
    "bcr_drug_uuid": "bd0e8a02-abc6-48f0-b9bb-1c327a772fde",
    "form_completion_date": "2011-8-22",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 152,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 498,
    "drug_cycles": 1,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_dose": 5,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 255
  },
  {
    "bcr_patient_uuid": "66a03e91-77c7-4aef-a825-6deef805640c",
    "patient_ID": "TCGA.74.6575",
    "bcr_drug_barcode": "TCGA-74-6575-D16931",
    "bcr_drug_uuid": "5d345e5f-8483-4366-9c33-9d7298fb0a49",
    "form_completion_date": "2011-8-22",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 73,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 120,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4560
  },
  {
    "bcr_patient_uuid": "9888bf87-d0d1-474b-960d-d76b13352e7c",
    "patient_ID": "TCGA.74.6577",
    "bcr_drug_barcode": "TCGA-74-6577-D16926",
    "bcr_drug_uuid": "0ba76d76-6f18-46a6-a4a9-45943f64f9b7",
    "form_completion_date": "2011-8-22",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 132,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 1,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_dose": 10,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "9888bf87-d0d1-474b-960d-d76b13352e7c",
    "patient_ID": "TCGA.74.6577",
    "bcr_drug_barcode": "TCGA-74-6577-D16924",
    "bcr_drug_uuid": "2d901e25-b8e9-4c7d-ba3d-d21b177f807f",
    "form_completion_date": "2011-8-22",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 99,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6300
  },
  {
    "bcr_patient_uuid": "4dee170b-175c-4e08-83f4-af1317b07209",
    "patient_ID": "TCGA.74.6578",
    "bcr_drug_barcode": "TCGA-74-6578-D16916",
    "bcr_drug_uuid": "1A5A915F-A227-45D6-8DEE-7B4E90AE1645",
    "form_completion_date": "2011-8-22",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 80,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6450
  },
  {
    "bcr_patient_uuid": "4dee170b-175c-4e08-83f4-af1317b07209",
    "patient_ID": "TCGA.74.6578",
    "bcr_drug_barcode": "TCGA-74-6578-D16917",
    "bcr_drug_uuid": "A90B91AC-EF99-41F9-A42C-1BD275DC09D0",
    "form_completion_date": "2011-8-22",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 103,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 750
  },
  {
    "bcr_patient_uuid": "4dee170b-175c-4e08-83f4-af1317b07209",
    "patient_ID": "TCGA.74.6578",
    "bcr_drug_barcode": "TCGA-74-6578-D16918",
    "bcr_drug_uuid": "E3C9CD99-3327-40B9-A7B3-F0C15AA5826B",
    "form_completion_date": "2011-8-22",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 222,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 1,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_dose": 10,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "28629bf9-f447-4650-8fc2-53f1e938ab71",
    "patient_ID": "TCGA.74.6581",
    "bcr_drug_barcode": "TCGA-74-6581-D16911",
    "bcr_drug_uuid": "b5258e5a-6ef4-471f-80f5-686fac8268f1",
    "form_completion_date": "2011-8-29",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 6,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 200,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6000
  },
  {
    "bcr_patient_uuid": "28629bf9-f447-4650-8fc2-53f1e938ab71",
    "patient_ID": "TCGA.74.6581",
    "bcr_drug_barcode": "TCGA-74-6581-D16910",
    "bcr_drug_uuid": "8c98d7d3-f329-49e9-a3d4-21da9ba48c2c",
    "form_completion_date": "2011-8-29",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 74,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7350
  },
  {
    "bcr_patient_uuid": "22b5cbba-cc78-4377-a08c-a9413294c3bf",
    "patient_ID": "TCGA.74.6584",
    "bcr_drug_barcode": "TCGA-74-6584-D16905",
    "bcr_drug_uuid": "3b7a36f8-b01b-459b-9779-a9ea7eea3237",
    "form_completion_date": "2011-8-29",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 99,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 5,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 120,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 12600
  },
  {
    "bcr_patient_uuid": "22b5cbba-cc78-4377-a08c-a9413294c3bf",
    "patient_ID": "TCGA.74.6584",
    "bcr_drug_barcode": "TCGA-74-6584-D16903",
    "bcr_drug_uuid": "45baecb1-3a68-442a-8790-e02b10ec1c05",
    "form_completion_date": "2011-8-29",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 65,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6750
  },
  {
    "bcr_patient_uuid": "22b5cbba-cc78-4377-a08c-a9413294c3bf",
    "patient_ID": "TCGA.74.6584",
    "bcr_drug_barcode": "TCGA-74-6584-D16904",
    "bcr_drug_uuid": "e9dddcd8-49f1-4a17-a253-862d933efcad",
    "form_completion_date": "2011-8-29",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 11,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 10,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "872abc8a-6c1f-4114-b993-7d0327fb38bd",
    "patient_ID": "TCGA.76.4925",
    "bcr_drug_barcode": "TCGA-76-4925-D28520",
    "bcr_drug_uuid": "8cef6f46-6be3-416a-bc83-e7749f78ff25",
    "form_completion_date": "2011-4-6",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8df94420-c736-4a36-b001-5dbe3dff17f0",
    "patient_ID": "TCGA.76.4926",
    "bcr_drug_barcode": "TCGA-76-4926-D28524",
    "bcr_drug_uuid": "35e4183f-a4ff-47ba-affa-3b4b7adf2edd",
    "form_completion_date": "2011-4-6",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 83,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 115,
    "drug_cycles": 2,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "dfa3ef71-7006-4c6d-81c4-e0c0c7b75c26",
    "patient_ID": "TCGA.76.4928",
    "bcr_drug_barcode": "TCGA-76-4928-D28530",
    "bcr_drug_uuid": "dea4b05c-6e7c-46a3-a0f7-fed8446cef13",
    "form_completion_date": "2011-4-6",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70,
    "drug_cycles": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "752a6e21-9a91-417f-beba-bfdf331d5cac",
    "patient_ID": "TCGA.76.4931",
    "bcr_drug_barcode": "TCGA-76-4931-D28536",
    "bcr_drug_uuid": "e85bb422-6797-4491-9a76-ff92f29ccdf2",
    "form_completion_date": "2011-4-6",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "d6de8d1c-e5ff-45cd-b53e-f943d2578713",
    "patient_ID": "TCGA.76.4932",
    "bcr_drug_barcode": "TCGA-76-4932-D28540",
    "bcr_drug_uuid": "c51de629-6d65-44b7-8650-b637d6eaa342",
    "form_completion_date": "2011-4-6",
    "pharmaceutical_therapy_drug_name": "TEMODAR (ESCALATION)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL"
  },
  {
    "bcr_patient_uuid": "8820ca5f-4f6b-4389-ba86-9015d0bcec1d",
    "patient_ID": "TCGA.76.4935",
    "bcr_drug_barcode": "TCGA-76-4935-D28546",
    "bcr_drug_uuid": "43c3b07e-27ce-4106-a5ea-7d70d7705997",
    "form_completion_date": "2011-4-6",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 176,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 250,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8820ca5f-4f6b-4389-ba86-9015d0bcec1d",
    "patient_ID": "TCGA.76.4935",
    "bcr_drug_barcode": "TCGA-76-4935-D28547",
    "bcr_drug_uuid": "0b95be72-b90d-462c-ad4e-996802e9c0e8",
    "form_completion_date": "2011-4-6",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 590
  },
  {
    "bcr_patient_uuid": "8c3b2851-fced-473c-9c11-731eb66d8f3e",
    "patient_ID": "TCGA.76.6191",
    "bcr_drug_barcode": "TCGA-76-6191-D28551",
    "bcr_drug_uuid": "1ab4e260-08cc-4b28-b828-3960daa2d538",
    "form_completion_date": "2011-9-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 423,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8c3b2851-fced-473c-9c11-731eb66d8f3e",
    "patient_ID": "TCGA.76.6191",
    "bcr_drug_barcode": "TCGA-76-6191-D28552",
    "bcr_drug_uuid": "d0b09649-545e-41b3-b841-a65e8c509717",
    "form_completion_date": "2011-9-22",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 269,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 423,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "68749001-c4c2-415d-830c-07e39c3a504a",
    "patient_ID": "TCGA.76.6192",
    "bcr_drug_barcode": "TCGA-76-6192-D28558",
    "bcr_drug_uuid": "fcbdbb77-3971-4f72-89ee-cd7e287e01f2",
    "form_completion_date": "2011-9-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 75,
    "drug_cycles": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "aa15f655-c1e9-4f4a-acee-2fb76ec82858",
    "patient_ID": "TCGA.76.6193",
    "bcr_drug_barcode": "TCGA-76-6193-D28562",
    "bcr_drug_uuid": "824b4277-ad11-46d8-aada-57230c2b195e",
    "form_completion_date": "2011-9-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 9,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "6ccc0eda-96f8-475c-9d8c-016b26fdd81d",
    "patient_ID": "TCGA.76.6280",
    "bcr_drug_barcode": "TCGA-76-6280-D30215",
    "bcr_drug_uuid": "037b620a-7bfb-458d-976a-52dfddf89bbf",
    "form_completion_date": "2011-12-9",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c472482e-225d-4ab0-8ba5-b659e7ff3e89",
    "patient_ID": "TCGA.76.6282",
    "bcr_drug_barcode": "TCGA-76-6282-D28567",
    "bcr_drug_uuid": "eb32e1d0-919c-4062-a67b-bcc714d944c7",
    "form_completion_date": "2011-10-21",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 320,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 374,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 890,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5340
  },
  {
    "bcr_patient_uuid": "c472482e-225d-4ab0-8ba5-b659e7ff3e89",
    "patient_ID": "TCGA.76.6282",
    "bcr_drug_barcode": "TCGA-76-6282-D28566",
    "bcr_drug_uuid": "20576251-852f-4915-a59b-a0c8f7f110bc",
    "form_completion_date": "2011-10-21",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 213,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 210,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9e2efb07-826f-4efc-8c69-8625cbc708a6",
    "patient_ID": "TCGA.76.6285",
    "bcr_drug_barcode": "TCGA-76-6285-D28571",
    "bcr_drug_uuid": "dc92ae92-3d93-46f6-a02c-e4e8fd94f1f2",
    "form_completion_date": "2011-9-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 250,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0a211ae1-a48c-4989-9379-04d59500d94d",
    "patient_ID": "TCGA.76.6286",
    "bcr_drug_barcode": "TCGA-76-6286-D28574",
    "bcr_drug_uuid": "2b1a6b22-68b4-4928-bf0a-e64f8ac91a05",
    "form_completion_date": "2011-11-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0a211ae1-a48c-4989-9379-04d59500d94d",
    "patient_ID": "TCGA.76.6286",
    "bcr_drug_barcode": "TCGA-76-6286-D28575",
    "bcr_drug_uuid": "b1233c5f-d90f-4d1b-b464-13d3c445590c",
    "form_completion_date": "2011-11-15",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 510,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 580,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 990,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5940
  },
  {
    "bcr_patient_uuid": "770aa1ee-aed9-4219-900e-63523cdf312f",
    "patient_ID": "TCGA.76.6656",
    "bcr_drug_barcode": "TCGA-76-6656-D28580",
    "bcr_drug_uuid": "87485212-4c9e-4475-befb-307dd8f1493e",
    "form_completion_date": "2011-11-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3763b815-308f-4b64-a3a7-56822079765f",
    "patient_ID": "TCGA.76.6657",
    "bcr_drug_barcode": "TCGA-76-6657-D28584",
    "bcr_drug_uuid": "c4039667-46cd-433f-8595-ca6b7eff6e42",
    "form_completion_date": "2011-11-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "19dd2c8f-05ca-44e8-8c19-bac0327f2ea9",
    "patient_ID": "TCGA.76.6661",
    "bcr_drug_barcode": "TCGA-76-6661-D28588",
    "bcr_drug_uuid": "c9f107da-f3f0-409d-8d34-39657b179200",
    "form_completion_date": "2011-11-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 115,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "92f323c8-dae4-4fdc-a108-148ddc238d1a",
    "patient_ID": "TCGA.76.6662",
    "bcr_drug_barcode": "TCGA-76-6662-D30220",
    "bcr_drug_uuid": "3a8a6c5b-73ea-4951-9e84-021e257b29f7",
    "form_completion_date": "2011-12-9",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 227,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "92f323c8-dae4-4fdc-a108-148ddc238d1a",
    "patient_ID": "TCGA.76.6662",
    "bcr_drug_barcode": "TCGA-76-6662-D30221",
    "bcr_drug_uuid": "8a8ba6a8-1c52-40b3-97d1-2ae40a89d637",
    "form_completion_date": "2011-12-9",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 254,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 360,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1440
  },
  {
    "bcr_patient_uuid": "933b9daf-a5bf-46cf-92b6-5ddd8279919c",
    "patient_ID": "TCGA.76.6663",
    "bcr_drug_barcode": "TCGA-76-6663-D28593",
    "bcr_drug_uuid": "ea54a5eb-afb3-4898-a7f2-33025286fee7",
    "form_completion_date": "2011-11-15",
    "pharmaceutical_therapy_drug_name": "ICT-107",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "933b9daf-a5bf-46cf-92b6-5ddd8279919c",
    "patient_ID": "TCGA.76.6663",
    "bcr_drug_barcode": "TCGA-76-6663-D28592",
    "bcr_drug_uuid": "0f5789e7-64e1-4c8d-ba2d-37faa6578d2a",
    "form_completion_date": "2011-11-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 320,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "97b4eeec-7230-446b-b376-6742fae6f6ab",
    "patient_ID": "TCGA.76.6664",
    "bcr_drug_barcode": "TCGA-76-6664-D28597",
    "bcr_drug_uuid": "e3e09b68-6edd-4098-bf83-40d26e23ba28",
    "form_completion_date": "2011-11-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 250,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "97b4eeec-7230-446b-b376-6742fae6f6ab",
    "patient_ID": "TCGA.76.6664",
    "bcr_drug_barcode": "TCGA-76-6664-D28598",
    "bcr_drug_uuid": "2f92f23e-ab72-4607-95e7-3eb280b3e767",
    "form_completion_date": "2011-11-15",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 223,
    "drug_cycles": 14,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 510,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7470
  },
  {
    "bcr_patient_uuid": "05944575-8473-4ed0-9de8-8091018001c2",
    "patient_ID": "TCGA.81.5911",
    "bcr_drug_barcode": "TCGA-81-5911-D28605",
    "bcr_drug_uuid": "5d9fc351-082e-409d-990f-dfa8f828cab5",
    "form_completion_date": "2011-11-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 104,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 108,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 330,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1650
  },
  {
    "bcr_patient_uuid": "05944575-8473-4ed0-9de8-8091018001c2",
    "patient_ID": "TCGA.81.5911",
    "bcr_drug_barcode": "TCGA-81-5911-D28604",
    "bcr_drug_uuid": "0a1a54e6-04da-4738-9796-e88b99aeeac1",
    "form_completion_date": "2011-11-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 130,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 260,
    "drug_cycles": 5,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 440,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 11000
  },
  {
    "bcr_patient_uuid": "05944575-8473-4ed0-9de8-8091018001c2",
    "patient_ID": "TCGA.81.5911",
    "bcr_drug_barcode": "TCGA-81-5911-D28603",
    "bcr_drug_uuid": "461bb260-265d-496e-900a-e2b27972049f",
    "form_completion_date": "2011-11-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 69,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 160,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 6720
  },
  {
    "bcr_patient_uuid": "ed879063-e603-4151-bf5e-22a4ee210281",
    "patient_ID": "TCGA.87.5896",
    "bcr_drug_barcode": "TCGA-87-5896-D43209",
    "bcr_drug_uuid": "4AD0F058-BB58-469D-9D74-C58994F37A48",
    "form_completion_date": "2013-5-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 642,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  }
]
